category,datetime,headline,id,image,related,source,summary,url
company,2022-09-24 08:00:00,S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market,116232016,,VRTX,Yahoo,S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market.,https://finnhub.io/api/news?id=c32f9d898336f2e582c5eb29b76aa17eb9086476992cff3f2dac7cf34608813a
company,2022-09-24 05:52:00,Recession Fears Increasing: Here's the Best Stock to Buy Right Now,116232124,,VRTX,Yahoo,"Here's my pick for the best stock to buy right now with recession fears rising.  Vertex Pharmaceuticals (NASDAQ: VRTX) has soared close to 30%, absolutely trouncing the S&P 500.  How has Vertex seemingly defied gravity?",https://finnhub.io/api/news?id=2d7a2a32afa4033429dddd478592efe844603140f5740d996111e7061cd84d11
company,2022-09-23 17:50:09,Vertex Pharmaceuticals (VRTX) Stock Moves -1.01%: What You Should Know,116225284,https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $283.45 in the latest trading session, marking a -1.01% move from the prior day.",https://finnhub.io/api/news?id=bb0e14e363d0d46e5d710b8720967b561a842ca5b08511b24684f15eed189c13
company,2022-09-23 09:58:28,Dow Jones Sells Off Ahead Of Powell Comments As Recession Fears Mount,116214630,https://s.yimg.com/uu/api/res/1.2/rgtb1UVBxvi6TstQZZC7yQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8044a9bba79173e86da34bc94023ad37,VRTX,Yahoo,The Dow Jones Industrial Average sold off Friday ahead of Fed chief Powell's comments at a Federal Reserve event in Washington D.C.,https://finnhub.io/api/news?id=56b68586bafc876c6416aae46e4a00f51b1fc4894c7a4bb32573d56792895fb5
company,2022-09-23 05:58:00,7 Growth Stocks to Buy During a Stock Market Crash,116216837,https://investorplace.com/wp-content/uploads/2022/07/growth-stocks-imagery.png,VRTX,InvestorPlace,"A stock market crash will only strengthen the outlook of these companies, making them good growth stocks to buy.",https://finnhub.io/api/news?id=5e37fc4da2e3fe99cac6df056feec54be3417a939dc88b0b8f194568dab8d471
company,2022-09-28 17:33:13,"Vertex Nears Buy, Joins Crispr To Advance A Gene-Editing First",116322926,,VRTX,Yahoo,"As biotech leaders Vertex and Crispr shoot for a gene-editing first, VRTX stock takes aim at a new breakout.",https://finnhub.io/api/news?id=b60f06707161938b39b9687c8f2fcbba6fc60260dc9bb78f5fca4b29f02148cb
company,2022-09-28 13:28:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",116373750,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.69% to $292.41 Wednesday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=55d9f39eb30ec6f227a1c6e3f788c61016a81c66b0d54cd72a63715974108abc
company,2022-09-28 13:17:05,"Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy Therapy",116312960,https://s.yimg.com/uu/api/res/1.2/UgiI07ytew_hNcL7MgLFiA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,Vertex (VRTX) and partner CRISPR intend to start a rolling BLA submission with the FDA for their gene therapy in thalassemia and sickle cell disease indications by November 2022.,https://finnhub.io/api/news?id=3ac8315405a86d28fc0299e9a5c968053baf071f45d18c3be59a1859e5ec16bd
company,2022-09-28 09:35:21,Dow Jones Rises Ahead Of Powell Speech; 10-Year Treasury Yield Briefly Tops 4%,116302444,https://s.yimg.com/uu/api/res/1.2/.bZtsgnchEamZO3REAT9sQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f507e9a69bd7ba001d8325d21822e555,VRTX,Yahoo,"The Dow Jones Industrial Average rose Wednesday, ahead of Fed chief Powell's speech, struggling to avoid a seventh straight decline.",https://finnhub.io/api/news?id=108758efc90429026a2d88fb00bb3f4119dc1346b624a39aefd3483b638e8da5
company,2022-09-28 08:00:00,3 Biotech Stocks to Buy and Hold for the Next 10 Years,116299144,,VRTX,Yahoo,"Several biotech stocks have outperformed the struggling market this year.  This list includes Vertex Pharmaceuticals (NASDAQ: VRTX), Exelixis (NASDAQ: EXEL), and Amgen (NASDAQ: AMGN).  Let's consider why these three biotechs are solid buys for the next decade.",https://finnhub.io/api/news?id=437c36148542a4bc937677843877f3eceef8f3a643035e2840ad188c2839451b
company,2022-09-28 06:20:00,"The 2 Best Stocks to Invest $5,000 in Right Now",116305688,https://s.yimg.com/ny/api/res/1.2/.mFMW4hEQhHlavGOLoEijA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/161d5ed81f0a68c0cce694137555eefb,VRTX,Yahoo,"Between rumors of a recession, rising interest rates, and inflation, it's tough to find stocks that you're confident will keep growing instead of going to zero.  Vertex Pharmaceuticals (NASDAQ: VRTX) is worth a $2,500 investment because it's the world's largest public business devoted to curing rare diseases, and it's proven to be quite adept at that goal so far.",https://finnhub.io/api/news?id=9748aadcbdadbef0f277e8b8df1f82da901be4660ba9526d30b6c6efdaece9a9
company,2022-09-28 06:00:00,Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever,116296357,,VRTX,Yahoo,Let's talk about two leaders in their markets and a well-diversified healthcare company with a track record of success.  Vertex Pharmaceuticals (NASDAQ: VRTX) has been generating returns for investors for quite a while.  Vertex is the global market leader in the treatment of cystic fibrosis (CF).,https://finnhub.io/api/news?id=1da1c1e05e2a00093895726747b7cc8e39753bb1af90614d548278310e4f60e8
company,2022-09-28 04:35:00,MaxCyte Signs Platform License with Vertex Pharmaceuticals,116373751,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Michael Susin MaxCyte Inc. said Wednesday that it has signed a strategic platform license with Vertex Pharmaceuticals Inc. to continue the use of...,https://finnhub.io/api/news?id=cf0f30d6ae7b496f23495639940153d8493d32e0269312f6405a5a382e06d31a
company,2022-09-28 03:19:00,MaxCyte signs strategic platform license with Vertex Pharmaceuticals,116306583,https://thefly.com/images/meta/hotstocks.jpg,VRTX,Thefly.com,"MaxCyte (MXCT) announces ... MXCT, VRTX",https://finnhub.io/api/news?id=91407db995d1752301b83e94645945fa7b9e62528b3a74f48532a4cee1d4256d
company,2022-09-27 20:17:39,S&P 500 Undercuts Bear Market Low As Treasury Yields Race Toward Key Level; What To Do Now,116287339,https://s.yimg.com/uu/api/res/1.2/eymQVLcg4AKsWPu_5soa1A--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f6a1c2a30ab1ccd7c6fc3e462e6a2395,VRTX,Yahoo,The S&P 500 joined the Dow Jones in undercutting bear market lows as the 10-year Treasury yield races toward 4%. Here's what to do now.,https://finnhub.io/api/news?id=089ff39b39e872efc5e1f1cc85904052ae883a17b3ff79a2eb3cc4d1f087c07e
company,2022-09-27 17:52:04,Why Vertex Pharmaceuticals Stock Triumphed On Tuesday,116287340,https://s.yimg.com/ny/api/res/1.2/We0g3uhmyqXkd6aH8tuJow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/b3dacac3cffc60c37a71ba3d05c3416b,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX), a commercial-stage biotech specializing in treatments for cystic fibrosis, saw its share price rise on Tuesday thanks to news about one of its pipeline programs.",https://finnhub.io/api/news?id=42d31bd9af33a0d44e59256fc8891d864f2374775394ced9d69c7fb5fff3826b
company,2022-09-27 16:14:10,Crispr Stock Jumps After Unveiling Timeline For FDA Submission Of First-Ever CRISPR Drug,116287341,https://s.yimg.com/uu/api/res/1.2/mDjcafWYBYHwpLnjvQ576Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/5ab8f6e19917f8ac35c5ff055f891ca2,VRTX,Yahoo,"Crispr said Tuesday it will begin asking the FDA to approve its gene-editing blood diseases treatment in November, and CRSP stock jumped.",https://finnhub.io/api/news?id=cfaef77006c276050f7b60444cba1d3ae1e5a78232ab928eec186f7442cae661
company,2022-07-20 10:51:51,Stock Market Today: Track Market Trends And The Best Stocks To Watch,114140578,https://s.yimg.com/uu/api/res/1.2/TQcagl7pYHbkxFjtqiLLlQ--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/28e88eac1c8027393a22cb7ae91a9299,VRTX,Yahoo,Check the Stock Market Today column to spot changes in market trend and track the best stocks to buy and watch.,https://finnhub.io/api/news?id=f5083a9f240cf8901058f53d1fe18b513b2a08ea3c0c4afa155c96a1c16c068b
company,2022-09-27 13:29:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,116373752,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 2.88% to $284.74 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=380729c9b0609ec619d11ac8f87e453adb3513e58c5f94dcd58af243978e6795
company,2022-09-27 12:37:00,"NEW YORK MARKET CLOSE: Nasdaq breaks into green, Dow and S&P still red",116306684,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d11bf08f9e451a4ddb613ef9c3c022b2fa04f65708c90555b60436a426bcadf8
company,2022-09-27 09:38:04,"CRISPR, Vertex say FDA granted rolling review to experimental CRISPR therapy",116287343,https://s.yimg.com/uu/api/res/1.2/S8SCotpO9m2XQyQUIGU5dw--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856,VRTX,Yahoo,"CRISPR Therapeutics Inc. and Vertex Pharmaceuticals Inc. said Tuesday that the Food and Drug Administration granted a rolling review to the exagamglogene autotemcel, the therapy the companies are developing to treat sickle cell disease and transfusion-dependent beta thalassemia. CRISPR's stock was up 3.1% in premarket trading on Tuesday, while Vertex shares gained 1.1%. Vertex said it plans to a submit an application to the FDA in November, with plans to complete the submission in the first quar",https://finnhub.io/api/news?id=05a68843141435cd77f605444cc1bc30bd75cfddc1430971fc927f3eb5f9c87d
company,2022-09-27 07:29:00,Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022,116287344,https://s.yimg.com/uu/api/res/1.2/ZW56t4vUUsjKsK53segl5g--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/99c7adfff8aca00ce2c86db470d897cb,VRTX,Yahoo,"BOSTON & ZUG, Switzerland, September 27, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that Vertex has concluded discussions with the U.S. Food and Drug Administration (FDA), and the FDA granted exagamglogene autotemcel (exa-cel) a rolling review for the potential treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Vertex will submit its biologics licensing application (BLA) for exa-cel for rol",https://finnhub.io/api/news?id=a0cb8d7550bb7b32277b5164d3a91286029b585f6201b65201b4fb659c1a6e58
company,2022-09-27 06:05:00,"Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley",116312945,https://thefly.com/images/meta/streetresearch_recommendations.jpg,VRTX,Thefly.com,"After Vertex Pharmaceutic... VRTX, CRSP, BLUE",https://finnhub.io/api/news?id=f31823114cbdca1c2e1e759d38627b79371fc627d13c33245c12b90abc767633
company,2022-09-27 05:58:00,Why Is Crispr Therapeutics (CRSP) Stock Up Today?,116284132,https://investorplace.com/wp-content/uploads/2021/11/crispr-theraputics-crsp-stock-1600.jpg,VRTX,InvestorPlace,Crispr Therapeutics (CRSP) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review.,https://finnhub.io/api/news?id=f82115fc283d4101a7075862fd39021d698e3bb4f43feb5e0ccd1e5035611cc9
company,2022-09-27 05:52:00,"S&P 500 Bear Market: Where to Invest $10,000 Right Now",116287345,https://s.yimg.com/ny/api/res/1.2/DCQnL4A7EIE79r7MJaHbpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/463a8954d3185c96ddae01eedc2b24ab,VRTX,Yahoo,"After an all-too-short bounce, the S&P 500 is again in a bear market.  The Nasdaq Composite Index has been firmly in bear market territory for weeks.  Arguably the smartest place to park $10,000 right now is in the U.S. Treasury's Series I savings bonds.",https://finnhub.io/api/news?id=c4183c1fdb3214f4fb92d008da5971986316fd67d467fced2af6840b4e1b6ad0
company,2022-09-27 05:38:04,"CRISPR, Vertex say FDA granted rolling review to experimental CRISPR therapy ",116373753,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,VRTX,MarketWatch,CRISPR Therapeutics Inc. undefined and Vertex Pharmaceuticals Inc. undefined said Tuesday that the Food and Drug Administration granted a rolling review to...,https://finnhub.io/api/news?id=9ccb3ee785a2d053f9682b8c52184a11b643eb57e49030b50d160a98580eac53
company,2022-09-27 05:14:00,IN BRIEF: Vertex Pharmaceuticals granted US rolling review for exa-cel,116284133,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6414749c470d6037517da79bdac01015384017a7f69364ad493e9d234fd5a7e5
company,2022-09-27 02:35:00,"Vertex, Crispr announce regulatory submissions for exagamglogene autotemcel",116284135,https://thefly.com/images/meta/hotstocks.jpg,VRTX,Thefly.com,"Vertex Pharmaceuticals (V... VRTX, CRSP",https://finnhub.io/api/news?id=ca4dbfc0b1587faa09329f6762a1649fe9939d4db2acb97da1f351d85f55624f
company,2022-09-27 02:28:00,Why Low Volatility ETFs Are Beating The Market,116306578,https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_etf_637509996655481395.jpg,VRTX,TalkMarkets,Low volatility investing is back in vogue since the market environment remains extremely challenging.,https://finnhub.io/api/news?id=eb8a2c900bcd5f347e741f65261e62b8b519bdf28f317385fc8b73cd75d7831c
company,2022-09-27 02:20:00,The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market,116283880,https://investorplace.com/wp-content/uploads/2022/08/hidden-bull-market.png,VRTX,InvestorPlace,"Despite the ongoing worries on Wall Street, these are the best stocks to buy to play the hidden bull market.",https://finnhub.io/api/news?id=ccc1b727bde4a72205d89981df541b60c99d71a5b442550ed973da6cf3feb072
company,2022-09-26 23:40:00,"Vertex Pharmaceuticals Moves Up In Market Cap Rank, Passing Analog Devices",116315550,,VRTX,The Online Investor,"the online investor,VRTX,ADI,",https://finnhub.io/api/news?id=6f066b1560d7678281fbd1078926fb9e677c42b4f2753e5578e736bbb99f5bd7
company,2022-09-26 17:29:03,Dow Jones Hits Bear Market After Today's Sell-Off; What To Do Now,116266229,,VRTX,Yahoo,Dow Jones futures were little changed ahead of Tuesday's open. The Dow Jones Industrial Average finished in a bear market Monday.,https://finnhub.io/api/news?id=3ceee2afacbda04c247d18efa19d1ac5ef9babac0403e2fe24b331f9fa3f225d
company,2022-09-26 13:29:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors,116373755,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 2.35% to $276.78 Monday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=1fdb88a4ed929f60b6e742d8e57dc708ed78b79e95e54b6a2a8f2c8c504ce36f
company,2022-09-26 13:17:35,"4 Stocks To Watch In Today's Stock Market: Hostess, J.M. Smucker, Toro, Vertex",116261659,,VRTX,Yahoo,"Hostess Brands, J.M. Smucker, Toro and Vertex Pharmaceuticals are stocks to watch, as the current stock market correction continues.",https://finnhub.io/api/news?id=f4112ec3d0557283fab3ede7a0dc70eb5f4756308f6e123c2eb3a144dd4e8af3
company,2022-09-26 09:52:01,Dow Jones Continues To Fall As Stock Market Correction Worsens; Treasury Yields Surge,116255597,,VRTX,Yahoo,"The Dow Jones Industrial Average dropped Monday, as the stock market correction worsened. The 10-year Treasury yield surged to new highs.",https://finnhub.io/api/news?id=b7c0559f3d0198f072fd1d8752ca640c44f5d6d9d0bf334448996e976523037c
company,2022-09-26 08:21:00,Can Healthcare Stocks Continue To Outperform? ,116261307,https://i2.wp.com/raygent.com/wp-content/uploads/2022/09/image-6.png,VRTX,TalkMarkets,Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis.,https://finnhub.io/api/news?id=db12f381290d9ccfc92cc5725bf1c5dd297fad1fe2826a86fd122e123e15cb37
company,2022-09-25 09:45:00,Is Now the Right Time to Be Buying Growth Stocks?,116249301,,VRTX,Yahoo,"There are plenty of fierce headwinds in play, but that doesn't mean you should sit on the sidelines.",https://finnhub.io/api/news?id=f614174806e421041c0c621b24e5f7814ffd3cac37fcbad8e611d3b38611626a
company,2022-09-25 08:02:46,Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 86%,116243021,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...",https://finnhub.io/api/news?id=4098e38d5ab36ff343dc418c8bf926a66054105311c736d2420e3c81aa6b6c29
company,2022-10-01 10:37:00,3 Growth Stocks Poised to Skyrocket,116372223,https://s.yimg.com/ny/api/res/1.2/Dw2MtCQDQGiNXpWR0lEoeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/e315bccb12db13661fc627cbcb28f91c,VRTX,Yahoo,"What's better than a growth stock that's performed well in the past?  The answer is easy: A growth stock that should perform well in the future.  Here's why they chose Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX).",https://finnhub.io/api/news?id=ef12c3d63fac46169982be86b7ad0e7258da68aa5259e5a2db866cb4ac4fe23d
company,2022-10-01 08:00:55,Vertex Stock Flashes Buy Signal; Gene-Editing Play Leads 5 Resilient Stocks In Bear Market,116373430,https://s.yimg.com/uu/api/res/1.2/3PGaTuB3RdXMwXJQngNeRA--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,Vertex Pharmaceuicals flashed a buy signal last week on positive gene-editing news. It's one of several resilient stocks to watch in the bear market.,https://finnhub.io/api/news?id=870f76fe71904c9bb1f97678d5c0ec090f1d0dbd557cc761413f7912afd50080
company,2022-09-30 13:28:00,"Vertex Pharmaceuticals Inc. stock falls Friday, still outperforms market",116373748,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.11% to $289.54 Friday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=a3afc57fce62ad56b7729ec92c78cb5a386e6e0b627aa3e28d2243f13b7a09f9
company,2022-09-30 10:06:20,Dow Jones Drops On Hot Inflation Data; Tesla Stock Rises Before AI Day,116366736,https://s.yimg.com/uu/api/res/1.2/WAuaz6qrZ4OYu_AuKxC0vQ--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f84dddde254e978a0083114ec56c1e2b,VRTX,Yahoo,The Dow Jones Industrial Average dropped Friday on hot inflation data. Tesla stock fell ahead of the company's AI Day.,https://finnhub.io/api/news?id=54cc0cf0aa23c423f8c91e4552c178de4acd15aa099c1aba9f5418dc222b5549
company,2022-09-30 09:45:00,"Got $1,000? 2 Safe Stocks to Buy This Month",116365596,https://s.yimg.com/ny/api/res/1.2/syqq7CGQUC0jcfTS4ONGBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/bdc80580addfea99fc8223d3f00eb814,VRTX,Yahoo,"If you're not familiar with Vertex Pharmaceuticals (NASDAQ: VRTX), this healthcare stock is certainly one to put on your radar.  The company develops and manufactures medicines that treat rare diseases.  As of right now, it has four approved products, and all of them treat cystic fibrosis.",https://finnhub.io/api/news?id=134b5ac9dffebec3442e326f9d3776e3820bd1d99ab67f0db43035737f0978f1
company,2022-09-29 23:36:00,VRTX vs. SRPT: Which Biotech Stock is Better?,116365020,https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1463056829-750x406.jpg,VRTX,TipRanks,"It seems that hedge funds have a love/hate relationship with the biotechnology sector, and it&#8217;s easy to see why they are split on the sector. In this piece, w...",https://finnhub.io/api/news?id=e24af020dc31140701c99025c16995b51e9e8493472884cbb156049e23e1d379
company,2022-09-29 17:50:09,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,116373994,https://s.yimg.com/uu/api/res/1.2/0K2vxHTAGj_tGrBqjPJ8Cg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $292.80 in the latest trading session, marking a +0.13% move from the prior day.",https://finnhub.io/api/news?id=d5c80dbb386b5c4115fa597252a0ad01715c91a9e22810a8a01960225192b5a7
company,2022-09-29 13:29:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,116373749,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.13% higher to $292.80 Thursday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=69ebf8a161c6c9814d3f5dcc69987d49e5a711c4b749f22df9d4f55154ef16ee
company,2022-09-29 06:20:24,Dow Jones Futures Fall As Treasury Yields Rebound; Eli Lilly Leads 7 Bullish Stocks,116324656,https://s.yimg.com/uu/api/res/1.2/PpHQWLIKatr9D7NT7X6nnw--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/89039c0e4d3b6c6a5f27c761dcb0809f,VRTX,Yahoo,"Dow Jones futures fell as Treasury yields rebounded, signaling Wednesday's rally may be short-lived. Eli Lilly leads some bullish stocks.",https://finnhub.io/api/news?id=5596d102dae6d549536ed411eb8b5d7e71235e1e8ae25344a07eb7046363fb72
company,2022-09-29 08:01:06,Vertex Pharmaceuticals' (NASDAQ:VRTX) five-year earnings growth trails the 14% YoY shareholder returns,116341068,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking...",https://finnhub.io/api/news?id=a5a442663d2f11bb898af552ecbe1977b87c5baff4c6529fd74a8ac4ab5c8a0a
company,2022-09-29 05:52:00,3 Stocks to Buy if You're Afraid to Buy Stocks,116333329,https://s.yimg.com/ny/api/res/1.2/tYb7SZQ9I_a2b6i4yjGm6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/84f098e363710a9e129814f8090f8f32,VRTX,Yahoo,Concerns are mounting that a full-blown recession could be on the way.  Here are three stocks to buy if you're afraid of buying stocks.  The stock market's huge downturn so far this year hasn't impacted Vertex Pharmaceuticals (NASDAQ: VRTX) in the least.,https://finnhub.io/api/news?id=4a818e3ec1025522caaecb6c05d7f57c76b8c5858ef3a35b9394dcecc79838ec
company,2022-09-28 17:28:24,"Dow Jones Jumps 549 Points As Treasury Yields Tumble, But Now What? Eli Lilly Leads 7 Bullish Stocks",116312650,https://s.yimg.com/uu/api/res/1.2/PpHQWLIKatr9D7NT7X6nnw--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/89039c0e4d3b6c6a5f27c761dcb0809f,VRTX,Yahoo,The major indexes rebounded as Treasury yields tumbled from 4% as the Bank of England resumed bond buying. Eli Lilly led stocks showing bullish action. Here's what to do now.,https://finnhub.io/api/news?id=dd7b5102c636ca527fdd64221477eb93a54efae85b46cff250765ae2843d0404
company,2022-10-06 15:16:26,This Biotech Stock Nears Buy Point As It Expands Into Other Markets,116516019,,VRTX,Yahoo,"Vertex Pharmaceuticals is approaching a buy point as this biotech stock expands into other markets, gains institutional investors.",https://finnhub.io/api/news?id=13f32b3a0b2b930efd2225472dbf6bbda17f24641b25c500db833b8a818abd94
company,2022-10-06 10:11:33,Dow Jones Slides As Jobless Claims Rise; Pivotal Jobs Report On Deck,116509792,https://s.yimg.com/uu/api/res/1.2/yFYixt4zfmpEGBBg4OOySw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/c17b5b65818a93054b26ab66c9c27269,VRTX,Yahoo,The Dow Jones Industrial Average fell Thursday after weekly jobless claims. The pivotal September payroll report is due out Friday morning.,https://finnhub.io/api/news?id=79c2c1c292eab795f8d6a0dd66fc9703ff2cabe370d5d222711a9460aea01558
company,2022-10-06 07:11:36,"Dow Jones Futures Fall: Market Rally At Pivotal Point; Tesla, Enphase Skid",116501008,,VRTX,Yahoo,"The stock market rally showed resilience, as the Dow Jones slashed early losses, but is at a pivotal point. Tesla fell while Enphase plunged.",https://finnhub.io/api/news?id=d9bb432b401dc7f39caae8f6628d19ae5a9627f4c21824636b175590e1887703
company,2022-10-06 07:11:00,VRTX November 25th Options Begin Trading,116506941,,VRTX,Stock Options Channel,"Staff article entitled VRTX November 25th Options Begin Trading, about stock options, from Stock Options Channel.",https://finnhub.io/api/news?id=c732ef85e966d66165746bc425ebe247323a13c4aaa1240b154767e7004539dd
company,2022-10-06 05:27:00,3 Stocks Savvy Investors Are Buying Hand Over Fist,116498411,,VRTX,Yahoo,"While the SPDR S&P Healthcare ETF is down 10% year to date, the SPDR S&P Biotech ETF has plummeted 29%.  Investors should always keep the long-term potential of businesses in mind when investing in the stock market.  Sunosi, purchased from Jazz Pharmaceuticals in May, has been Axsome's blockbuster drug.",https://finnhub.io/api/news?id=e5620a4485ae5f6e4e3509d38097bbd75058b2bed2392c9765d6be22d0f49d21
company,2022-10-05 20:29:36,"Dow Jones Futures Rise: Market Rally At Pivotal Point; Tesla, Enphase Fall",116479522,,VRTX,Yahoo,"The stock market rally showed resilience, as the Dow Jones slashed early losses, but is at a pivotal point. Tesla fell while Enphase plunged.",https://finnhub.io/api/news?id=57d8e3ff274ed6661d6913bcd63ba86f00022b67e3114e7786a376c099a5534a
company,2022-10-05 18:00:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,116484924,https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $302.02, marking a +0.46% move from the previous day.",https://finnhub.io/api/news?id=b9e4f302ce26bd8c1bcc23df0c5eba06fb67001789b14621d4e8181feb4f74ac
company,2022-10-05 09:32:39,"Dow Jones Sells Off After Jobs Data; Key Economic Data, OPEC Meeting On Tap",116465827,https://s.yimg.com/uu/api/res/1.2/uxo.dg1pgKxG1EJbzNo7WA--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f54329aa9ab50e9d6ad1daa1cc8128e6,VRTX,Yahoo,The Dow Jones Industrial Average sold off 300 points Wednesday after a stronger-than-expected ADP employment report.,https://finnhub.io/api/news?id=f084036159b15f2fedb2005bc0e6f0d2de0d4b8c84aba8ae49401d744bcfce0d
company,2022-10-05 09:51:46,Why Vertex Pharmaceuticals' Shares Rose 2.8% in September,116466373,https://s.yimg.com/ny/api/res/1.2/PSCdBktqC5pDQeI028txpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a3fdd80244358acff64c98c503f6bf31,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX), a biopharmaceutical company that specializes in gene-editing therapies, saw its shares rise 2.8% in September, according to data provided by S&P Global Market Intelligence.  Vertex easily went against the tide, though.  Vertex, known for its franchise of therapies to treat cystic fibrosis (CF), a rare genetic disorder that affects the lungs, pancreas, liver, kidneys, and intestines, showed that it is about to expand its portfolio of marketed drugs.",https://finnhub.io/api/news?id=5f27160757272740e95b7c677a900aa78a625395eb0a3942e4a4c60ec5a634ae
company,2022-10-05 08:00:57,Vertex Among 25 Market Leaders On The IBD Breakout Stocks Index,116467944,,VRTX,Yahoo,"As the market shows signs of a rebound, Vertex, Enphase and Shockwave Medical are among 25 stocks to watch.",https://finnhub.io/api/news?id=1c6630f7e2d821c8bb79dba10c526cd0b77256fc07037bba443f745cc45213be
company,2022-10-05 06:30:00,3 Healthcare Stocks That Could Make You Richer,116456818,https://s.yimg.com/ny/api/res/1.2/KQqzjhsnI44uL4mv5NUSHA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTY-/https://media.zenfs.com/en/motleyfool.com/18247768d4b9496f598d5b15a56f72ca,VRTX,Yahoo,"If you're looking to get richer over time (and who isn't?), healthcare stocks are often a good choice.  Vertex Pharmaceuticals (NASDAQ: VRTX) is at a major turning point in an already successful story.  Vertex is the leader in the global cystic fibrosis (CF) treatment market.",https://finnhub.io/api/news?id=18e9fa22b47b7239e42ed0a57b7544877a02d2acd646e9fd49c3345f591003d4
company,2022-10-04 12:00:48,"Stock Market Holds Morning Gains, Oil and Gas Play Breaks Out",116444330,https://s.yimg.com/uu/api/res/1.2/Oi97KbNdro2sPbtI1twDbw--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/a63d1b5c336762b502ecba3983eea649,VRTX,Yahoo,"The stock market rallied for a second day, with fewer job openings than expected driving the upside. This diabetes stock rises on approval in Europe.",https://finnhub.io/api/news?id=fed39f5ec6c26f3e981797a175e2013b6866cec31e7463a8d6d85c4a82b659e4
company,2022-10-04 10:23:00,3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,116436642,https://s.yimg.com/ny/api/res/1.2/hnZFB7fl9o8lqdw2dmj0Eg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/50dc77772b8361f2764b3b6e9b2d5476,VRTX,Yahoo,"Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Biogen (NASDAQ: BIIB) are developing remarkable therapies that, instead of merely treating disorders, have the potential to cure them or at least make an impact that no other drug has to date.  The reason that's not a big cause for alarm is that the company's second-quarter revenue of $2.86 billion would be up 20% over the same period in 2021 if its COVID-19 therapy, REGEN-COV, was excluded from total revenue.  The company's sales of the treatment ended late last year when government contracts for the therapy ended.",https://finnhub.io/api/news?id=0da62927d857d82005a1a42b9d3cccac3a20b124d22d516c5b00bbbb66f8f59a
company,2022-10-04 09:55:52,"Dow Jones Surges 600 Points As Treasury Yields Tumble; Apple, Tesla Rally",116444332,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,"The Dow Jones Industrial Average surged 600 points Tuesday, as the 10-year Treasury yield continues to tumble. Apple and Tesla rallied.",https://finnhub.io/api/news?id=b59d9611deb2ef3482a649e6a7f325bc918c59497bc03aff942ec7b54d7b5cea
company,2022-10-04 09:00:01,Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock,116444333,https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee,VRTX,Yahoo,"Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://finnhub.io/api/news?id=6177d800896e5e0f81f80600a9e03b7a09a255654a28cddffefab826a378ad34
company,2022-10-04 07:34:00,Spiros Segalas Snatches Up Ver - GuruFocus.com,116431712,https://static.gurufocus.com/photos/others/Investing_Portfolio_Guru.jpg,VRTX,GuruFocus,GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Guru releases 3rd-quarter portfolio,https://finnhub.io/api/news?id=e3fd2215d1889633f76d0574ada69f67ccbb9b2e515021a73b366cabdf020394
company,2022-10-04 06:40:00,1 Growth Stock That'll Beat Amazon and 1 That Probably Won't (for Now),116440660,https://s.yimg.com/ny/api/res/1.2/keyTeOX8FV2tmKKPAfcxwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/8218ff95ab4638cadeacb4074421b714,VRTX,Yahoo,"The two companies are collaborators, but they aren't equally likely to be a better purchase than Amazon.",https://finnhub.io/api/news?id=b52722923c2b3eda6edeb84e6241ac4d713375fa25831d7a0060217ab8a42d2a
company,2022-10-03 22:31:21,"Dow Jones Surges 765 Points To Start New Stock Market Rally Attempt, What To Do Now",116409482,https://s.yimg.com/uu/api/res/1.2/ImTGLmZxCha0674nUj9e2w--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f28d348f9516dd787376418c486867ca,VRTX,Yahoo,"Dow Jones futures were little changed ahead of Tuesday's open. A new stock market rally attempt started Monday, as the Dow Jones industrials surged.",https://finnhub.io/api/news?id=127885bff18059f685237cfaf038963a0043207ab2183a838abb90475aca443f
company,2022-10-03 20:26:10,Vertex Pharmaceuticals: A Buy For Growth Potential,116412588,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317189603/image_1317189603.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Vertexâs cystic fibrosis franchise is the main source of value at present. Learn more about VRTX stock and my recommendation.,https://finnhub.io/api/news?id=3818655cf4b00a4ebaa9847c683da4b07d53d58a9eb162eda366afc527a079f4
company,2022-10-03 17:12:16,"ARKG: Too Hard To Pin Down, Too Volatile For Comfort",116406377,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/181898348/image_181898348.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"ARKG's objective is compelling and inoffensive, but their current approach to realizing it feels too vague and scattershot. Click here to read more.",https://finnhub.io/api/news?id=e08b9d23664aeefb061aad387c2e81fd836a1aa1b454b45973502a869837816e
company,2022-10-03 16:07:52,Stocks To Watch In Today's Market Include Dow Jones Leader UnitedHealth,116407300,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,Dow Jones leader UnitedHealth is one of the top stocks to watch in today's market rally. The current stock market correction continues.,https://finnhub.io/api/news?id=f048a6d55006fb17077518f2addd488b04f8f430b23b4a7c4e2e4a75a822a967
company,2022-10-03 15:19:24,Vertex Among 9 Stocks To Watch In Struggling Market,116404488,https://s.yimg.com/uu/api/res/1.2/pS3oSwhMHyYWdHICM4rZ6A--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/1ae5cb5e2efcf8dff9671ddeba0e03d3,VRTX,Yahoo,"As the market indexes work through a downturn, Vertex is among nine stocks to watch showing relative strength.",https://finnhub.io/api/news?id=fb3bedfd8221a0669ffd844e8b4da1a00f486300efc8358c5308843dc7357acd
company,2022-10-03 10:06:23,Dow Jones Rallies As Tesla Stock Dives On Deliveries Miss,116407301,https://s.yimg.com/uu/api/res/1.2/jyYDBjHF7bnIEtCEQeuhfg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/1856de03212e386cb58e628bf758fa91,VRTX,Yahoo,The Dow Jones Industrial Average rallied 450 points Monday. Tesla stock skidded after the company missed estimates on vehicle deliveries.,https://finnhub.io/api/news?id=a04ea8cf77b9cf4b9c54acb55f9d30ce8c3b8285068464b3f5a372a947c3091f
company,2022-10-03 09:16:01,bluebird's (BLUE) Gene Therapy Approvals to Drive the Top Line,116409490,https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5,VRTX,Yahoo,"bluebird's (BLUE) recent FDA approvals for its gene therapies, namely beta-cel for beta-thalassemia and eli-cel for cerebral adrenoleukodystrophy, are expected to drive the top line.",https://finnhub.io/api/news?id=3d2de6f233c52dc360159293132eefb177cfd7f6b1ac299a958355b7e30c1aad
company,2022-10-03 08:01:04,Investing in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago would have delivered you a 87% gain,116409492,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...,https://finnhub.io/api/news?id=60ff9a24436b31694078c0c20e072a5f9285a8e4018dff7543a0b324e523d4a9
company,2022-10-03 03:04:43,Spero Therapeutics: The GlaxoSmithKline-Deal Changes Everything And Protects Shareholder Value,116395020,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/576902966/image_576902966.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"Following the breakthrough deal with GSK, Spero is in a comfortable position to advance its pipeline. Read more to see why I'm bullish on SPRO stock.",https://finnhub.io/api/news?id=b02fa9411c51b28b412d113f683836a56acb4f66b8643dd1a570836746141597
company,2022-10-03 00:36:00,Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio ,116429088,https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg,VRTX,TalkMarkets,Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.,https://finnhub.io/api/news?id=e586d7b067baa4caedf4f0bf0873b3145abd9657570bee9335d39e0401f9311e
company,2022-10-10 14:30:06,"Top Analyst Reports for NVIDIA, Pfizer & Citigroup",116579108,https://s.yimg.com/uu/api/res/1.2/NEHe1muaZrc.shoTO7sbCQ--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fdfe32922c97375611ef6256c04a840b,VRTX,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Pfizer Inc. (PFE) and Citigroup Inc. (C).",https://finnhub.io/api/news?id=70b46b81a7038db2a345bfa72df6cc38339c373ee5f7b3c9cc6996e303dfbc63
company,2022-10-10 11:25:03,Here's Why You Should Invest in Vertex (VRTX) Stock Now,116579109,https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,Vertex's (VRTX) CF sales are primarily being driven by higher sales of Trikafta. Programs in five disease areas are now entering or progressing through late-stage clinical development.,https://finnhub.io/api/news?id=bb33c0f59fe5e4a6a061e28308580ac4e1656f7a9d2baa6f7ffedac483a86d6a
company,2022-10-10 10:10:35,Dow Jones Reverses Ahead Of Earnings Season; Tesla Hits Record China Deliveries,116572273,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,The Dow Jones Industrial Average reversed lower Monday ahead of earnings season. Tesla stock reported record China deliveries in September.,https://finnhub.io/api/news?id=4970d117b97367303b8e3b013f7990da93055ba69dc9f886ed2f049954389db2
company,2022-10-10 06:15:48,These 7 Biotech Stocks Are Set to Boom in 2023,116622884,https://s.yimg.com/uu/api/res/1.2/pW9aO0H8tivOegZ.fyiNIg--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investorplace_417/9bb111fcd366518d135337b181372598,VRTX,Yahoo,"Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good measure. This combination makes these companies attractive to value investors. In general, however, investing in biotech stocks is not for risk-averse investors. Many of these companies are smaller players. They may or may not be generating revenue, much less profit. But it’s usually at these compa",https://finnhub.io/api/news?id=6c165fc065cc7261bb4f333620af57d49ee8ab21a6ac8ae8cdd4b5e2a28c4fa7
company,2022-10-10 01:20:00,7 Biotech Stocks Set to Boom in 2023,116574701,https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png,VRTX,InvestorPlace,This article looks at seven biotech stocks that look like good options to move significantly higher in 2023,https://finnhub.io/api/news?id=4058fe2d03c000dcbefa38211357ac3e738f205fae0e796f38aaf2d8855c3126
company,2022-10-07 17:50:09,Vertex Pharmaceuticals (VRTX) Stock Moves -1.14%: What You Should Know,116541939,https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.23, moving -1.14% from the previous trading session.",https://finnhub.io/api/news?id=79b2efae9caf0cac9d54ff74bd038139c9915f1e743bb3b4fbf7b4d67f8fc90c
company,2022-10-07 13:17:39,IBD Stock Of The Day Vertex Pharma: Why Its 'Sandbox' Approach Is Unusual In Biotech,116526212,,VRTX,Yahoo,Vertex Pharmaceuticals is the IBD Stock Of The Day as VRTX stock climbs higher on expectations for its next act in gene editing.,https://finnhub.io/api/news?id=ffb76499a9ea46f34682a533413a2bfa1d8af31425e9dc12161675de82842c27
company,2022-10-07 16:15:00,2 Cathie Wood Stocks That Are Beating the Market This Year,116532903,,VRTX,Yahoo,"Has famed investor Cathie Wood lost her touch?  Vertex Pharmaceuticals is close to hitting a new all-time high as the drugmaker's business is firing on all cylinders.  During the second quarter, Vertex Pharmaceuticals' top line jumped by 22% year over year to $2.20 billion.",https://finnhub.io/api/news?id=27ef9893384107850f9060d5ab936dd30d46b6de316268ca5c3026d9fc38ec98
company,2022-10-07 15:14:41,Is Vertex Pharmaceuticals Incorporated (VRTX) a Good Value Stock?,116541943,https://s.yimg.com/uu/api/res/1.2/RqAKkC.S5mdZgyAUtzNS4g--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/20f5140b0d6593c9f87e143fb6bf21b3,VRTX,Yahoo,"Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. In the second quarter, majority of the equity indexes declined due to interest rate hikes, Russia-Ukraine war, and Federal Reserve’s balance-sheet tapering. Mid-cap and small-cap stocks poorly […]",https://finnhub.io/api/news?id=0350a07f80382759e6890230a08bdd5f94d31222eab29e1520d17ce859079435
company,2022-10-07 13:57:55,10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital,116533537,https://s.yimg.com/uu/api/res/1.2/5iMGcPKO4skbZ8ye0.xPlQ--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92d702cb1939a07ee3904ea9dae314aa,VRTX,Yahoo,"In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd’s Armistice Capital. To skip our analysis of Steven Boyd’s profile, investment strategy, and 13F holdings, you can go directly to see the 5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital. […]",https://finnhub.io/api/news?id=2ff637e8c840ba5fee4d1c499e590031dff1d7c96a61200ba217db7477c1a9d5
company,2022-10-07 10:02:31,Dow Jones Plunges 500 Points On Jobs Report; AMD Stock Tumbles On Revenue Warning,116519699,,VRTX,Yahoo,The Dow Jones Industrial Average plunged 500 points Friday on the September jobs report. AMD lost 8% after a third-quarter revenue warning.,https://finnhub.io/api/news?id=5c6714be5c747f7ee48d21e895c7859c749b500fab334ec3889f6f33ad677c98
company,2022-10-07 10:00:37,The Best Mutual Funds Invest Huge Sums In These 24 Stocks,116520155,,VRTX,Yahoo,"As the market tries to rebound, the best mutual funds bet big on 24 stocks including Vertex, Lilly and Enphase.",https://finnhub.io/api/news?id=74a17a6976baa0058a2a719f65493c59686bf6cab3b2dfd32c5d5ea9d0f213f5
company,2022-10-07 09:00:11,Pinning Down Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) P/E Is Difficult Right Now,116526215,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated's ( NASDAQ:VRTX ) price-to-earnings (or ""P/E"") ratio of 24x might make it look like...",https://finnhub.io/api/news?id=8e4a6bc8ed2e81df71490d556714c34bb19477c25423d3ad9034716e58578e86
company,2022-10-07 06:25:00,"4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire",116516018,,VRTX,Yahoo,"Most investors would like to see their stock portfolio grow significantly, especially if they have quite a few years left until retirement.  Alphabet (NASDAQ: GOOG), Vertex Pharmaceuticals (NASDAQ: VRTX), Eli Lilly and Company (NYSE: LLY), and Meridian Bioscience (NASDAQ: VIVO) all show solid potential to grow your investments significantly.  Alphabet's stock has risen 105% over the past five years.",https://finnhub.io/api/news?id=6dd60277d47ab1942b0a9dc606309b1a0f18224e95ff16b60331d0dcb9d33e27
company,2022-10-14 17:45:09,Vertex Pharmaceuticals (VRTX) Stock Moves -1.12%: What You Should Know,116651976,https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $293.21, marking a -1.12% move from the previous day.",https://finnhub.io/api/news?id=d5b89e5918cf428d123aa774a0e5f4431f47aaeb3ec61365c91d14f6958b660a
company,2022-10-14 13:29:00,"Vertex Pharmaceuticals Inc. stock falls Friday, still outperforms market",116710058,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.12% to $293.21 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=9d84b125ba382f01fb43e20ce75eea6ad26a469fe545a197c34db1cbfa019db7
company,2022-10-14 10:09:51,"Dow Jones Reverses As JPMorgan, UnitedHealth Rally On Earnings; Retail Sales Miss",116637714,https://s.yimg.com/uu/api/res/1.2/WAuaz6qrZ4OYu_AuKxC0vQ--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f84dddde254e978a0083114ec56c1e2b,VRTX,Yahoo,The Dow Jones Industrial Average reversed lower Friday on hot inflation data. JPMorgan and UnitedHealth rallied on earnings results.,https://finnhub.io/api/news?id=8fa2736434014ba91c2bdd5ee8381a91cb317a017e125b31ed25e64d1f349a28
company,2022-10-14 08:22:51,"Dow Jones Futures Rise As JPMorgan, UnitedHealth Rally On Earnings; Retail Sales Data Next",116635793,,VRTX,Yahoo,"Dow Jones futures rose in mixed premarket action Friday, ahead of retail sales data. JPMorgan and UnitedHealth rose on Q3 earnings results.",https://finnhub.io/api/news?id=80cecb1992dadfeb2b197c92dac9e12b854b8dc2d1c35785f1547188579d2bf0
company,2022-10-14 05:57:00,My Best Stocks to Buy Now and Hold Forever,116635795,,VRTX,Yahoo,"Unsurprisingly, Warren Buffett gave some excellent investing advice several years ago.  Let me begin by acknowledging that Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) faces some challenges.  Alphabet's shares have also fallen more than 30% year to date.",https://finnhub.io/api/news?id=18ec050c73c63c663fd3ed988145bd2797919f51bc4c20109ccbb66fefb1480e
company,2022-10-13 16:05:00,Vertex to Announce Third Quarter 2022 Financial Results on October 27,116632971,https://s.yimg.com/uu/api/res/1.2/45DVGAn.oa51b01RQmM4yQ--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/dda8a7d13c5ea0f0152931f20accf8f6,VRTX,Yahoo,"BOSTON, October 13, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2022 financial results on Thursday, October 27, 2022 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (877) 270-2148 (U.S.) or +1(412) 902-6510 (International) and reference the ""Vertex Pharmaceuticals Third Quarter 2022 Earnings Call"".",https://finnhub.io/api/news?id=4d363c5b6b61ba008355ad3ad8389e8fd58772ba6404960a4e1db7eceadebe32
company,2022-10-13 13:29:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market",116710059,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.21% to $296.54 Thursday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=9da794488d67a59b431c626101ba978d11fa27a7efe15841000b940c60c759f5
company,2022-10-13 10:11:03,"Dow Jones Dives 500 Points On Hot Inflation Report; 10-Year Treasury Yield Tops 4%; Apple, Tesla Drop",116623372,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,The Dow Jones Industrial Average dived Thursday on hot inflation data from the consumer price index. The 10-year Treasury yield topped 4%.,https://finnhub.io/api/news?id=3927cd9971b0f2d478e2e388ade131a613d81b51b4f70b1cad89b5320cf39790
company,2022-10-13 08:12:17,Dow Jones Futures Rise On U.K. U-Turn Ahead Of CPI Inflation Report,116624235,https://s.yimg.com/uu/api/res/1.2/airnnVxwS.i.PK0mNwoYZg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/e9479c8a67f808f28e765f5fe526ebb3,VRTX,Yahoo,"Stocks were quiet Wednesday, as investors avoided rallying into the CPI inflation report. EV plays Albemarle and Aehr Test Systems dived.",https://finnhub.io/api/news?id=e8df800431a65630c83082b94ccddf2ef6358dfe8f9e8c773ef0a5cb448ddd1c
company,2022-10-13 06:30:00,3 Red-Hot Stocks That Could Continue to Beat the Market,116622892,https://s.yimg.com/ny/api/res/1.2/AA7oL3R4sqV6h3DlX1dnLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f0a5cd166bee5505afaa514b7d8c6018,VRTX,Yahoo,"Investors often favor that industry during tough times because its earnings are less at risk -- patients can't do without the products these companies sell.  Shares of Axsome Therapeutics (NASDAQ: AXSM), Regeneron Pharmaceuticals (NASDAQ: REGN), and Vertex Pharmaceuticals (NASDAQ: VRTX) have actually been climbing this year, and it doesn't look as if those trends will end any time soon.  Axsome Therapeutics attracted investors' attention as it moved closer to product commercialization.",https://finnhub.io/api/news?id=6b4b4e3f12830d211c8c49bb6be0de5656c608bbe39aa2a4b67a6054d9663531
company,2022-10-13 05:52:00,"The Best Stocks to Invest $5,000 in Right Now",116622872,https://s.yimg.com/ny/api/res/1.2/PZVZ4KeZlGs9cyPQclTEnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/43f913d3016ee7810c797fea2b6c3774,VRTX,Yahoo,"Here's why I think that Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), MercadoLibre (NASDAQ: MELI), and Vertex Pharmaceuticals (NASDAQ: VRTX) are the top picks.  Thanks to its 20-for-1 stock split conducted in July, you can buy a lot more shares of Alphabet with less money than you could've in the past.  For one thing, Alphabet's share price has fallen more than 30% year to date.",https://finnhub.io/api/news?id=d4234f9fa10d4fd745582b088cdfb45d4e3a4f450f8e787a9cd8de0b91fdedde
company,2022-10-13 00:40:17,Dow Jones Futures Rise Ahead Of CPI Inflation Report; Investors Avoid This Mistake,116615019,https://s.yimg.com/uu/api/res/1.2/airnnVxwS.i.PK0mNwoYZg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/e9479c8a67f808f28e765f5fe526ebb3,VRTX,Yahoo,"Stocks were quiet Wednesday, as investors avoided rallying into the CPI inflation report. EV plays Albemarle and Aehr Test Systems dived.",https://finnhub.io/api/news?id=db432ac5a00981f3c1d5186f5e5d108027524c6c2db134176fd7fe993523d565
company,2022-10-12 13:29:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",116710061,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.70% to $290.13 Wednesday, on what proved to be an all-around poor trading session for the stock market, with...",https://finnhub.io/api/news?id=72dd0702e1b34b491db55ea9230c0e74a51d097bfd2d8721001a0f2cd0e8bd73
company,2022-10-12 12:11:04,Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic,116613692,https://s.yimg.com/uu/api/res/1.2/c23rHSrGLTeyi6ecjtGakg--~B/aD0zNDY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b,VRTX,Yahoo,"The FDA clears Vertex's (VRTX) Investigational New Drug application for VX-634, a small molecule AAT corrector, thereby allowing the company to initiate a first-in-human clinical study in healthy volunteers.",https://finnhub.io/api/news?id=9a4538fa0a3307537ebbcf4ddf7f8f21303c054858c1f8ec706754d3f609862d
company,2022-10-12 10:09:24,Dow Jones Reverses On Hot Inflation Data; Fed Minutes Up Next; PepsiCo Jumps On Earnings,116606988,https://s.yimg.com/uu/api/res/1.2/lHIw_Ps1VeRSQ0CK03ECLw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/49a3c4e232f130829377771b2230292e,VRTX,Yahoo,The Dow Jones Industrial Average fell Wednesday on hot inflation data. Minutes from Federal Reserve's policy meeting are due out today.,https://finnhub.io/api/news?id=92c81509bb672e8d3c6df5e95f5c14ea97a2aaa3083639f9c8ab019b3edebc7f
company,2022-10-12 09:37:00,2 Breakout Growth Stocks to Buy for the Long Haul,116607460,https://s.yimg.com/ny/api/res/1.2/0HdZkp3V6u29hEIcor0jiA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTY-/https://media.zenfs.com/en/motleyfool.com/74f917e45f505e2f3941ef48d22dbcd0,VRTX,Yahoo,These unstoppable stocks could be resilient choices to buy and hold in the next bear market and beyond.,https://finnhub.io/api/news?id=f5dcafd41d4ed554bd37cfb98978ada634cb373340547e76d647ed6ec2404d96
company,2022-10-12 08:27:33,"Dow Jones Futures Rise, Bond Yields In Flux With Inflation Reports Due",116604559,,VRTX,Yahoo,Futures pared gains as the 10-year Treasury yield in flux with big inflation reports due. The S&P 500 is at bear market lows.,https://finnhub.io/api/news?id=beeb07c56ed59e17f0bdbd9992dd20085563b250340170cb3202fe10bbed04bc
company,2022-10-12 08:15:00,"The Best Stocks to Invest $50,000 in Right Now",116604437,,VRTX,Yahoo,"The stock market has left many investors uneasy lately.  With valuations of many once-high-flying stocks tumbling in recent months, as well as concerns about a global recession rising, businesses across a range of industries are facing unique challenges.  If you have $50,000 to put in the stock market right now, here are three powerhouse stocks to consider for at least part of that investment.",https://finnhub.io/api/news?id=9ac40572f19ef9ce7cb6287ec69255a544b4c61a6e73e76534996db8ba221777
company,2022-10-12 06:00:00,Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold,116602315,https://s.yimg.com/ny/api/res/1.2/i7D0E8Vt_4QeraAjeQOBYg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/dd055c4b29c56ae40e6f1559bc559853,VRTX,Yahoo,Axsome Therapeutics wowed investors when it soared more than 80% this year through August.  Investors cheered Axsome's first steps in the world of product commercialization.  Vertex is best known for its leadership in the world of cystic fibrosis (CF) treatment.,https://finnhub.io/api/news?id=9aa27823bb901e53275444bffe7260fbad850b901356cf779e033595b8a4b4f4
company,2022-10-11 21:26:33,"Dow Jones Futures: S&P 500, Nasdaq Hit Fresh Bear Market Lows; Big Inflation Reports Due",116595407,https://s.yimg.com/uu/api/res/1.2/CQxZyKUHtUwRNyKBSRQ1HA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/dd3d8b33d715764a9a678ecf8d0d54d9,VRTX,Yahoo,The Nasdaq and S&P 500 sank to new bear market lows Tuesday as chip stocks and Tesla slumped. Big inflation reports are ahead.,https://finnhub.io/api/news?id=0c01a5c81f78363666b3273f2faf979ea46765274bb90d8b0a70659c9e3a306b
company,2022-10-11 12:11:15,Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward,116599043,https://s.yimg.com/uu/api/res/1.2/845m5tdLMAxEQfMjXJGs2w--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/5871ce10ae0059a9a683a40f3eaf3f96,VRTX,Yahoo,"Vertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1 antitrypsin deficiency (AATD), a rare genetic disease characterized by a protein folding defect that can lead to liver and lung disease. Vertex announced that the FDA had cleared the Investigational New Drug (IND) Application for VX-634, enabling the company to initiate a first-in-human clinical trial for this small molecule AAT corrector in healthy volunteers. Also see: Vertex Pharma's Flagship",https://finnhub.io/api/news?id=61d54c36c0511a833d174500af7b5454df8f1ae228b7c09288029751f976cedf
company,2022-10-11 10:07:39,"Dow Jones Falls, Tech Stocks Dive As 10-Year Treasury Yield Nears 4%",116593849,https://s.yimg.com/uu/api/res/1.2/WAuaz6qrZ4OYu_AuKxC0vQ--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f84dddde254e978a0083114ec56c1e2b,VRTX,Yahoo,"The Dow Jones Industrial Average fell Tuesday, as the 10-year Treasury yield neared 4% after gains in recent sessions.",https://finnhub.io/api/news?id=d7f12d62f19eba3dfdea9bdafc99a727c986add26b999ff610b1e06a84a24eac
company,2022-10-11 08:00:17,Subdued Growth No Barrier To Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Price,116599045,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"With a price-to-earnings (or ""P/E"") ratio of 23.6x Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) may be sending...",https://finnhub.io/api/news?id=aeb4b141ca62321fddea750ccab7a03da698ca555412e1e9ca1c5fb91a49ef49
company,2022-10-11 08:00:00,Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency,116599046,https://s.yimg.com/uu/api/res/1.2/EWDDTEXZ.JX7rgXOJLpHoA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a4ef01ac873114e83a7605a268f93cc7,VRTX,Yahoo,"BOSTON, October 11, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the advancement of its investigational program targeting alpha-1 antitrypsin deficiency (AATD), a rare, genetic disease characterized by a protein folding defect that can lead to liver and lung disease.",https://finnhub.io/api/news?id=2fb303702777ff6c314a2bd92655ea141da75b14c2564c36c46a41d63129db70
company,2022-10-11 05:52:00,3 Top Biotech Stocks Defying the Bear Market,116583671,https://s.yimg.com/ny/api/res/1.2/e30JEnnFdGTnowi.66VtfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/2c4c649a22cd047b0c427c760f7c7495,VRTX,Yahoo,"If there is, it's wrong too -- at least when applied to the stock market.  As a case in point, here are three top biotech stocks that are defying the bear market.  Few stocks in any sector have outperformed Vertex Pharmaceuticals (NASDAQ: VRTX) in 2022.",https://finnhub.io/api/news?id=49cd93008a89da239999ba2c53239c97229da85a5659802e1a531cf33b3c30a4
company,2022-10-18 13:29:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",116710056,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.06% to $300.17 Tuesday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=aa05c232df78fbe623d5a33255a7029058ccc8b3b11abd085c9639d043c3b6b0
company,2022-10-18 10:00:00,2 Top Healthcare Stocks to Buy for the Long Haul,116701019,,VRTX,Yahoo,"Amgen is more established and has a dividend, while Vertex is one of several companies looking for therapies using the CRISPR Cas/9 gene-editing technique, which won the Nobel Prize just two years ago.  Amgen helped pioneer biotechnology and sells its therapies in more than 100 countries.",https://finnhub.io/api/news?id=6b4d8ae9178a46c2bccffd938d97ab0c562c39d87cd80f212b9fefe82d9cda6f
company,2022-10-17 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",116710057,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.30% to $297.02 Monday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=93ba4b6db62722a2926e1050995b86dfc356526c5fa8766adec6f14dd473f261
company,2022-10-17 10:05:25,Dow Jones Surges 600 Points As Bank Of America Jumps On Earnings; Apple Called Top Pick,116688877,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,"The Dow Jones Industrial Average rallied Monday, as Bank of America jumped on strong earnings results. Apple stock was named a top pick.",https://finnhub.io/api/news?id=fd2968372212373c7b28ec24d6f74774b0cd50da4d8d22b9c45819c4d934ef7f
company,2022-10-16 00:49:00,Vertex Pharmaceuticals price target raised to $293 from $288 at Piper Sandler,116721865,https://thefly.com/images/meta/streetresearch_recommendations.jpg,VRTX,Thefly.com,Piper Sandler analyst Do ... VRTX,https://finnhub.io/api/news?id=7ddec193504816290a07174a3b8aeee837a52d2529bad4deb9ecd1ac4837d2e3
company,2022-10-15 07:00:14,Investor Optimism Abounds Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) But Growth Is Lacking,116668788,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated's ( NASDAQ:VRTX ) price-to-earnings (or ""P/E"") ratio of 23.5x might make it look...",https://finnhub.io/api/news?id=36925bc327bb88b86b50cf5aac1755b999c30acf2469dd5de55b3e76694a44bd
company,2022-10-22 10:00:00,2 Powerhouse Stocks That Could Go Parabolic,116787769,https://s.yimg.com/ny/api/res/1.2/3vspf12LLSYOBRCIT82kAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04Mzg-/https://media.zenfs.com/en/motleyfool.com/9ff99feaa73a4bf10ebcdf8051d96383,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has a unique competitive edge over the average healthcare stock in that it is the market leader in a multibillion-dollar industry with minimal competition.  Vertex develops and manufactures drugs that treat cystic fibrosis patients.  CFTR modulator therapies are changing the landscape of the fight against cystic fibrosis -- a disease that afflicts 40,000 individuals in the U.S. alone -- and there are only four of these therapies that have as yet been approved and made it to market.",https://finnhub.io/api/news?id=8aba35f28399a1618476f772f1d3a87f7cb8123cf74e6c901246cdc04cc2d47a
company,2022-10-22 08:45:00,3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later,116787045,https://s.yimg.com/ny/api/res/1.2/Oe26FLMLz.2EQrPJTrLpRA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/569da15fd47cabd5afc62a0f73da8a1f,VRTX,Yahoo,"Here's why they chose Bristol Myers Squibb (NYSE: BMY), Viatris (NASDAQ: VTRS), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Prosper Junior Bakiny (Bristol Myers Squibb): Drugmaker Bristol Myers Squibb is among the select group of companies that are outperforming the market this year.  The company's shares are up by 13% year to date.",https://finnhub.io/api/news?id=44d9a66667bdb78dc825f21f4b3303fbaece3cabde11ef8ce2fd7a0d02d908b3
company,2022-10-22 08:00:08,S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength,116786475,https://s.yimg.com/uu/api/res/1.2/mPlGoDa3v4Cv7o8BuanPyg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/ebe20c203c3b0cfed4e66190762b8db4,VRTX,Yahoo,"S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market.",https://finnhub.io/api/news?id=1e2fc4d40d0a0487cd40b6894d638fd8ccd6b2c707e79b55391ee5c01bd4be09
company,2022-10-21 19:54:13,"Market Rally Roars, 5 Growth Stocks Near Buy Points; Apple, Big Earnings Due",116781800,https://s.yimg.com/uu/api/res/1.2/a0t.inReeuKrEK6qSpC7bA--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/1ac3263e6685e13c3e43c5e0104c961c,VRTX,Yahoo,The market rally has stepped up on Fed pivot hopes. Snowflake is among 5 high-growth stocks near buy points. Apple headlines a huge week of upcoming earnings.,https://finnhub.io/api/news?id=00ef79b77a0927e8fa23df970e0dbfcfa420b1b86cb6fb2e39887ed97223f630
company,2022-10-21 13:29:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",116785444,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 3.39% to $300.00 Friday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=c5abdb015b7ea2407d6e4b8a0470cd908b8a0b1c2d433c3e2f3e01647040c696
company,2022-10-21 10:50:00,Vertex Pharmaceuticals Stock Near Buy Zone With Earnings Due,116783668,,VRTX,Yahoo,"Vertex Pharmaceuticals is forming a base and near a possible buy point ahead of its next quarterly earnings report, expected on or around Oct. 27.",https://finnhub.io/api/news?id=caefbbd71ad22decd50497c8c8ecfdd2c02cd1e53b0d32a808d8a5cb3f201f52
company,2022-10-21 09:30:00,These 3 Stocks Are Winning the Bear Market -- Here's How,116778064,,VRTX,Yahoo,Picking the right markets to compete in makes surviving bear markets much more manageable for these companies.,https://finnhub.io/api/news?id=b1ef389cf1ea83f328ad7446578b3610c84842bbc3b5d821f8b87272845dd0fc
company,2022-10-21 07:32:00,First Week of VRTX December 16th Options Trading,116788520,,VRTX,Stock Options Channel,"Staff article entitled First Week of VRTX December 16th Options Trading, about stock options, from Stock Options Channel.",https://finnhub.io/api/news?id=5144451913198e555cc7535b244674fef8d022db2d3aee94343affabea2fdca6
company,2022-10-21 01:01:00,Top 5 3rd Quarter Trades of Pa - GuruFocus.com,116787815,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=104cb1ff276f49050ee0453d9cce8795eabdd052732efca5979397a3d9b1290e
company,2022-10-21 01:01:00,TriaGen Wealth Management LLC  - GuruFocus.com,116788521,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=534ab9482e8e54de18e9f5a4d9b7e4e6ef42cdd278d074aa9a7b62e987251b1d
company,2022-10-20 17:50:09,Vertex Pharmaceuticals (VRTX) Stock Moves -0.64%: What You Should Know,116756447,https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $290.16, marking a -0.64% move from the previous day.",https://finnhub.io/api/news?id=384283f0e12b7e5eda5baa1f9660fb77f32fccd842304e43462f9f3491995a7c
company,2022-10-20 13:29:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,116778651,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.64% to $290.16 Thursday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=1a4be231bfda32b738a6dc90502ea8c88e47c0fba407f934646148b4afc3b02d
company,2022-10-20 10:01:02,Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth,116744842,https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba,VRTX,Yahoo,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=fbe2c4aeecbbd6364b6f3a103ddfab7851c7d54b8baae9ea9b302d5c4131095c
company,2022-10-20 01:01:00,FOSTER DYKEMA CABOT & CO INC/M - GuruFocus.com,116754126,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=ac7aa2b187f86dc408df1a30e0c51d5372c82a0c578ec95a1e42a6c1caf6ee8d
company,2022-10-20 00:31:33,HQH: A Dividend Paymaster That Fails To Register Price Growth,116736568,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1363842522/image_1363842522.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Tekla Healthcare Investors is able to generate steady yield and currently trades at a good discount to its NAV. Read more to see why HQH is a Buy.,https://finnhub.io/api/news?id=44e3ceaa6735a44d2ae48e01c7a49530361cf5019b93c83838fca7214c20dbc4
company,2022-10-19 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",116778653,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 2.72% to $292.02 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=b95c0d1c5eccbd14366808349cd7d9d6ce35ac506c389ba70cd6909598c93aa2
company,2022-10-19 09:53:00,2 Under-the-Radar Biotech Stocks to Buy in 2022,116714485,https://s.yimg.com/ny/api/res/1.2/xCXjIEDL95F_j9JWPcpfMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/7cdaf727c29f46741eefeb67a7537921,VRTX,Yahoo,"With that said, let's examine two biotech stocks that could be excellent long-term bets: CRISPR Therapeutics (NASDAQ: CRSP) and Sarepta Therapeutics (NASDAQ: SRPT).  CRISPR Therapeutics is a clinical-stage biotech.  The company's targets include several forms of cancer and two rare blood-related conditions called sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT).",https://finnhub.io/api/news?id=9367cd9c0ae5cdfd92860cbb9a2b470e29da28fb68284521c71898fd16c8c353
company,2022-10-19 09:46:12,Dow Jones Falls As Netflix Soars On Earnings; Tesla Earnings Next,116714486,https://s.yimg.com/uu/api/res/1.2/HDjemjYlp7Z5vRwiz3dW9Q--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,"The Dow Jones Industrial Average fell Wednesday, as Netflix soared on strong earnings results. Tesla earnings are due out after the close.",https://finnhub.io/api/news?id=dcd4f6141f35e6ec6840c9c529bc786136d7b4acaa803b989abf10eafad0c328
company,2022-10-19 09:07:00,2 Unstoppable Stocks That Are Beating the Bear Market,116714487,https://s.yimg.com/ny/api/res/1.2/qT90.TprnT60mQd0uVN7uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/1667fee9d0f7d08b9d1770c7407b01f6,VRTX,Yahoo,"Biotech company Vertex Pharmaceuticals is a top name in cystic fibrosis (CF), and that has been what's driving its sales growth today.  Last month, Vertex said it planned to submit a biologics licensing application for exa-cel to the Food and Drug Administration for a rolling review that will begin as early as November and will be complete early next year.  Shares of Vertex have soared 35% this year, eclipsing the S&P 500.",https://finnhub.io/api/news?id=9d96a404782a794ae25f84fe75630479bfe93539973135b90d9340c5c715eed8
company,2022-10-19 07:00:59,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Business Is Yet to Catch Up With Its Share Price,116714488,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"With a price-to-earnings (or ""P/E"") ratio of 24.1x Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) may be sending...",https://finnhub.io/api/news?id=ce3e5ac2fd6f3fc3b36fce22e48fb6259c367c5275e1729013389b80bc2a4c53
company,2022-10-18 23:23:14,TECL: Lining Up A Supercharged Bet On Fed Reversal Within Months,116712316,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359333024/image_1359333024.jpg?io=getty-c-w750,VRTX,SeekingAlpha,The Direxion TECL ETF is one of the most intriguing investment options. What do I say the timing for betting on TECL is not here yet? Click here to find out.,https://finnhub.io/api/news?id=4e2ccd57010dae1ed5843a295e42bbe014bff5d64f6a9a57df436af97807c5f2
company,2022-10-18 23:10:02,Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update,116712000,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1239809496/image_1239809496.jpg?io=getty-c-w750,VRTX,SeekingAlpha,ARK Investâs 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.,https://finnhub.io/api/news?id=f48859b972c29f6dc02a8960ad7f2d699ca0c79b543e3622777860a05c19b72b
company,2022-10-18 21:30:00,Biogen and 10 Other Healthcare Stocks Thriving in This Bear Market,116717576,https://images.barrons.com/im-646794/social,VRTX,MarketWatch,"Of the 56 stocks in the S&P 500 that have seen their share prices climb at least 10% since Jan. 3, 11 are healthcare stocks, a Barron's screen found.",https://finnhub.io/api/news?id=50a85e508a1c05cbd2584647931cefb92229bfec998f0bfed400dbfe0ea76bdf
company,2022-10-26 14:48:06,"Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More",116843304,https://s.yimg.com/uu/api/res/1.2/4qYAeIby_0fxQYGokmloZw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1,VRTX,Yahoo,Let's analyze how the four pharma/drug/biotech companies are placed before the quarterly earnings release on Oct 27.,https://finnhub.io/api/news?id=6d0bc69a4bddcd1578edbe9cbea7d80b678f1055a3936e8a4c4489a745d5e211
company,2022-10-26 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,116891470,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.64% higher to $311.18 Wednesday, on what proved to be an all-around mixed trading session for the stock...",https://finnhub.io/api/news?id=1831054c699d078ac6b5ccb3fbdc21d6afe49b6bbed8b79f65969fe444c85aa7
company,2022-10-26 05:30:00,2 Monster Stocks to Buy Without Any Hesitation,116852176,https://s.yimg.com/ny/api/res/1.2/OZJvhvMG2T2MIi1MLSGXAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d3bb52d494a04c6d297adec1652fdb85,VRTX,Yahoo,"Many investors are hesitating before buying stocks.  Let's take a closer look at these players to buy -- without any hesitation.  AbbVie (NYSE: ABBV) sells treatments in a variety of high-growth areas, including immunology and neuroscience.",https://finnhub.io/api/news?id=896f6f48fa87aece35cf7b6720924956a4fa6ae678116883bb83b4c8c427ea34
company,2022-10-25 21:01:00,David J Yvars Group Goes on Bu - GuruFocus.com,116850650,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=8e79fec8e32c08e08c21c7a508105e075d85dcee8a02fa2ff4003fc3a63c4868
company,2022-10-25 21:00:00,Top 5 3rd Quarter Trades of MO - GuruFocus.com,116850219,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=17a75d731ea5c5c558f285c0ace10172c7cc8eb599cb1f3f2acddc1ac35db428
company,2022-10-25 13:34:05,Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?,116825089,https://s.yimg.com/uu/api/res/1.2/UgiI07ytew_hNcL7MgLFiA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"On Vertex Pharmaceuticals' (VRTX) Q3 earnings call, investors' focus will likely be on the sales performance of its cystic fibrosis medicines and updates on its non-CF pipeline candidates.",https://finnhub.io/api/news?id=fd541f12a2850fa9074164d8209cd3fd4c93a5ccacf1bfa9f4e44ca239f6e03c
company,2022-10-25 13:30:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,116828517,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.42% to $309.21 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=f92615e7f945d79ffde0b51243e68eb8889af23b08ad9ea8b00e7d186a75a148
company,2022-10-25 12:53:04,CRISPR (CRSP) to Report Q3 Earnings: What's in the Cards?,116821806,https://s.yimg.com/uu/api/res/1.2/.gb6XNijFKw.G0R_D0zzsw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6e7a581172a57923b1e9381146e28fb5,VRTX,Yahoo,"CRSIPR Therapeutics (CRSP) is expected to update its pipeline candidates, specifically exa-cel, its lead candidate, in its third-quarter earnings.",https://finnhub.io/api/news?id=fb6a456942992d9ed474932822e7819154bb207e2b7527921f3baed7a7ac0c49
company,2022-10-25 10:01:02,Earnings Preview: Ultragenyx (RARE) Q3 Earnings Expected to Decline,116821481,https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b,VRTX,Yahoo,Ultragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=5fc9ccace48787f2c0ef165baeb6b7a2929dbbd682468b2ab258c794f696827f
company,2022-10-25 02:51:00,Vertex Pharmaceuticals Reaches Analyst Target Price,116819311,,VRTX,ETF Channel,"Staff article entitled Vertex Pharmaceuticals Reaches Analyst Target Price, about ETFs, from ETF Channel.",https://finnhub.io/api/news?id=ad53c58f794cb2c02370fafbe2281d31e32e2dbc8d04b7e99a5d903a0c355b7f
company,2022-10-24 21:46:00,"AbbVie CF combo progressing, worth keeping eye on, says RBC Capital",116846615,https://thefly.com/images/meta/streetresearch_recommendations.jpg,VRTX,Thefly.com,"RBC Capital analyst Brian... VRTX, ABBV",https://finnhub.io/api/news?id=5965a2bf5e849390256abed9ac2ba47af3d8f5c1430dc1d071507a018bdb0ee7
company,2022-10-24 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",116828518,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 3.50% to $310.50 Monday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=a10ff7e5f25b6f380228960dd7c90d4ed8202c3782ff4827f9e91233b1a6d735
company,2022-10-24 08:08:13,"Dow Jones Futures Signal Market Rally To Extend Gains; Tesla Cuts Model 3, Y Prices In China",116802068,https://s.yimg.com/uu/api/res/1.2/3q6Bj_o6nnTK9NM4xrQXeg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/746311e562c04897c0ca49a75e80b06a,VRTX,Yahoo,Futures signaled further market rally gains. Snowflake leads 5 growth stocks near buy points. Tesla cut Model 3 and Y prices in China.,https://finnhub.io/api/news?id=db0dd545ba834f91ec1b310d0137e8d9523ebdf295010bb613af7a0730205509
company,2022-10-24 05:01:00,Top 5 3rd Quarter Trades of E  - GuruFocus.com,116804901,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=cd50609a1f4f16daad8d87fc5965cc563f6e438a9e478a59546c9f4821d5b120
company,2022-10-24 03:23:00,Vertex Pharmaceuticals price target raised to $327 from $319 at JPMorgan,116819315,https://thefly.com/images/meta/streetresearch_recommendations.jpg,VRTX,Thefly.com,JPMorgan analyst Jessica ... VRTX,https://finnhub.io/api/news?id=e11bf30940bc27f71eebab68864687ae3e4d3dd993edc6774b7e6d9f992cd5d0
company,2022-10-23 22:36:13,"Dow Jones Futures: Market Rally Gains Steam; Tesla Cuts Model 3, Y Prices In China",116800621,https://s.yimg.com/uu/api/res/1.2/3q6Bj_o6nnTK9NM4xrQXeg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/746311e562c04897c0ca49a75e80b06a,VRTX,Yahoo,Futures signaled further market rally gains. Snowflake leads 5 growth stocks near buy points. Tesla cut Model 3 and Y prices in China.,https://finnhub.io/api/news?id=4b421eed303b4397ef0060ca5961b37d740185fed15e741d269e46633ee2da29
company,2022-10-23 08:01:24,Vertex Pharmaceuticals' (NASDAQ:VRTX) investors will be pleased with their favorable 100% return over the last five years,116801120,https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...,https://finnhub.io/api/news?id=2755c806e8768d9a13cdbcc15cd44897403ec2c9cebe59b028a8e6404b6cee84
company,2022-10-23 07:45:00,RGA Investment Advisors Q3 2022 Investment Commentary,116794839,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397687090/image_1397687090.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"For RGA Investment Advisors, the third quarter saw a continuation of the ugly trend from the first half of the year. Click here to read the full fund letter.",https://finnhub.io/api/news?id=a0f37b8d8eb7e1270c4dab59bd801ec8082ff70aa03bc5e752a6bce9573e437b
company,2022-10-23 05:55:00,Which Stocks Are Most Likely to Thrive in a Recession? Here's What History Shows,116800672,https://s.yimg.com/ny/api/res/1.2/H_ufwtk7o_jAXs07jLd8bw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTc-/https://media.zenfs.com/en/motleyfool.com/e87a6117b31402cb945c3d59a4a8ef63,VRTX,Yahoo,Recession-proof stocks must offer something that makes investors want to buy them even when the economy is tanking.,https://finnhub.io/api/news?id=37baa5f2fd4ac146b048875ee68c9cca6b0f1458dc7295b68c97a28f054df195
company,2022-10-23 04:39:54,Tekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAV,116794447,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397335462/image_1397335462.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Tekla Life Sciences currently has a high 10% yield. The CEF is currently trading 10.5% below NAV. Read why investors are getting HQL at an attractive valuation.,https://finnhub.io/api/news?id=39f2b2da6ea132f39340c41a4d82c407e545c5a52652e5ce189b8614ec2d043a
company,2022-10-30 09:30:00,"The Best Stocks to Invest $20,000 in Right Now",116880654,https://s.yimg.com/ny/api/res/1.2/lK0ZEr2I9w9olfobc9.icA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/ba81728e86c18d13fedb34d11b2fc667,VRTX,Yahoo,A long-term investment in any of these powerhouse stocks could reap generous returns for many years to come.,https://finnhub.io/api/news?id=0ea99cc64d12e06b26af0c45c9c67a241526405d8e3ede2c5b49f39f471f514b
company,2022-10-30 07:33:00,Vertex Pharmaceuticals (VRTX) Receives a Hold from SVB Securities,116906507,,VRTX,TipRanks,"In a report released on October 27, David Risinger from SVB Securities maintained a Hold rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report). The compan...",https://finnhub.io/api/news?id=018dfefe7a24a43a16aadb89ae1d78670e8bcaa3d891d0c634f58446d4d8dc97
company,2022-10-30 07:23:00,Vertex Pharmaceuticals (VRTX) Gets a Hold from Robert W. Baird,116906509,,VRTX,TipRanks,Robert W. Baird analyst Brian Skorney maintained a Hold rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report) on October 28 and set a price target of $280...,https://finnhub.io/api/news?id=3c859625ce68581a31f1430120228e1d6123ab84f3c9131413f4e5c8f9820b5b
company,2022-10-30 06:00:00,5 Top Stocks for November,116867496,https://s.yimg.com/ny/api/res/1.2/5NNMYGZKoM3mJMM0uZYLtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/94b921a63cc4ee7cd28b4e202dae2708,VRTX,Yahoo,"Trevor Jennewine (Microsoft): Microsoft saw its share price tumble more than 7% following its earnings report for the first fiscal quarter (ended Sept. 30, 2022).  Worse yet, guidance came in short of Wall Street's expectations, as CFO Amy Hood said weak PC demand would persist into the second quarter, negatively impacting revenue from Windows and Surface devices.",https://finnhub.io/api/news?id=8e8985e560a796251274b3dfde59ca6d65cb6d709faa17450c322137686e3619
company,2022-10-29 06:06:00,This Bear Market Could Be the Best Investing Opportunity in More Than a Decade,116880656,https://s.yimg.com/ny/api/res/1.2/QLEij9ScEHe.6Ek_aFoZ9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/629ef9012d9821c5b641e5368f359ac0,VRTX,Yahoo,"This bear market could be the best investing opportunity in more than a decade.  For investors, the present (or at least the near future) could be a time to party like it's 2009 instead.  No one knew how long the bear market would last.",https://finnhub.io/api/news?id=3c0138958d57b7a3cd5b30cee02b66b3e8558d1715e19fbcaefe32e4b890d99d
company,2022-10-28 18:36:57,Why Shares of Vertex Pharmaceuticals Jumped 9.03% on Friday,116862162,https://s.yimg.com/ny/api/res/1.2/idvSvIfpA5qCb22yToFKzg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/357e3e6cc88e475665d6e0af465da1b4,VRTX,Yahoo,"Shares of Vertex Pharmaceuticals (NASDAQ: VRTX), a biopharmaceutical stock that specializes in cystic fibrosis (CF) and gene-editing therapies, saw its shares jump 9.03% on Friday.  The company released its third-quarter earnings report after the market closed on Thursday and the numbers were strong enough to give the stock a boost on Friday.  Vertex reported revenue of $2.33 billion, up 18% year over year, and net income of $931 million and earnings per share (EPS) of $3.59, both up 9% over the same period in 2021.",https://finnhub.io/api/news?id=e7a0473be77883830c00bc89dff1f4e9a6ff0b9a38c7e73b1a8a717ed4b533db
company,2022-10-28 16:05:21,Vertex Shrugs Off Recent Malaise With A Third-Quarter Beat-And-Raise,116880658,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,"Vertex beat third-quarter expectations and raised its sales outlook, helping VRTX stock surge on Friday, shrugging off Thursday's pain.",https://finnhub.io/api/news?id=a440a921814667c6420668c5b5fe0173ea6988eea12460a73fa2821b54313836
company,2022-10-28 15:00:24,Top 10 Gainers on Friday,116873608,https://media.zenfs.com/en/insidermonkey.com/c5a299131495043dc9951e0d351ca092,VRTX,Yahoo,"In this article, we will take a look at the top 10 gainers on Friday. If you want to see some more stocks rallying today, go directly to Top 5 Gainers on Friday. All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc. (NASDAQ:AAPL), Intel Corporation (NASDAQ:INTC) and […]",https://finnhub.io/api/news?id=59d8bdd1a4f8419da26e520424d15e0af17718d548a77e28237467a15a2c7ea2
company,2022-10-28 13:29:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",116891468,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 9.03% to $313.89 Friday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=325b84a26d6037c4aac2535861780b0b4d7a706f362ad8ce6bf25bb57c3d290a
company,2022-10-28 12:07:04,"Vertex (VRTX) Beats on Q3 Earnings, Ups 2022 Sales Guidance",116862163,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,Vertex Pharmaceuticals' (VRTX) third-quarter 2022 earnings and sales beat estimates. VRTX also raises its revenue guidance for 2022. The stock rises in the after-market trading.,https://finnhub.io/api/news?id=ff22db565e5109ed5e1b7136cb9e8bb9b491dd8b574327a47326730410452e49
company,2022-10-28 01:00:28,"Dow Jones Futures: Apple Holds, Amazon Joins Megacap Meltdown; What To Do Now",116852002,https://media.zenfs.com/en/ibd.com/664f1b4ff42de09eb4726407140edff8,VRTX,Yahoo,"Apple dipped after the iPhone giant topped views. Amazon crashed on guidance, joining the megacap earnings meltdown.",https://finnhub.io/api/news?id=184898868801ebf707600819bb171597d94546adff8dc0ae0dae000e51b3a28c
company,2022-10-28 07:53:00,"Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Vertex Pharmaceuticals (VRTX) and Argenx Se (ARGX)",116882589,,VRTX,TipRanks,Companies in the  Healthcare sector have received a lot of coverage today as analysts  weigh in on Teleflex (<span class='tr-stock-ticker' style='color:blue; font-w...,https://finnhub.io/api/news?id=9121da08bfd8f5c0592a967ca466a058eee3fa889f0a7cb81e50d8da07310e7f
company,2022-10-28 07:42:00,Morgan Stanley Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),116906513,,VRTX,TipRanks,Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report) today and set a price target of $285.00. T...,https://finnhub.io/api/news?id=162cca367fd899520684dce848338154368a0177d552d40cb7c42d1e48103c06
company,2022-10-28 04:09:00,"Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Vertex Pharmaceuticals (VRTX)",116882590,,VRTX,TipRanks,There&#8217;s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edwards Lifesciences (<span class='tr-stock-ticker' style='colo...,https://finnhub.io/api/news?id=61edf4a05697b0299c4a488590f0835dc51fef3ad14961e96b6bb05a3bb6a2e3
company,2022-10-28 03:38:00,Vertex Pharmaceuticals price target raised to $330 from $315 at Cowen,116906516,https://thefly.com/images/meta/streetresearch_recommendations.jpg,VRTX,Thefly.com,Cowen analyst Philip Nade... VRTX,https://finnhub.io/api/news?id=af77b894cc9a990ac18550b057b0ba5517fe632127df38309be488acb477055e
company,2022-10-28 03:38:00,Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo,116906515,,VRTX,TipRanks,Wells Fargo analyst Mohit Bansal maintained a Buy rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report) today and set a price target of $335.00. The compa...,https://finnhub.io/api/news?id=a4bf86137091e0f7abc52537002fe3bf3d8430d26582f0df8a6dd14608f7c18c
company,2022-10-28 01:43:00,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Vaccitech Plc (VACC),116906518,,VRTX,TipRanks,There&#8217;s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (<span class='tr-stock-ticker' style='co...,https://finnhub.io/api/news?id=9748a03c56ee72f8455057e0d48d2c8d129b1322cf45b689a56aa026fe4296fa
company,2022-10-28 01:43:00,Needham Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),116906517,,VRTX,TipRanks,Needham analyst Joseph Stringer maintained a Hold rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report) today. The company&#8217;s shares closed yesterday...,https://finnhub.io/api/news?id=4160a3e2a5337a137d2915fb77fba1ed7a5aacb36efc2a560423bfa63bd04d90
company,2022-10-27 22:00:39,Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call Transcript,116852168,https://media.zenfs.com/en/motleyfool.com/9423776c936289a42895d326bcfb918f,VRTX,Yahoo,"Image source: The Motley Fool.  Vertex Pharmaceuticals (NASDAQ: VRTX)Q3 2022 Earnings CallOct 27, 2022, 4:30 p.m. ETContents:  Prepared Remarks Questions and Answers Call Participants  Prepared Remarks:  OperatorGood day, and welcome to the Vertex Pharmaceuticals third quarter 2022 earnings call.",https://finnhub.io/api/news?id=59e060e551429f4d5e8286c6192920210eed2998eb2b421d58473ce7ba715d42
company,2022-10-27 17:29:06,Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript,116850868,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Q3 2022 Earnings Conference Call October 27, 2022, 4:30 PM ET Company Participants Susie Lisa - Senior Vice President, Investor...",https://finnhub.io/api/news?id=341bf441b97a021ed999a8e4cb99e6d03e47d980ef16cd5591d2251b6eed8795
company,2022-10-27 17:25:09,Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Surpass Estimates,116852169,https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94,VRTX,Yahoo,"Vertex (VRTX) delivered earnings and revenue surprises of 8.67% and 4.69%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=814cb30f30048bd3be564113f6fde89d0d175bc8720c1a84287126c1630fdd98
company,2022-10-27 16:07:34,Vertex Pharmaceuticals Incorporated 2022 Q3 - Results - Earnings Call Presentation,116850835,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2022 Q3 earnings call.,https://finnhub.io/api/news?id=5d20b0617fa2023c394ef5c9245de10402f139786557c03c1f457abeda7afa4b
company,2022-10-27 16:01:00,Vertex Reports Third Quarter 2022 Financial Results,116852171,https://media.zenfs.com/en/business-wire.com/9c5257f5c5cd026cb5659e9ed522a248,VRTX,Yahoo,"BOSTON, October 27, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2022 and increased its full year 2022 revenue guidance.",https://finnhub.io/api/news?id=a3f349ff42de65b65f54d79dc5a6f7ac9c87100630ebc0858a1dc9245667b294
company,2022-10-27 15:09:41,Cramer's lightning round: Stay with Vertex Pharmaceuticals,116870482,https://image.cnbcfm.com/api/v1/image/102079128-1539342565979105501689.jpg?v=1666912181&w=1920&h=1080,VRTX,CNBC,"""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.",https://finnhub.io/api/news?id=be5a333e9230e6466968c530afa606b6f1837f55755dfe2918688d7507d3ee6a
company,2022-10-27 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",116891469,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 7.48% to $287.89 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=d48d1b1ec2ce0efd46462127ab0f12801428ce2e08cbc992758ae6bd2b6e081a
company,2022-10-27 13:11:13,"Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more",116853516,https://image.cnbcfm.com/api/v1/image/106786928-1604892915282-gettyimages-1229053402-AMAZON_PRIME_DAY.jpeg?v=1666905073&w=1920&h=1080,VRTX,CNBC,These are the stocks posting the largest moves in extended trading. ,https://finnhub.io/api/news?id=59ce515600107a09348f92e01dfeab669cc171ed8da1adb54e49c7bdd62f7ee1
company,2022-10-27 12:17:00,Vertex: Q3 Earnings Snapshot,116906519,,VRTX,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c23287f1408c0fd2f3782957c7abed97083270c2defaba325695bb3b75647861
company,2022-10-27 09:30:00,Better Buy: CRISPR Therapeutics vs. Bluebird Bio,116852172,https://s.yimg.com/ny/api/res/1.2/bzXz1IwILPUL4LpQUjYg.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a782d6450799b430c051a71478ebbfcc,VRTX,Yahoo,"Gene editing refers to techniques that allow researchers to modify the DNA of various organisms.  Given that it offers the potential to help discover innovative therapies, it isn't surprising that more and more drugmakers are turning to the technology.  Two prominent biotechs that focus on gene editing are CRISPR Therapeutics (NASDAQ: CRSP) and Bluebird Bio (NASDAQ: BLUE).",https://finnhub.io/api/news?id=8a82205aea6882709d82c37655b1b5ddb76a0799f9deca98d3e0fd4ed443a69f
company,2022-10-27 09:01:24,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 81% Above Its Share Price,116852173,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Does the October share price for Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) reflect what it's really worth...,https://finnhub.io/api/news?id=9b13f5ec3f3d4f98afd757a727ff1bf0c696bea8f25ed92182228100002ba460
company,2022-10-27 08:34:00,Notable companies reporting after market close,116849481,https://thefly.com/images/meta/earnings.jpg,VRTX,Thefly.com,"Notable companies reporti... AAPL, AMZN, TMUS, INTC, GILD, VRTX, EW, DXCM, COF, PINS, ZEN, FSLR, TXRH",https://finnhub.io/api/news?id=fbe9d51c9407a7a50ebed9c268a74f8926ee4bc237f766c627041b89329ebd68
company,2022-10-26 23:05:00,Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B,116906523,https://thefly.com/images/meta/earnings.jpg,VRTX,Thefly.com,Consensus $8.77B.... VRTX,https://finnhub.io/api/news?id=17cf1b005eb1c9ae9ffb144e415a95b33df0fadf5ee3e54ed0c03d70f7b94326
company,2022-10-26 23:04:00,"Vertex Pharmaceuticals reports Q3 EPS $4.01, consensus $3.64",116906524,https://thefly.com/images/meta/earnings.jpg,VRTX,Thefly.com,Reports Q3 revenue $2.33B... VRTX,https://finnhub.io/api/news?id=df66063822e4a4ba5400567876238e222f60aa213f06fad27ae620d7410bc7f9
company,2022-10-26 20:48:00,GLOBAL BRIEFING: Meta quarterly revenue drops; Xi wants US cooperation,116846855,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f9656d5a610344bc44d1cc8c3b9859551c25b5646992eb7b614a19fab93f6d73
company,2022-11-03 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",116942991,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.42% higher to $311.30 Thursday, on what proved to be an all-around dismal trading session for the stock...",https://finnhub.io/api/news?id=99a7c2dee61cde3c27eff58430ceaea9e22606f02c672fd1267835641abf5aa6
company,2022-11-03 10:17:18,Pfizer: Q3 Earnings Review - Planning For Life After COVID,116937529,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1287045622/image_1287045622.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"Pfizer released its Q3 2022 earnings on 1st November. PFE had another blockbuster quarter, generating $22.6B revenues & $8.6B net income. Read more here.",https://finnhub.io/api/news?id=2b273c17b2452fa58ca9c1e9a66c49929c9b4e47fbbae3593febe130ab937c7a
company,2022-11-03 08:10:00,Investors in drug stocks should ignore dubious valuations based on rigged methodologies,116942992,https://images.mktw.net/im-657156/social,VRTX,MarketWatch,The QALY is a methodology imported from socialized medicine systems that helps to put a fig leaf on their denials of access to breakthrough drugs.,https://finnhub.io/api/news?id=f747d5c48a70ee1c1e552e9c1f39e5d8307e9c426b2b9056cb5d3a949f0e3239
company,2022-11-03 08:00:00,Vertex to Present New Data on its Portfolio of Cystic Fibrosis Medicines at the 2022 North American Cystic Fibrosis Conference,116940252,https://media.zenfs.com/en/business-wire.com/ada9a7bdf222ef981b5108cc5377a31a,VRTX,Yahoo,"BOSTON, November 03, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that multiple abstracts on the company’s portfolio of cystic fibrosis (CF) medicines will be presented in posters and oral presentations at this year’s North American Cystic Fibrosis Conference (NACFC), including studies demonstrating the clinical benefits and long-term safety of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor).",https://finnhub.io/api/news?id=bec7cff3cd9983afb75e743c8255d529061106b6f0cf5d5a295595fe130fdac9
company,2022-11-03 06:00:00,Bear Market Investing: Should You Buy Today's Top Performers?,116933937,https://s.yimg.com/ny/api/res/1.2/wafgi13JG2_5E4UOndsQVw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d654e0737388f995ed6f8cbfcc992ebb,VRTX,Yahoo,"Across industries, headwinds such as rising inflation and general economic woes are weighing on companies and stock performance.  Now, the question is: Should you hop on the bandwagon and buy shares of some of the top performers?  Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed more than 40% since the start of the year, and for good reason.",https://finnhub.io/api/news?id=3dd0771bc4746321073b69db85d370d0edd58d54a1c34eed5bfc2f4a15eb8448
company,2022-11-03 05:06:00,3 Nasdaq 100 Stocks to Buy Hand Over Fist in November,116931619,https://s.yimg.com/ny/api/res/1.2/LV8UNDhZuvkbfBcFdQpUjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTA-/https://media.zenfs.com/en/motleyfool.com/ae3abbb078c7d04970bea66ca6d69fec,VRTX,Yahoo,The innovation-driven Nasdaq Composite and Nasdaq 100 -- the Nasdaq 100 is comprised of the 100-largest non-financial Nasdaq-listed companies -- have both lost over a third of their value on a peak-to-trough basis.  What follows are three Nasdaq 100 stocks investors can confidently buy hand over fist in November.  The first Nasdaq 100 stock that's an absolute screaming buy in November is fintech-giant PayPal Holdings (NASDAQ: PYPL).,https://finnhub.io/api/news?id=c13e60432a916f7cd22b25c7270f07c217c2d191037acb1dc0d10eae1eb77741
company,2022-11-02 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,116927177,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.33% to $310.01 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=5e980e39dcc62391d6d04165734864d1f14b625bda16f0bb460979ed35922c02
company,2022-11-02 11:32:03,What Awaits Lantheus Holdings (LNTH) This Earnings Season?,116928793,https://media.zenfs.com/en/zacks.com/35605100ebd4321550c15aea81c175cb,VRTX,Yahoo,Lantheus Holdings' (LNTH) third-quarter results are likely to reflect solid top line results on the back of robust product adoption.,https://finnhub.io/api/news?id=3d1c6907f96de86b7f42a2ba44df49efb4de25a67875344a0adbd9407dc096f5
company,2022-11-02 05:52:00,Is Vertex Pharmaceuticals About to Become a Dividend Stock?,116908742,https://s.yimg.com/ny/api/res/1.2/wKC8yk_fOtaJWvB7k8am7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MDA-/https://media.zenfs.com/en/motleyfool.com/a9cd94e850f1a6a638a2216f120e2741,VRTX,Yahoo,The big biotech has a cash stockpile of nearly $10 billion. Here's how Vertex plans to use the money.,https://finnhub.io/api/news?id=91b3b9bf76ffdedaad7f422c70afaadcb32e310f3d97be92f18000cb2bbc1f5f
company,2022-11-01 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,116891466,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.71% higher to $314.20 Tuesday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=11375e582462dd83568be8cc1beefa11e2f98f1f7e27ec9b066d35e6e3588260
company,2022-11-01 03:10:00,ClearBridge All Cap Growth Strategy Q3 2022 Portfolio Manager Commentary,116879289,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/500619014/image_500619014.jpg?io=getty-c-w750,VRTX,SeekingAlpha,The ClearBridge All Cap Growth Strategy performed in line with its Russell 3000 Growth Index benchmark in the Q3 2022. Click here to read the full fund letter.,https://finnhub.io/api/news?id=496bfc2fd011a06400545cceb35649d2e42823d3810db7af8ad7745aa0aa977f
company,2022-11-01 03:01:00,Highview Capital Management LL - GuruFocus.com,116905876,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=a611afc73fcee2cf3c186294e4c92151529179049374e798687a4f720c82c8d1
company,2022-11-01 01:00:00,Top 5 3rd Quarter Trades of JE - GuruFocus.com,116892308,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=d904d12cf930e6ece6710c6d0bbc3c5f25efbd9a86a7a4bd7d2f7c78d78bd9e4
company,2022-10-31 22:09:00,Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),116906498,,VRTX,TipRanks,Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Vertex Pharmaceuticals (VRTX &#8211; Research Report) yesterday and set a price target of $289.00. ...,https://finnhub.io/api/news?id=0b83e2f82ed692e963e4f5dbaaba00c4bd96e75c5d80a5bdce68fb56a18d314c
company,2022-10-31 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Monday, still outperforms market",116891467,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.60% to $312.00 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=447320e0df0392defed3cc505637e3a5f56cf989bbcc6dd7b995393a39236034
company,2022-10-31 09:00:20,Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 44% Discount?,116880651,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Today we will run through one way of estimating the intrinsic value of Vertex Pharmaceuticals Incorporated...,https://finnhub.io/api/news?id=e5e97b666341388685ce7639ab909985b690d5fcc88f3550910eed08cce0626e
company,2022-10-31 08:49:56,Top 10 Stock Picks of Eli Casdin’s Casdin Capital,116871251,https://media.zenfs.com/en/insidermonkey.com/fe25e8b2ea6512ae48ec312ea037ed79,VRTX,Yahoo,"In this article, we discuss the top 10 stock picks of Eli Casdin’s Casdin Capital. If you want to skip our detailed analysis of Casdin’s investment philosophy and performance, go directly to Top 5 Stock Picks of Eli Casdin’s Casdin Capital. Unprecedented inflation, increasing interest rates, and a worldwide recession pose risks to the 10-year upward […]",https://finnhub.io/api/news?id=83fc4e3428a9630632941a3f37bea39960adb079c19e80f294ab7f2e57d909ac
company,2022-10-31 07:58:00,Can Biotech Stocks Continue Rallying In This Bear Market? ,116889218,https://i0.wp.com/raygent.com/wp-content/uploads/2022/10/image-6.png,VRTX,TalkMarkets,Despite a vicious bear market in 2022 biotech stocks have come back in October recovering with the XBI up 3.72% to $83.76 on Friday.,https://finnhub.io/api/news?id=de4754ef0cfa2e044c44cbdf23ed92cf8121534a863046e1b1cc3941dcabc8e4
company,2022-10-31 07:52:00,Biotech Alert: Searches spiking for these stocks today,116870990,https://image.thefly.com/catalog/201906/img_535.jpg,VRTX,Thefly.com,"Stay ahead of biotech stocks seeing a surge in interest from retail and financial professional investors with this exclusive recap from The Fly KZIA, ETON, ACOR, VRTX, SURF",https://finnhub.io/api/news?id=2ccbd6f0360e0cb68b98848467fb57605db09ecf05b2e6bd0fedba86e8982bc0
company,2022-10-31 05:52:00,Here's a No-Brainer Stock to Buy Now That's Trouncing the Market,116880653,https://s.yimg.com/ny/api/res/1.2/K_BInxz3ksyttZMSXzH9lg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f676685c265b3dd8680d5011ba6452ad,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) shares have skyrocketed more than 35% year to date.  Vertex enjoys a monopoly in treating the underlying genetic cause of cystic fibrosis (CF).  Vertex Chief Operating Officer Stuart Arbuckle said in the Q3 call that the company expects to file for U.S. approval of Kalydeco in treating children ages one month to less than four months before the end of this year.,https://finnhub.io/api/news?id=678dac06b595c7314f917fab3792b51c3788fa87c14e3375d163cacc969bd9df
company,2022-11-07 12:29:00,"Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market",117038850,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.81% to $303.23 Monday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=1180fbb3b2f54529f359caf1d87c4b6ad2313960614f0402f8cd067530d35740
company,2022-11-06 10:00:00,"Got $1,000? 2 Smart Stocks to Consider Buying Right Now",116968258,https://s.yimg.com/ny/api/res/1.2/C00MS0cukreMbRXHHcYx0A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/60bd4902d9d41e830c69522f534733b1,VRTX,Yahoo,"While no stock is entirely impervious to factors like the economy or market volatility, healthcare stocks can be a wise place to park your cash; they are businesses that face consistent demand and can provide steady, gradual portfolio returns over time.  If you have $1,000 to invest right now, here are two smart stocks to consider.  Vertex Pharmaceuticals (NASDAQ: VRTX) may not be as familiar a name as other healthcare companies, but if you're looking to expand into these types of stocks, it's certainly one to add to your watch list.",https://finnhub.io/api/news?id=3d584c9d9f73920b48d3ff492761ebf8aab2f5242c53698012819d33aa7f1b86
company,2022-11-06 08:20:00,"Got $1,000? 2 No-Brainer Stocks to Buy and Hold for at Least the Next Decade",116970001,https://s.yimg.com/ny/api/res/1.2/.239mMJoU1UeFvZk1dU6Gg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f2fc3e7ddde0406fcec79fe8f2128091,VRTX,Yahoo,"In the current environment, with ongoing macroeconomic and foreign currency headwinds, geopolitical unrest, and fears of a global recession, companies across all sectors are being tested.  Biotech stocks tend to be somewhat volatile, higher-risk investments in the world of healthcare stocks.  As always, though, there are exceptions, and Vertex Pharmaceuticals (NASDAQ: VRTX) is arguably one of the most prominent.",https://finnhub.io/api/news?id=a7a3e92614d6cf7306b7e8d8080aad98a4dd434f3e742913a9599c10ef55a0e7
company,2022-11-05 08:41:00,4 Growth Stocks to Buy and Hold Forever,116968425,https://s.yimg.com/ny/api/res/1.2/NcgSzHdfKhztnZWOgW8uDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTM-/https://media.zenfs.com/en/motleyfool.com/a3cc33bcd19c4751042e6366547fef06,VRTX,Yahoo,"Investing in the stock market isn't for the faint of heart these days, but the decisions you make now about your portfolio could impact your financial future for years to come.  If you have the money to put into your portfolio at this point in time, there are still great businesses to be found, even if some of them have seen shares decline in recent months against the backdrop of broader market volatility.  Today, we're going to take a look at four top growth stocks that you may want to consider adding to your buy list before we hit the end of 2022.",https://finnhub.io/api/news?id=55fa88648c161b40c01211760a45a3695708ed13f3f896007c4f9d2ff222fc7c
company,2022-11-05 07:01:00,Vanguard Health Care Fund Exit - GuruFocus.com,116984941,https://static.gurufocus.com/photos/others/iStock_healthcare_money_2013_09_25.jpg,VRTX,GuruFocus,GuruFocus Article or News written by James Li and the topic is about: Health care-oriented fund releases quarterly portfolio,https://finnhub.io/api/news?id=4f44ac9f209f671594a12506b971e98881fb041b7cef170cbe600d5c3bd6be8e
company,2022-11-04 17:46:23,Top Biotech Stocks for Q4 2022,116963247,https://media.zenfs.com/en/investopedia.com/723171c6679e91c85fa3258a4eecc520,VRTX,Yahoo,"The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions.  This means that investors may wait for years before knowing whether a drug under development will pay off.  The industry includes smaller start-up companies with recent traction as well as large, well-established corporations that aim to develop a range of drugs and technologies.",https://finnhub.io/api/news?id=398e993d43381f6f534b43381af40cd1d0f733e16ebd5c500dce002ee1769628
company,2022-11-04 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",116975705,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.80% to $308.82 Friday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=53939a21b0f86d1f4f795dba051f12df1dfa3658788eeb08821325ebc65e3158
company,2022-11-04 11:18:03,"Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up",116953960,https://media.zenfs.com/en/zacks.com/cb4b690d325dd8102d704a07d05bf229,VRTX,Yahoo,Puma Biotech (PBYI) beats earnings and revenue estimates for third-quarter 2022. It increases product revenue guidance for full-year 2022 to reflect improving demand trends for Nerlynx in the United States.,https://finnhub.io/api/news?id=d1656de85ee2ba92a3c6dcdee946c73df873bda1fefb97842cd8b51cb38034b7
company,2022-11-04 10:45:02,"TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down",116953961,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,"TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.",https://finnhub.io/api/news?id=c49e769f86c50153680aa85be369f81c8289005ab709398320920a4ca72f83b9
company,2022-11-04 09:07:00,2 Biotech Stocks That Could Make You Richer,116953962,https://s.yimg.com/ny/api/res/1.2/sWmjzeUFQ3D4AA085fXO8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/032787ff3c8466fd6e2bdb5aeccbe5f3,VRTX,Yahoo,"Equity markets are deep in the red for the year, and so is the broader biotech industry.  Vertex Pharmaceuticals is living proof that drugmakers do not necessarily need a diversified and deep lineup to be successful.  Here's the catch: Vertex holds a monopoly in this area.",https://finnhub.io/api/news?id=ef3781f1bdf7a4778d15b24ae8657627a1e623426001cc9311a3100ccc679d16
company,2022-11-04 09:00:45,Is There An Opportunity With Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) 38% Undervaluation?,116953963,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,How far off is Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) from its intrinsic value? Using the most recent...,https://finnhub.io/api/news?id=d54d627a4619f09c07bd56a628d69d4f7776303c864607730bda769429c6574d
company,2022-11-04 08:00:00,Vertex Announces Partnership with Basketball Hall-of-Famer Alonzo Mourning to Raise Awareness of APOL1-Mediated Kidney Disease (AMKD),116953964,https://media.zenfs.com/en/business-wire.com/eecbfbd830c66cedf5715c9b1d2d7faf,VRTX,Yahoo,"BOSTON, November 04, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with basketball Hall-of-Famer Alonzo Mourning to launch ""Power Forward"" (www.PowerForwardTogether.com), an educational initiative aimed at raising awareness of APOL1-mediated kidney disease (AMKD), highlighting the importance of early diagnosis and genetic testing.",https://finnhub.io/api/news?id=405934963a961619bd910f090b1b1ad818c8ee3c221be42fdc1c4444a701c9a8
company,2022-11-11 12:29:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",117126283,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 2.50% to $303.26 Friday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=149c9fea38b952972b8806cc320d7028dce4dadb4b1a69d0d4ffb0e9babf69a2
company,2022-11-11 09:00:00,3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,117110223,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) is something of a unicorn in the world of stocks right now.  While the S&P 500 has slid by nearly 20% over the past 12 months, Vertex is up by around 60% in that same period.  While it's true that healthcare stocks tend to outperform when the market is down, this is far from the only tailwind driving Vertex's precipitous growth in such a volatile market.",https://finnhub.io/api/news?id=e470921eb165c003cf255fe14ab8ec12658b4611ee08bb5c91b7387c67a0881b
company,2022-11-11 08:18:42,"Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more",117116153,https://image.cnbcfm.com/api/v1/image/107056560-1651758861219-gettyimages-1166686090-a66i9653_2019080744630691.jpeg?v=1668190722&w=1920&h=1080,VRTX,CNBC,These are the stocks posting the largest moves in midday trading. ,https://finnhub.io/api/news?id=82df2b3cabd580a4ad3b9f2661f94ebe359255fa22361779477a133c92c1ff22
company,2022-11-10 12:29:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market",117126284,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.55% higher to $311.03 Thursday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=e2ca160914b675be2da4e5a1d7a3ac55c154099d3a66f10c9737d15b85608b77
company,2022-11-10 11:40:04,"Jazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive Sales",117073470,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,VRTX,Yahoo,Jazz's Q3 earnings and sales beat expectations on strong demand for new drugs and drugs added with the GW Pharmaceuticals acquisition. The company raises the mid-point of its 2022 sales guidance.,https://finnhub.io/api/news?id=07e222bea6c06b6adb2142086539eeef11ef0502ab96da15d0744b4f3a180904
company,2022-11-10 10:20:03,"AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up",117073471,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,VRTX,Yahoo,"AstraZeneca (AZN) beats third-quarter estimates for earnings while sales come in line. AZN raises its 2022 earnings growth guidance, keeping its sales forecast unchanged.",https://finnhub.io/api/news?id=f7420c2cc736c96054421517f043db4ac271c739dcd381aa0d04821e4719317c
company,2022-11-10 06:51:00,"SECTOR GAMMA AS Buys 1, Sells  - GuruFocus.com",117074347,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=7d1761f928d4a418b8dbc691b627003ad5f12ed8e27a9f90fe867d8c98b462dc
company,2022-11-10 06:05:00,3 Top Healthcare Stocks Defying the Bear Market,117067438,https://s.yimg.com/ny/api/res/1.2/DmTP4GkN8zF9g_mOMPag5g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d2931e66b25aee37d6e92ac6e8486cf4,VRTX,Yahoo,"Many healthcare stocks' earnings reports lately include the phrases ""inflationary pressures,"" ""labor shortages,"" ""supply chain issues,"" and ""short-term macroeconomic conditions"" to describe why earnings are flat or down.  UnitedHealth Group (NYSE: UNH), AbbVie (NYSE: ABBV), and Vertex Pharmaceuticals (NASDAQ: VRTX) are all up 8.5% or more this year despite the headwinds affecting so many companies.  It's easy to see why UnitedHealth Group's shares are up more than 8.5% so far this year.",https://finnhub.io/api/news?id=5ee05e9afca63bbe4631d681e307f0e02692ef1be6fa19d29517a655ab72787c
company,2022-11-09 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,117038846,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.93% higher to $309.34 Wednesday, on what proved to be an all-around rough trading session for the stock...",https://finnhub.io/api/news?id=d65c19c74c35cfc3830f75ae27c81fe9b4615ee1982b22b2b3a911de1e2ca707
company,2022-11-09 08:00:00,Vertex to Participate in Upcoming Investor Conferences,117029714,https://media.zenfs.com/en/business-wire.com/71635ba50aa3a6f023c58fe6e9920fad,VRTX,Yahoo,"BOSTON, November 09, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced its participation in the following upcoming investor conferences:",https://finnhub.io/api/news?id=c991d3448af08677bc96a4b27dbce7dc8ad48f3fdc496974a8b7bdb23175f155
company,2022-11-08 12:45:05,Here is Why Growth Investors Should Buy Vertex (VRTX) Now,117004176,https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a,VRTX,Yahoo,"Vertex (VRTX) is well positioned to outperform the market, as it exhibits above-average growth in financials.",https://finnhub.io/api/news?id=e7d5ebca06517b4ef265439ffcd2cf0ae73be321dda232f9272c2046068c3257
company,2022-11-08 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market",117038848,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.08% to $306.50 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=b8d868d525d64af7d43eb06034278c586e9de48b84be321b1f0186e3fabce31d
company,2022-11-08 11:22:04,"Perrigo (PRGO) Lags on Q3 Earnings & Sales, Lowers '22 EPS View",117004177,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,VRTX,Yahoo,Perrigo (PRGO) reports dismal third-quarter 2022 results. Unfavorable currency movements force management to lower earnings outlook for 2022. Shares down.,https://finnhub.io/api/news?id=ba3ac04d8f0cb3f1fc225730b1f631e1e20f3aed2fa96a4f12aac06fc6dd8146
company,2022-11-08 10:18:58,Should You Invest in Vertex Pharmaceuticals Incorporated (VRTX)?,117004178,https://media.zenfs.com/en/insidermonkey.com/bc370b62cbf5817664f6fa2ccb73beb1,VRTX,Yahoo,"ClearBridge Investments, an investment management company, released its “ClearBridge Aggressive Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark index, Russell 3000 Growth Index, in the third quarter. The healthcare sector was the primary contributor to the strategy’s performance, while communication services detracted from […]",https://finnhub.io/api/news?id=2a280443f17ee4640d5a36c270b2d9d0249633525f4b8efac3097fc9ba9c0832
company,2022-11-08 08:00:32,Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 105%,117004179,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...",https://finnhub.io/api/news?id=01f47f4a4c766befd3e6affb49daa634e809d35adfeefdb3ecda6a0530078b11
company,2022-11-08 06:46:28,Kymera: Upcoming Trial Data Will Make Or Break The Company,116994127,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345098965/image_1345098965.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Kymera has some critical trial data coming up this quarter. Other IRAK4 inhibitors have been having trouble. Click here to read a full analysis of KYMR stock.,https://finnhub.io/api/news?id=51d4e3ff61af556b4642679ee278254b91c645529c420eb84228b525890e4201
company,2022-11-15 16:16:09,Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal,117170671,https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a,VRTX,Yahoo,Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.,https://finnhub.io/api/news?id=b4fb266c4a29e888f4270bc219484c70e4340595a148ce52566ed1b934841073
company,2022-11-15 10:09:03,AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use,117164388,https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41,VRTX,Yahoo,"The CHMP recommends expanded use of AstraZeneca's (AZN) three key cancer drugs, Lynparza, Enhertu and Imfinzi.",https://finnhub.io/api/news?id=9f54da2ee360f142f34a2ef890c2ce57100d9e1686471fd9a0c6e7001a82d2ba
company,2022-11-15 06:30:00,Crispr Therapeutics Stock: Bull vs. Bear,117155509,,VRTX,Yahoo,"Crispr Therapeutics (NASDAQ: CRSP) may be about to prove the strength of its gene-editing technology.  The biotech company is submitting its candidate to treat blood disorders to regulators in the U.S., Europe, and the U.K. this month.  If regulators give Crispr the nod, it may soon reach the major milestone of product commercialization.",https://finnhub.io/api/news?id=e94820c8d0b04073dd9c51f8af13049a26e9366e177b84056b2523c93da2dbc0
company,2022-11-15 06:00:00,5 Top Stocks to Buy Before 2023,117155654,,VRTX,Yahoo,"Amazon (NASDAQ: AMZN) is a leader in two markets set to grow in the double-digits this decade: e-commerce and cloud computing.  As a result, Amazon's reported declines in operating income.  Amazon has the market position and financial resources to weather these times.",https://finnhub.io/api/news?id=db155f2b7fe181144a69d93c963d5b62a979a2bc848a2c644332da06fcee2cbd
company,2022-11-15 05:01:00,"BRIDGER MANAGEMENT, LLC Buys 1 - GuruFocus.com",117159530,https://static.gurufocus.com/images/logo_global.png,VRTX,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=a50ff34808d9046f85e5dcf0d468633ee37ca2b33e2f9deeee41d83f23f3d33a
company,2022-11-14 19:50:00,"Tweedy, Browne Fund Q3 2022 Commentary",117151509,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/170208977/image_170208977.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"In this volatile environment, the Tweedy, Browne Funds trailed their respective primary benchmark indices for the quarter. Click here to read the full fund letter.",https://finnhub.io/api/news?id=d1f529657d415390e2f7279a37a16f6bfe95ccb52657685ed6aa1e72498057a0
company,2022-11-14 13:15:01,This Biotech's Bull Signal Has Never Been Wrong,117145981,https://media.zenfs.com/en/schaeffers_investment_research_24/218dcf8a97b5c7b7061403a79cc23415,VRTX,Yahoo,"The stock could hit fresh highs, if past is prologue",https://finnhub.io/api/news?id=17ac06e49fce222817083633ddcaf595d7e57c720fb2aafe0c8bf7f82c3ac9e0
company,2022-11-14 08:24:00,Vertex Pharmaceuticals: Is the Recovery Story Intact?,117145982,https://s.yimg.com/ny/api/res/1.2/e539PWSDwttGawMEsVNXaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/thestreet.com/ff9430e4e3dfe339c88d4224d9da79d7,VRTX,Yahoo,Vertex Pharmaceuticals  is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.  Trading volume has been stable but an increasing pattern would be preferred.  The On-Balance-Volume (OBV) line shows a rise over the past year telling me that buyers of VRTX have been more aggressive than sellers.,https://finnhub.io/api/news?id=9ef205e973952c5c22c5f9cdbec86fe90306c1ee0495d6a270e60e13111018bc
company,2022-11-14 06:00:00,Vertex Pharmaceuticals: Buy at the High?,117145984,https://s.yimg.com/ny/api/res/1.2/lV7bqd08BVxQokUpM_vxNA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/ef69f91b51ea7edea8d79d426a6b9ae4,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days.  The biotech company is developing two candidates that could make it even stronger in the billion-dollar cystic fibrosis (CF) treatment market.  Vertex already is a leader in the market.,https://finnhub.io/api/news?id=8e3f22e531cd1ce9bbf2a97efb7a3babcf1b3e7e021c269a71075b201cc04196
company,2022-11-13 13:28:25,Vertex: High Growth For Years Ahead,117138953,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1326625612/image_1326625612.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Vertex is the market leader company for Cystic Fibrosis disease. The company reports unexpected sales and earnings growth in recent quarters Q3.,https://finnhub.io/api/news?id=dd7b258b859f483ba7892042f817363216b6d69ae6da141055e9c4c0b7fa6eac
company,2022-11-13 08:00:33,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 63% Above Its Share Price,117136762,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Vertex Pharmaceuticals...,https://finnhub.io/api/news?id=fef8a659724cc933f21c8f76adae7920fe8a26fa128677d0bac58a92b3a03b85
company,2022-11-12 08:05:00,"Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade",117129740,,VRTX,Yahoo,"While there are no guarantees when it comes to investing in the stock market, setting defined goals for your portfolio and investing accordingly in companies that align with your risk tolerance and interests can help you build a profitable basket of holdings that stand the test of time.  Vertex Pharmaceuticals (NASDAQ: VRTX) is one company that has fundamentally changed the meaning of a cystic fibrosis diagnosis.  This means that among a range of benefits, these drugs can help cystic fibrosis patients live longer.",https://finnhub.io/api/news?id=47b88cd1f5aa9b60fc5c29d8958846d48ad973668dd66f3ff6e3086ba566317a
company,2022-11-19 09:15:00,3 Unstoppable Growth Stocks to Buy and Hold,117212283,,VRTX,Yahoo,"Three simple words can make you a lot of money over the long run: buy and hold.  Here's why they chose Pfizer (NYSE: PFE), Thermo Fisher Scientific (NYSE: TMO), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Prosper Junior Bakiny (Pfizer): Pfizer has grown its top line at an incredible pace over the past two years.",https://finnhub.io/api/news?id=a657c40bc021d9520a6eaf529bd5b7c9389f5e34db4764bae2a81946d766cb8e
company,2022-11-19 07:39:27,"Market Rally Holds Key Levels, But This Has Been Difficult; Tesla Woes Continue",117210482,,VRTX,Yahoo,Dow Jones futures: The market rally found support but new buys struggled. Here are seven investing rules to follow. Tesla stock hit fresh bear-market lows.,https://finnhub.io/api/news?id=83be3d31122a1c522cd43b71b836ac5d4ac1ef2107a30539edbc97c1e280393b
company,2022-11-19 06:30:00,Bear Market Blues? 3 of the Best Stocks to Own in 2023,117212285,,VRTX,Yahoo,"Most investors are more than ready for stocks to take off in a new bull market.  Vertex Pharmaceuticals (NASDAQ: VRTX) is heading for its biggest catalyst in a long while.  First, it marks Vertex's move beyond its cystic fibrosis (CF) specialty into another treatment area.",https://finnhub.io/api/news?id=b65cf2eb77755e8d9e806f6315444fe79f8784ae920e6d8f740600e27aec23f9
company,2022-11-18 16:51:27,Dow Jones Futures: 7 Investing Rules For A Tricky Market Rally; Tesla Skids To Bear Market Lows,117200184,https://media.zenfs.com/en/ibd.com/684f385ad61aefe8aae4973a061ad5be,VRTX,Yahoo,Dow Jones futures: The market rally found support but new buys struggled. Here are seven investing rules to follow. Tesla stock hit fresh bear-market lows.,https://finnhub.io/api/news?id=e25972dd7401228bf302cc205de6bcfca26ae116a27a500416606f9e3a92517e
company,2022-11-18 12:29:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,117204542,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.53% to $314.63 Friday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=35909ad3ff6e933626cce6e97f3453f0b7ce58185b67cc30d73531892832abe4
company,2022-11-18 08:00:09,An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 37% Undervalued,117197935,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Today we will run through one way of estimating the intrinsic value of Vertex Pharmaceuticals Incorporated...,https://finnhub.io/api/news?id=67b5e6d309531dead9bb97262b6b0b4e87c6fe96ad24c66cc4368c745bf741ae
company,2022-11-18 05:56:00,3 Top Growth Stocks to Buy Sooner Rather Than Later,117196042,https://s.yimg.com/ny/api/res/1.2/.cuG1mqShz8ZUIoyNHqoTA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/5fc6064833962bed8b29c3418c29c8f8,VRTX,Yahoo,"If you want some great investing advice, just listen to The Rolling Stones: You can't always get what you want, but time is on your side.  The biggest knock against MongoDB is that it isn't profitable yet.",https://finnhub.io/api/news?id=88f77f16b6ec89530b4a55b64b24f98afd866a1d8d92ee58a37a3480c2153cc6
company,2022-11-17 12:29:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,117204544,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.46% to $309.90 Thursday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=58bcca61dd5cb647bcb1a7eb6fbc2da2377bc9903829d269e032b6ef563c4000
company,2022-11-17 11:40:04,VRTX or TECH: Which Is the Better Value Stock Right Now?,117191369,https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9,VRTX,Yahoo,VRTX vs. TECH: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=dfabe192f7de096083d1ed17ab2a78d17b1690ea56e9760b8a633f195740eec0
company,2022-11-17 10:07:00,2 Growth Stocks That Could Double in 2023,117184965,https://s.yimg.com/ny/api/res/1.2/F3Z1fMQF48hAXWv1Gc.V6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/a0ba4622b43e2899815430865420a4dd,VRTX,Yahoo,"Investing in biotech companies, especially relatively small ones, can be a double-edged sword.  With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics (NASDAQ: CRSP) and Bluebird Bio (NASDAQ: BLUE).  Right now, CRISPR Therapeutics is a clinical-stage biotech.",https://finnhub.io/api/news?id=eca4d64fd58b3dfecfa2e9036cd3d637fdd2cd825949aef3e2df213d9f35bd49
company,2022-11-16 12:29:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gains,117204545,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.05% higher to $305.44 Wednesday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=a4492365c4028f1dbedad418ab2da760c3e7012962e7f8b7015fb6b31a3fb6ce
company,2022-11-16 09:37:32,Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Outperformed in the Third Quarter,117179019,https://media.zenfs.com/en/insidermonkey.com/03a6e5ed068a6575327e23896182338c,VRTX,Yahoo,"Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund underperformed its benchmark index. Its Investor Class fund ARTLX returned -7.04%, Advisor Class fund APDLX posted a return of -7.07%, and Institutional Class fund APHLX […]",https://finnhub.io/api/news?id=565375e38df8dafb996b341a72255ac117e47c05f915da88a9319578c4a123a7
company,2022-11-16 05:20:00,2 Hot Growth Stocks That Can Continue to Soar in 2023,117176491,https://s.yimg.com/ny/api/res/1.2/0OF6d6JMeUjoZC6vXfi11A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a49c3e41d3b016fbe700577417426a3d,VRTX,Yahoo,Two of the hottest stocks on the markets this year are Vertex Pharmaceuticals (NASDAQ: VRTX) and Occidental Petroleum (NYSE: OXY).  Vertex is up almost 37% so far in 2022 and Occidental is up an amazing 156%!  Here's why these two hot growth stocks could continue to do well in 2023.,https://finnhub.io/api/news?id=9b3f3d8a2dc995b5e386a9afc17b650f3c50debfccd1e274828bc4d5c443695c
company,2022-11-16 04:26:05,Vertex Pharmaceuticals Incorporated (VRTX) Jefferies London Healthcare Conference (Transcript),117171514,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Jefferies London Healthcare Conference November 16, 2022 4:10 AM ET Company Participants Stu Arbuckle â Executive Vice President and...",https://finnhub.io/api/news?id=a6502138543c5cc5b3f853d04202ac6bbdcb4fb42ed5df237a5d2b86e6922837
company,2022-11-23 18:47:47,7 Stocks on the Perfect 10 List,117299136,https://media.zenfs.com/en/investorplace_417/8e17ec9d014916c3675298beb4850cb4,VRTX,Yahoo,"A stock that scores a perfect 10 should be on every investor’s list of stocks to buy. Any company that receives full marks on quality, value, or growth are stocks I’d considering a perfect 10. For this article, I’m using StockRover’s stock screening tool, which screens for such qualities among a very large basket of companies. Despite many of these stocks to buy scoring so highly on one particular attribute, the market has heavily discounted most of these companies. Thus, it appears a tug-of-war",https://finnhub.io/api/news?id=141643e91501e997ac5de1d46e756c84bafac7449c5919599227173ba25a4557
company,2022-11-23 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",117296668,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.65% to $316.16 Wednesday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=19bf0bee8358813e2f229233dbf15a4eb7ae5df327d50ed26e8569f6d4b3502f
company,2022-11-23 09:59:02,GSK to Withdraw Blenrep From U.S. Market on FDA Request,117267431,https://media.zenfs.com/en/zacks.com/44fc6e96ff9dff6be2f033510781bcfa,VRTX,Yahoo,"GSK, at the request of the FDA, is set to withdraw the U.S. marketing authorization for Blenrep. The FDA's request comes after the failure of a phase III confirmatory study, DREAMM-3.",https://finnhub.io/api/news?id=6ca8984a8f928c91c4420c2f93f46042e2bd71c4b8242794634d686eec966ac4
company,2022-11-22 12:29:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,117296669,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.67% to $321.48 Tuesday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=67f4d85eb4982ee9823852352c8f158bba7667264232cef8294b2fa613e5d6f5
company,2022-11-22 10:00:15,"We still think there's more room for biotech to go higher, says Jefferies' Yee",117256583,https://image.cnbcfm.com/api/v1/image/107155846-16691460531669146051-26734515867-1080pnbcnews.jpg?v=1669147215&w=1920&h=1080,VRTX,CNBC,"Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss what's behind the general move higher in biotech stocks, why biotech stocks were under-owned not long ago and if it's too late to 'nibble' on stocks in the sector.",https://finnhub.io/api/news?id=7e21fa18916b8fe72f13b787205058eb3ead11af4c663d86fb3db5f7728da2f5
company,2022-11-22 06:15:11,AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag,117249930,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,"The FDA grants priority review status to AbbVie's (ABBV) BLA for epcoritamab for the relapsed/refractory large B-cell lymphoma (LBCL), a form of NHL.",https://finnhub.io/api/news?id=738f9651c189d42abe5f1cc591f873e550e02a996dd3be4040c2c9b2d9afadac
company,2022-11-22 06:02:12,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 36% Below Their Intrinsic Value Estimate,117254854,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Today we will run through one way of estimating the intrinsic value of Vertex Pharmaceuticals Incorporated...,https://finnhub.io/api/news?id=c2b2a72d88ccbb2529b6ab1f587ced6a2823f6741d6d8901f056a9e0a2ebbfe3
company,2022-11-21 12:29:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains,117296670,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.50% higher to $316.20 Monday, on what proved to be an all-around rough trading session for the stock market,...",https://finnhub.io/api/news?id=d7ed5e8774fc734470accd557b4a3038ef20f4351fe7faa1111f3a071869a37f
company,2022-11-21 09:40:02,Why Vertex Pharmaceuticals (VRTX) is a Top Value Stock for the Long-Term,117240847,https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a,VRTX,Yahoo,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,https://finnhub.io/api/news?id=d7ec3b8890d698e551c60fb7b1e3b8b5798f453cdac62c486d647a98fc7a1aec
company,2022-11-26 06:00:57,Are Robust Financials Driving The Recent Rally In Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock?,117294390,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ:VRTX) has had a great run on the share market with its stock up by a significant 11...,https://finnhub.io/api/news?id=cf813dfc39076abd005175b6e349328de2b5cb28d35f2bd042606fa195b502b5
company,2022-11-25 05:52:00,Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead,117288548,,VRTX,Yahoo,Cathie Wood remains optimistic. Her ARK Invest exchange-traded funds (ETFs) have continued to scoop up stocks during the steep downturn this year. But she's apparently not optimistic about all of her ARK holdings.,https://finnhub.io/api/news?id=ad5ab3bcbc447db27e93226412dc76f54e5d7c810ab4b8c5e6a47b57cd3f36d4
company,2022-11-24 11:25:04,BioMarin (BMRN) Up After FDA Scraps AdCom Meet for BLA Filing,117278867,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,VRTX,Yahoo,"The FDA decides not to hold an advisory committee meeting for BioMarin Pharmaceuticals' (BMRN) regulatory filing seeking approval for hemophilia A gene therapy, valrox.",https://finnhub.io/api/news?id=c67cc5aeeca885ac7c5c6ccc23876b621e22da1655f306de6e08d774a745b0ec
company,2022-12-01 17:45:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,117367189,,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $320.76, moving +1.38% from the previous trading session.",https://finnhub.io/api/news?id=2e18224a8a52f46f7d9aa12f4b2de026a7baead091fdee7b4f6e5be0ca0d7010
company,2022-12-01 12:44:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",117410777,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.38% to $320.76 Thursday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=ba8465a5b66999aad66bd0051a135d8957eec4eb9f0df0096bbf0100c7c54272
company,2022-12-01 10:00:00,3 Growth Stocks That Are Too Cheap to Ignore,117360879,,VRTX,Yahoo,"The stock market hates uncertainty, and the global factors driving the market in 2022 have understandably left many investors feeling frustrated.  While no one can predict when this volatile period will wrap up, the history of the stock market has shown that patient investors who maintain stakes in great businesses can sustain and compound rewarding returns with time.  Currently, the company relies on its portfolio of cystic fibrosis (CF) medicines to drive revenue and profits, and it continues to deliver on both fronts year after year.",https://finnhub.io/api/news?id=688c3ed38fa20f6b5363e47493a653e8b6df346c540de02b0e3f1005feb639b5
company,2022-12-01 09:03:02,Vertex Pharmaceuticals Incorporated present at 5th Annual Evercore ISI HealthCONx Conference (Transcript),117362863,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) 5th Annual Evercore ISI HealthCONx Conference November 30, 2022 9:15 a.m.",https://finnhub.io/api/news?id=d88455fbc14744f98640c364d5b53b551e3253ec523db5a1e39de5029f639b1a
company,2022-12-01 08:09:01,Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug,117359899,https://media.zenfs.com/en/zacks.com/f84faa3d65021260b4cd14c75493ef6c,VRTX,Yahoo,Data from a phase III early symptomatic Alzheimer's disease study shows that Eli Lilly's (LLY) donanemab leads to a significant reduction of amyloid buildup in the brain and P-tau in the blood after six months.,https://finnhub.io/api/news?id=b48b94618316b2c70b6b17b95d93e4b83a4696f1d020147b58e006a27cafcace
company,2022-12-01 06:00:00,Looking for a Once-in-a-Decade Buying Opportunity? Buy These 3 Stocks Before 2023,117358172,https://s.yimg.com/ny/api/res/1.2/Ax_Nb8DOhTwbrEHi5P3kGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e4718777e2d6b1ae9d8f845c3c8d6671,VRTX,Yahoo,The dark cloud of a bear market has a silver lining: It offers investors opportunities to get in on great stocks for a bargain price.  Today's bear market is handing us a few once-in-a-decade buying opportunities on a silver platter.  Vertex shares are heading for a 44% gain so far this year.,https://finnhub.io/api/news?id=d8600c239edf3829f4952597555cd4b5169ea579a08d9153ff3dc5b3ff258836
company,2022-11-30 12:30:14,Top Healthcare Stocks,117347033,,VRTX,Yahoo,"The top healthcare stocks include Azenta Inc. for best value, McKesson Corp. for fastest growth, and Signify Health Inc. for most momentum.",https://finnhub.io/api/news?id=db403d448312452d542b4f0dd673d57e97df69ba4083d2f5fb7bd75fd2ee283f
company,2022-11-30 09:00:11,Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 37% Discount?,117349216,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Does the November share price for Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) reflect what it's really worth...,https://finnhub.io/api/news?id=41051a784a2e87a6855d8f2d929c2cd36c2b6a151dc34965114849cf5c430bec
company,2022-11-30 08:53:01,Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects,117346313,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,Detailed data from Biogen (BIIB) and Eisai's Clarity AD shows that treatment with lecanemab in the early stages of Alzheimer's disease reduces the rate of cognitive decline but is associated with adverse events like brain hemorrhage.,https://finnhub.io/api/news?id=71804be07b812414bf1d8967c280f2c663a0b38118cfcfa7fa29e844cd8b12c7
company,2022-11-29 12:44:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,117333560,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.33% higher to $316.33 Tuesday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=cfcd631e77f5f4704e01e04ce35fba1b58a537344a705540635ed6e066f986f5
company,2022-11-29 04:07:50,Vertex Pharmaceuticals: Growth Outside Of Cystic Fibrosis Critical For Additional Value Creation,117323467,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1353602218/image_1353602218.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"Vertex reported strong results in the third quarter, driven by growth in ex-U.S. markets. VRTX is well-positioned for long-term growth. Read more on VRTX here.",https://finnhub.io/api/news?id=682e0f9b42852f5696a0832816f0255f4a491b3050bb399511c85ad9f8724abe
company,2022-11-28 06:38:00,Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead,117664321,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=208fa3633b2a94fa32d7a3553068a9b065b73571a108040b6d4b7be918096f3b
company,2022-11-28 05:33:00,2 Stocks Near 52-Week Highs That Could Climb Higher,117308464,https://s.yimg.com/ny/api/res/1.2/Q6NZU4lt1Y3RKHavB6WL3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d6272472236be1e037147b7993e1bd60,VRTX,Yahoo,"Rising interest rates and a looming recession that those higher rates could cause are weighing heavily on stock prices across the board.  Shares of Biogen (NASDAQ: BIIB) have been on a roller coaster over the past couple of years.  The stock rocketed higher in 2021 after the FDA granted a highly controversial approval to the company's Alzheimer's disease drug, Aduhelm.",https://finnhub.io/api/news?id=18305e0e5fef076411e9ae8da2f8070f123e956fc0562767727ff03ccf380f5e
company,2022-11-28 03:55:00,Early notable gainers among liquid option names on November 28th,117923936,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=79a9e81384d5ad7ae8143c810c776300c902b13551ca65029d4038989455ffaf
company,2022-12-05 12:44:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,117410774,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.17% to $317.60 Monday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=4bd3b9fd8b609895f159a66bbff94bff95f25295b6893f8e78059cef818cd97c
company,2022-12-05 10:36:03,GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe,117403561,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,"GSK's new drug application (NDA) for momelotinib is under standard FDA review, with a decision expected on Jun 16, 2023.",https://finnhub.io/api/news?id=723507e4af959f08a50906a086c831727fef882e0040a8d875f5b716d37c129c
company,2022-12-05 09:15:02,Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run?,117403562,https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c,VRTX,Yahoo,"Genmab AS Sponsored ADR (GMAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",https://finnhub.io/api/news?id=1b65737044b0b664e7fa3b75fbf7fb0bb7a0b8f97011ee3737e0651d3e2d1279
company,2022-12-05 06:24:26,2 Generational REIT Buying Opportunities,117403027,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155142981/image_155142981.jpg?io=getty-c-w750,VRTX,SeekingAlpha,REITs are volatile and this results in a lot of opportunities to profit. Read why REITs are again priced at historically low valuations.,https://finnhub.io/api/news?id=0fc84bcfd9d2cbd2918ce3206d76948ce09b50263fc46543d8a7c55580f3de8f
company,2022-12-04 10:15:00,Is This Biotech Stock a Buy Following a Landmark Approval?,117396738,,VRTX,Yahoo,"Provention Bio (NASDAQ: PRVB) is a small-cap biotech whose shares have doubled in the past three months.  The company can thank the expected and eventual approval of Tzield for that performance.  In mid-November, Tzield became the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for the delay of the onset of type 1 diabetes (T1D) in at-risk patients.",https://finnhub.io/api/news?id=7015faf466c1a4c5ad8baa4f4730a7f14a595f09c223c097043be5fdc99857de
company,2022-12-04 08:00:30,Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 124%,117396739,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...",https://finnhub.io/api/news?id=74a9a7cfcd4a09ff3770c56df6b5bf09981d53a4e4107eb92d70c996d6f8ffc8
company,2022-12-03 07:31:00,3 Stocks to Buy Hand Over Fist in December,117387876,,VRTX,Yahoo,"Here's why they think that AbbVie (NYSE: ABBV), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX) are stocks to buy hand over fist in December.  Prosper Junior Bakiny (AbbVie): The end of the year is always a great time to review your investment portfolio.  The drugmaker is set to lose U.S. patent protection for its biggest cash cow -- autoimmune-disease medicine Humira -- next year.",https://finnhub.io/api/news?id=6bf441499e2a4580bb7b6830ece325a0cd9fe7b669aa9e87060c28682694e110
company,2022-12-03 07:09:00,My 2 Top Growth Stocks to Buy for 2023 and Beyond,117387421,,VRTX,Yahoo,Long-time shareholders of these companies can testify that both have patterns of beating the market.,https://finnhub.io/api/news?id=f6e4982938b77914d65b95c3d7074737f57dd630309fb7131db4e4fa037a6a7e
company,2022-12-03 05:57:00,12 Top Stocks to Buy in December,117387202,,VRTX,Yahoo,"The number 12 is tightly linked with December. It's the 12th month, of course. There are 12 days of Christmas, according to the traditional carol. Allow me to add one more connection with 12 to the list.",https://finnhub.io/api/news?id=992bd10fca2c34c85290f034227ff09fad7eddbc301f5e8d2a3589efbfa5d404
company,2022-12-02 12:45:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",117410775,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.19% higher to $321.37 Friday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=f56458ebc7231ab7cb4318eae38aa676a4037c36cd52021451e98886341b0f3f
company,2022-12-02 11:05:04,"Roivant (ROIV), Pfizer Form Vant for Inflammatory Disease Drug",117381836,https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e,VRTX,Yahoo,"Roivant Sciences (ROIV), Pfizer's (PFE) new Vant company will take care of funding the global development of RVT-3101 in inflammatory and fibrotic diseases.",https://finnhub.io/api/news?id=ffc918544f48f2fb4ad429f1fd2d1902caf7427508a70a447a43e49c600e8961
company,2022-12-02 09:45:08,BBH: Portfolio Of Large-Cap Biotechnology Stocks Has Delivered Strong Returns,117378542,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358625679/image_1358625679.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"BBH has an asset base of $520 million, posted strong growth over the past 6 months, and is trading much higher than its pre-pandemic price range. Click here to learn more.",https://finnhub.io/api/news?id=5e5f3f8e58df8e06fb2eb5be86c731e7de3eec7229b466a5c6ffc5c13a637f5a
company,2022-12-02 06:30:00,"If You Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today",117374027,,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) has been a bright spot in this year's bear market.  The past few years have brought Vertex ups and downs.  Vertex stock was trading at about $140 exactly five years ago.,https://finnhub.io/api/news?id=9ad54fad6fb50199419b67fdaa1ab95f01a99dee6ff6b308816c0ad7c1fd1475
company,2022-12-02 05:15:00,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,117374028,,VRTX,Yahoo,"If you're looking to add more stocks to your portfolio right now, here are three top healthcare stocks to consider when formulating your list of long-term buys.  Vertex Pharmaceuticals (NASDAQ: VRTX) has a near monopoly over the multibillion-dollar cystic fibrosis treatment industry with its portfolio of medicines.  In a patient with cystic fibrosis, the CFTR gene becomes mutated, which means this protein is not able to function normally.",https://finnhub.io/api/news?id=8f7e2383f3563bf733ddef8bcb9aa7b1944ed5738fab651afe1e2699e209853f
company,2022-12-09 17:42:48,Our 7 Top Biotech Stock Picks for 2023,117487530,https://media.zenfs.com/en/investorplace_417/180ce84be58b62c67d477717f09599bb,VRTX,Yahoo,"If there’s a silver lining regarding the coronavirus pandemic, it’s that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow, the Covid-19 crisis proved that when humanity comes together, it can foster incredible advancements at breakneck speed. Moving forward, this segment will carry this momentum toward other breakthroughs. Nevertheless, even the top biotech stock picks for 2023 can’t avoid economic realities. With macro",https://finnhub.io/api/news?id=fb20577934e7b2ab9b2fc1a8af3fe648462fc51c2bbc170166bfef1363357450
company,2022-12-09 12:24:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors,117491584,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 2.83% to $312.22 Friday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=2d1562d5184652fc117fc59344619abde069144f933d43f8d6bc42b853c368dd
company,2022-12-09 09:00:00,2 Growth Stocks That Could Help Set You Up for Life,117454955,,VRTX,Yahoo,"The market has taken growth investors for a bumpy ride over the past year.  Vertex Pharmaceuticals (NASDAQ: VRTX) is one of them.  Not only does the company have an incredible history of delivering favorable revenue growth and profits, but its stock has been a high performer for investors even in the volatility of the past year.",https://finnhub.io/api/news?id=3753576432a462929e991c54e164358e42f2216418e06d1be5fc1091737b5e06
company,2022-12-08 20:01:00,"Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX) and Design Therapeutics (DSGN)",117847527,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0b0dada68f651ec8d2c2d89127409da1e1a54cb43800807fe7d8c66a2cbd8430
company,2022-12-08 12:45:05,3 Reasons Growth Investors Will Love Vertex (VRTX),117445056,https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4,VRTX,Yahoo,Vertex (VRTX) could produce exceptional returns because of its solid growth attributes.,https://finnhub.io/api/news?id=157a62c16229f50436be8c6a1e30314a401c30f437768ad008d99fbd1f389c93
company,2022-12-08 12:45:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,117491585,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.18% to $321.32 Thursday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=1ba7bf7842f8dc83f197da3300642a1667f417cad99068778901ca868307d394
company,2022-12-08 11:51:00,Health Care Up on Merger Views -- Health Care Roundup,117491586,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,Health-care companies rose amid anticipation of further merger activity in the sector. The U.S. Food and Drug Administration extended the authorization of...,https://finnhub.io/api/news?id=0fa646d24508b80283e1732941ae1c0f80eeae08d73201b14f46b43fdf7526c4
company,2022-12-08 10:58:17,Entrada Therapeutics Stock Gains On Licensing Pact With Vertex For Form Of Neuromuscular Disorder,117445057,https://media.zenfs.com/en/Benzinga/4264ba751567d9467bc08cdddb21c38d,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Entrada Therapeutics Inc (NASDAQ: TRDA) announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV) therapeutics for myotonic dystrophy type 1 (DM1). The collaboration includes Entrada's program for DM1, ENTR-701, which is in late-stage preclinical development. Under the terms of the agreement, Entrada will receive an upfront payment of $224 million and an equity investment of $26 milli",https://finnhub.io/api/news?id=91422af64f4bb530b498882de2625e20e76530ca0e517d412910ea6990ca8dae
company,2022-12-08 10:21:28,Entrada Skyrockets On $250 Million Deal With Vertex In Muscular Dystrophy,117442305,https://media.zenfs.com/en/ibd.com/c43dd1c1b1ad881e7b4c3c4ebaf2eacb,VRTX,Yahoo,"Entrada Therapeutics inked a $250 million deal with Vertex Pharmaceuticals to develop a muscular dystrophy drug, and the biotech stock surged.",https://finnhub.io/api/news?id=e5768999a74c8a1d47881d79e116b880c09f7872495dcca25aec3ffb5f2aa4d9
company,2022-12-08 09:41:02,Wall Street Bulls Look Optimistic About Vertex (VRTX): Should You Buy?,117442306,https://media.zenfs.com/en/zacks.com/7d53224209023d7c3760cb474c0d4f0a,VRTX,Yahoo,"Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",https://finnhub.io/api/news?id=851a4700b8739dab359340e031e28843a6ff4df6a7090f83aa1de5a3c202ab06
company,2022-12-08 08:34:00,Entrada Therapeutics Shares Rise 18% After Vertex Collaboration News,117491587,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,"By Stephen Nakrosis Shares of Entrada Therapeutics Inc. were trading higher on the Nasdaq Thursday, following news the company will collaborate with Vertex...",https://finnhub.io/api/news?id=7038b387f5d301c571453193f060ee0dc8d53fa61bf1e8f160cb0d4422ac1a34
company,2022-12-08 07:01:59,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Been Rising: Are Strong Financials Guiding The Market?,117442307,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals' (NASDAQ:VRTX) stock up by 9.9% over the past three months. Given that the market rewards strong...,https://finnhub.io/api/news?id=3d665855093ab585721898c4d40a067daa98956009f7d767fd359f06c7062ad6
company,2022-12-08 07:00:00,Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1),117441366,https://media.zenfs.com/en/business-wire.com/14287f24dd1777b681511126ea645d17,VRTX,Yahoo,"BOSTON, December 08, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™) therapeutics for myotonic dystrophy type 1 (DM1). The collaboration includes Entrada’s program for DM1, ENTR-701, which is in late-stage preclinical development.",https://finnhub.io/api/news?id=2d37bd008952b73c2d2b586b32404177c1fd83300c2592a1587d44335a118782
company,2022-12-08 06:30:00,2 Unstoppable Growth Stocks to Buy in 2022 and Beyond,117440890,https://s.yimg.com/ny/api/res/1.2/FinJ4GjkYYF_p43RimWlnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/1f782871f2305b33c992244944ece8d4,VRTX,Yahoo,Two biotech companies are great examples of this: giant Vertex Pharmaceuticals (NASDAQ: VRTX) and up-and-coming player Axsome Therapeutics (NASDAQ: AXSM).  Vertex shares have climbed about 40% so far this year.  Vertex may be about to show that it can expand beyond its specialty of cystic fibrosis (CF) treatment -- and with a potential blockbuster product.,https://finnhub.io/api/news?id=117faa63ff8c29c31b30afb340c8dbfa67bd5ff6144eef6f30b69f75d59392ed
company,2022-12-08 03:24:33,Entrada Therapeutics shares jump on collaboration with Vertex,117491588,https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg,VRTX,MarketWatch,Shares of Entrada Therapeutics Inc. undefined rallied 15% in premarket trading on Thursday after the company announced a deal with Vertex Pharmaceuticals...,https://finnhub.io/api/news?id=8d8c599adf3302b0629487e6821a6ff2447e9bb16890e7395d7a0781009aec27
company,2022-12-08 01:38:00,Vertex Pharmaceuticals Reaches Analyst Target Price,117923905,,VRTX,ETF Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b2c8a8de4f7b4fec0a3d87f7c138e5952ab42aa225976f1b593d41ee321fbe83
company,2022-12-08 01:06:00,"Vertex Pharmaceuticals, Entrada Therapeutics enter EEV therapeutics pact",117773853,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d6c0c17ea643c5737f0d80a4ed10b7262b99fdc9fbaaaca8ba9adff3cb760c9c
company,2022-12-07 17:45:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,117436589,https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $317.58, marking a +1.85% move from the previous day.",https://finnhub.io/api/news?id=bb037d9657d8c4a0a06f1ab627123fddff17a8365a0e022144a0ed233dcf8344
company,2022-12-07 12:44:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",117491589,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.85% to $317.58 Wednesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=54af53daad402e417fdd7836963961598ac1c4ce981442247d73c39109260e6f
company,2022-12-07 11:44:04,Centene (CNC) Invests Nearly $8M to Build Texas Community Center,117432421,https://media.zenfs.com/en/zacks.com/1742c873e164807fdc15d34abf611170,VRTX,Yahoo,"Centene (CNC) collaborates with CHDI to establish a new community center in Texas, reflecting efforts to expand its Managed Care business across the state.",https://finnhub.io/api/news?id=c3cd72e7ce5aa1ce806884d8f3b9a516564857a8380ef21cb24ccc2a3bf0a910
company,2022-12-07 10:27:03,"Biogen (BIIB), Sage Finish Zuranolone NDA Filing for Depression",117431449,https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b,VRTX,Yahoo,"Biogen (BIIB) and Sage Therapeutics (SAGE) NDA submission for zuranolone for treating MDD and PPD is based on data from two late-stage studies, LANDSCAPE and NEST.",https://finnhub.io/api/news?id=e1ea0123c36666d7a2810c6bf6cfa02f27d40f1ef639a6211a14aaac8364a84e
company,2022-12-07 08:53:00,3 Fierce Stocks That Are Screaming Buys in December,117430256,,VRTX,Yahoo,"As 2023 approaches, it marks the end of what can be called a turbulent year for the stock market.  In a volatile market, it is smart to own stocks that have high growth prospects.  Thanks to its rising top and bottom line, Vertex Pharmaceuticals (NASDAQ: VRTX) shares have surged 46% so far this year.",https://finnhub.io/api/news?id=60cb78b137caf911c5e3cad36e42523097999e7183203e73a65eee72bdb3c40b
company,2022-12-06 13:00:06,2 Sector ETFs Hovering Around a 52-Week High,117423657,https://media.zenfs.com/en/zacks.com/79091dbe958a0ceedc2cec88ba60b675,VRTX,Yahoo,"We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.",https://finnhub.io/api/news?id=bda3cd80df675d0f6401a6371abc1131e7a44d45e7b27f89db05228c8480cc53
company,2022-12-06 12:45:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,117491592,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.82% to $311.81 Tuesday, on what proved to be an all-around grim trading session for the stock market, with...",https://finnhub.io/api/news?id=67e603327e24b4939ba08b67c9b8ac199cde9f1ddd2332f928e35897b03c1b58
company,2022-12-06 10:53:52,3 Stocks to Buy Before 2023 That Can Set You Up for Life,117416795,,VRTX,Yahoo,"Given all the market uncertainty this year and the downward trend of the major indices, it's no surprise that some investors are hesitant to buy right now.  Knowing the right time to pull the trigger on a stock purchase (or a sale) is often one of the hardest parts of being an investor.  Three such buy-now opportunities are Vertex Pharmaceuticals (NASDAQ: VRTX), Mattel (NASDAQ: MAT), and Nvidia (NASDAQ: NVDA).",https://finnhub.io/api/news?id=eba40fd58b699200a04affdab708eb48239bf5e5a85ccb5da561782bd22db9d8
company,2022-12-06 10:00:00,Is It Too Late to Buy Vertex Pharmaceuticals Stock?,117416267,,VRTX,Yahoo,"Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade.  The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high.  Vertex has certainly been impressive, but are the company's best days already in the rearview mirror?",https://finnhub.io/api/news?id=696a605be6d7e7c3fffce83154f9006332d6a1390c9b7ff3c15eb57d661994b4
company,2022-12-13 12:31:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",117560803,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 2.26% to $307.09 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=92010296ba085c9be0cb46d22aebd605163ff346dfbf78b732ff3fa79d0ab6ce
company,2022-12-13 11:01:04,Vertex (VRTX) to Start Clinical Study on mRNA-based CF Therapy,117510422,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"Following clearance of the IND application by the FDA, Vertex (VRTX) intends to start a clinical study evaluating a single ascending dose of VX-522 in cystic fibrosis patients in the coming weeks.",https://finnhub.io/api/news?id=9d973595277623b91ed9bca3d83cf9c16bc3a5e77de2f6cb78da2d1d3fd12221
company,2022-12-13 07:08:00,More Likely to 5X First: Johnson & Johnson vs. Vertex Pharmaceuticals,117495406,https://s.yimg.com/ny/api/res/1.2/RK0NSulVgUP1yE65t1MssA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/13f9e59aaf9ba021eab217ad8b2f1942,VRTX,Yahoo,"Racking up a five-bagger investment -- when one of your holdings grows by 5x -- is quite the accomplishment, and finding potential five-baggers is a great way to set your portfolio up for success.  On that note, powerful pharmaceutical businesses like Johnson & Johnson (NYSE: JNJ) and Vertex Pharmaceuticals (NASDAQ: VRTX) are stable enough and profitable enough to 5x, and they've both done it before.  Johnson & Johnson's market capitalization is around $461 billion, making it one of the largest businesses in the world.",https://finnhub.io/api/news?id=9237fe2a441c71ee44ec410544209b0765229b58f57be5abe490a3c53f137072
company,2022-12-13 05:57:00,3 High-Flying Stocks to Buy and Hold If a Recession Is on the Way,117494446,,VRTX,Yahoo,"Citigroup CEO Jane Fraser expects a recession in 2023.  Here are three high-flying stocks to buy and hold if a recession is on the way.  Biotech stocks often soar, regardless of what's going on with the economy.",https://finnhub.io/api/news?id=db43acafc810460ecae74fc1b47459e127b42c97171acf4a9a56cd539d33ebd9
company,2022-12-12 12:31:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",117491583,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.63% higher to $314.19 Monday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=bf466355cec97dc892e11ad4d12258fbce040fe555ad12e480d720e80a264801
company,2022-12-12 08:35:01,3 Non-Energy S&P 500 Stocks With Enough Energy to Boost Returns,117488237,https://media.zenfs.com/en/zacks.com/4cfd310fb615a3a27b3a06029b3fce96,VRTX,Yahoo,"Though energy companies have been among the best-performing stocks in the S&P 500 index, here we discuss some top-performing non-energy S&P 500 stocks like MRK, VRTX and MCK.",https://finnhub.io/api/news?id=25ebf4f8345e0c6fe7ac4064eaa278d855668aedd18f97135f886305f052aae0
company,2022-12-12 08:00:00,"Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA",117488238,https://media.zenfs.com/en/business-wire.com/38cd35f0ce12c37ac1314e4fecdb2300,VRTX,Yahoo,"BOSTON, December 12, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application for VX-522, a messenger ribonucleic acid (mRNA) therapy targeted at treating the underlying cause of cystic fibrosis (CF) lung disease for the approximately 5,000 people with CF who cannot benefit from a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. Vertex plans to initiate a sin",https://finnhub.io/api/news?id=5abce56331e52b799f360ce97ab418f1d614403cdc6d1c41b631f053f1b8f158
company,2022-12-12 06:00:35,Getting In Cheap On Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Is Unlikely,117481388,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"With a price-to-earnings (or ""P/E"") ratio of 24.5x Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) may be sending...",https://finnhub.io/api/news?id=3c4d87645d69a43b248cc7093fbb21a49b4987d00d24c8fd60a068d7a94d4693
company,2022-12-12 04:56:00,Vertex receives IND clearance for mRNA cystic fibrosis therapy,117923876,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=007cd34574d35c921de6db09bd067d2012d95c4f63be1749f4784aede32d473b
company,2022-12-12 02:08:00,FDA clears Vertex IND application for VX-522 to treat CF,117923881,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87ac7b359fbd791fbddd080af983b725dd6969edbb2eb784c4e6bedef7bad2c2
company,2022-12-11 05:52:00,3 Red-Hot Stocks That Could Continue to Beat the Market,117474122,,VRTX,Yahoo,"Axsome Therapeutics (NASDAQ: AXSM) has absolutely sizzled this year.  The biotech stock has more than doubled, with most of the gain coming in just the last couple of months.  It should file for FDA approvals of AXS-07 in treating migraine and AXS-14 in treating fibromyalgia next year as well.",https://finnhub.io/api/news?id=0dfc4dbcd0e10617da1f304267f869393e1540a4dddff135a69701fe4dd94105
company,2022-12-10 08:00:00,Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition,117467436,https://media.zenfs.com/en/business-wire.com/2f5a0175ba1ba669bb9925731a759356,VRTX,Yahoo,"BOSTON and ZUG, Switzerland, December 10, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced an oral, encore presentation of clinical data from patients with sickle cell disease (SCD) or transfusion-dependent beta-thalassemia (TDT) treated with the investigational therapy exagamglogene autotemcel (exa-cel) in CLIMB-111 or CLIMB-121 and followed in CLIMB-131, a long-term follow-up study. Vertex will also present new health economics and",https://finnhub.io/api/news?id=893c841bc8ef028975e88cf8c1a0dfb50b620b0e20e9d40c4dd44e00efceb6e1
company,2022-12-10 06:10:00,3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023,117466959,https://s.yimg.com/ny/api/res/1.2/U0bYLN9IBHSSynfnO3e_tw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/387d40b527fa07b59d130eb9f3ba3a36,VRTX,Yahoo,"With this in mind, we asked three Motley Fool contributors to pick high-flying stocks in 2022 that can keep soaring in 2023.  Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Merck (NYSE: MRK), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Keith Speights (Axsome Therapeutics): With just a few weeks left in the year, shares of Axsome Therapeutics have more than doubled.",https://finnhub.io/api/news?id=0e25352c3b678f36db9ebba4646a3f25283b34b8ddbd1b977ed00ae50689e7ed
company,2022-12-17 09:15:00,3 Beaten-Down Stocks That Could Explode Higher in 2023,117555506,,VRTX,Yahoo,"Three Motley Fool contributors were asked to pick beaten-down stocks that they think could explode higher in 2023.  Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Moderna (NASDAQ: MRNA), and Zoetis (NYSE: ZTS).  David Jagielski (CRISPR Therapeutics): CRISPR Therapeutics' shares have underperformed in the current bear market, with the gene-editing stock down almost 40% year to date.",https://finnhub.io/api/news?id=f664cd7683bb1c6305fcc916b45ae676455f99bb15ef5e39431a8fbfafa8fb20
company,2022-12-17 05:52:00,Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows.,117554290,,VRTX,Yahoo,"Fannie Mae expects a modest recession to begin in the first quarter of 2023, and 60% of the economists polled by Reuters think the U.S. economy will enter a recession sometime next year. Economists surveyed by Bloomberg think there's a 65% risk of a recession over the next 12 months.",https://finnhub.io/api/news?id=c5a5c6aa3415fe804fe7e41878aaa512b962cec75eb8ddbd4cdc4690930ff089
company,2022-12-16 16:00:00,Which Is the Better Buy: Vertex or Invitae?,117546818,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) and Invitae (NYSE: NVTA) have gone in different directions this year when it comes to share price, with Vertex's stock up more than 43% so far and Invitae's shares plunging over 84%.  Looking at these two biotech stocks from a long-term perspective, is Invitae now the better buy?  Or is Vertex's strong run this year likely to extend into 2023?",https://finnhub.io/api/news?id=d20cc142a0c8cfd3df327836c9f244ac3fb22e174f5741eef1e8d16b6a6fae83
company,2022-12-16 12:31:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",117560800,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.17% to $304.80 Friday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=9ec0e8fb8894c8c44bf49468eb1da7caac120d202a55086f57ce0fce1b7ab69b
company,2022-12-16 08:06:01,4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023,117538241,https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24,VRTX,Yahoo,"Here are four drug companies, MRK, VRTX, IMCR and IMVT, that are up 40% or more in 2022 so far and still have room for growth in 2023.",https://finnhub.io/api/news?id=33266a527c649cdea617672f6f4a78d7315174aca79655993571d47efe337de5
company,2022-12-16 06:00:37,Getting In Cheap On Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Is Unlikely,117535507,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated's ( NASDAQ:VRTX ) price-to-earnings (or ""P/E"") ratio of 24.2x might make it look...",https://finnhub.io/api/news?id=5b87e5a722a11bf69c7447cd59b8c20cd59b4eac80a958eb8a81c720becacd3e
company,2022-12-15 17:45:10,Vertex Pharmaceuticals (VRTX) Stock Moves -1.18%: What You Should Know,117528718,https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.40, marking a -1.18% move from the previous day.",https://finnhub.io/api/news?id=987da7adfab882317f5d82f86354d1feff21189a5f2610687934fcca7c0c5848
company,2022-12-15 17:28:30,U.S. Parkinson's disease incidence far higher than earlier estimates -study,121406384,,VRTX,Reuters,"The annual number of new Parkinson's disease diagnoses in the United States is likely 50% higher than estimated, based on a broad analysis of insurance claims and population growth detailed in a study published on Thursday that could help increase funding and care for the...",https://finnhub.io/api/news?id=ea505be29b770d546f8b0d1f2342518b984d70b20c707eafd58128fb0860a19e
company,2022-12-13 13:03:39,Sickle cell cure will be cost-effective if health disparities  considered -study finds,117500225,https://static.reuters.com/resources/r/?m=02&d=20221213&t=2&i=1616976719&r=LYNXMPEIBC0UJ,VRTX,Reuters,"Multimillion-dollar gene therapies being tested for sickle cell disease will be cost-effective in the United States if health disparities tied in part to decreased access to healthcare are taken into account, researchers said at a meeting of blood-disease specialists.",https://finnhub.io/api/news?id=ef1c95098ccfdd137cc28c57d05f22bb371288774223d882f86d382299a90e30
company,2022-12-15 17:05:46,"IBD Stock Of The Day Vertex Eyes A Brighter 2023 On Moderna, Crispr Plans",117528719,https://media.zenfs.com/en/ibd.com/04120e7925304978edaafb306abe4198,VRTX,Yahoo,"Vertex is the IBD Stock Of The Day. The FDA signed off on its newest study in cystic fibrosis, but VRTX stock is trading sideways.",https://finnhub.io/api/news?id=07c1272cd7dde8976bb2ddeacc88315575ce5dd63bcaf8a6e0800f4378971285
company,2022-12-15 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,117560801,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.18% to $308.40 Thursday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=f887016eb63113cbba16aa72cb6bada12feee36f15fc998caf487d4a957b4651
company,2022-12-15 10:07:00,3 Growth Stocks With More Potential Than Any Cryptocurrency,117528363,https://s.yimg.com/ny/api/res/1.2/XDgEIlFgCgysiwF68J_xsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0742d24ed3022b55052028c229466931,VRTX,Yahoo,"While it's true that growth stocks don't make investors jump for joy like they used to, companies in this investment category that can win over the long term are still to be found.  Vertex Pharmaceuticals (NASDAQ: VRTX) is a bit of a rarity in the world of healthcare stocks, boasting a business that tends to generate revenue and earnings growth at a clip well beyond that of the average stock in this space.  Case in point: The company has seen its annual revenue and earnings surge by respective amounts of 204% and 789% in the past five years.",https://finnhub.io/api/news?id=6293fdbc5bfd87fdb601e3c455e9f50ac4f57edc23c5c76a209666ba769bd972
company,2022-12-14 17:50:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,117528721,https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $312.09 in the latest trading session, marking a +1.63% move from the prior day.",https://finnhub.io/api/news?id=d6f174b614cc4e18eca1c57d3b8e9d9f50c09c2a548d81a2663797d7c484d656
company,2022-12-14 12:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,117560802,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.63% to $312.09 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=a1cf7d8513bc85d97f6ea0f604f310bd285d99165dd3bf4d204b199690356904
company,2022-12-14 09:45:02,Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio,117528722,https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,VRTX,Yahoo,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,https://finnhub.io/api/news?id=05c7b074d9c4c0af9a5d4fc60dd0e86fd57bda18b0d4dd89de89bfb18e34c2c1
company,2022-12-21 17:45:10,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,117609045,https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $290.55 in the latest trading session, marking a -0.91% move from the prior day.",https://finnhub.io/api/news?id=ef505117b2de4fee52a09d6ee7326858926e299fdf38a59e43a7676491f432c3
company,2022-12-21 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,117692739,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.91% to $290.55 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=57a7ef54a44a641f966936dbcf3b11393394f9138bfee33f8d512213958b668c
company,2022-12-21 10:15:00,"Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond",117599683,,VRTX,Yahoo,"For many investors, now would be an opportune time to take advantage of great stocks trading at a discount.",https://finnhub.io/api/news?id=ee2d138dbd28a295b0bad6ca8b6c19d990be92c0309d3875aebb37d546de571a
company,2022-12-21 10:00:00,3 Growth Stocks That Are Too Cheap to Ignore,117599684,,VRTX,Yahoo,"Despite the short-term impact that $10 billion worth of write-downs had on Teladoc Health's (NYSE: TDOC) balance sheet in the first half of 2022, the company remains an undefeated leader in the global telehealth market.  While more companies are expanding into the telehealth space, few are doing so at Teladoc's scale.  In the most recent quarter, Teladoc's revenue surged 17% from the year-ago period to $611 million.",https://finnhub.io/api/news?id=7d1d8eb742fc570353cb101383e7e69181584c796e4230b12c79a7d5dbff9e0a
company,2022-12-21 09:45:00,3 Growth Stocks That Are Screaming Buys in December,117599686,,VRTX,Yahoo,"If you have the cash to invest right now and are looking to add some powerhouse growth stocks to your portfolio before year's end, here are three notable contenders to consider.  Vertex Pharmaceuticals (NASDAQ: VRTX) isn't a household name like some healthcare stocks, but this biopharmaceutical company has grown into a giant in the rare disease drug market over the more than three decades since its founding.  In fact, its cystic fibrosis products generated $7.6 billion in revenue for all of 2021, in a market that was valued at around $9 billion as of 2020.",https://finnhub.io/api/news?id=18ac559e337f44e56b1ecbd4293e52fc5d7a7312d775c5425b1e82a235e71e7d
company,2022-12-21 08:15:00,"The Best Stocks to Invest $20,000 in Right Now",117598858,,VRTX,Yahoo,"If you have $20,000 to invest in the stock market right now, you're likely searching for durable businesses with a strong track record of growth that can generate consistent returns in a wide variety of markets.  Despite increased competition through the years, Johnson & Johnson (NYSE: JNJ) remains a giant in each of the three key markets in which it operates: consumer health, pharmaceuticals, and medical devices.  The company's consumer health business, which it is about to spin off into a stand-alone company called Kenvue, sells some of the world's most well-known daily use brands like Band-Aid, Tylenol, and Listerine.",https://finnhub.io/api/news?id=1c2a3e31fe87289da155d3ad49909a4bd5606096bb22843f98efb4d37acfe281
company,2022-12-21 06:16:46,XBI: Attractive Value In Diversified Biotech Growth,117601011,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1395657542/image_1395657542.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Valuations on biotechnology stocks have moderated substantially since the pandemic peak in 2021. Click to read my analysis of the SPDR S&P Biotech ETF (XBI).,https://finnhub.io/api/news?id=58c417a94bece7fd134bf3fa546f31167f009d6ce8721ed13a50843061b8a486
company,2022-12-21 01:30:00,Avidity Biosciences: Proof-Of-Concept Achieved In DM1 For AOC Platform,117597514,https://media.gettyimages.com/id/1252460783/photo/physiotherapist-with-disabled-person.jpg?b=1&s=170667a&w=0&k=20&c=gA45uVmLj5_7dwq-1j3aJHVaNMckdvDqgL4J_V85Fq8=,VRTX,SeekingAlpha,"Avidity seeks to tackle a fundamental challenge in the RNA space, namely delivery outside the liver via AOC platform technology. See why the stock is a Buy.",https://finnhub.io/api/news?id=3e0fe3e9177ba96d0d6ccedd28d089cbddcb8c6b743b089b9790cd5130e27fe5
company,2022-12-20 18:16:35,Vertex Pharmaceuticals: Expect Growth Beyond Trikafta,117594330,https://media.gettyimages.com/id/1222132825/photo/human-respiratory-system-lungs-anatomy.jpg?b=1&s=170667a&w=0&k=20&c=VOwJ6IFnuGi9RSCUGNkVy37pfIADAfwjhath4vf8rdk=,VRTX,SeekingAlpha,Vertex revenue grew 18% y/y in Q3 2022. Read why I have started accumulating VRTX stock as a long-term investment.,https://finnhub.io/api/news?id=6dbd2a260b0fb7f5a44440c2a8c92f018326bbbc025a386ee2be7080b420ca8f
company,2022-12-20 12:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,117606818,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.56% higher to $293.23 Tuesday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=2593f9f0abebc0615892baa951bda3b931b0778668ac814b62fcecd46c65397c
company,2022-12-20 10:03:03,Entrada (TRDA) Down on Regulatory Update for DMD Candidate,117588030,https://media.zenfs.com/en/zacks.com/fdfe32922c97375611ef6256c04a840b,VRTX,Yahoo,Entrada (TRDA) plunges on clinical hold notice from the FDA regarding its Investigational New Drug Application (IND) for Duchenne muscular dystrophy (DMD) candidate.,https://finnhub.io/api/news?id=b64a4c4be3fa2e3af4a3718baf401c72390af8df978509d7ec3bfab5b5de0f62
company,2022-12-20 06:00:54,Unpleasant Surprises Could Be In Store For Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Shares,117585790,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated's ( NASDAQ:VRTX ) price-to-earnings (or ""P/E"") ratio of 22.9x might make it look...",https://finnhub.io/api/news?id=839ac6d44e9551a7ddc142f410ec254fae3d44245dc0b5252992628b195b5f02
company,2022-12-19 23:22:00,Tuesday Talk: Where is Santa?,117662151,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9b7e4d67a3e28c03d35b7b106245c73c1edb99f517a48112219c9c13cd89c1c7
company,2022-12-19 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors,117606819,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 4.33% to $291.59 Monday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=94fe26d809b699873d094e1346baa733e379a49c21066307ed8b093a2419a311
company,2022-12-19 07:53:12,"The Zacks Analyst Blog Highlights Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant",117573984,https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057,VRTX,Yahoo,"Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=0c76f04a46ba018f39eba367485b966315fe23a825b2069544c9cc26afe94c6e
company,2022-12-19 00:26:00,Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro,117662154,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=62c8b2068425af5206972caa3ebf25b16dfdf4626961cfbfa3337a370300eeef
company,2022-12-18 23:18:00,Vertex Pharmaceuticals downgraded to Hold from Buy at Jefferies,117923861,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=99fad0833c92937618f1f1ff1e1a211c72dbb2c5c7ffb37da4b56cb803ae0696
company,2022-12-18 22:06:00,"Vertex Pharmaceuticals downgraded to hold at Jefferies on valuation, stock outperformance",117923863,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=643de1d627246b3afe0c54c46ec421b5480ee2784bebcfc7b286f37d25d2cfe9
company,2022-12-18 09:30:00,Where Will Vertex Pharmaceuticals Be in 10 Years?,117568593,https://s.yimg.com/ny/api/res/1.2/r73y9IKQccsh8.iLIiSx_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c6f9aa9623c231bda28cde0c23750de1,VRTX,Yahoo,"For a company like Vertex Pharmaceuticals (NASDAQ: VRTX), 10 years isn't a long time. The drug-development process takes between 12 and 14 years, on average, around 8 years of which are devoted to clinical-stage testing and the regulatory-review process.",https://finnhub.io/api/news?id=7c05a9ddf786c766c7a1b035ed23504cff8439878cfcaab2324b33778fd590a3
company,2022-12-18 06:45:00,Buying These Unstoppable Stocks Before 2023 Could Be a Genius Move,117566087,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatments.  Vertex's latest CF drug, Trikafta, still has plenty of revenue growth ahead.  Instead, it has to do with Vertex's candidate for blood disorders, exa-cel -- a one-time curative treatment for two blood disorders with limited treatment options today.",https://finnhub.io/api/news?id=9895ab05bea087165fbf18dfaa4fa7379b9f1a89cbe660a36d62116bb8c0019c
company,2022-12-18 06:00:00,Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock,117566088,,VRTX,Yahoo,The bear market has weighed on stocks across industries this year.  Biogen (NASDAQ: BIIB) and Vertex Pharmaceuticals (NASDAQ: VRTX) have both climbed in the double digits -- and for good reason.  Which one of these top stocks represents the better bear market buy right now?,https://finnhub.io/api/news?id=cf2f92fa5f20d2d4c83c580b629a5c7d054e2984d3db8852b4fe611833490a69
company,2022-12-18 05:55:00,My 3 Best Stocks of 2022 -- and Why I Think They'll Win Again in 2023,117566089,,VRTX,Yahoo,"Devon Energy (NYSE: DVN) would be in a close second place for me if I only looked at share price gains this year.  Counting dividends, Devon has generated a year-to-date total return of more than 50%, with only a few days remaining in 2022.",https://finnhub.io/api/news?id=be6c93b6b5e85f728f9718b24356f4ea05304ee4958bf5b845372ea3db6b81b6
company,2022-12-18 00:00:17,IBBQ: Healthcare Dashboard For December,117565452,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310024666/image_1310024666.jpg?io=getty-c-w750,VRTX,SeekingAlpha,The pharmaceuticals/biotechnology subsector has good value and quality scores. Click here to read more about IBBQ ETF.,https://finnhub.io/api/news?id=e5bf97def27912b4a2d83c6964251e037ef37a2457f0e776d37832fcc5e3cfcb
company,2022-12-24 06:00:57,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 38% Below Their Intrinsic Value Estimate,117679829,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Vertex Pharmaceuticals...,https://finnhub.io/api/news?id=0d8d19937cfa738279d6bb6ced16307fb873c0673869f17c20e8131033599526
company,2022-12-23 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",117692736,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.44% to $289.69 Friday, on what proved to be an all-around favorable trading session for the stock market, with...",https://finnhub.io/api/news?id=42ebf1506d1d9bda486a0268fe1152bb944c388c4ce5656d66c14874a3ebd86a
company,2022-12-22 12:31:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,117692738,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.16% to $293.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with...",https://finnhub.io/api/news?id=a7104c4e5263585a7438e1af4860834382c4a1213f2a0d19e24bbd197620f499
company,2022-12-22 10:25:02,Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?,117617120,,VRTX,Yahoo,"Crispr expects to make history in 2023 with a first-ever request in gene-editing technology by the same name, which could stoke shares.",https://finnhub.io/api/news?id=60a6e2cf2bb4838c56779cf474143775b096dddc8e97788fd20bd0b3fa1646a6
company,2022-12-22 09:35:00,2 No-Brainer Biotech Stocks to Buy Right Now,117615965,,VRTX,Yahoo,"Vertex Therapeutics (NASDAQ: VRTX) and Amgen (NASDAQ: AMGN) have swum against the tide all year, with their shares rising as the S&P 500 has struggled.  While Vertex's pipeline is about to extend well beyond cystic fibrosis (CF), Amgen's combination of emerging drugs, plus the accretive nature of its deal to buy Horizon Therapeutics, could reward investors in the long run.",https://finnhub.io/api/news?id=575dd42eecdbf74a972b7e02aa63517e7a8b226daab81611d1ac6c12bcf932a5
company,2022-12-22 08:00:00,"4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire",117615435,,VRTX,Yahoo,"Most investors won't build life-changing wealth from the stock market overnight, but when you're investing in wonderful stocks for many years at a time, you don't need to hit a one-time jackpot to build and sustain meaningful returns.  Here are four different stocks, each on a unique growth trajectory, that have the potential to multiply a $100,000 investment by at least 5 times in the years ahead.  E-commerce spend will account for 31% of all retail transactions in the U.S. alone by 2026, compared to its current share of 23%, according to Morgan Stanley.",https://finnhub.io/api/news?id=521f0a743999a65fd81504d183db66bc765fa2a567a1072ba2d5eeca98c6a8f3
company,2022-12-21 21:01:00,"Thursday Sector Leaders: Healthcare, Utilities",117923843,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=54ebdd84871b3e7119df77da561bb3e1d445b6c2afe7256bd0cae3a6a91823fc
company,2022-12-29 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market",118001798,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.16% to $289.08 Thursday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=bbb593ad94bb5b7d70264cabcdf923a4ea8888442c7a59a8953b18373ef4ed91
company,2022-12-29 10:15:00,2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond,117856080,,VRTX,Yahoo,"For instance, biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Incyte (NASDAQ: INCY) -- both of which feature in Wood's Ark Genomic Revolution ETF -- have outperformed the market over the past year.  Let's consider why both of these Cathie Wood stocks can still deliver solid returns.  It'd be hard to find a biotech giant that has performed better than Vertex Pharmaceuticals this year.",https://finnhub.io/api/news?id=c55d6807d2fd80d596c2107e8717e869d2a37df57d86c2ff76f70e65e491e0a9
company,2022-12-28 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, still outperforms market",118001799,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.54% to $285.76 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=9bf2b34293e8dc5127933151e5318b5c81c7b03227f5ab3b54121372322d23e6
company,2022-12-28 09:53:00,"2 Top Stocks to Invest $2,000 in Before the End of 2022",117826681,,VRTX,Yahoo,"Despite what the broad share price decline across sectors might indicate, there are plenty of wonderful companies that are still delivering strong performance in this macro environment.  While the broader market has continued to take investors for a wild ride over the past year, Vertex Pharmaceuticals (NASDAQ: VRTX) has kept delivering strong shareholder returns.  While it's true that healthcare companies tend to outperform the broader market during bearish periods, Vertex's remarkable performance is nothing new, with the stock having delivered a total return of nearly 600% over the past decade.",https://finnhub.io/api/news?id=08efebce159d8ece8175d18e61e9b3643383438f52c2e5e589d08c9dc66202ec
company,2022-12-28 06:00:09,Subdued Growth No Barrier To Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Price,117835313,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"With a price-to-earnings (or ""P/E"") ratio of 22.5x Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) may be sending...",https://finnhub.io/api/news?id=0d2cff026af1d3e85109a395a928851f270e0aee6a56e5187e623a7c0a402c13
company,2022-12-28 02:55:47,Vertex: Progress Towards Expanding Cystic Fibrosis Market Continues,117813112,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962515/image_1386962515.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Vertex Pharmaceuticals is doing very well with respect to sales of its CF franchise. Click here to read why VRTX is a great speculative biotech play.,https://finnhub.io/api/news?id=aed351d06356dff7b4fa3d8685b8d72553678f39a0ddce9f7badebf1e4314418
company,2022-12-27 17:50:10,Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know,117811924,https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $287.32 in the latest trading session, marking a -0.82% move from the prior day.",https://finnhub.io/api/news?id=1f431c0b388e0e6ed0baf89424dcfd77225fec1812e85b39f6ebdd1e3cf710c0
company,2022-12-27 12:30:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,118001800,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.82% to $287.32 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=ed9396e839169a15d1d06e14db38e2156886b62950fcadbaa135dce1c9322920
company,2022-12-27 06:15:00,Is Vertex Pharmaceuticals a Buy?,117811925,https://s.yimg.com/ny/api/res/1.2/Eq8Q89atPVgxcMc0dQWiIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b9b2b0769fa0f2227738d9aa8064cd40,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) has beaten the bear market by far this year: The stock is heading for a 30% gain.  Vertex is the global leader in the cystic fibrosis (CF) treatment market.  Vertex sells four CF drugs.,https://finnhub.io/api/news?id=1cdc5790e481b9417f6d78c939878fd04a4f139a5c94b67ff7f1f0c2e384404f
company,2022-12-26 05:30:00,Here Are the Best Stocks To Own as 2022 Draws to a Close,117802852,https://s.yimg.com/ny/api/res/1.2/20OwxFdQehs_JyLeIWCBBg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f3bd094e95c6d06fa8948b1e02d6989a,VRTX,Yahoo,"Amazon (NASDAQ: AMZN) is heading for a 49% loss this year, and it's trading at its lowest in relation to sales since 2015.  If you look at Amazon's earnings reports this year, you may wonder why I'm so optimistic.  After all, the company has reported declines in operating income quarter after quarter.",https://finnhub.io/api/news?id=0798f4ab0062f96eeedb3f40c0c526c7b0ad39600728de3bf4d12c2d4a26b957
company,2023-01-01 06:00:17,Risks To Shareholder Returns Are Elevated At These Prices For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX),118073138,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"When close to half the companies in the United States have price-to-earnings ratios (or ""P/E's"") below 14x, you may...",https://finnhub.io/api/news?id=44b96a6ed86293a019854194bbc4a28c9cb46e8eec36b0fc6241e6b9568240f9
company,2022-12-30 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,118001797,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slumped 0.10% to $288.78 Friday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=1bb950bb396d4a63555f333f05ceacac973be47058c97641a9df434c451b04a9
company,2022-12-30 06:12:00,What You Missed On Wall Street This Morning,117923825,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=567ebe15151cb6f530f1e68bb3860edef0865909adc587d5398a91e23d2891b9
company,2022-12-30 05:25:00,VRTX Makes Notable Cross Below Critical Moving Average,117923826,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=80ed17c5e35753afa7d81f316453aa8ae34ecaddf62e161a2f5134b29ffe1537
company,2022-12-30 02:02:00,Opco reveals three biotech stocks that will outperform in 2023,117923828,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f4c27c66a2e6ca0ce8b0745fd25e94d0f73977a46b1fb157d66ee343d29006eb
company,2022-12-29 21:07:00,5 Stocks That Outperformed the S&P 500 in 2022,117987180,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=42a8f72feb4d6e340fee0bfbdd2f7cd611855379e66562fa5f1e4eaa667d9cbb
company,2023-01-06 18:50:42,3 Biotech Companies to Watch in 2023,118195848,https://media.zenfs.com/en/investorplace_417/2ecd29e404fd05eb4a8938ce8c5ceee3,VRTX,Yahoo,"Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world of healthcare. Undoubtedly, these stocks offer a valuable option for investors seeking in innovative solutions to benefit a glob",https://finnhub.io/api/news?id=55b7f92b060ba3228160803e456b039068f5ea160dfbf35e650342a778201279
company,2023-01-06 16:16:00,Barron’s Trader Stock Picks Had a Better Year Than the Market. What Worked—and What Didn’t.,118221600,https://images.barrons.com/im-698607/social,VRTX,MarketWatch,"The call we’re most proud of was one made before 2022 began, when we warned the year would start off badly. We stayed bearish, and we’re glad we did.",https://finnhub.io/api/news?id=382d7cf5831913281ef03ecddbb7df076bd0952494856c8d3967fedf695ed2a1
company,2023-01-05 23:33:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",118190930,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0f7bac2d72f3760b1063101dc61e01c34d9a903339d91053da02a5257fa1389c
company,2023-01-05 12:05:49,"Biotech stocks: Vertex looks bullish on ‘rapidly-growing CF business,’ analyst says",118145395,https://s.yimg.com/ny/api/res/1.2/YTHyNzbrJvdfOEKA4SNbNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/os/creatr-uploaded-images/2023-01/24abddb0-8d1b-11ed-b7be-ccbfc780c30e,VRTX,Yahoo,"Bank of America Global Research Sr. Pharma Analyst Geoff Meacham joins Yahoo Finance Live to discuss China's COVID-19 chaos, the pharma space, biotech stocks, and the outlook for biopharma.",https://finnhub.io/api/news?id=cd384d871eee0be38ab3c96f8e0bb1d1577c6d7ab3b4d8947684f636e9bca1fa
company,2023-01-05 07:00:24,Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 81%,118145396,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...,https://finnhub.io/api/news?id=d37fa8e1ed69fae0e1b8dd69093626c53570fa706e3d954d2bd3337ca0650f34
company,2023-01-05 05:31:00,February 24th Options Now Available For Vertex Pharmaceuticals (VRTX),118190931,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2e2c7faeb8abacd63ddc3c2f18fea796718db1e1e2f8cd8b2df7bd4313a4a3f3
company,2023-01-04 23:32:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,118190932,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cc6eb80204e431a56d93588de12a5d94c5b1bcd5d0aa353cfb0c830db84d6632
company,2023-01-04 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",118125003,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.28% higher to $286.83 Wednesday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=df0e96351934fe552ee0539b5f8f0d5c07304456337b080690d91a8a1dbda6d4
company,2023-01-04 08:22:38,"ARKG: Despite A Huge Price Loss In 2022, Not The Right Time To Accumulate",118116848,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345098965/image_1345098965.jpg?io=getty-c-w750,VRTX,SeekingAlpha,ARKG ETF invests in small-cap and mid-cap companies engaged in genomic revolution. Find out whether it's time to take a position in the fund.,https://finnhub.io/api/news?id=ca9e09a29c6467c4d170f2d4550195c6a82e4af13cc27d39990c17e5a8e76b04
company,2023-01-04 08:00:00,Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9,118120531,https://media.zenfs.com/en/business-wire.com/0c7d0227b81b5be0ef7b2beef6dcd6b8,VRTX,Yahoo,"BOSTON, January 04, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. ET/8:15 a.m. PT.",https://finnhub.io/api/news?id=7043062a7053163ae79f5556bb2d34c88c2542bde02858baa48557e88a1160b6
company,2023-01-04 05:52:00,3 Must-Have Stocks to Buy in 2023,118111520,https://s.yimg.com/ny/api/res/1.2/CtI0a8VWPGlloiF6mjGqgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/598d0cebb123ead9aa02674111b4031b,VRTX,Yahoo,"The company's Google Search dominates the search-engine market.  There's no compelling reason to believe that Alphabet won't remain on top.  Sure, the advertising business is struggling a bit right now.",https://finnhub.io/api/news?id=f6c6997f8caf4b88b292ed62378e85cfddd780061d9b5e23541891ca492b4246
company,2023-01-04 05:30:00,"Where to Invest $100,000 in 2023",118117039,,VRTX,Yahoo,"Dividend stocks are a good bet because they guarantee you recurrent income.  This indicates dividend growth is important to that particular company.  You'll want your dividend stock to hold earnings growth potential, too.",https://finnhub.io/api/news?id=6f9f3801771670de8c330bcc52117e43580a3e41e8748251a78010f5196249a7
company,2023-01-04 05:06:00,10 Top Stocks That Can Make You Richer in 2023,118110913,,VRTX,Yahoo,"When the closing bell tolled, the benchmark S&P 500 ended down by 19%, with the iconic Dow Jones Industrial Average and tech-heavy Nasdaq Composite also entering bear market territory during the course of the year.  The first top-notch stock that can help you build wealth in the new year is payment processor Mastercard (NYSE: MA).  To begin with, Mastercard's management team has kept the company focused on payment processing while avoiding the lending arena.",https://finnhub.io/api/news?id=9b526e290f9832c183c74c439cda7f1d1487956c9d0597fde7d862bd9082777b
company,2023-01-04 00:38:15,CRISPR Therapeutics: 2023 Could Be The Right Year,118111110,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/972347130/image_972347130.jpg?io=getty-c-w750,VRTX,SeekingAlpha,CRISPR Therapeutics AG is a gene editing company based on CRISPR/Cas9 technology. Read more to see why my rating is a buy on CRSP stock.,https://finnhub.io/api/news?id=cc4366d838ff954fd832917a8777d0fdef8ef60e2e4d52ee8e1c375429c6e907
company,2023-01-03 17:50:10,Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know,118106113,https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $286.02, moving -0.96% from the previous trading session.",https://finnhub.io/api/news?id=1c36f4b2583e24be0735f3d04afdcf924b9b855906bdbd9948348e607b5b2f47
company,2023-01-03 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,118125005,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. dropped 0.96% to $286.02 Tuesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=7d0eb6c87dc6ede432ce9b1f180548e02735c960c89fb4cc93f4dac8442f8a89
company,2023-01-03 10:45:00,3 Top Healthcare Stocks Defying the Bear Market,118097897,https://s.yimg.com/ny/api/res/1.2/THvopnPmjIISpn6dOipmsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/4be8c61e32f69e8d2a82469a7ab26fe5,VRTX,Yahoo,Let's take a closer look at these three healthcare stocks defying the current bear market.  Shares for TransMedics Group rose 222% in 2022.  The price jump was due in part to the company's financial performance and partly to its extended moat as the only organ transplant system approved by the Food and Drug Administration (FDA) to transport multiple organs.,https://finnhub.io/api/news?id=effa3724fe108c34589b2129feba5539ccd9eb186f8abf888d4ae98def6ee4bb
company,2023-01-03 05:52:00,3 Stocks to Buy for 2023 That Are Practically Money Machines,118096924,https://s.yimg.com/ny/api/res/1.2/pzTZVm9.yH9w0koiRBk1vA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04Njc-/https://media.zenfs.com/en/motleyfool.com/9c3659c26f891251b82529d9371ca98f,VRTX,Yahoo,"With this in mind, here are three stocks to buy for 2023 that are practically money machines.  Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) should report 2022 revenue in the ballpark of $280 billion, with its Google Search product leading the way.  With those kinds of huge numbers, it's not surprising that Alphabet has amassed a ginormous cash stockpile.",https://finnhub.io/api/news?id=8484f8267bdce034e577198d0b261b60f85f63dd75498ed66cde53fa79874792
company,2023-01-10 17:50:10,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,118217016,https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $288.75, marking a +1.95% move from the previous day.",https://finnhub.io/api/news?id=3b63e52c39b8f7dcf762425f5a345eaaf59106beedaa4b01dcb2ca2893eb32d0
company,2023-01-10 11:55:04,Moderna (MRNA) Reports 2023 Business View & Pipeline Updates,118201314,https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a,VRTX,Yahoo,Moderna (MRNA) expects to record a minimum of $5 billion in revenues from COVID vaccine sales in 2023. It also expects to incur around $4.5 billion as R&D expenses in 2023.,https://finnhub.io/api/news?id=6324852a7d84a1be04deff8a5f1f6c4953da24ab02a7d86dd959ac091101e0ac
company,2023-01-10 11:32:00,"Healthcare Stocks, a Star in 2022, Are Going Nowhere in 2023",118227942,https://images.barrons.com/im-700768/social,VRTX,MarketWatch,"Public commentary from management just hasn't been enough to provide a boost., partly because dividends are low relative to the shares' prices.",https://finnhub.io/api/news?id=fb0e8a9b2ec75e8f7fd5b12f83dc8ab7e5fa1db3faf98ad810ff502e9b84ef78
company,2023-01-10 08:15:00,2 Growth Stocks That Could Help Set You Up for Life,118200204,https://s.yimg.com/ny/api/res/1.2/6ShCJ9vfuRBhl9jOiD8BmQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/bb8972a9392a33ff9c81142c79a3170d,VRTX,Yahoo,"Growth-oriented stocks have faced serious headwinds lately, and the volatility may continue well into 2023.  If you have spare cash to put to work to build your portfolio right now, here are two fantastic growth stocks in the healthcare space that you may want to consider adding to your buy list before the end of January.  Vertex Pharmaceuticals (NASDAQ: VRTX) has largely eluded the trends driving the broader market over the last year.",https://finnhub.io/api/news?id=9a68d72dd74fbbaff17459cf2ef44e796019565cc2b7b8214cf5b301c4f58fa3
company,2023-01-10 05:50:00,"Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade",118200205,https://s.yimg.com/ny/api/res/1.2/tLRgbIojkfTWVs8pQ6Pu3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/d60b5140e3bbb5cf69222dce4ed40fa4,VRTX,Yahoo,"Turning an initial $300,000 investment into seven figures in a decade may seem like a lofty aspiration, but it would require an annualized return of just around 13% to make that happen.  Considering that the S&P 500 has delivered total returns of 220% over the past decade, which works out to 12.3% on an annualized basis, this begins to look like a much more attainable goal.",https://finnhub.io/api/news?id=815ef6fa808cc18f9f3990c839b664711323b6d415852d6ccbb5e86844276d89
company,2023-01-09 23:32:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market",118433202,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=505c5e1d3f423afe70054247c4de814d8a9748945f1570e0a931ce88b1475b56
company,2023-01-09 08:00:00,3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,118201865,https://s.yimg.com/ny/api/res/1.2/mMm9Aq4X9bmf6wgOKn4XjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/28a450beb9692fc97300760b527ce68e,VRTX,Yahoo,"While the day-to-day machinations of the financial markets have left many investors feeling discouraged lately, stocks can still be a fantastic way to build and sustain wealth over a period of many years.  Vertex Pharmaceuticals (NASDAQ: VRTX) is at the forefront of cystic fibrosis (CF) treatment, a space on track to eclipse $17 billion by the end of the decade.  Therapeutic drugs designed to target the root cause of CF and enhance a patient's quality of life, known as CFTR modulators, remain key to managing the disease for thousands of people globally.",https://finnhub.io/api/news?id=7af6a305a2bd2af33d2fe394be343127f140e3e2958022b58ffa28bf4a037271
company,2023-01-09 07:12:00,41st Annual J.P. Morgan Healthcare Conference,118433203,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f588d4300291e986e36cd459ab4facf441ed7a6bc152e2afb35e1498b842969f
company,2023-01-09 07:07:00,Vertex Pharmaceuticals Incorporated (VRTX) 41st Annual J.P. Morgan Healthcare Conference - (Transcript),118433204,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=93cf8292951d01ab5e8f86b53b4c6eed5cbf036edb64063f96d3ba0568c3e15b
company,2023-01-09 06:00:25,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?,118217022,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"It is hard to get excited after looking at Vertex Pharmaceuticals' (NASDAQ:VRTX) recent performance, when its stock has...",https://finnhub.io/api/news?id=571084bef8a8df778c38e30dd426c74a064149a3e2a7bc4b37beee8ef5506fb6
company,2023-01-09 05:18:00,Royalty Pharma: An Attractive Business Model But An Uncertain Outcome For Vertex`s CF Royalties,118433205,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b1ee5cf1cff9f322f127dac3a6bd5b261d40bfffb38798a5f0fe559efd279a8d
company,2023-01-09 03:58:00,Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish,118410897,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f83fefa5be94df1074ad7a1a39515544c9e922a9906d355aec559e01c3ef7a2d
company,2023-01-08 09:45:00,2 Healthcare Stocks That Could Make You Richer,118196630,https://s.yimg.com/ny/api/res/1.2/rrcIp5JmTn0C5pltFolwnw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e693c7a440af087400d7a864b293dd77,VRTX,Yahoo,"While the healthcare industry may not seem at first glance like the most exciting place to invest your cash, it has proven to be one of the most resilient sectors for investing.  Healthcare companies tend to supply the products and services that consumers need no matter what is happening with the market or the economy.  If you are looking to add cash to more fantastic healthcare stocks in the month of January, here are two no-brainer buys that can enrich your portfolio over the long term.",https://finnhub.io/api/news?id=8b8ef2ea509f1e7391a989c632ab043b6a392cc11ee7d6fa42821e5d3a5145c0
company,2023-01-07 06:15:00,"Looking for Growth in 2023? Where to Invest $5,000",118193122,https://s.yimg.com/ny/api/res/1.2/Wh6L25qodOr.nJSQV2IN7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/60167e11234e8db0173689356e3bd4af,VRTX,Yahoo,"This year, some of the stocks most heavily hit by the market downturn could start to make a comeback.  And they're trading at 28 times forward earnings estimates, which looks cheap considering Etsy's earnings performance in tough times.",https://finnhub.io/api/news?id=9a1217ca9b99fc0abe1a63e2944421d8cd4ac5b5eb2e7f6b6b5c410a05d4bac2
company,2023-01-07 05:30:00,These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.,118191839,https://s.yimg.com/ny/api/res/1.2/bRpMLRm8QsXaeQlkc86tiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/1829593b0920cba62c7bdceb3fb0ffe3,VRTX,Yahoo,Axsome Therapeutics (NASDAQ: AXSM) soared more than 100%.  Vertex submitted a potential blockbuster in a new treatment area to regulators.  Let's check out why Axsome and Vertex are still stocks to buy.,https://finnhub.io/api/news?id=0dd74ab9e1c475927e6c0661bfa70d1341ec24259ecde60a1f5a4d36699dc183
company,2023-01-14 06:15:00,3 Dirt Cheap Stocks to Buy in January,118262472,https://s.yimg.com/ny/api/res/1.2/qXIg3Z5_8TQL_l_pmX3gOA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/19455d87d9ab0903f920091a09e211be,VRTX,Yahoo,"While the stock market has performed abysmally over the past 12 months, there are plenty of stocks available at steep discounts.  Three Motley Fool contributors were asked to identify dirt cheap stocks to buy in January.  Here's why they chose Pfizer (NYSE: PFE), Teva Pharmaceutical Industries (NYSE: TEVA), and Vertex Pharmaceuticals (NASDAQ: VRTX).",https://finnhub.io/api/news?id=6121140c13e21d20b36bc4d2406a1c413c4e4e721d799c9ae2619aa68172e46c
company,2023-01-14 06:00:00,Is It Too Late to Buy Vertex Pharmaceuticals Stock?,118263155,https://s.yimg.com/ny/api/res/1.2/tNsD3ZDQ9MRx3oAkqi.wPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9ed147ecb36c5fd57e44785e1c4cc675,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) did something most other biotech companies didn't last year: It beat the bear market.  Vertex was on its way to proving it could be successful in areas beyond CF.  The company had reported positive data for its blood-disorders candidate and then began regulatory submissions.,https://finnhub.io/api/news?id=4ecae260c24b6b00f040a3acf041c1ad648a2725a48cf536db8e8e14397f1439
company,2023-01-13 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",118309599,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.58% to $300.94 Friday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=ac661e4ba290e173305d6542f9db0bf97215b5dc98053b89c3842b83e405c7a7
company,2023-01-13 07:00:21,"If EPS Growth Is Important To You, Vertex Pharmaceuticals (NASDAQ:VRTX) Presents An Opportunity",118240417,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",https://finnhub.io/api/news?id=d9ea4360b2383b4f9f28a696c1c84b285a86baf1bddcc04b753de264ff7618e4
company,2023-01-12 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",118309600,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.37% to $296.25 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...",https://finnhub.io/api/news?id=1d5f532972d5cc4a5b50cf011610cdbb7b9fb438bbf97623b78cded6a4b2538f
company,2023-01-12 09:40:00,Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever,118207048,https://s.yimg.com/ny/api/res/1.2/9Xuj4zqQnFw19snREO8m4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/130c5d42b25928f2fb36a7f562eafdf4,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and cannabis company Green Thumb Industries (OTC: GTBIF) are three stocks that offer potential long-term rewards.  Boston-based Vertex Pharmaceuticals is a biotechnology company whose cystic fibrosis (CF) drugs have proven to be a huge success.  Trikafta is currently Vertex's best-selling CF treatment.",https://finnhub.io/api/news?id=ac942fbccf268730028a60d937728490e1b615fc1eb975a8b06e57e426ab6a68
company,2023-01-12 08:28:00,2 Top Healthcare Stocks to Buy for the Long Haul,118207049,https://s.yimg.com/ny/api/res/1.2/KdOXHI1GjbdDuB4GosvxdQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDM-/https://media.zenfs.com/en/motleyfool.com/d9310cb8039f038e5275ad2a9a3455e5,VRTX,Yahoo,"The healthcare industry may not carry the same glitz and glamour for investors as other sectors.  The rare disease drug market is a fast-growing but historically underserved space on track to see its valuation grow to about $340 billion by the year 2030.  A key player in this industry is Vertex Pharmaceuticals (NASDAQ: VRTX), a company that has made a name for itself and built a robust history of profitability around its portfolio of medicines that treat the rare genetic disease cystic fibrosis.",https://finnhub.io/api/news?id=694a128ab22350366d9425cad028c276443c40dc6aa96d8132041dc50e2f6d26
company,2023-01-12 07:45:00,1 Top Growth Stock Set to Crush the Market Again in 2023,118217004,,VRTX,Yahoo,"Last year, biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) did not disappoint its shareholders.  The good news for investors is that the company has developments that could lead to a similarly strong showing in 2023.  Over the past decade, the only medicines that Vertex commercialized have targeted cystic fibrosis (CF), a rare genetic condition that damages patients' lungs and causes digestive problems.",https://finnhub.io/api/news?id=17f5cc8c3475ba1ae72683e0a05ad92a4542b608b97bc034a050192dcc3b8f3e
company,2023-01-12 06:34:21,"Vera: Disappointing Data From Phase 2 ORIGIN Trial, Initiating Coverage With A Sell Rating",118202609,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1349441051/image_1349441051.jpg?io=getty-c-w750,VRTX,SeekingAlpha,Veraâs phase 2b ORIGIN data was underwhelming with lower than expected proteinuria reduction ~31% even at 9 months. Read about the VERA's outlook here.,https://finnhub.io/api/news?id=f4af1d5c351c590d2d2aa28d483b3993f5ef702e128e933c422da734aca9ee28
company,2023-01-12 05:52:00,4 Growth Stocks to Buy and Hold Forever,118205289,https://s.yimg.com/ny/api/res/1.2/vgW1vHcEcPJkrdWkV8yWhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/edf092aaa56b601c82cd396ef2d60913,VRTX,Yahoo,"Warren Buffett would tell you the answer is ""forever.""  TikTok is a serious challenger to YouTube's dominance in the video app market.  OpenAI's ChatGPT AI tool could threaten Alphabet's most important business -- Google Search.",https://finnhub.io/api/news?id=1fa976c8dc390e043eaac422a39d070c324908ccfdf14ae1ef594e2b9c330cfa
company,2023-01-12 05:36:00,VRTX March 3rd Options Begin Trading,118433194,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c3008ccf7c548c3f915fd5a7946cdb7fca14e23d8e19a57dd1a0209bd51dce82
company,2023-01-12 04:39:56,IBB: A History Of Outperformance During Recessions,118202247,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1354171890/image_1354171890.jpg?io=getty-c-w750,VRTX,SeekingAlpha,iShares Biotechnology has outperformed the S&P 500 during all 3 recessions in the U.S. since inception in early 2001. See why I'm bullish about IBB ETF now.,https://finnhub.io/api/news?id=51425a6aa3e767d662d77e31f174f1780fac56c748fa207e446de56f107023b7
company,2023-01-11 19:15:36,Prime Medicine 'Crispr 3.0' Vs. Crispr Therapeutics,118198086,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1295493003/image_1295493003.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"Despite being founded 10 years ago, CRISPR Therapeutics could very well lose out to 3-year-old Prime Medicine. Read more to see the comparison.",https://finnhub.io/api/news?id=68bcc5234ef762b08fe83cce27e20d9a485ab42200f1fe44481a048e96cb650e
company,2023-01-11 15:03:00,Vertex Pharmaceuticals Stock Sees Rising Relative Strength,118217008,,VRTX,Yahoo,A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue?,https://finnhub.io/api/news?id=78289913a6f45ddea3f3f9f6092d26fe9fe8dd6b5a1b189c7418488cf61c2fef
company,2023-01-11 12:31:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",118309601,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.21% to $292.25 Wednesday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=7ae614fae15aec505348eb499a3e67ac893e530d6b4dd93c8d908813613fc90a
company,2023-01-11 08:44:19,2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,118217010,,VRTX,Yahoo,"The stocks for healthcare companies IQVIA Holdings (NYSE: IQV) and Vertex Pharmaceuticals (NASDAQ: VRTX), for example, have been on the upswing recently thanks to reports of increased revenues, rising earnings, and management outlooks that point to more growth on the way.  IQVIA's shares were down more than 18% over the past year, but they're up more than 18% over the past three months.  The company is starting to see volumes get back to normal now that the worst effects of the pandemic are fading.",https://finnhub.io/api/news?id=3b1a3dfe448358784482800fc8613904aa3f0fe14ce2e4c39abecb8ca09d4723
company,2023-01-11 07:34:48,Ranking The 10 Largest Biotechs By Pipeline,118194522,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1153436387/image_1153436387.jpg?io=getty-c-w750,VRTX,SeekingAlpha,"The pipeline is the heart of all drug discovery companies, leading to all growth in the future. Here we rank biotechs by pipeline, click to see the list.",https://finnhub.io/api/news?id=32dc11f2a46a529f7c54d43a690b9fed88795676b63d86e10b9ff57ba95fd9bd
company,2023-01-11 07:10:00,"Vertex, Arbor Biotechnologies extend agreement on precision gene editing technology",118433197,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7d8456bdaa308c146659bd710fc9b659d3a7ddd3c2d0fa8ca237f1da47510632
company,2023-01-11 06:19:00,Prime Medicine `Crispr 3.0` Vs. Crispr Therapeutics,118433199,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2f13eb563638cd8cd5df276c59aa6df6076527b0dbfd1420282f6efb8d6e7adb
company,2023-01-11 05:52:00,3 Top Healthcare Stocks to Buy for January,118198640,https://s.yimg.com/ny/api/res/1.2/cR8vZ5ydCHJK9N6JHmkUsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8faff076e8ff73c4ac7daf15359c76c4,VRTX,Yahoo,My Motley Fool colleague Sean Williams even predicts that it will be the year's top-performing sector.  Here are three top healthcare stocks to buy for January.  Vertex also is moving forward with early-stage clinical testing of VX-522.,https://finnhub.io/api/news?id=adc767892d2f23fb039d4f392d40c21b1b17c98ebfd1fd96dbb57f49dd0bc9f6
company,2023-01-11 05:10:00,2 Supercharged Stocks to Buy Right Now That Could Soar in 2023,118205043,https://s.yimg.com/ny/api/res/1.2/wTrtY4E3hWw4aU.oqjHw8g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/27d318ddbd0b8c28960c92df6360443c,VRTX,Yahoo,"Major indices such as S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average fell by around 19%, 34%, and 9%, respectively, in the past year.  Despite the broad sell-off, a few stocks, such as Pinduoduo (NASDAQ: PDD) and Vertex Pharmaceuticals (NASDAQ: VRTX), managed to excel even in the difficult macroeconomic environment thanks to a solid growth story and robust financials.  China-based e-commerce player Pinduoduo built an online marketplace to bring cheap and high-quality products (electronics, fashion, household items) and agricultural produce to price-conscious consumers.",https://finnhub.io/api/news?id=dc5ccdc2192e1145ca5ab5052325abbeef4dc95c3e63e74e157f25baeb05c815
company,2023-01-11 01:02:00,Vertex Pharmaceuticals expands collaboration with Arbor Biotechnologies,118433200,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=55c2e7e8b66ee764f965470c79a640df83b0e8db8aabeb87e1bc3b4a2fb57323
company,2023-01-18 17:50:10,Vertex Pharmaceuticals (VRTX) Stock Moves -0.68%: What You Should Know,118310767,https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed at $309.86 in the latest trading session, marking a -0.68% move from the prior day.",https://finnhub.io/api/news?id=259dbc1b541a1b30152b4bdf4f8b3d1aba83ddde5a42f4b50a20f71df393cfe5
company,2023-01-18 16:47:17,How IBD Stock Of The Day Vertex Is Stacking Up Billions In Potential Sales,118310768,,VRTX,Yahoo,"Vertex is Wednesday's IBD Stock Of The Day. As the biotech eyes several blockbuster opportunities, VRTX stock is finding renewed support.",https://finnhub.io/api/news?id=9f1cb5851579f668d6a136f4e33a907c3ad457c06855bb730dec3cb0fc6ed486
company,2023-01-18 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,118309597,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.68% to $309.86 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=9ca118b397e87b8f1bfc44bb6cfbfaf56517c32c60eae0ecd4cae2fae85dd8b5
company,2023-01-18 09:45:02,Vertex Pharmaceuticals (VRTX) is a Top-Ranked Growth Stock: Should You Buy?,118304054,https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c,VRTX,Yahoo,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,https://finnhub.io/api/news?id=e98fcf2ba4961077a0b7416596ed9efca407936d31b9e7ec97177112aad3f72a
company,2023-01-17 22:15:36,Dow Jones Futures Rise On Bank Of Japan Surprise; Tesla Jumps,118298941,https://media.zenfs.com/en/ibd.com/9080cd15e60edbdf44f41f3d46db3472,VRTX,Yahoo,"Futures rose and yields fell as the Bank of Japan stayed dovish. The market rally paused while Tesla stock jumped. United Airlines, Moderna rose overnight. Microsoft job cuts loom.",https://finnhub.io/api/news?id=80cb0e09f7c195118668ae667a7c1a968414132fdab6606fb3b140072bf41acb
company,2023-01-18 06:00:00,5 Reasons to Buy Vertex Pharmaceuticals Now,118304056,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) defied 2022's bear market thanks to its tangible business progress.  Over the course of the year, the biotech company and its partner Crispr Therapeutics brought their treatment candidate for blood disorders toward the commercialization finish line.  Vertex has started off this year with gains too, and its winning streak may be far from over.",https://finnhub.io/api/news?id=1a617929457ed894b74c075b3e1f59190cfa531c7188a582f36f94aabc78a931
company,2023-01-18 05:01:00,David J Yvars Group`s Top 5 Buys of the 4th Quarter,118433182,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=acdd1d2b377fec1ae1eb4ef8e6df2f55c91c8685c8e77d5c6292d10c651c15b9
company,2023-01-18 01:10:00,Vertex Pharmaceuticals initiated with a Hold at Canaccord,118433183,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=45f079212408b0a91757136c9809c5fdbe31841be358d31f881a25b252a4990a
company,2023-01-17 23:12:36,Dow Jones Futures: Bank Of Japan Surprise; Tesla Jumps,118299113,https://media.zenfs.com/en/ibd.com/9080cd15e60edbdf44f41f3d46db3472,VRTX,Yahoo,"Futures rose and yields fell as the Bank of Japan stayed dovish. The market rally paused while Tesla stock jumped. United Airlines, Moderna rose overnight. Microsoft job cuts loom.",https://finnhub.io/api/news?id=03c0795502417cc87cece53bffb6eaffe6b126a2228b9d72c7365aa2ceb749b6
company,2023-01-17 21:47:00,7 Biotech Stocks That Will Make You Rich in 10 Years,118433185,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a87264e621e4a432bbe8485e2b0fabf5a1913efc2c6280769ae5250ed7918316
company,2023-01-17 17:21:36,"Market Rally Pauses, Tesla Keeps Rebounding; United Airlines, Moderna, Microsoft In Focus",118295673,,VRTX,Yahoo,"The market rally had a quiet day, with Tesla leading. United Airlines and Moderna rose overnight on news. Microsoft job cuts loom.",https://finnhub.io/api/news?id=7eaf5f443dfe2bf29a750b74bc0d3033260d7476ee37a81c6ac908e8edb077a3
company,2023-01-17 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,118309598,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 3.67% to $311.98 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=8a1c8cb2249b1714ebc7bb766426e14fb36639f2474d0bbad99c2a8b61775fde
company,2023-01-17 08:00:00,Vertex to Announce Fourth Quarter and Full Year 2022 Financial Results on February 7,118293616,https://media.zenfs.com/en/business-wire.com/44c4bcc8d714696ba46fe085acb21026,VRTX,Yahoo,"BOSTON, January 17, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2022 financial results on Tuesday, February 7, 2023 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (877) 270-2148 (U.S.) or +1(412) 902-6510 (International) and reference the ""Vertex Pharmaceuticals Fourth Quarter 2022 Earnings Call"".",https://finnhub.io/api/news?id=b745d4ed5a94dabf881da87c033437cc49152ac699680433886e0ce8c4473fc5
company,2023-01-17 07:48:00,"SVB Securities upgrades Vertex to Outperform, raises price target to $374",118433186,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5cde659a236682675d80d6a1bd08eb25b319eae1e8f083c1f1ae13751a061cbc
company,2023-01-17 03:01:00,"TEALWOOD ASSET MANAGEMENT INC Buys 3, Sells 2 in 4th Quarter",118433187,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e3df66a3cac2c4a8ed62f70edd32123fd01643e56aa319ca9cd073419051228d
company,2023-01-17 01:32:00,"Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)",118433189,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9a5642b93d48fbbe30bc613c688b0553164f58ec2f6d011fac209527dc9d0555
company,2023-01-17 01:11:00,Vertex Pharmaceuticals upgraded to Outperform at SVB Securities,118433190,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c65d04868945bae8b2bbd706e54de1429838db9be73edd6c7083b719c8c18121
company,2023-01-16 08:30:00,3 Biopharma Stocks That Could Help Make You a Fortune,118281805,,VRTX,Yahoo,"As any biotech investor will tell you freely, investing in biopharma is rife with risks.  Clinical trials can miss the mark, and successful medicines on the market can get outcompeted by newer entrants.  To do that, they tend to have a mix of reliable sales alongside a bunch of ambitious projects to provide upside.",https://finnhub.io/api/news?id=5198ce039b058df78e143c6793c4e259cda8175d7465a4c2c454f66d1b073e2a
company,2023-01-16 05:30:00,2 Stocks Down More Than 25% to Buy Right Now,118279171,,VRTX,Yahoo,"Two healthcare stocks in particular have caught the attention of Motley Fool contributors Adria Cimino and Keith Speights.  Keith Speights (Intuitive Surgical): I have bad news, good news, and great news with respect to Intuitive Surgical (NASDAQ: ISRG).  Intuitive Surgical was also negatively affected by COVID-related lockdowns in China.",https://finnhub.io/api/news?id=cf6674d18969935006da411598726c6244c2db7a701e155ff2560b75adda506a
company,2023-01-22 06:02:00,Global drug spending to reach $1.9T by 2027 ��� IQVIA,118424132,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3c76391a5988e263e2f354cb96e63e2fc29246e463bbe650a3e49030266163ef
company,2023-01-21 18:34:46,10 Best Healthcare Stocks For Recession,118341563,https://media.zenfs.com/en/insidermonkey.com/890c4401a89cc86500f543fa95466f94,VRTX,Yahoo,"In this article, we will take a look at the 10 best healthcare stocks for recession. You can skip this part and go to 5 Best Healthcare Stocks For Recession. The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop. Data shows that the Health Care Select Sector SPDR exchange-traded […]",https://finnhub.io/api/news?id=c8cb2fcca7a8aa1d03149de80264cca2ded7cf34a837647e89b4601868647df0
company,2023-01-21 09:10:48,"BP Stock, Baidu Lead 5 Stocks Near Buy Points With Big Growth Potential",118340417,https://media.zenfs.com/en/ibd.com/13926a0b1c6deeeaa488f4e6463294cd,VRTX,Yahoo,BP and Chinese search leader Baidu lead this weekend's watch list of 5 stocks near buy points with strong growth opportunities.,https://finnhub.io/api/news?id=28345884042a32350333a075920a8e035063a329ab6cda539ab4055bb9119e0e
company,2023-01-21 06:55:00,3 Smart Stocks to Buy if a Recession Is on the Way,118340522,https://s.yimg.com/ny/api/res/1.2/iNJyMItTGopZ3nU9bdg1GQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04Nzg-/https://media.zenfs.com/en/motleyfool.com/77d5e9a25b406b743e731099805e43ae,VRTX,Yahoo,"Here's why they picked Gilead Sciences (NASDAQ: GILD), Johnson & Johnson (NYSE: JNJ), and Vertex Pharmaceuticals (NASDAQ: VRTX).  David Jagielski (Gilead Sciences): Investors can minimize their risk in the event of a recession by investing in businesses that provide essential products and services and that also pay a dividend to help offset declines in the event of dropping share prices.  Gilead Sciences meets both of those criteria, as its HIV treatments are vital to patients.",https://finnhub.io/api/news?id=df03dde8d7f33132f5dc996d8f8dfd1d6945e4b3d4d3f8484104ab1dcf783452
company,2023-01-20 10:23:00,"The Best Stocks to Invest $5,000 In Right Now",118331300,https://s.yimg.com/ny/api/res/1.2/B_yig2KsOkDi8Qlb7Ue0uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/1c4a977887472158931912275287ebd6,VRTX,Yahoo,"The stock market has already marked its fair share of high highs and low lows in 2023, and we're not even a full month in.  Vertex Pharmaceuticals (NASDAQ: VRTX) isn't one of those healthcare stocks with a massive portfolio of drugs that has tapped out its heyday of superior growth.  At present, Vertex has just four approved drugs in its portfolio, and all of them treat the genetic disease cystic fibrosis.",https://finnhub.io/api/news?id=bee839b61542504d71405131d93763af1b2db783b56bd4c5541fecb3cbb3da4f
company,2023-01-20 09:36:57,Dow Jones Falls Ahead Of Housing Data; Netflix Surges On Subscriber Growth,118331090,https://media.zenfs.com/en/ibd.com/1062edc6073a2f5b593ddf0af446393b,VRTX,Yahoo,The Dow Jones Industrial Average fell Friday ahead of housing data. Netflix stock surged after the company's stronger-than-expected subscriber growth.,https://finnhub.io/api/news?id=53292d0f4947e5c7037d9e9f972140f3166e20e64abbe35e863589820abd1531
company,2023-01-20 09:15:00,2 Healthcare Stocks You Can Buy and Hold for the Next Decade,118332078,,VRTX,Yahoo,"While the stock market volatility continues, day in and day out, not all companies have witnessed declines in their results.  In fact, many wonderful businesses are continuing to thrive in the current environment -- and that includes healthcare stocks.  If you're looking to add no-brainer healthcare stocks to your portfolio right now, here are two top names you'll want to consider when formulating your list of buys.",https://finnhub.io/api/news?id=2e27e2db27bb1c7a4d2429c6fe2f0fc471749a708f63310854e6a7b2d70d148d
company,2023-01-20 06:52:06,"Dow Jones Futures: Netflix Jumps On Subscribers, Google Slashing 12,000 Jobs After Market Rally Breaks Key Levels",118330438,,VRTX,Yahoo,"The market rally suffered more damage as the S&P 500 fell below its 50-day line. Netflix subscriber growth easily beat. Google will cut 12,000 jobs.",https://finnhub.io/api/news?id=3d48a85e587d33c0dee4affd462b6574e092eb4f333f468208c4c092cbc77916
company,2023-01-20 00:24:00,Top 5 4th Quarter Trades of Brendel Financial Advisors LLC,118412039,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6cef35e17867ce89a0358cb83940e188f8266ac6a55809f8b897f5c667ec783e
company,2023-01-19 18:48:06,"Dow Jones Futures Rise, Netflix Jumps On Subscribers After Market Rally Breaks Key Levels",118324372,,VRTX,Yahoo,The market rally suffered more damage as the S&P 500 fell below its 50-day line. Netflix subscriber growth easily beat.,https://finnhub.io/api/news?id=7bdf7879048ea272c442ceca91399292f45dcf62095056bcf314ac92f53ad6fe
company,2023-01-19 16:57:06,"S&P 500, Nasdaq Break Key Levels, But Watch These 5 Stocks; Netflix Subscriber Growth Strong",118322811,,VRTX,Yahoo,The S&P 500 and Nasdaq fell below their 50-day lines. Medpace and Exxon lead resilient stocks. Netflix jumped late as subscriber growth easily beat views.,https://finnhub.io/api/news?id=ae10c830df2cb2e6e28a2ba7893932affdff1fc9136d23d32f31a20b32750337
company,2023-01-19 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,118376637,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. dropped 0.62% to $307.94 Thursday, on what proved to be an all-around poor trading session for the stock market, with...",https://finnhub.io/api/news?id=aff6f7deb08d7c3cba4c5f0c8674274b787cd090e675a04a63451ef1cc5802df
company,2023-01-19 10:00:43,Dow Jones Falls 225 Points After Jobless Claims; Netflix Earnings Due,118319009,,VRTX,Yahoo,The Dow Jones Industrial Average fell 225 points Thursday after first-time jobless claims. Netflix earnings are due out after the market close.,https://finnhub.io/api/news?id=9f55a53ca59cedeb30ee8624399d8ce39cad13b695f4f24a1ec612c4f5224637
company,2023-01-19 05:30:00,3 Unstoppable Stocks to Keep Buying in 2023,118316502,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,VRTX,Yahoo,"Investors bought certain stocks hand over fist.  In most cases, these particular companies offered investors a solid reason to be optimistic about their future.  Up-and-coming biotech Axsome Therapeutics (NASDAQ: AXSM) commercialized its first two products.",https://finnhub.io/api/news?id=2e4a853671c963ad4b4a793164c594548f9203dbf6462338cb6508d1257e9782
company,2023-01-19 04:48:00,Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler,118433180,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6f2f4615e6105ef9eac17763c9afc796870b10606c36458f473b18dc39a26a7b
company,2023-01-18 19:10:00,Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength Rating Benchmark,118310765,,VRTX,Yahoo,"Vertex Pharmaceuticals stock now meets that criteria, with a jump from 75 to 84 Wednesday.  As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.  Is Vertex Pharmaceuticals Stock A Buy?",https://finnhub.io/api/news?id=bc0d52ac6fc09429c33ad9e1c69a434177bd08826f6bc90e7fbba41387d6a5fc
company,2023-01-26 10:01:28,"Dow Jones Reverses Lower After GDP, Jobless Claims; Tesla Surges On Earnings, Musk Comments",118385024,https://media.zenfs.com/en/ibd.com/aeaa0e1be20d5f21088765e6b03c3242,VRTX,Yahoo,The Dow Jones reversed lower after GDP and first-time jobless claims. Tesla stock surged on earnings and CEO Elon Musk's upbeat comments.,https://finnhub.io/api/news?id=1d7c60949bbd9c999291f2e29e2bd3b5fbbf700808891d9b6b0dfc1304143eae
company,2023-01-25 23:31:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,118433167,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=73fafbdedf1c9f40b9c7743929eb636ca4a621e361e550b1553d1963ccf2386a
company,2023-01-25 17:20:18,3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later,118387457,https://media.zenfs.com/en/investorplace_417/b912a2b47d4b301fa5481b7d77ee6c13,VRTX,Yahoo,"To many investors, gene editing sounds like the plot of a science fiction movie. The concept of being able to edit our DNA to cure genetic diseases is quite unbelievable, and the upside of gene editing to treat rare diseases is impressive. However, many gene editing stocks are making waves, looking to advance toward eradicating cancer and other serious illnesses. But ever since 2012, gene editing has been a reality, at least in terms of having the technology needed to edit genes. Don’t get me wr",https://finnhub.io/api/news?id=09c32ee0f0c0efc9d784cd897ea9ede2cf2bd9a7693a3ab35959f194bd916fad
company,2023-01-25 10:02:37,"Dow Jones Falls 325 Points As Boeing, Microsoft Drop On Earnings; Tesla Skids Ahead Of Earnings",118362696,,VRTX,Yahoo,"The Dow Jones dropped 300 points Wednesday, as Boeing and Microsoft fell on earnings. Tesla earnings are due after the close.",https://finnhub.io/api/news?id=f3449608c6aa0cb0a9b8b13b5756091628e678c6d418c2e18387b968a1784f21
company,2023-01-25 03:01:00,"Top 5 4th Quarter Trades of Lindbrook Capital, LLC",118433168,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7d489afee003f54263589ff6a403f73311382cb59c5ed5f0a3740995aa31ae0b
company,2023-01-24 23:21:00,3 Gene Editing Stocks to Buy Now OR You`ll Be Kicking Yourself Later,118433170,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8de230f8185cf60545c0be3ef888fc1ed68222e9c84f705e25d765a9e7ec1343
company,2023-01-24 23:04:00,7 Cream-of-the-Crop Stocks to Buy Today,118410711,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bd6f9b7d4a941a409c471f155588efff00983993a2a4fcc27348b074a7915f66
company,2023-01-24 17:50:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,118366018,https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $313.57, marking a +0.56% move from the previous day.",https://finnhub.io/api/news?id=01c8a7a9708b0828645b11fd6779635f1d902ab1d573e421481379a7198479e6
company,2023-01-24 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,118376634,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.56% higher to $313.57 Tuesday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=1149a8d8c3d61938bbb962425a20574a93566975ce36f0c8629c9a8df3aa9fd2
company,2023-01-24 10:13:59,Dow Jones Falls 200 Points With 8 Key Earnings Movers; Microsoft Earnings Due,118356547,https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee,VRTX,Yahoo,The Dow Jones Industrial Average fell 180 points Tuesday as J&J and Verizon reported earnings. Microsoft earnings are due out after the stock market close.,https://finnhub.io/api/news?id=c8a1cb976a8a03a325592cf358464d69922cd94655d61a85e1a4b601a6b0af78
company,2023-01-24 05:26:00,Morgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX),118433172,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=369fab56ae3511fc470792d656579c7c9d499b0b267ef1af5ab0fc488a9b73f1
company,2023-01-23 12:37:28,"Stocks To Buy And Watch: Dow Jones Banking Giant JPMorgan, 3 Others In Or Near Buy Zones",118348972,,VRTX,Yahoo,"Among the top stocks to buy and watch, Dow Jones banking giant JPMorgan is below its recent buy point, while Axon is breaking out today.",https://finnhub.io/api/news?id=66a7536113326d7fda781786b2329b7e4abfe8f4ad9b5d83b2ead56ef6489c93
company,2023-01-23 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",118376635,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.64% higher to $311.81 Monday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=a65932b0b657afa8a7b86f9d8c092c5c0b0332b187bc7dcfef5a9223472da32f
company,2023-01-23 09:53:46,"Dow Jones Rises As Dollar Fades; Economic Data, Earnings Reports Due; AMD Surges On Upgrade",118348896,,VRTX,Yahoo,"The Dow Jones rose Monday ahead of a busy week of key economic data and earnings reports, with Tesla earnings due out Wednesday.",https://finnhub.io/api/news?id=cb7c56daf2deed8fd25b024cb2f56f09760e5de54b97dae88aa61123d24e9e56
company,2023-01-23 07:50:00,Healthcare Sector Is Lagging As We Enter 2022 Earnings Season,118418452,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9957d503a5e539084f7abee93d032bd159f7c5db3c14782308468df98031df4c
company,2023-01-23 05:02:02,Healthcare Outlook 2023,118347941,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345347757/image_1345347757.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. Read more here.",https://finnhub.io/api/news?id=901fdf5f20709c0abeea555b7f59a1eaa98eed8a4b5ad266ce3d68b4334a0ed4
company,2023-01-23 04:50:00,First Week of March 17th Options Trading For Vertex Pharmaceuticals (VRTX),118433175,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3e51de8d5d37cefe663a4389f50954306698207536734a710f8371512b78289a
company,2023-01-30 17:50:10,Vertex Pharmaceuticals (VRTX) Stock Moves -0.46%: What You Should Know,118426189,https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $319.98, marking a -0.46% move from the previous day.",https://finnhub.io/api/news?id=1789c6ca10ba156cd52414e8c402ca0ce5bf3d06414813ca03127076fa9fa524
company,2023-01-30 09:55:52,Dow Jones Falls 100 Points With Fed Meeting In Sight; Tesla Stock Upgraded To Buy After 33% Surge,118399216,https://media.zenfs.com/en/ibd.com/1062edc6073a2f5b593ddf0af446393b,VRTX,Yahoo,"The Dow Jones fell 100 points Monday, with the Federal Reserve's policy meeting set for this week. Tesla stock was upgraded to buy.",https://finnhub.io/api/news?id=2ba7c3666b6a64f2f4a55a4dd3b450287c7d799827de73e583e426370f151354
company,2023-01-29 23:32:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,118433163,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87ed5a19615f266ebf50ffabe862ce26e776cd6fe6223d3f1a50b6404c13121d
company,2023-01-27 10:11:22,Dow Jones Reverses After Inflation Data; Intel Plunges 10% On Earnings,118388049,https://media.zenfs.com/en/ibd.com/c2b75dc8024878493d21703dee8e0168,VRTX,Yahoo,The Dow Jones Industrial Average reversed higher Friday after key inflation data. Intel stock plunged over 10% on an earnings miss.,https://finnhub.io/api/news?id=4a9326a56a4dc00a3669ca7b53dcefd74ab4a23954ed769ef6638c9a4471e2b7
company,2023-01-27 09:53:00,"The Best Stocks to Invest $20,000 in Right Now",118384437,https://s.yimg.com/ny/api/res/1.2/8hwBTmD8WsM9nW7nSFen3A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/3ea0c77bbac9e4f01651a3250764f65e,VRTX,Yahoo,"Companies in the healthcare industry in particular are often known for producing steady performance even in a tough macro period as they aren't exposed to the same economic cyclicality that other industries are.  Vertex Pharmaceuticals (NASDAQ: VRTX) is a healthcare company that specializes in medicines and therapies targeting rare diseases.  Right now, the company's approved medicines are all for the rare genetic disease cystic fibrosis, and it controls the lion's share of this multibillion-dollar market with its four products that treat the ailment.",https://finnhub.io/api/news?id=6dfd1b3006e4ee364e5d93008382b78855bbcd34f1054748e352a3ce95ba6d3e
company,2023-01-27 07:14:31,bluebird bio: More Share Dilution Likely,118383052,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1364653006/image_1364653006.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"In our opinion, bluebird bio faces significant challenges that could decrease future investor returns. Read more to see BLUE's headwinds and why I think more share dilution is likely.",https://finnhub.io/api/news?id=9e0be75ae4149b939b974f81e902e695428d1d76cf5c1199d0b07fbac75f3730
company,2023-01-27 06:50:00,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,118393579,https://s.yimg.com/ny/api/res/1.2/7z5sAVKs0AmD51gTXt1U8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b3c86c5b0e287a18590e66cc94ea8095,VRTX,Yahoo,"If you want solid healthcare stocks that will be worth buying and holding for the next 10 years, you need to set the bar pretty high.  But thanks to its portfolio and late-stage pipeline therapies, its next few years should feature strong growth.",https://finnhub.io/api/news?id=c9ec38e276191d75909956bc48cf2b18ce0f2f37d57b20da7e71bddc7719f78b
company,2023-01-27 01:57:00,VRTX Crosses Above Average Analyst Target,118433165,,VRTX,ETF Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=403b825f471e95a8b3634028f2656c1f2b26c6a850ba3499ad4fac9a825abd46
company,2023-01-26 23:31:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",118433166,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=76343968e8919f9e94317a55353857981dec42c3f3c024903e0f7ef211f82e5d
company,2023-02-03 14:02:07,Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?,118484148,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"On Vertex Pharmaceuticals' (VRTX) Q4 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and updates on its non-CF pipeline candidates.",https://finnhub.io/api/news?id=16066fd19a073618db5c3de36297269876e2985e94c2b8ffb55ee207d20d6139
company,2023-02-03 09:37:00,2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,118475307,https://s.yimg.com/ny/api/res/1.2/cEC1Y7_VH.FH7UC3XXlTCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/524ea8c232835bfe8979c04b4c2c1510,VRTX,Yahoo,Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities.  Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM).  Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.,https://finnhub.io/api/news?id=ef7f2faeca325769aa170fb6ba322055e2baa226ce5591ea08e9dee43d5dac0d
company,2023-02-02 23:34:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors,118605922,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0d64366afb48193c5a52caa51a4c50819bffb408f2f64cda27f116ff62f5ea8a
company,2023-02-02 10:00:03,Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,118442581,https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f,VRTX,Yahoo,Ultragenyx (RARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=bfe7af28a34989105bc7125bb0f6e748dc7705c8a9c0efba1b97b3f1542756a7
company,2023-02-02 09:53:00,2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade,118442582,https://s.yimg.com/ny/api/res/1.2/5opvkpVQxj_8QwB8LkZfjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/6cd4b6fc65786fa79e2e1745ca77a38c,VRTX,Yahoo,"The healthcare industry has proven to be a remarkably resilient place to put capital to work in a wide range of environments.  From life-saving medicines and therapies to vaccines, these are just a few examples of the essential products that healthcare companies make that render them particularly defensive investments in a bearish environment.  AbbVie (NYSE: ABBV) is a pharmaceutical giant.",https://finnhub.io/api/news?id=d9fe383b3be774e98beb16a7a466158a95e650ae3c441c7d600549bb07278d36
company,2023-02-02 05:52:00,3 No-Brainer Stocks to Buy in February,118441640,https://s.yimg.com/ny/api/res/1.2/gd9bYckt7Q.rxJTAYfBXzQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/6b0e9cb217713718d3f5a9758eeee1e1,VRTX,Yahoo,"Wouldn't it be nice if investors had an ""easy button"" like the one that was featured in Staples commercials years ago?  Unfortunately, the ""easy button"" doesn't exist.  Actually, Amazon's stock has already begun a rebound, up more than 20% year to date after plunging nearly 50% in 2022.",https://finnhub.io/api/news?id=8e85740306f9e8c6c00646b12c7d00d86431fbb4d463b3a2c3bcfc99cc601d3b
company,2023-02-01 23:31:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,118605923,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=53354d0252f9e7ddfb7e6a42693170f0d791f9e5e6eeb386c4393a4c198c99b3
company,2023-02-01 22:32:00,Parnassus Comments on Vertex,118605924,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1c1f1b0718f68ca80ec0bb542c5dbea3f82bf34ff15483e4792cdb6ab061e394
company,2023-02-01 17:45:10,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,118426179,https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $317.27, marking a -1.8% move from the previous day.",https://finnhub.io/api/news?id=eba6560238570218cff25a10008a8497407db038c2609397644e7b8e8e64190d
company,2023-02-01 05:52:00,A New Bull Market Could Arrive in February: 3 Stocks to Buy Now,118426181,https://s.yimg.com/ny/api/res/1.2/ZdQakO2fTlQc9PdkpIp0jQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/9ac59279f8f837da64607b30826f3cb9,VRTX,Yahoo,What will it take for a new bull market to begin?  The commonly accepted definition of a bull market is when stock prices rise 20% or more above their previous low.  A new bull market realistically could be on the way in February.,https://finnhub.io/api/news?id=1aa242bd109a8be83991bbdc3904047892e11118693bc321f8cdc104de1a8b92
company,2023-01-31 23:32:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,118433157,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7956f58dabd4e2fc6a2292befe50b459fc04735649b5cb98968435d69039507d
company,2023-01-31 21:01:00,Top 5 4th Quarter Trades of FOSTER DYKEMA CABOT & CO INC/MA,118420699,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0a7d802584b2d820198b8464c7cf4a6888a4fe96d1ce91666614c3b56fd54f2
company,2023-01-31 21:01:00,"MOODY LYNN & LIEBERSON, LLC Buys 4, Sells 1 in 4th Quarter",118432829,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3911defe370a391451006c6a2dd7691bcbc27d7d332377ccee96571082dd38da
company,2023-01-31 16:14:07,"This Clue Helps Spot The Best Stocks To Watch, Including These 11",118404148,https://media.zenfs.com/en/ibd.com/29816c3b155ef19bd51cdfb6d63443e9,VRTX,Yahoo,"The best stocks to watch often hail from the top-ranked industries. Here's a look 11 stocks, including VRTX ad ULTA, that fit that bill.",https://finnhub.io/api/news?id=1adfbc045dd8e24d859a8aa93c10041584fdecd6f6bc5436bb18bdef9b345c85
company,2023-01-31 10:00:03,Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,118426185,https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2,VRTX,Yahoo,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=eadaf0cfe1619096cdf393c2637894a4e79edd852079371d550d46181818648a
company,2023-01-31 10:00:00,3 Things About CRISPR Therapeutics That Smart Investors Know,118404176,https://s.yimg.com/ny/api/res/1.2/OWFZqaaQkJDWTjV.CahQhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/4cddcc38693712cb4aa5be883b7bd2f7,VRTX,Yahoo,"It's easy to see why investors might assume that early-stage gene-editing companies like CRISPR Therapeutics (NASDAQ: CRSP) are too inscrutable to approach.  In fact, smart investors know (at least) three key things about this business, and you should too -- especially if you're considering purchasing shares sometime soon.  CRISPR has a few partners, but its most important one by far is Vertex Pharmaceuticals (NASDAQ: VRTX).",https://finnhub.io/api/news?id=e912bcaa7dab2af4dfc47ab866840f5be6b17128deb5c500872d7eddf86e682d
company,2023-01-31 05:01:00,"Top 5 4th Quarter Trades of VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.",118419312,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c87e4120f22a8ee6427d0c48645368c93109ba869097ce230e0538a7d92827ac
company,2023-01-31 05:01:00,"Highview Capital Management LLC/DE/ Buys 3, Sells 2 in 4th Quarter",118423189,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=307ef0cd1c4f7fd6b6757224bf4236235a074d5957092e7bc6a0a5917a3249f8
company,2023-01-30 23:31:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",118433162,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9e9ec1171ca2ec9fefc578f71196a837e9b0ced4f371a305e7d075e912278e77
company,2023-02-07 18:49:44,"Dow Jones Futures: Market Rallies On Powell, Microsoft AI Arms Race; Fortinet, Enphase Jump On Earnings",118497096,https://media.zenfs.com/en/ibd.com/9080cd15e60edbdf44f41f3d46db3472,VRTX,Yahoo,The stock market rallied Tuesday on Fed chief Jerome Powell and a Microsoft AI arms race. Fortinet and Enphase were big winners late.,https://finnhub.io/api/news?id=3c851b4b8ecdb1e42b956089057febb1dad85af842bb5bc89bfad29791443981
company,2023-02-07 17:15:10,Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Beat Estimates,118497097,https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4,VRTX,Yahoo,"Vertex (VRTX) delivered earnings and revenue surprises of 6.52% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=c5fbcf93c0f64a61ad632fd596f680daf697fc359ff9efd2d156ae1efb77ed2a
company,2023-02-07 17:02:14,Vertex Offers Upbeat Guidance After Beating Fourth-Quarter Profit Views,118497098,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,Vertex Pharmaceuticals offered an upbeat look for 2023 sales after reporting an earnings beat and in-line sales.,https://finnhub.io/api/news?id=9de1d4334f71876c432fdb034b978b8d0d0bf773300a6213dbaea608b6b86da6
company,2023-02-07 16:10:25,Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript,118499800,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Q4 2022 Earnings Conference Call February 7, 2023 4:30 PM ETCompany ParticipantsSusie Lisa â Senior Vice President-Investor...",https://finnhub.io/api/news?id=83a25993f7fd671b2b88e1ea66b533a2ce78b93aab6f5c9fdb8b9ecc2b0b8eb0
company,2023-02-07 16:01:00,Vertex Reports Fourth Quarter and Full Year Financial 2022 Results,118497099,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,VRTX,Yahoo,"BOSTON, February 07, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2022 and provided full year 2023 financial guidance.",https://finnhub.io/api/news?id=486d110dca18f64fdfd76cb3a7424e2fdf65c5cddbe5093535861a5913510bca
company,2023-02-07 13:51:59,The 7 Best Biotech Stocks to Buy for February 2023,118528661,https://media.zenfs.com/en/investorplace_417/180ce84be58b62c67d477717f09599bb,VRTX,Yahoo,"While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech stocks to buy offer investors incredible upside opportunities. Better yet, the volatility largely centers on developments of the industry itself rather than the broader economy. By that, I mean biotechnology firms may enjoy some economic insulation as their relevance supersedes variables like interest rate dynamics. Still, it doesn’t mean that the best biotech stocks to buy are immune from",https://finnhub.io/api/news?id=df33961c885a560d0273d1958cf8e5414b5058dcf4897d765ffc02b45654badc
company,2023-02-07 13:09:47,Vertex Pharmaceuticals Incorporated 2022 Q4 - Results - Earnings Call Presentation,118496416,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2022 Q4 earnings call.,https://finnhub.io/api/news?id=ca90baa625a5fa805549b259f82a34a657f26b103930b89545420ec87ea6c08a
company,2023-02-07 12:07:00,Vertex Pharmaceuticals sees improved annual earnings and revenue,118605901,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=04576817bbd5999260355286dc266725f461ade522849eae2981e43616eaa261
company,2023-02-07 11:11:00,Vertex: Q4 Earnings Snapshot,118605902,,VRTX,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=27e6dcce0e80a0fa6010865d97cba452dd7384b313153454836df5547be0c631
company,2023-02-07 11:07:00,Vertex Pharmaceuticals Sets $3B Share Repurchase Program,118640081,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Kathryn Hardison Vertex Pharmaceuticals Inc.'s board of directors has approved a new share repurchase program for up to $3 billion of common stock. The...,https://finnhub.io/api/news?id=249d56310f79beed5f96ab9ec29c9223a28865c02d754177543caf395f885617
company,2023-02-07 10:45:00,Vertex Pharmaceuticals Battles Back With A Boost To 81 RS Rating,118497100,https://media.zenfs.com/en/ibd.com/37fad342ab4fe642cc2a7ae97fe0a35d,VRTX,Yahoo,"Vertex Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81.",https://finnhub.io/api/news?id=68768288949d6bbe85957ad86e5254fc0096ddc6c47a4036fb4fcfc57388516b
company,2023-02-07 07:39:00,Vertex under fire as activists demand generics for best-selling drug,118605905,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e52819dedcdd41e86ba8e579e519ab5643941322b2a9195a043a84381c7d956e
company,2023-02-07 07:09:00,Notable companies reporting after market close,118605906,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=385af21236aa5fc53b48ff83d1dbe294e1a5e023d1fcf7649a669399be66452a
company,2023-02-07 05:55:00,3 Top Stocks to Buy If There Is a Market Pullback,118497101,https://s.yimg.com/ny/api/res/1.2/qbohcISkhEqW6Ui62mn_fQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTc-/https://media.zenfs.com/en/motleyfool.com/1e34e067810b4e9c957397f27c802445,VRTX,Yahoo,"It's even possible that we could soon see the beginning of a new bull market.  Investors could have the equivalent of this happen with the stock market.  If the stock market indeed retreats, one of the most likely culprits is that investors fear a recession is coming.",https://finnhub.io/api/news?id=e3aecbf7bb355c8ef75702ba02a9ab947bc03050dbaf0eb7589164dd0211de88
company,2023-02-07 05:06:00,3 Nasdaq 100 Stocks to Buy Hand Over Fist in February,118490024,https://s.yimg.com/ny/api/res/1.2/mkyY4854Bjrj0RtJfOpn9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTA-/https://media.zenfs.com/en/motleyfool.com/497a2552405e68cad485b4938e10feb6,VRTX,Yahoo,"After growth stocks were Wall Street's savior in 2021, they were primarily responsible for dragging the major indexes into a bear market last year.  The growth-dependent Nasdaq Composite and Nasdaq 100 -- an index comprised of the 100 largest nonfinancial companies listed on the Nasdaq exchange -- each plunged 33% in 2022.  Thankfully, when there's pain on Wall Street, you can always find opportunity.",https://finnhub.io/api/news?id=b3948ace881e115fd013606e8c7cb18ccf26a87b4aa53d83eb60b76606e66bfb
company,2023-02-07 00:22:00,"Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports",118605908,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e9613c9a6bf6bdac529a6310ddb3cf3049e65f281888c82acfb1b7014f8afb7a
company,2023-02-06 23:32:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",118605910,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5df53c54a5a1d721faa9cff3ad019f5276b6b6e635d9f6a9a6c15513eca8e424
company,2023-02-06 22:40:00,Vertex indicates slowdown in growth; announces share buybacks,118605911,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=03ec483952a92ffb5f12df89e9a564f17bdc851fe3895a4423d7fc4c0badb0fd
company,2023-02-06 22:05:00,"Vertex Pharmaceuticals Non-GAAP EPS of $3.76 beats by $0.25, revenue of $2.3B in-line",118605912,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b1b8ba10ed66d3101876c3f1b09a23c9980ff738ddb8562e2217539c654f08c2
company,2023-02-06 22:04:00,Vertex Pharmaceuticals board authorizes $3.0B buyback,118605914,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4e284c4cf29f9f3b9df962afe5f2e253edd476de514ffd709305ea9b4f9aef28
company,2023-02-06 22:04:00,"Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B",118605913,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6bfaef6a857041b6f590da2f6eb5db933bf6a7eae88c57faea93a9e06d965bd6
company,2023-02-06 22:03:00,"Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51",118605915,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ac0cc8e670e62bb985ed62857a2526a42e1af7e5deae6904276d137fb60bbe2b
company,2023-02-06 21:19:00,Vertex options imply 3.7% move in share price post-earnings,118605917,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9c42c08da41a8a61d65dda1f437b9d71469154ee6eb143cb3e63b40f60a0cbc9
company,2023-02-06 19:25:00,GLOBAL BRIEFING: Australia lifts interest rates by 25 basis points,118605918,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8b4a271fdb12bf31b58d1ffe279990c68f85a66801d2a513f6cbc409fb4992e4
company,2023-02-06 17:34:42,"In virtuous cycle, foundation uses drug royalty riches to back new cystic fibrosis drug research in Bay Area",118486227,https://s.yimg.com/ny/api/res/1.2/mx5PX94b3doJf5_m81EjRg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xODAw/https://media.zenfs.com/en/bizjournals.com/b21dffb38e8f6624edf59204248be7aa,VRTX,Yahoo,The Cystic Fibrosis Foundation is spinning some of the half-billion dollars it received as part of a royalty deal in 2016 into Bay Area companies looking at ways to tackle persistent infections and perhaps even mutation-fixing cures.,https://finnhub.io/api/news?id=011b777d127230ce2a5ad4b10b7c7b1f6e58e49860776926b6ce21c6f2019ef1
company,2023-02-06 15:58:00,Vertex Appears a Bit Under the Weather Ahead of Earnings,118486228,https://s.yimg.com/ny/api/res/1.2/MAsIuDGJTz._PDdtyDnqBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/thestreet.com/c528f75738fe8790a1ae1bfac6f08638,VRTX,Yahoo,Vertex Pharmaceuticals  is scheduled to report their latest quarterly top- and bottom-lines on Tuesday after the close of trading.  Prices pulled back to test the rising 200-day moving average line and a close below the early January low will turn the trend lower and could precipitate further declines.  The trading volume has been steady instead of increasing and the On-Balance-Volume (OBV) line shows a steady rise into late January.,https://finnhub.io/api/news?id=1fee32300ad70c13402b031c6ee90dfc67fa83908d4c03fd3b411d5e40a0b2f7
company,2023-02-06 10:30:03,"Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL",118480367,https://media.zenfs.com/en/zacks.com/f54f709ae65e32f6086a21eeef8d44f3,VRTX,Yahoo,"Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.",https://finnhub.io/api/news?id=87d75467d17783082c079bb5e85c1136471c8dd7222434ca48518c17ed92e8eb
company,2023-02-06 05:48:00,Global company events calendar - next 7 days,118588251,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=26a4d06be8501e1878b2c85f5eb42008c70c8205cf71fd31372501484c4eff02
company,2023-02-05 23:32:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",118605920,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8f44a567fd1ec6d43a282a0b91c5234263393703ebcd563cea0fe3312a657dcd
company,2023-02-05 02:47:00,When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?,118589139,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6a921b116abc5dbbc3e43c6dcf528bd493c667d139116bfa6ab6b60c4ee76322
company,2023-02-11 14:31:00,3 Surefire Growth Stocks You Can Buy Right Now,118555234,,VRTX,Yahoo,"With this in mind, we asked three Motley Fool contributors to identify surefire growth stocks you can buy right now.  Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Keith Speights (Axsome Therapeutics): It usually takes only one big product to be a game changer for a small biotech stock.",https://finnhub.io/api/news?id=efa073b07586c6746031ea15c656e30f57aea552ef723626680ce4093bfb5173
company,2023-02-11 13:13:00,2 Biotech Stocks That Could Help Set You Up for Life,118555236,,VRTX,Yahoo,Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) and Regeneron Pharmaceuticals (NASDAQ: REGN) are each up about 20% over the past year.  The biotech companies have shown increased revenue and earnings per share (EPS) over the past three years and have burgeoning pipelines that should continue to drive growth.,https://finnhub.io/api/news?id=d527aa1563591411f79ed4eb8a297fd81dedfa288f7ff5d35b37d16b7b3d70c4
company,2023-02-11 05:30:00,This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.,118555237,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) stock climbed more than 31% last year even as the overall market touched bear territory.  Now, investors may wonder if the good news is priced into Vertex shares -- and if gains are over.  First, though, a quick summary of Vertex's story so far: The company is the global leader in CF treatment.",https://finnhub.io/api/news?id=909477f270d88daea5734ab68b2c21bc403a644b870276e87c721a17b7470a8c
company,2023-02-10 13:40:27,25 Biggest Massachusetts Companies and Stocks,118526608,https://media.zenfs.com/en/insidermonkey.com/27724ca1374c6463a25b7def50922d8d,VRTX,Yahoo,"In this article, we will be taking a look at the 25 biggest Massachusetts companies and stocks. To skip our detailed analysis, you can go directly to see the 5 biggest Massachusetts companies and stocks. If all U.S. states were countries, Massachusetts would be 32nd largest economy in the world based on a 2021 GDP […]",https://finnhub.io/api/news?id=b6d2f2ce15cf0a2a741ef043a5830e55f97b0e73f00f7b91a9e0a968e62ec085
company,2023-02-10 05:52:00,3 Stocks That Could Soar Whether There's a New Bull Market or Not,118528655,https://s.yimg.com/ny/api/res/1.2/6l.KLUhzgQ8M2d8sdl7m7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/e77f3a0929637ab60067aed9a7d94d48,VRTX,Yahoo,Here are three stocks that could soar whether there's a new bull market or not.  Axsome Therapeutics (NASDAQ: AXSM) stock more than doubled last year while the S&P 500 plunged.  The reality is that Axsome's performance this year won't hinge in the least on what the overall stock market does.,https://finnhub.io/api/news?id=2a50453c3d22fcae9c395a78f7e546ed57d22250ffbf904444d24bf26d23fc5e
company,2023-02-10 05:35:00,2 Top Stocks to Buy Without Hesitation in 2023,118524907,https://s.yimg.com/ny/api/res/1.2/DyWDAmerCMV7vejvgtQv9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b1735961e6e7f4dc332a0d3c0b6694b3,VRTX,Yahoo,"Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, soon to be split into two separate entities.  The company is in the process of spinning off its consumer health business into a new company called Kenvue, while its medical device and pharmaceutical businesses will remain under the umbrella of the Johnson & Johnson name.  CEO Joaquin Duato noted in the company's recent 2022 earnings call that ""we filed our form S-1 with the SEC, giving us the option to pursue an IPO as a potential step in the separation.""",https://finnhub.io/api/news?id=869fc900b7be8c70e78be0726f1c020e8a24354346e8feed91a790d3fbf7f0a1
company,2023-02-10 05:17:00,Is Vertex Pharmaceuticals Stock a Buy Right Now?,118525999,https://s.yimg.com/ny/api/res/1.2/d0LGoVrwVuRDq33LHBZMOA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTg-/https://media.zenfs.com/en/motleyfool.com/81d357aa3c7b7963665bec51ac02d619,VRTX,Yahoo,"Investors looking for stocks that can produce impressive gains regardless of the general market's direction should turn their attention to the biopharmaceutical industry.  Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) gained a stunning 33.5% in 2023 while the Nasdaq Composite index that it's a part of sank 33.1% lower.  Of course, one very good year doesn't necessarily mean Vertex Pharmaceuticals can keep climbing in the years to come.",https://finnhub.io/api/news?id=2d87609670a697775ed909d6b03c9497dc1300dc0e14d8c557bea663bc73f5ec
company,2023-02-09 23:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,118605875,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d73374b8dfb60f6b3a2d5adb4ba265df84374866398f309f58f54abfbae6d6c3
company,2023-02-09 14:25:20,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2022 Earnings Call Transcript,118522165,https://media.zenfs.com/en/insidermonkey.com/f587b9191d2baf106d80ccfc53ff9340,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2022 Earnings Call Transcript February 7, 2023 Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter and Full Year 2022 Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. […]",https://finnhub.io/api/news?id=386780a526ad8d6b9ffa1169e641a924eec9672cd0c676ca9b105d9023479026
company,2023-02-09 10:56:13,Vertex Pharmaceuticals: As Strong As Ever In Cystic Fibrosis,118516270,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/495358386/image_495358386.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Despite a snapped streak of 20+ quarters of revenue beats, Vertex Pharmaceuticals is a decent buy. Click here to see our take on VRTX stock.",https://finnhub.io/api/news?id=e4cc95d32d67b69b1438970bacede48d73cd5d6346b23b770b9ef48057a33b92
company,2023-02-09 09:48:02,CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?,118522166,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,VRTX,Yahoo,"Devoid of marketed drugs, investors' focus will be on CRISPR Therapeutics' (CRSP) pipeline, specifically its lead candidate exa-cel, in its fourth-quarter earnings.",https://finnhub.io/api/news?id=bcae2b817022029bb89977345785ffc4b04d422ddc0e19f7a10bf23855c05a7c
company,2023-02-09 06:35:00,VRTX Crosses Below Key Moving Average Level,118605878,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=747f180f8006c6222562f53a7f89a95f5cec5896f39bdca55e9eeb9bee719f3a
company,2023-02-09 05:56:00,Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?,118522167,https://s.yimg.com/ny/api/res/1.2/glDTxRaYKfBUDck0M9idSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/5b83bc6e540ab920c1889439df8a958b,VRTX,Yahoo,"With a new bull market potentially near, investors might be forced to soon make such hard decisions.  If we were talking about which of these biotech stocks is the better pick for a bear market, it would be an easy decision.  All we have to do is look at how Vertex and CRISPR Therapeutics stocks performed in the bear market last year.",https://finnhub.io/api/news?id=53629f10c39581db8bea8fc818209115209645153fc9f3ae5373e0aeaa1b3467
company,2023-02-09 05:37:02,Vertex Pharmaceuticals Full Year 2022 Earnings: In Line With Expectations,118522168,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals ( NASDAQ:VRTX ) Full Year 2022 Results Key Financial Results Revenue: US$8.93b (up 18% from FY...,https://finnhub.io/api/news?id=791eecc76eeea549fdbe40935192881c797c4abfcdcd634722d15b68bed0e444
company,2023-02-09 05:30:00,Wall Street Expects This Stock to Jump 70% This Year. Here's Why It Could Happen.,118522169,https://s.yimg.com/ny/api/res/1.2/6OhH0u4lM..YZiS8OHp2nA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/48b16dcb951191842bc261491f0dc02b,VRTX,Yahoo,"CRISPR and partner Vertex Pharmaceuticals have applied for authorization of exa-cel, a candidate to treat blood disorders.  If all goes well, Wall Street's average forecast for a 70% jump in CRISPR shares within the coming 12 months could happen.  CRISPR and Vertex use this technology in exa-cel to tackle the blood disorders beta thalassemia and sickle cell disease.",https://finnhub.io/api/news?id=9f0dbe0785078ab007d7e36ca6387326b90aa5211bfcb82f2e1b38df522d7f05
company,2023-02-09 01:31:00,"Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Vertex Pharmaceuticals (VRTX) and AbbVie (ABBV)",118605880,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=00d57a5a3e97a6403c97e11989fd26372874c21b708889e82f2a6f50623676d4
company,2023-02-09 01:05:00,Entrada Therapeutics closes agreement with Vertex,118605883,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0fdd271bce106ca377c5fc1431aa7a1b539879135abc1cba608af8a980abec8f
company,2023-02-08 23:31:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,118605884,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ada81624f7832b5174048b05ffb6e702452418985a1ad892aa8b6b60cc0ea019
company,2023-02-08 22:02:00,Vertex��Pharmaceuticals: As Strong As Ever In Cystic Fibrosis,118605885,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6c7bbafd5a1c90efd3b95058b1ef6cc2189c02028e48001a625dbcfb984a12cf
company,2023-02-08 21:06:24,Meta Platforms Announces $40 Billion Share Buyback - Buyback Wednesdays,118515138,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=69db0e2ba13382a0d0630599fbc4c8e76c80935e63e94f5c92be515a98bffa1a
company,2023-02-08 16:09:14,Vertex Stock Topples As Investors Seek Clearer Vision Of Future Despite Huge Profit Beat,118522170,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,Vertex Pharmaceuticals' fourth-quarter sales divided analysts Wednesday as VRTX stock toppled on a lack of near-term catalysts.,https://finnhub.io/api/news?id=9b31a70756b21f83eeef9517f657afc3ee2cbd03c0e98f2a4ae829515134247e
company,2023-02-08 14:00:00,2 Top Biotech Stocks Defying the Bear Market,118514262,https://s.yimg.com/ny/api/res/1.2/Dt4CQGySmgQWR3NkYVc_Hg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/426954c5a574369d49c30438c902effe,VRTX,Yahoo,"The bear market crushed many top healthcare stocks -- from young high-growth players to long-established companies generating billions of dollars in earnings.  Vertex is the worldwide leader in the cystic fibrosis (CF) treatment market.  In fact, last year product revenue climbed 18% to more than $8.9 billion.",https://finnhub.io/api/news?id=cfb9c5d1bcd76a1a54b3957c114131f0e733ddbbad57c21606c73c9125a0362b
company,2023-02-08 13:52:10,Vertex Pharmaceuticals: Pioneering Scientific Advances To Tackle Serious Diseases,118511497,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368429013/image_1368429013.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Vertex focuses on creating transformative medicines for serious diseases, with a special emphasis on specialty markets. See why VRTX stock is a Buy.",https://finnhub.io/api/news?id=8a6b80d11b51224f82c19f6869c5774c4dc8aab9c3fea0d11afab03e628bb0f4
company,2023-02-08 10:53:03,"Vertex (VRTX) Beats on Q4 Earnings & Sales, '23 View Encouraging",118507035,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,Vertex Pharmaceuticals' (VRTX) four-quarter 2022 earnings and sales beat estimates. VRTX also issues better-than-expected revenue guidance for 2023.,https://finnhub.io/api/news?id=df639daa722db481d4acd14384aea6d8b548faa1379d94d4717b2a2592afdda6
company,2023-02-08 08:22:44,"Dow Jones Futures Fall, AI Arms Race Intensifies; Fortinet, Enphase, Uber Jump On Earnings",118503999,https://media.zenfs.com/en/ibd.com/9080cd15e60edbdf44f41f3d46db3472,VRTX,Yahoo,"A Microsoft-Google AI arms race is keeps expanding. Fortinet, Uber and Enphase were big winners early Wednesday.",https://finnhub.io/api/news?id=4f12b691be4d4f51c32d02befdff1b1b8603575ce81d3597c5c4b998bc15e12f
company,2023-02-08 05:46:00,Vertex Pharmaceuticals (VRTX) Gets a Buy from BMO Capital,118605887,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a90d5992de42de903778d8bdd12a1ac75c6334084d724fa0bbe9c08d68f6ab17
company,2023-02-08 05:35:10,Here's What Key Metrics Tell Us About Vertex (VRTX) Q4 Earnings,118522176,https://media.zenfs.com/en/zacks.com/579c66d7eb0bc34658c6fee68420f397,VRTX,Yahoo,"Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",https://finnhub.io/api/news?id=7869a0e7b7c3126314dc1b8560e35fa62686da6994c9be97dac7abc80a8e166f
company,2023-02-08 05:31:00,"Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Vertex Pharmaceuticals (VRTX) and Inspire Medical Systems (INSP)",118586421,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3afada5cc4fd687d893b40c702c7c63751348b246c5f73db1dcd482bd357e0cf
company,2023-02-08 05:26:00,Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),118605889,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b979d93011b76851057167154168ddb5ea7971fe354fd7f7594a1aeac8f1e2fd
company,2023-02-08 05:25:00,Piper Sandler Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),118605890,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=654006f740357d87da16d802840edd7e1f298018f92f588b74d07cecee48b1cf
company,2023-02-08 05:01:00,"Sivik Global Healthcare LLC Buys 3, Sells 2 in 4th Quarter",118605891,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cc429028a77434b3d93ea65b62203120eb81a33d1839705ac79684d7bd76378d
company,2023-02-08 02:57:00,Vertex Pharmaceuticals price target lowered to $365 from $374 at SVB Securities,118605892,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=013ebba3025b0faf09aef78b677b03d7599553e48734f79e3ccde3c068a82a9c
company,2023-02-08 02:51:00,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Siegfried Holding AG (OtherSGFEF) and Demant (OtherWILLF)",118605893,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c493dfe6bb63255864b28dd259d8fed3350c5e8182585aeac3b01e03af319b44
company,2023-02-08 01:30:00,"Analysts` Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Illumina (ILMN) and Vertex Pharmaceuticals (VRTX)",118605894,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=04d2a44be42f74e8be2216eaf406cc479e5edfef113d4a63be516b676a7c46a4
company,2023-02-08 01:02:00,Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Rocket Pharmaceuticals (RCKT),118600935,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=628937105e3c0138cc08fc2c111b8d1831086bea299f0dbeb422a3dd2950ae5d
company,2023-02-08 01:00:38,Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript,118522178,https://media.zenfs.com/en/motleyfool.com/ce68ea0b0cd2631701fe87e542e7a165,VRTX,Yahoo,"My name is Susie Lisa, and as the senior vice president of investor relations for Vertex, it is my pleasure to welcome you to our fourth quarter and full year 2022 financial results conference call.  On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex' CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief financial officer.",https://finnhub.io/api/news?id=855fad9e8de5386982c025ef023efbe3b007801ce0800c549542a3fd875e0120
company,2023-02-08 00:10:00,Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright,118605897,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c58d3258428803bf1f963fbc0468f92f6707e9832c95e79d5e587d844c0f7aa6
company,2023-02-07 23:41:00,Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays,118605898,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=164d614e89d53d92100bf2a5d86fcc853e4133d352c4c23a9251cc6f5192d636
company,2023-02-07 23:32:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,118605899,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=aceebff124a2124a3169bb945161a10f436cf56cdc574b8654fc35df11625710
company,2023-02-07 21:37:05,Vertex has built a CF empire. Next up: cell and gene therapy.,118522179,https://s.yimg.com/ny/api/res/1.2/clQeTDC5uIJpJzLLfw9yhA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTk-/https://media.zenfs.com/en/bizjournals.com/28be92496a7c3d14abcc843b525be628,VRTX,Yahoo,The pharmaceutical giant's next play is a CRISPR-based gene therapy that could launch as soon as this year.,https://finnhub.io/api/news?id=65266e187defc96901213fb2263fc1aeccbceed4fb1ee3d59dde30d52547ced6
company,2023-02-07 19:32:00,GLOBAL BRIEFING: Stocks called higher after Fed chair remarks,118591955,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=260dc700abdfcfe1b93597eff3489e5b90f7b01b5a5b94973ed64ee39b6a0d84
company,2023-02-15 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",118640073,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slumped 0.50% to $298.75 Wednesday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=b2271003f5dbae69aff446345a94b85f42af4772c81258cad467f6accb5d6d5c
company,2023-02-14 12:31:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market",118640076,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.36% higher to $300.25 Tuesday, on what proved to be an all-around rough trading session for the stock market,...",https://finnhub.io/api/news?id=2933dbad41d14b853b8a533e7e2202f54017c3c5f73a3715fa2506995656bbb0
company,2023-02-13 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",118640079,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.60% higher to $299.18 Monday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=3b3053ce5955d2a251108f740e853efd70bca3dd524918c0ce2b271b5d5d3a9c
company,2023-02-13 09:15:00,3 Growth Stocks With More Potential Than Any Cryptocurrency,118583978,https://s.yimg.com/ny/api/res/1.2/OVE6zOXksdaWYKkwsk8sZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9878025fadf1c10e6fb807b474240b37,VRTX,Yahoo,"If you have money to put into the stock market right now, there are plenty of companies just begging to be bought with tremendous growth potential to tap into in the years ahead.  Vertex Pharmaceuticals (NASDAQ: VRTX) is coming off of another robust year of growth in 2022.  The company delivered approximately $9 billion on the top line in the 12-month period, paired with earnings of $3.3 billion and operating income of $4.3 billion.",https://finnhub.io/api/news?id=61d423f1f3ebeaadc0bd2254cbe113c42af314c6469191a64f51e42e5d4e7bfb
company,2023-02-13 08:30:00,2 Top Healthcare Stocks to Buy for the Long Haul,118602623,https://s.yimg.com/ny/api/res/1.2/KBsfb6x7pUnshVBpQBvmXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/20ce819fdeab7139f4ff27f764c1ef41,VRTX,Yahoo,"The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses.",https://finnhub.io/api/news?id=dc1a57d933fa3ac4aef8632c1a187ec60f7e28a0ab167292bb98eb32ac90ecad
company,2023-02-13 05:50:00,3 Unstoppable Growth Stocks to Buy for 2023 and Beyond,118602624,https://s.yimg.com/ny/api/res/1.2/hWDHoJdygWsLSaBj_tvtXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTg-/https://media.zenfs.com/en/motleyfool.com/a7be0e49d6963d277bfa093d97f10392,VRTX,Yahoo,"Here are three unstoppable growth stocks to buy for 2023 and beyond.  Sure, Disney's (NYSE: DIS) stock performance last year made it look very stoppable.  Bob Iger, who previously served as Disney's CEO and was called to duty again in November 2022, knows what he's doing.",https://finnhub.io/api/news?id=cc7be82ddc3472ed437dcb6cb87598715fa17d13ba6b86ee4074a4a37ca6355e
company,2023-02-13 05:25:00,2 Top Stocks to Buy in February and Hold Forever,118585977,https://s.yimg.com/ny/api/res/1.2/VxcoJAhCODF96vrxVkiDDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4d1c5e4da4a748e1add1286becb999c7,VRTX,Yahoo,"The stock market can be a fantastic way to build and sustain strong financial returns, but only if you stay in the market for many years.  While there are plenty of healthcare companies that sell surgical robotics systems, none have come close to snagging the market share of Intuitive Surgical.",https://finnhub.io/api/news?id=d05b02e1822936c41cea9cf1533827b16b7c59bbc4404ab75e6cdf5b88032e9e
company,2023-02-12 23:39:00,Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers,118592318,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=10f08388234bf361f3f17cd986888c2f377c7bf59f6e899a840fb4850b3dd7c3
company,2023-02-12 23:34:00,Large Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers,118592319,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e6051668d3b39c62d477e1c3305e73c31b5437fed8ea9d8961632f332b36e4da
company,2023-02-12 20:53:00,ARK Invest: The 7 Words That Explain Why Wall Street Can`t Stand Cathie Wood,118605873,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e88856163950f64ea175b7ac9baf270496aecf35a5e97f930f6994f22f0f20ed
company,2023-02-12 05:50:00,"The Best Stocks To Invest $5,000 in Right Now",118565735,https://s.yimg.com/ny/api/res/1.2/jcTwSWDhBgQ11ccTn11_GQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d4230c9e549e85ae26da6e94d964bf6d,VRTX,Yahoo,"When Bill Miller says a stock is a great pick, it pays to listen.  Specifically, Miller called Amazon ""one of the easiest names in the market right now.""  This optimism about Amazon isn't just because the stock remains more than 40% below its previous high (although that is the case).",https://finnhub.io/api/news?id=c5f47fb11357872bbe47bcd625d579f7881db699375423f8daa28bc481d64bec
company,2023-02-19 10:00:00,"Got $1,500? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond",118685026,https://s.yimg.com/ny/api/res/1.2/VWxQ2kW_21.hx7gpFnnFFA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/94dbc30675df93a45f5dee4ac931eb3a,VRTX,Yahoo,"The stock market has challenged the fortitude of even the most seasoned investors over the past year, with extreme volatility driving shares of some of the largest and most popular companies down.  Regardless of what stocks do in the coming weeks or months, superior businesses primed for growth can come out on top in the long run.  Vertex Pharmaceuticals (NASDAQ: VRTX) has actually beaten the market over the trailing 12 months, delivering a share price increase of around 30% compared to the S&P 500's negative return that currently sits right around 7%.",https://finnhub.io/api/news?id=b0a4b6de35ef484ab5ae77ff4dd71b577c596166240dcb772df6c98c42e44ee0
company,2023-02-19 09:45:00,2 No-Brainer Growth Stocks to Buy Right Now,118693007,https://s.yimg.com/ny/api/res/1.2/KWQ238bxbl0JkzeJeCWLGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/6b94b12ab8ce6420c3d3f16331975105,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has amassed a profitable and high-revenue growth business around a relatively small portfolio of drugs.  While the addressable market for Vertex's existing portfolio of cystic fibrosis drugs is massive -- management estimates that as many as 20,000 people globally could benefit from the company's products but are not yet taking them -- and additional indications for these drugs are expanding its patient population, the company is looking to new sources of growth.  It currently has an impressive pipeline of products spanning disease areas ranging from rare blood disorders to type 1 diabetes to acute pain.",https://finnhub.io/api/news?id=b1330d08f9be2488842309644a33bf7011af68a466eb5dfee1638756a938f923
company,2023-02-18 05:50:00,3 Top Stocks to Buy and Hold for the Next Decade and Beyond,118644740,https://s.yimg.com/ny/api/res/1.2/soK9riFVY9C7I3ngDkROXA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/cdedbfb7c382f96898aaee1ec9270ad5,VRTX,Yahoo,"Can Amazon successfully expand into new major markets?  If Amazon CEO Andy Jassy is right, over the next 10 to 15 years nearly 95% of global IT spending could be in the cloud.  Sure, it's possible that the company could be toppled.",https://finnhub.io/api/news?id=749cc6144caf34c8394d538a3413dfafaf9e4d6dd21da53e69245529221b2dca
company,2023-02-17 14:00:00,Beat the Dow Jones With CRISPR Therapeutics Stock,118644786,https://s.yimg.com/ny/api/res/1.2/H06AvGekCATvzu5XwhTZ6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/5fdb7716bda72b81f74a4a5abf824ea1,VRTX,Yahoo,"Back in 2020, CRISPR Therapeutics (NASDAQ: CRSP) left the Dow Jones Industrial Average (DJIA) in the dust.  The stock soared more than 150%, while the DJIA delivered a modest 7% increase.  Investors were excited about biotech companies -- and CRISPR's gene-editing technology caught their attention.",https://finnhub.io/api/news?id=c7d3aff379b495b46f4b8728f0101b50d1e8a9b98adcc0c81400a179b180f8f5
company,2023-02-17 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",118640068,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.55% higher to $293.66 Friday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=6689eead2304a69e51b1213cd4bb9f30a85a225919cb4c92e95c9f25faf779fa
company,2023-02-17 04:54:00,First Week of VRTX October 20th Options Trading,118656262,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a1139a1b0b640b64c4147916cb3ad7c39e7fe8dc1a917a795c9eb8c201b0a752
company,2023-02-16 12:30:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,118640071,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 2.25% to $292.04 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=49a86200548475317905545fd0292a9b995549d33d4ec0e7225001f9d6bace4f
company,2023-02-16 06:07:00,2 Monster Stocks to Buy Hand Over Fist in 2023,118615801,https://s.yimg.com/ny/api/res/1.2/HMtHji3Dt7MVN9.gLELxtw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f82755916ea0b473bd4ad6b12340fe36,VRTX,Yahoo,A pandemic favorite and a healthcare growth stock each have something to add to the long-term investor's portfolio.,https://finnhub.io/api/news?id=21fb3f12ef39e5fc80d88b68f5bd266e3b78d21b4ff5c165e6fecb552abae360
company,2023-02-23 12:30:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,118936560,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.61% to $292.57 Thursday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=ccbdb240524e168b080dd3dad03771d8a169c5f557ec6fa6dbed4d67d285c5ff
company,2023-02-23 12:21:07,Industry Leaders Building Breakouts And Buy Zones Right Now,118872519,https://media.zenfs.com/en/ibd.com/29816c3b155ef19bd51cdfb6d63443e9,VRTX,Yahoo,"The best stocks to watch often hail from the top-ranked industries. Here's a look 15 stocks, including CROX and ABNB, that fit that bill.",https://finnhub.io/api/news?id=96960f87b97f1e358dd4ae6271f2e129a88158a703a95a44d625d8ddc3cec342
company,2023-02-23 12:08:05,"Moderna (MRNA) Lags on Q4 Earnings, COVID Jab Sales Down Y/Y",118875307,https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a,VRTX,Yahoo,Moderna's (MRNA) fourth-quarter earnings and sales miss expectations. Management reiterates guidance to record a minimum of $5 billion from COVID vaccine sales in 2023.,https://finnhub.io/api/news?id=55726008deaacc37c2854e788ba3d2dddf10bbeaa202c8e4e2e2000d2e4d7ce0
company,2023-02-23 02:25:00,Oppenheimer Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),118868820,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=24203f4f8f7c0f9023964057d65ab11ab02ccd6e54636855da106041de3b5944
company,2023-02-22 12:42:05,"CRISPR (CRSP) Q4 Earnings Surpass Estimates, Sales Miss",118856542,https://media.zenfs.com/en/zacks.com/5d7c5069f10e4fdbdb15068596f6e724,VRTX,Yahoo,"CRISPR Therapeutics' (CRSP) fourth-quarter 2022 loss is narrower than expected, while sales miss estimates.",https://finnhub.io/api/news?id=9abcc9cb6b2844ea5f047f819fb6309af36cbab0414886814e9568a9be253680
company,2023-02-22 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,118936561,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.64% higher to $294.36 Wednesday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=44c9003570a791d3635944eed1ed138df5a90f7556a97495a2309e36eb768105
company,2023-02-22 11:10:00,Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done,118836185,https://images.barrons.com/im-729937/social,VRTX,MarketWatch,"The company said it expects to complete a filing for FDA approval for the treatment by March, highlighting its lead in a competitive field.",https://finnhub.io/api/news?id=f42a78a0ba0ed81bda62c52cf59dd6a6e330dc5897f56de3e5e35e71bb056069
company,2023-02-22 10:31:03,"The Zacks Analyst Blog Highlights JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills",118832542,https://media.zenfs.com/en/zacks.com/d6f20a00b84c969c6a59aa3e4de742dd,VRTX,Yahoo,"JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills are part of the Zacks top Analyst Blog.",https://finnhub.io/api/news?id=b802f8282aa99ea4eaabc98d916889aebba5d30a7d5c8a45ad70ad86172b14f3
company,2023-02-22 07:39:00,CRISPR surges 14% most in over two years after Q4 earnings,118833336,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8b4319769f05328e5841c845585bf9b604136535c477d4482826af431f60322d
company,2023-02-22 07:33:00,CRISPR surges 13% most in over two years after Q4 earnings,118833337,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=500f46e83031c379ea3bb6fc7b26096bdab3899ee6bab73be719da78a62e3b57
company,2023-02-22 01:49:00,Crispr Therapeutics price target lowered to $123 from $153 at Chardan,118833344,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5c28dce90f82205547d60d43858396f79467d8114958fbdc4d55f32dc7ec07d9
company,2023-02-21 20:29:00,AbbVie sued in Netherlands for breaching human rights over Humira pricing,118835452,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c17c5d4bfc76adc591fda55ea747ea08a5210810f3af2bf659555810a6331403
company,2023-02-21 16:11:09,"Top Stock Reports for JPMorgan Chase, Elevance Health & Vertex Pharmaceuticals",118802407,https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4,VRTX,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Elevance Health, Inc. (ELV) and Vertex Pharmaceuticals Incorporated (VRTX).",https://finnhub.io/api/news?id=ec8a00ec7eba57e0e1d149e46c55565d13c958a5e3b88f72192cf33eeb0052a3
company,2023-02-21 16:05:00,Vertex to Present at Cowen’s 43rd Annual Health Care Conference on March 7,118802409,https://media.zenfs.com/en/business-wire.com/72d2fd4098bacb04ed3e81f8743a83c7,VRTX,Yahoo,"BOSTON, February 21, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 2:50 p.m. ET.",https://finnhub.io/api/news?id=386f18a5d00c2ebfc9220318d1b55bb3ebc4ccd092f8a2cb122c49f6b934d660
company,2023-02-21 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, still outperforms market",118936563,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.40% to $292.48 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=2fd983aa76216efc2aee4d9b53780cf0dbcc31cbbe6c7daebea308eb0243afd4
company,2023-02-21 09:53:00,2 Bruised Growth Stocks to Buy While They're Cheap,118770646,https://s.yimg.com/ny/api/res/1.2/Acwq9nwfukJflAKDqnZXtg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/cf2454d1f46d72bc54897268a747c138,VRTX,Yahoo,"Every time the market gets a stock wrong, you have an opportunity to profit by buying and holding it, and that's especially true for growth stocks that are likely to flourish again in due time.  With that in mind, let's examine two temporarily down-on-their-luck growth stocks that are positioned to rally after they execute on their core strategies a bit longer.  Ginkgo Bioworks (NYSE: DNA) saw its shares fall by 69% over the last 12 months, but that could be just the opening that value-hunting investors need to start a position.",https://finnhub.io/api/news?id=0d39a5ca2297db3442b2cd107ca6480431832e408158a358853a5cf6eab58550
company,2023-02-21 06:45:00,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,118767819,https://s.yimg.com/ny/api/res/1.2/twggbQs5faxIcZ5_dRUf1A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/7d779b823eebd2c48d136c19b02345a4,VRTX,Yahoo,"The healthcare industry has long proven itself to be a resilient place for investors to park their cash.  Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to report explosive financial growth from its core portfolio of products, all while expanding its pipeline into new disease areas ripe for disruption.  It's delivered a total return of 24% over the past year, compared to the S&P 500's negative return of 7% in that same period.",https://finnhub.io/api/news?id=0901b79e54eac58c40018bccb046acf692fb28977d7263efb73afd4fcfd56ece
company,2023-02-21 03:01:00,"BRIDGER MANAGEMENT, LLC Buys 1, Sells 4 in 4th Quarter",118770661,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=915fe3aafa8a96026c2f0136f3246198c186105a48868dbf6ac460f91b8d103a
company,2023-02-27 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",118977896,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.01% higher to $287.40 Monday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=bf9c8c6e771af768959593036a425a27f71f604bbb80b94cd7a1c2d2df2f3824
company,2023-02-27 08:25:49,Beyond Crispr's Exa-Cel Program: A Scalable Pipeline,118951051,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1389535764/image_1389535764.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,CRISPR Therapeutics is a gene-editing startup that uses CRISPR/Cas9 technology to develop therapies. Click here to read my full analysis of CRSP stock.,https://finnhub.io/api/news?id=eec47635e101982359edbd5b13089b218389b4b491e17c5532e5ddd20038ef7c
company,2023-02-27 07:32:00,Beyond Crispr`s Exa-Cel Program: A Scalable Pipeline,118952173,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=10eeea91c6b99dcda2e318a76299b3472be9c85f58a481505a1fbc4120ce1b06
company,2023-02-26 07:17:00,Baron Health Care Fund Q4 2022 Quarterly Letter,118939962,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=642c71aff227a2200763b4f6d8f5efd69ffa3780761feed076b3c309e3f56ae6
company,2023-02-25 06:25:00,3 Stocks to Buy Right Now That Are Cash Cows,118926132,https://s.yimg.com/ny/api/res/1.2/CLyHUyNF29gSySsuwPig_w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/03bc61dcb9632c1fff4868badc266ade,VRTX,Yahoo,"With this in mind, three Motley Fool contributors were asked to pick stocks to buy right now that are cash cows.  Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Prosper Junior Bakiny (AbbVie): There are many ways in which a company can be deemed a ""cash cow.""",https://finnhub.io/api/news?id=270c6552e4335281db7b9a734822244f30569f3dc2db76d1106d921de007ea00
company,2023-02-25 05:50:00,"3 Top Stocks to Invest $3,000 in Right Now",118924462,,VRTX,Yahoo,"Will a new bull market begin soon? Maybe, but maybe not. But some enticing opportunities await investors regardless of what happens. Some stocks have prospects that are simply too attractive to ignore.",https://finnhub.io/api/news?id=2f1dd11439124b23fd3ae94621bb8464073a6df6a0192b188020af513562703c
company,2023-02-25 05:06:00,Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the Dip,118924707,,VRTX,Yahoo,A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on innovation-driven businesses.,https://finnhub.io/api/news?id=0e683abb913bd428a17fb424aa94a60182f8f99ecbe4d628a8dfcecb39e578af
company,2023-02-25 04:07:10,Regeneron: Innovation And Disruption Done Right,118926893,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1370480661/image_1370480661.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Regeneron Pharmaceuticals' collaborative energy is strong and the medium-term looks good. Check out why we rate REGN stock a Hold for now.,https://finnhub.io/api/news?id=a0537f0792321a4426cd98a5b6e3902631dc380c93824d6f0fe41d50d6e21c46
company,2023-02-24 12:30:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",118936559,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.78% to $287.37 Friday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=9f6ab32a087a40998a2fc31981ca889dad5321f9ec32306094de4573ece99d64
company,2023-02-24 07:00:23,Will Weakness in Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Prove Temporary Given Strong Fundamentals?,118893133,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"With its stock down 7.2% over the past month, it is easy to disregard Vertex Pharmaceuticals (NASDAQ:VRTX). But if you...",https://finnhub.io/api/news?id=6fc03101757ccce349ab08c27001335734dd6de13da2407f56e030a4210651af
company,2023-02-24 01:12:00,Vertex Pharmaceuticals management to meet with Truist,118903088,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=025076949e51356731e53477a0fcf49cbcbd65ce682980ffd7266eebc68ff4f6
company,2023-03-03 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors,119049824,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.09% to $290.51 Friday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=1599f101a1c172d05fef62fe1b5795d5810d6222c547c8b89f5c9e94b8ee50b5
company,2023-03-03 10:58:07,"AXON, MBLY, AVGO Lead Top-Rated Stocks In Top 20 Industries",119035748,,VRTX,Yahoo,"AXON, MBLY, LSCC, CROX and AVGO lead 23 top-rated stocks to watch leading moves in the top-ranked industries.",https://finnhub.io/api/news?id=60ae8096ead70dc1a6372f56d92c5cc654a9864c03de69b06978ef08bc7cdf36
company,2023-03-03 08:41:00,"2 Growth Stocks to Invest $1,000 in Right Now",119037856,,VRTX,Yahoo,"While the bear market might have convinced some investors that growth stocks are permanently out of fashion, you don't need to look very far to find a few companies that are bucking the trend by powering forward despite gloomy conditions.  Vertex Pharmaceuticals (NASDAQ: VRTX) is a rare disease drug developer that's worth an investment of $1,000 because it's in the process of making big moves that'll almost certainly transform (and grow) the company.  With a top line of $8.9 billion in 2022 -- all of which was derived from its sales of drugs treating cystic fibrosis (CF), a rare hereditary pulmonary disease -- Vertex is now diversifying its sources of revenue.",https://finnhub.io/api/news?id=0fd97e0e95c3e5b086fc403c2e38a92bf2687240cab02573b27ba058bd7ae657
company,2023-03-03 05:21:00,3 Nasdaq 100 Stocks to Buy Hand Over Fist in March,119031452,https://s.yimg.com/ny/api/res/1.2/qNTQx4J4mb3P3sJEY5HQRA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTA-/https://media.zenfs.com/en/motleyfool.com/b77fbc809850c64b98054213bf750966,VRTX,Yahoo,"The growth-focused Nasdaq Composite and Nasdaq 100 -- an index comprised of the 100 largest nonfinancial companies listed on the Nasdaq exchange -- were hit the hardest.  More specifically, every bear market decline throughout history in the major indexes (which can also include the Nasdaq 100) has eventually been put into the rearview mirror by a bull market.  With the Nasdaq 100 well off of its all-time high, bargains abound.",https://finnhub.io/api/news?id=67f657e10f4d5e89c379892fd9280a780f95ab4bf44ca614cc2a232467f0dc93
company,2023-03-02 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,119029209,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.16% to $290.76 Thursday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=da5cfae6486601b5c3e540fb128e5e810434c63aaed4a58c2b6663a19c2a1775
company,2023-03-02 10:45:00,3 Incredible Growth Stocks to Buy if the Market Dips,119018497,https://s.yimg.com/ny/api/res/1.2/T4rr2jAO.n7ppTf9FRFErA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02ODY-/https://media.zenfs.com/en/motleyfool.com/ddcd1a780896af9f3f1c02e820fa9639,VRTX,Yahoo,"U.S. stock markets are in a precarious place.  Bargain hunters bid up a wide swath of growth equities during the first month of the year, but these same equities, on balance, found it hard to retain these monthly gains over the course of February.  The core issue at play is the uncertainty surrounding the future of inflation, U.S. interest rates, and the global economy.",https://finnhub.io/api/news?id=6cff99ad2d8067115a8d4fcd0e8c7739198b394495188f26e8a154e540d21a48
company,2023-03-02 09:00:32,Are Investors Undervaluing Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) By 32%?,119018498,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Key Insights Using the 2 Stage Free Cash Flow to Equity, Vertex Pharmaceuticals fair value estimate is US$430 Vertex...",https://finnhub.io/api/news?id=7e8f6e156aa6893e5410b9de559ee48511dc333827b25b61670f432523e799b3
company,2023-03-02 05:36:00,April 14th Options Now Available For Vertex Pharmaceuticals (VRTX),119045785,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=48463296cafe4da8aafb32dd11bdb68911ae36021d7ecb7b49680fc15efe08a4
company,2023-03-01 13:27:02,ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing,119001832,https://media.zenfs.com/en/Benzinga/fdbf94a37876f0de7fdfed635a38c509,VRTX,Yahoo,"ImmunoGen Inc (NASDAQ: IMGN) announced a global, multi-target license and option agreement that granted Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) rights for ImmunoGen's ADC technology to discover targeted conditioning agents for use with gene editing. After each target's research period, Vertex will have the option to obtain a worldwide, exclusive license to research, develop, and commercialize conditioning agents employing ImmunoGen's technology for that target. ImmunoGen will retain f",https://finnhub.io/api/news?id=2582823d6af9fffbdf18c4dcede2da5e75cbff886a8ad37070cf80d549b3efb4
company,2023-03-01 12:30:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gains,119014842,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.32% higher to $291.23 Wednesday, on what proved to be an all-around mixed trading session for the stock...",https://finnhub.io/api/news?id=54c216573c44f9339e8f486385133050213f723cfe86f95b4a5bf50ed2840567
company,2023-03-01 07:39:00,"Immunogen confident in early Elahere launch, says Guggenheim",118996552,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ac4f9b4a75b543bee959398ab1f99e7f98229831fd057c50e441e97232749580
company,2023-03-01 01:25:00,"ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen's ADC Technology in the Development of Novel Targeted Conditioning Agents",118996080,,VRTX,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=12c03d3e21ed3e11f6a13a74bf1a82310db478d1083f7700d596cd3b2416332b
company,2023-03-01 01:01:00,Vertex in pact with ImmunoGen to expand gene editing reach,118993544,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cbc97ab56098ebda7e862688089e0d59ff788820de86f4e50276c788af51fc44
company,2023-03-01 00:26:00,ImmunoGen announces license agreement with Vertex Pharmaceuticals,118996084,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2f6cc53b9d35e8c159ed828c81f0908d031a477e22b81dd98d59a749ba69b0dd
company,2023-02-28 12:32:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119014843,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.01% to $290.29 Tuesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=6c01a2dd306cc789bf45183e4f974e882d907bf290d26d3eac18f28131ee531f
company,2023-02-27 23:04:00,The 20 worst U.S. stocks in February: the biggest loser dropped 35%,118977096,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee67b16b7bba72ab5699924a82c5af06b07f8c753ec12dadca3e59d39da2eca9
company,2023-03-07 14:51:05,Vertex Pharmaceuticals Incorporated (VRTX) 43rd Annual Cowen Healthcare Conference Transcript,119102691,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) 43rd Annual Cowen Healthcare Conference March 7, 2023 2:50 PM ETCompany ParticipantsReshma Kewalramani â President and Chief...",https://finnhub.io/api/news?id=d0026fcf01d5dee61933d990acd30d4aaec50732f3a4a2fc31993f7002afb393
company,2023-03-07 12:31:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,119116342,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.73% to $286.58 Tuesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=73496e83a7de7c28c028dc0c4bb5743005e67038c9848195c7edc1d3d58a6faa
company,2023-03-07 09:00:23,Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 67%,119103629,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...,https://finnhub.io/api/news?id=4d2e6163e126a006065daa6c44be3dab213d16f27ecf5e5d52cf8cb8f402aad5
company,2023-03-07 03:00:00,Vortex Energy Corp. Announces Letter Agreement for Acquisition of Blue Ocean Salt Corp.,119109866,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1523f98c7732a141a38bb21c3aa092d52d0373b8b59f18bdc4c7b76235bf66ad
company,2023-03-07 00:51:00,"MaxCyte revenue grows in 2022, expects further revenue climb in 2023",119109870,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0bc16fcb02ac886d7ed76a9e0ea5297d1c2a9ce9bda505ac39ad4e0762ebcf1f
company,2023-03-06 20:52:00,7 Cathie Wood Stocks for Your March Buy List,119108488,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eb6ba8fe1f5b235e81b8a066239b5926b9f3be517e602e7d791d439bc20529b0
company,2023-03-06 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119095106,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.38% higher to $291.62 Monday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=b7670d88edcecca5bad35cf7ca6377034fdae504495a88c813912b6f2181f8bf
company,2023-03-06 12:13:26,3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing,119150144,https://media.zenfs.com/en/investorplace_417/03737c9cbe7ca910ba80c3b95d561df1,VRTX,Yahoo,"The 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work on developing tools to change the genetic code of living cells, tools called CRISPR/Cas. Yet long before their trip to Stockholm, they and other scientists had been diligently founding companies to monetize this new discovery. These companies bring new avenues in medicine and biotech that a smart investor can advantage. CRISPR/Cas allows scientists to work on curing previously incurable genetic di",https://finnhub.io/api/news?id=5f45589686ce85c8a6d824ef258dcbd06559acdad3a2c1d1bac9879b991859a0
company,2023-03-04 07:25:00,3 Things About CRISPR Therapeutics That Smart Investors Know,119064456,,VRTX,Yahoo,"Shares of CRISPR Therapeutics (NASDAQ: CRSP) are down nearly 17% over the past year but up over 16% so far in 2023.  The clinical-stage biotech company is named for the CRISPR/Cas9 gene-editing method that won the Nobel Prize for chemistry in 2020, and the buzz for the company seems to be growing.  The company is looking to CRISPR/Cas9 gene editing to find therapies for a multitude of maladies.",https://finnhub.io/api/news?id=e8d7d30e892465fb5430f6856c139d3622da8aadb4a632ab7522da53a417167a
company,2023-03-04 06:14:00,3 Game-Changing Stocks to Buy in March,119064355,,VRTX,Yahoo,"Three Motley Fool contributors were asked to select stocks to buy in March that truly are game changers.  Here's why they picked Beam Therapeutics (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), and Vertex Pharmaceuticals (NASDAQ: VRTX).  Keith Speights (Beam Therapeutics): Base editing is an approach to editing genes invented in 2016 by a team led by David Liu.",https://finnhub.io/api/news?id=b7c97afb27e9ccfe3017d0f2dd6640dc114ede203b6584afff5df3ccb5131c62
company,2023-03-04 05:52:00,Prediction: These 3 S&P 500 Stocks Will at Least Double in 7 Years,119064458,,VRTX,Yahoo,"This punchline comes to mind when I look at the S&P 500.  Which stocks in the S&P 500 will work the most for investors throughout this decade?  When asked about Amazon, the first thoughts of many individuals would probably be about the company's online shopping platform or its Prime Video streaming service.",https://finnhub.io/api/news?id=c37b9a446c23c3732952747d85110073606dfd49c95258d528ed85eae85ac455
company,2023-03-11 09:00:35,Is Now The Time To Put Vertex Pharmaceuticals (NASDAQ:VRTX) On Your Watchlist?,119177743,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...",https://finnhub.io/api/news?id=1c42849a8a4d6b979610a95b1f84bf1aabfacffa153383a9363a47b73a164d8f
company,2023-03-10 17:45:10,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,119170194,https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $287.24, marking a +0.13% move from the previous day.",https://finnhub.io/api/news?id=fe3e91c63a8f7531bb8e1970ff40590f9f121b8e7f66ee6c0b756bc8bfc65947
company,2023-03-10 12:30:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",119180577,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.13% higher to $287.24 Friday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=55de707d3f47516358a454ba1e7312fe530627c14f5d8d982544d6d802ce6c94
company,2023-03-10 09:25:02,Vertex (VRTX) to Begin Clinical Study on Type I Diabetes Drug,119170198,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) receives FDA clearance to begin clinical development of VX-264, which has the potential to treat type I diabetes.",https://finnhub.io/api/news?id=414f5910225314f6498985b1d09c22b0f51abc02173fd59be80398dc6054affa
company,2023-03-10 08:30:00,This HealthCare Company Is Gearing Up for Its Next Launch: Here Is Why The Stock Is a Buy,119170199,https://s.yimg.com/ny/api/res/1.2/khvfWlF_KVxjJCry54WJMQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/eb6b211ad211549f5d33b88b19b9d05c,VRTX,Yahoo,"Over the past decade, biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) has made a fortune thanks to its monopoly in treatments for cystic fibrosis (CF).  Despite its success in CF that continues today, Vertex has sought to diversify its lineup of medicines -- and the company seems very close to accomplishing this goal.  Vertex Pharmaceuticals has been developing exa-cel, a therapy for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT), in collaboration with CRISPR Therapeutics.",https://finnhub.io/api/news?id=bc1487a46a5f73cfd73c295928dbcc62e2079a9a58a56a692ecf2ae5994c6ba8
company,2023-03-10 08:15:00,"If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today",119163230,https://s.yimg.com/ny/api/res/1.2/u7qxbjaCYw4FiTjLyuZK5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/bbf420381f32e73a9570273f7defcb2e,VRTX,Yahoo,"Growth stocks took off during 2020 amid the early stages of the pandemic.  One of the stocks that benefited from that bullishness was CRISPR Therapeutics (NASDAQ: CRSP), a Cathie Wood favorite.  By January 2021, amid the meme stock hype, shares of CRISPR reached highs of more than $200, and the stock was looking like a fantastic buy.",https://finnhub.io/api/news?id=3fbaa45d9751ab4bf8be0b4506055964eb3f045b4d4e423f52042f2cfcc0dc55
company,2023-03-10 01:44:00,GLOBAL BROKER RATINGS: BoA raises Vertex Pharma; Barclays cuts Segro,119159596,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fff78cf2ecb376b8fbe9b08764953a7c09cebaa93239cc12593ced04c8c6ef17
company,2023-03-09 11:30:04,Vertex (VRTX) Down 2.8% Since Last Earnings Report: Can It Rebound?,119150138,https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9,VRTX,Yahoo,Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://finnhub.io/api/news?id=e4ae1abad3b0d6c994a4f2f0b3e972466e046965ff2613f7017c7df8909996bf
company,2023-03-09 09:53:00,2 Top Stocks to Buy in March and Hold Forever,119141410,https://s.yimg.com/ny/api/res/1.2/nIWZ6g9q10jjAkBuxbVFkg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0b9203fdc386cdd2f4bc284590ad46fb,VRTX,Yahoo,"If you're looking for more great stocks to add to your portfolio this month, you don't have to look far to find quality businesses with compelling growth stories.  Provided you have the capital on hand to invest right now that you can put into your portfolio and leave alone for the next few years, even the current choppy waters of the market are still presenting investors with wonderful opportunities to buy great companies.  Here are two names to consider adding to your portfolio in the near future and holding for years.",https://finnhub.io/api/news?id=c442179a8a5e4a3c49ff304015d3cad534c75152613e1b14fd9d57e9af6864ea
company,2023-03-09 09:00:00,2 Explosive Stocks That Could Go Parabolic,119143336,https://s.yimg.com/ny/api/res/1.2/PPGRWWSMScM2NEV4xrjFFA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/67d2b6eefc0d4845511f3bcdb9bc070b,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has built a name for itself in the rare disease drug market with its global footprint in the cystic fibrosis treatment space.  It's estimated that there are 88,000 people in North America, Europe, and Australia alone that have the genetic disease.  Vertex is the only company on the market with approved CFTR modulators -- drugs that work to correct the underlying genetic malfunction causing cystic fibrosis.",https://finnhub.io/api/news?id=7237c202b60a7acc7141611af4d00ad9bc7b8be885e37ac6e9fbc0caa4bd771b
company,2023-03-09 08:50:00,Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold,119135152,,VRTX,Yahoo,"Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up more than 19% over the past 12 months during a period in which many other gene-editing biotech stocks tumbled.  The company is profitable thanks to its cystic fibrosis therapies, and its key CRISPR-editing therapy, exa-cel, is waiting for approval from the Food and Drug Administration (FDA) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).  It might be too late to get in on the Vertex run-up, but there's another CRISPR-editing company that could be an even better long-term buy, one that Vertex is already collaborating with on exa-cel: CRISPR Therapeutics (NASDAQ: CRSP).",https://finnhub.io/api/news?id=371c4031a6a9c0a7fbc63a96b55c56db8f3f2d8b73ebe471e98c4f0b6559852b
company,2023-03-09 08:00:00,"Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 Diabetes",119150142,https://media.zenfs.com/en/business-wire.com/01fa4e0a4e427154d7cd5e2f57889daa,VRTX,Yahoo,"BOSTON, March 09, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for VX-264, a stem cell-derived, fully differentiated pancreatic islet cell therapy encapsulated into a Vertex-developed, immunoprotective device with the potential to treat type 1 diabetes (T1D). The VX-264 program does not require the use of immunosuppression, which may broaden the population of pe",https://finnhub.io/api/news?id=31d0da6a1ff5373e25d9381710c4ed5c736b4fc99eb20be8667f2f9f8765b4ee
company,2023-03-09 07:25:00,"Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations",119140429,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=282503bced356a76dbc25f0775e30e7fddc7dc906c14a46e9085165412a703d3
company,2023-03-09 05:52:00,4 Growth Stocks to Buy and Hold Forever,119135029,,VRTX,Yahoo,How long does Warren Buffett like to own a stock?  Here are four growth stocks to buy and hold forever.  Amazon (NASDAQ: AMZN) can legitimately claim to rank as one of the most disruptive companies ever.,https://finnhub.io/api/news?id=4ed18d8b626f69537e305fb21abfc31d28488c8a01ae4c96a59fe3ae4a06df94
company,2023-03-09 02:52:00,Vertex gets FDA nod to start trial of cell therapy VX-264 for type 1 diabetes,119147109,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d4bc455add7d2cf1f71ac40d137db66dc3d6fe3429726f83c18f27ad5eef0519
company,2023-03-09 02:09:00,Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes,119147112,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=da198c09f126f6f993f8cc5465973e512c51dd7c2be884be0aa1f99433e77ca5
company,2023-03-08 23:32:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119147114,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1fc7bf680dc74a45c8e5f245f4fafe7a163b3000e93407e0a7aba6b623c65a4e
company,2023-03-08 12:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,119116340,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.49% to $285.18 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...",https://finnhub.io/api/news?id=07eb12fa1d9f8c811393b0b32bc0238d1f0b7fb4bff7d246facf6317617f717f
company,2023-03-08 05:57:00,2 No-Brainer Growth Stocks to Buy Right Now,119125796,https://s.yimg.com/ny/api/res/1.2/vxKi6BIlrnbvFAth1aMoRg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b446b74222b32ac1e3ac9e9318051b3d,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has a solid track record of steady revenue growth and profitability thanks to its portfolio of top-selling cystic fibrosis medicines.  Its flagship product, Trikafta, is approved to treat more than 90% of the cystic fibrosis patient population in the U.S., and the continued expansion of indications for its portfolio of medicines over the years extended the availability of these products to younger and younger groups of patients.  Vertex Pharmaceuticals also bears the distinction of being the only company with cystic fibrosis medicines on the market that target the underlying cause of the disease.",https://finnhub.io/api/news?id=320059d692f002de19ff2981e0aa1da530bcbc4ba71c4106a21dcfc00eb26858
company,2023-03-15 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, still outperforms market",119281534,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.33% to $294.27 Wednesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=c1a43dd854650d24bfa06bbb2e12c0488f9112543388e5b9798ac8d401fb1c81
company,2023-03-15 06:37:00,The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector,119251784,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=859fe55302bf1e8c62a6c49ca81800a5404438c89f0b1f6d9cf12581d8f075e0
company,2023-03-14 13:31:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",119236316,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.61% higher to $295.25 Tuesday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=63b29aa59aad89b039f00dff7d3b080cbfa88eea677bddcdbe196f2e0c7aad36
company,2023-03-13 14:58:00,Vertex Pharmaceuticals Stock Gets Technical Rating Upgrade,119217560,,VRTX,Yahoo,"Vertex Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating",https://finnhub.io/api/news?id=8cd21e97874d85c1be0162fb2d31e9e0599cf94f8b2ab59e373ff745a23a5c81
company,2023-03-13 13:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,119218116,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.17% to $293.46 Monday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=4677cc5b1b8c3397e6e5447e761ea5e497a60641432793f40a5f0b638dcc3b5a
company,2023-03-13 05:52:00,Prediction: These 3 Stocks Will Be in the Dow by 2030,119197178,https://s.yimg.com/ny/api/res/1.2/tIJHifVMasq8le1dmiwosg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/a76e92fd9ab3d0f839b73a127ff33802,VRTX,Yahoo,Being added to the Dow Jones Industrial Average would just be another feather in the cap for these successful stocks.,https://finnhub.io/api/news?id=918078a6f532cb805d80931e802a62ae30da94577409b332b5f9f158e930a93b
company,2023-03-12 07:53:00,3 Supercharged Stocks With More Potential Than Any Cryptocurrency,119189640,https://s.yimg.com/ny/api/res/1.2/XTsEbB9PfOBqXpE.HZYdjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a8efc12d8458a5856fe4e8fb20d39e23,VRTX,Yahoo,"Airbnb (NASDAQ: ABNB) continues to benefit from the travel recovery, but its recent financial reports indicate a growth story that is broadly eclipsing that of the typical travel stock.  With a platform that caters to vacationers, business travelers, and those blending both in the digital age, Airbnb can benefit from the post-pandemic travel recovery as well as long-term trends.  On the flip side, with a difficult economy causing worries about income security, more and more people are looking at Airbnb as a way to earn extra money as hosts.",https://finnhub.io/api/news?id=9891a3a3b4bc0a3bf4e56562874ba0757c6fa849f78d75e4e50da72cf43ede90
company,2023-03-19 05:56:00,Worried About the Banking Turmoil? These 3 Stocks Shouldn't Skip a Beat,119306633,https://s.yimg.com/ny/api/res/1.2/rOgUVuMr4rwWGMnpbXEf3w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03ODU-/https://media.zenfs.com/en/motleyfool.com/652eec15a8ba78a08d33fc123422f9bd,VRTX,Yahoo,"If you're worried about how the banking sector turmoil will impact your investments, let me help ease your mind.  As a result, investors who own renewable energy stocks shouldn't have anything to worry about.  You can invest in Brookfield Renewable in a couple of ways.",https://finnhub.io/api/news?id=1d06edf34441d9645f5dba4ba6c5ae6ed35f02efcf19c32f5ba3875e33fc4812
company,2023-03-18 06:14:00,3 Beaten-Down Stocks That Could Soar This Year,119308270,https://s.yimg.com/ny/api/res/1.2/E.5jedLppQH7tHUeObhroA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/d3704f1cace8d65bc70b40ee10a2e926,VRTX,Yahoo,"Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Exelixis (NASDAQ: EXEL), and Intellia Therapeutics (NASDAQ: NTLA).  Prosper Junior Bakiny (CRISPR Therapeutics): Unprofitable clinical-stage biotech companies got hammered last year.  Gene-editing specialist CRISPR Therapeutics fits that description to a T, so it got dragged down along with the broader market.",https://finnhub.io/api/news?id=3486c3d3673d489b66f89a6e293905747a1c0773e6c5f470dc91249e5e584a53
company,2023-03-17 17:50:09,Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know,119314705,https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.77, moving -1.62% from the previous trading session.",https://finnhub.io/api/news?id=46fad61288be00b4e0548fbe49329ba73cc2cc8f236f2ea04af861de4006b419
company,2023-03-17 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",119326821,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 1.62% to $295.77 Friday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=e724534552af37f8b2a9740dbaedfebd6562bca916601a7c19178e24a7c02ad7
company,2023-03-17 13:01:40,3 Pharma Stocks That Could Benefit from Global Healthcare Trends,119312116,https://media.zenfs.com/en/investorplace_417/409f6e1ab859ae7b9ff86cb0e0a84252,VRTX,Yahoo,"When it comes to finding good pharma stocks to buy, I try to focus on companies that are developing drugs that can help huge numbers of people. After all, high profits are the ultimate key catalyst for stocks, and it’s much easier for companies to generate gigantic profits if there is a huge demand for the products they are developing. The following three drug stocks certainly fit that criterion. One has a very promising treatment for cancer, which is a leading cause of death in both the U.S. an",https://finnhub.io/api/news?id=97703c9e65465797aadf6d0d5424b6fcae4f0edc755abe20f03461bc2f0e4a62
company,2023-03-17 12:33:07,Semiconductor Stocks Ignite Breakouts And Buy Zones,119294799,https://media.zenfs.com/en/ibd.com/29816c3b155ef19bd51cdfb6d63443e9,VRTX,Yahoo,"The best stocks to watch often hail from the top-ranked industries. Here's a look 23 such stocks, including AMAT, AVGO and MBLY.",https://finnhub.io/api/news?id=a2ded4517e9d50dbaf2c246bc93f414fd4d2478df2272aba4bd6e0f103d7c0eb
company,2023-03-17 11:30:03,Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?,119296256,https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,VRTX,Yahoo,Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://finnhub.io/api/news?id=ec336c5948f4adffce34c611df8f1e43ce98f120bc89f43e1880a865abc0cb71
company,2023-03-16 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119287965,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.16% to $300.64 Thursday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=e5a16156d0932b05b25b3d081410443b73d3768e36663a68e23232ed9806e6f7
company,2023-03-16 08:44:14,Vertex: On The Verge Of Becoming A Very Serious Proposition For Buyers,119273219,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1346213103/image_1346213103.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex is a Cystic Fibrosis powerhouse that earned revenues of $8.9bn in 2022 and was highly profitable. See why I think VRTX stock looks like a buy.,https://finnhub.io/api/news?id=b46673553d2a5aa1970e43646077998d4e699a7f06d37dd9451a242d03e98057
company,2023-03-16 08:00:00,Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin (VX-147),119283228,https://media.zenfs.com/en/business-wire.com/32c62fb4be94266dc893d8896a3e477c,VRTX,Yahoo,"BOSTON, March 16, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced publication in the New England Journal of Medicine (NEJM) of results from preclinical studies and a Phase 2 study evaluating the efficacy and safety of inaxaplin (VX-147) on top of standard-of-care in people with focal segmental glomerulosclerosis (FSGS) and two APOL1 variants, a severe, rapidly progressive form of chronic kidney disease also known as APOL1-mediated kidney disease (AMKD). AMKD is caused by",https://finnhub.io/api/news?id=9d4ad027ff7d6f347ffc65e1b7082f039c9e97547001d82a65b43f877fd0faeb
company,2023-03-16 02:31:14,PBE: Healthcare Dashboard For March,119269693,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1175270464/image_1175270464.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Healthcare equipment is the less attractive subsector regarding both valuation and quality. Click here to find out why PBE is a Hold.,https://finnhub.io/api/news?id=c7491c8078cc18110f8ca9e1d2dcf1d8feefea9645b61548bc31df0b181e1f03
company,2023-03-23 11:30:07,Semiconductor Plays Dominate This Screen Of 21 Stocks To Watch,119381029,https://media.zenfs.com/en/ibd.com/29816c3b155ef19bd51cdfb6d63443e9,VRTX,Yahoo,"The best stocks to watch often hail from the top-ranked industries. Here's a look at 21 such stocks, including AMAT, AVGO and MBLY.",https://finnhub.io/api/news?id=68a78104afa10b1fbefe4a6ebaf7928c552ad01850856c51066cdea9897381a6
company,2023-03-23 11:30:03,Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound?,119381746,https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781,VRTX,Yahoo,Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://finnhub.io/api/news?id=c0ed5ec2012d110b474e2e63b591fda538e8778302cda14e167342c62cabc9f5
company,2023-03-23 10:07:00,"This Cathie Wood Stock Could Nearly Double, According to Wall Street",119424923,https://s.yimg.com/ny/api/res/1.2/xDgKj0y8q72dZ9zAqgSAwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8d09fc8511d07fd4dce551611ddb4828,VRTX,Yahoo,"One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP).  This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in the Ark Genomic Revolution ETF, an exchange-traded fund overseen by Cathie Wood.  Wood isn't the only one on Wall Street who likes CRISPR.",https://finnhub.io/api/news?id=bc3f47b2ec095224f5a4860a1ebfdb8c20bf697de71acd9fdc572f02dd0d2339
company,2023-03-23 07:45:00,This Is My Highest-Conviction Stock to Own in 2023 and Beyond,119371598,,VRTX,Yahoo,"While one could say the same about many biotech companies, Vertex has an advantage very few of its peers do: For CF patients, it's the only game in town.  Vertex markets the only medicines that target the underlying causes of CF.  In 2022, the company's revenue of $8.93 billion jumped by 18% year over year.",https://finnhub.io/api/news?id=b336c31365b585d16f5f50f302cb0c34a2ee709535370b24a2c58f72f059f8cf
company,2023-03-23 05:50:00,"Got $3,000? 3 Growth Stocks to Double Up on Right Now",119369687,https://s.yimg.com/ny/api/res/1.2/ESD.biGBom.y633G2aMK2w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/ed1e07a5be6870d88c903a2ed0968a8b,VRTX,Yahoo,"If you've got $3,000, here are three growth stocks to double up on right now.  Amazon (NASDAQ: AMZN) has gotten off to a great start this year, with shares jumping around 16%.  There are two main reasons behind Amazon's weak stock performance.",https://finnhub.io/api/news?id=f3debf82f30ffa830bab73366988909d78f151ec978ff4b332749056005bd1a4
company,2023-03-23 00:32:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",119379443,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8fbe180e2f7ac4e9d911cbed04400ff592abd1aec556cc2a72363685e9f63263
company,2023-03-22 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,119371867,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.58% to $297.87 Wednesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=944d1af2af584ad99c7b76483e3733dfb74ede4d0008748651b2b6b864f58e62
company,2023-03-21 21:53:30,Bernstein Initiates Coverage of Vertex Pharmaceuticals (VRTX) with Outperform Recommendation,119342375,,VRTX,Fintel,,https://finnhub.io/api/news?id=34831bd9226afbc9e4a494cb0fb11083f0e8840fc7939caf09c7a27705869145
company,2023-03-21 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",119347547,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.24% to $302.66 Tuesday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=cd806b3874bbd8036b435f11086c312be924d59d84e76b2489bb42cbb35084cd
company,2023-03-21 11:59:03,Here's Why You Should Add CRISPR Stock to Your Portfolio,119341957,https://media.zenfs.com/en/zacks.com/c0c563b233f28a1874a33c46aadaa70e,VRTX,Yahoo,"CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.",https://finnhub.io/api/news?id=12ab26baed6f51eadbf5eec7c523483cc71873bc75f502e119278ae190b02083
company,2023-03-21 08:45:00,"Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations",119335381,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d94b6bf196eb5960cde880a6604ab4d56423af203fdbf7d25bfb2c51eca13567
company,2023-03-21 05:50:00,"The Best Stocks to Invest $20,000 in Right Now",119364105,https://s.yimg.com/ny/api/res/1.2/9VszZFSpO0UMFCnwFp_63w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4458abcf2272aab9bbe4b610b164f67d,VRTX,Yahoo,Critics of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) believe that the company is lagging behind OpenAI and Microsoft in the artificial intelligence (AI) race.  It could be a huge mistake to underestimate Alphabet's AI expertise or Google Search's resilience.,https://finnhub.io/api/news?id=5a06a9ebb2cd82ab9e3cfecd682bd9dc5a36e963792404412bd09e02c1114e2d
company,2023-03-20 23:57:00,Vertex Pharmaceuticals initiated with an Outperform at Bernstein,119338378,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=854982be3287a0c516dbadea0ed255d7b8f1a4f2faa323ed69b2d0e52ec2b492
company,2023-03-20 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",119326820,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.08% to $298.95 Monday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=938d96d12e566505615a2f2e876579b5af8e47070137f5e41a32161f10aa6ee2
company,2023-03-20 09:30:01,Brokers Suggest Investing in Vertex (VRTX): Read This Before Placing a Bet,119314700,https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4,VRTX,Yahoo,"According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",https://finnhub.io/api/news?id=10997c0280d8a5301c67e95de82e59d88c395324d390bd1beaa15bc5e3fa0f11
company,2023-03-20 05:50:00,3 Monster Stocks to Buy Without Any Hesitation,119304696,https://s.yimg.com/ny/api/res/1.2/MYz_BJrb849DVpYjpw0dKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/c8ebc24b53ba0b543d9ea5e28c743381,VRTX,Yahoo,These stocks are monsters now. They'll probably be much bigger monsters over the next decade and beyond.,https://finnhub.io/api/news?id=bb5b6410a24f3142be5acabeef9df8e71df02b3303444670978efa66198bbc67
company,2023-03-20 05:47:41,Vertex Pharmaceuticals For Strong CF Franchise Growth Plus Exciting Pipeline,119301908,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317189603/image_1317189603.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals is noted for its dominance in the cystic fibrosis therapy space. Click here to see why VRTX stock is a Buy.,https://finnhub.io/api/news?id=97bc47c963baee0f48799efc4ee5099902e6e4278f55e26b3eb49e90f7bf720b
company,2023-03-20 05:21:00,3 Surefire Stocks That Can Thrive During a Recession,119304917,https://s.yimg.com/ny/api/res/1.2/gT_qsX9sELNX_BsaSzkhdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d2311a1be80ba7c1fb79e78df1faf9ac,VRTX,Yahoo,These time-tested businesses have the sustainable cash flow and catalysts needed to outperform when the U.S. economy isn't at its best.,https://finnhub.io/api/news?id=2979d681db2080b1fdde7321705b08a175d22ad7d3565607d70d26290de247f5
company,2023-03-20 04:00:00,Vortex Energy Corp. Announces Appointment of Paul Sparkes as Chief Executive Officer & Director,119309229,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=85d7b18a1a2c579a2216a08a56cdec532c063d733f1bb4d8cc3b389008d0c2d6
company,2023-03-27 17:50:09,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,119457614,https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day.",https://finnhub.io/api/news?id=83615b5f90f30d13cde9abc2661cefcf0e2dce6587f6356b0c708e8f6a86d26b
company,2023-03-27 13:31:44,IBD 50 Stocks To Watch: Vertex Pharmaceuticals Nears Buy Point; Institutions Scoop Up Shares,119444033,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,Vertex Pharmaceuticals is forming a base and back above its 50-day moving average. VRTX stock ranks third out of 792 biotechs.,https://finnhub.io/api/news?id=b8751343462ce572e9604143e5b9585d1b806c0fe4fffb4416f9cebd815adab6
company,2023-03-27 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market",119451174,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.88% to $308.47 Monday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=580ef08877dcb7284a0874d2e1e57010e91c76d00251a6788465ec1b35303911
company,2023-03-27 08:00:40,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Has Fared Decently: Is the Market Following Strong Financials?,119444034,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 9.4% over the past three months. Since the market usually pay for...,https://finnhub.io/api/news?id=2eef08c6d22eca670423425a8e697acaf0d2e0ea04f55ff10f796676bd8e6b2c
company,2023-03-27 08:00:00,Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes,119444035,https://media.zenfs.com/en/business-wire.com/b124a9025bb0a27674db327dbae066a6,VRTX,Yahoo,"BOSTON & ZUG, Switzerland, March 27, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex’s hypoimmune cell therapies for type 1 diabetes (T1D).",https://finnhub.io/api/news?id=0c05da89a14ea33678a793864a5834500a7224cbcc43315f8a8c3edcac0fe9ba
company,2023-03-27 03:04:00,"Vertex Pharmaceuticals, Crispr Therapeutics enter CRISPR/Cas9 licensing pact",119452322,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3314eee479f6f53944c61e5ce704a887e698154889508c5ba48e37c3b4061087
company,2023-03-26 05:54:00,Want $1 Million in Retirement? Buy and Hold These 5 Stocks,119423544,https://s.yimg.com/ny/api/res/1.2/41Sw.NDfFZ.EPvnuV4o2tw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTg-/https://media.zenfs.com/en/motleyfool.com/2ac5b3669414f061519757f5e075a1d6,VRTX,Yahoo,There's no guarantee that you'll be a millionaire retiree. But these stocks could improve your odds.,https://finnhub.io/api/news?id=50b61940dd59016dde044068754ad0f842663a39a2f9e999d2325936208174f4
company,2023-03-25 05:41:00,Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend,119422157,https://s.yimg.com/ny/api/res/1.2/rMLqZpyHVIXv5ciWjZsvuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/9f7c2923c8c4b77bee5f450540d84cf5,VRTX,Yahoo,"The past 15 months haven't been easy for growth stock investors.  The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market.  You don't need an economics degree to see that every bear market in history has been wiped away by subsequent recoveries.",https://finnhub.io/api/news?id=6f6c506ad733a7f30efc1801c292e8d99059ed5b4cd8b165be92dafa49588ce8
company,2023-03-25 04:20:00,The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket,119441782,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ec51f41072ecdc7cb78e8946d7705defc2abd68fa2efb4eb4f16bc8f894c19b7
company,2023-03-24 15:30:25,"Lightning Round: Occidental is Warren Buffett's favorite, it's not my favorite",119420994,https://image.cnbcfm.com/api/v1/image/107215132-1679699479MM-Block-E-032423.jpg?v=1679700625&w=1920&h=1080,VRTX,CNBC,"Mad Money host Jim Cramer weighs in on all manner of stocks, including Barrick Gold, Occidental, Lumentum Holdings, Nordic American Tanker, Petrobras, Vertex Pharmaceuticals, Dana Inc. and Catalyst Pharmaceuticals.",https://finnhub.io/api/news?id=a6d24807c2adead34d98a0191d92897c7355620a1f5dcf7002ec2eaf8daffa44
company,2023-03-24 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",119451175,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 3.16% to $314.39 Friday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=e54f3c2d97547e71d03983f77b0db7b4151ffbc7c6b9c8e6ad747869dc1c89ef
company,2023-03-31 13:35:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",119556155,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.93% higher to $315.07 Friday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=65f5ee249750a5e766b63812147ee2cff51fa54f080a2b4327d97319495149cd
company,2023-03-31 09:00:00,This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors,119546140,https://s.yimg.com/ny/api/res/1.2/2pb4zBUtNZSkudqK5FDiVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f89d7916cd96864f7c9e829901f96778,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has made a fortune developing medicines for cystic fibrosis (CF), a rare disease that causes damage to the lungs.  The company is awaiting approval for exa-cel -- a therapy for the blood disorder sickle cell disease -- which it developed in combination with CRISPR Therapeutics.  Recently, these two longtime partners announced a new deal to target another disease, type 1 diabetes (T1D).",https://finnhub.io/api/news?id=e57e83e1c913f8d7227b154cc1bcf8f62049a48f21a72e5e85d70fc5f6ad38dd
company,2023-03-31 07:45:00,"Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market",119532325,https://s.yimg.com/ny/api/res/1.2/XRmrkSp85x2w7dJ7eAEPUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/2366b93961695b756dd323d551b06a56,VRTX,Yahoo,"The market has kept investors on a rollercoaster ride over the past year, and the choppy waters may continue for some time to come.  No one can predict when smooth waters may be here to stay, particularly given the ongoing economic volatility that's affecting the current investing environment.  Here are two such stocks to consider buying in the near future, regardless of whether another full-fledged bear market appears in 2023.",https://finnhub.io/api/news?id=98dd48f7cb3afc9a936c4cea958f2d3ad10cd8d531c4409d0e66cb313e4596af
company,2023-03-31 00:07:54,Buy Crispr Therapeutics On Approval Odds,119529360,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/845814134/image_845814134.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Crispr Therapeutics is nearing the launch of CTX001, which likely has high approval odds. Click here to find out why CRSP stock is a Buy.",https://finnhub.io/api/news?id=c1df83f637f88ad1059875e03a244066c86e7f0920e8c44d15872f7537fa19c1
company,2023-03-30 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",119556157,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slumped 0.66% to $312.16 Thursday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=cc987cb6658bfd7b37eda943e40f4280c2c8dc54c3dae40f0699adb699c9362b
company,2023-03-30 10:30:00,What Bear Market? These 2 Winning Stocks Are Still Worth Buying.,119530335,https://s.yimg.com/ny/api/res/1.2/FoFTrRxNrFh1vX.YX95J6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTE-/https://media.zenfs.com/en/motleyfool.com/6d4595382866f4d62f9a26ee26df58ae,VRTX,Yahoo,The stock market is in a precarious place.  The sharp rise in both interest rates and bond yields has weighed heavily on most stocks since the first quarter of 2022.  The top-shelf drugmakers Novartis (NYSE: NVS) and Vertex Pharmaceuticals (NASDAQ: VRTX) are two prime examples.,https://finnhub.io/api/news?id=6ba0db44b9c14ecbb289fe074137716ebe6220456acdc2e35b7ac4a762beb79a
company,2023-03-30 10:00:00,"2 Top Stocks to Buy With $1,000 Right Now",119528610,https://s.yimg.com/ny/api/res/1.2/tDyW2N1ZgK2sLsXX7F_Q1g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/092a1855429cd3386961c21cfb68f87f,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) may not be a household name like some healthcare companies, but this is a business that investors may be hard-pressed to overlook, bull or bear market.  Vertex has a long history of profitability and revenue growth, and amassed earnings of $3.3 billion in 2022 alone.  The life expectancy for cystic fibrosis patients has improved dramatically over the past few decades.",https://finnhub.io/api/news?id=4986b214c53582922ae2c45cd2c4fe7b4c7f8359ebcdd4a5513c38a625efadc5
company,2023-03-30 09:53:00,2 No-Brainer Stocks to Buy Before the Next Bull Market,119529632,https://s.yimg.com/ny/api/res/1.2/lWCqB8MlQ6gPGShVnJol_w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/f6f5b7701b8e6da4bc8fbf726c5f3a93,VRTX,Yahoo,"While no one can predict when the next prolonged bull move will appear, the stock market has proven time and again its ability to rebound from even the most dire periods of volatility.  Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to deliver gains against the backdrop of the broader volatile market over the last year, but this isn't only a testament to the typical resilience of the healthcare industry in times of economic turmoil.  The company continues to rake in revenue, profits, and cash from its portfolio of cystic fibrosis medicines -- currently the only drugs on the market that target the underlying root causes of the genetic ailment.",https://finnhub.io/api/news?id=6e7d2d16722b71caf2da9a8fda031ada2e391dff76289a0b090271102067de43
company,2023-03-30 09:40:00,2 No-Brainer Growth Stocks to Buy and Hold for Years,119523764,https://s.yimg.com/ny/api/res/1.2/YrP2tFuuYzj4aV_msmFivA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/77b3a25c7ef27bc6946d35c271b74cc4,VRTX,Yahoo,A long-term investment in these highly profitable businesses could pay off in manifold returns over the next 5 to 10 years.,https://finnhub.io/api/news?id=54c6efe1ada45ca25303c3ac4560f89fc2b84ec55ded88fd77881cff76b97a27
company,2023-03-29 14:00:00,Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie,119494354,https://s.yimg.com/ny/api/res/1.2/QEJOFPFPgOEN2JB0FMtcWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTI-/https://media.zenfs.com/en/motleyfool.com/10878ece04d8be3248e9ab1b52913bea,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market.  Vertex and AbbVie also happen to offer a lot of growth potential.  Vertex has a new potential blockbuster drug on the horizon.,https://finnhub.io/api/news?id=bb46e249d1e69776927faf7b38aa997a5de152e228b23ae926f6bffaf318f506
company,2023-03-29 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",119513622,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.32% higher to $314.24 Wednesday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=4e50840ab3c6c8c9fcb284bbdc4d37920f5efaec0925117fb8d94264f110e8b5
company,2023-03-29 08:27:00,"Bluebird Bio reaction to lovo-cel BLA delay `overdone,` says Raymond James",119495923,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=851c5772834e5cde5ba4382e7f464c403593266442068b614fc252c44cb5ad4c
company,2023-03-29 05:26:00,The 3 Best Growth Stocks to Buy in the Biotech Sector,119517490,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0cc920e34d0e68fdb8351d3abfdeccf779e689f91c87105cf33884b23356e031
company,2023-03-29 02:39:00,Vertex Pharmaceuticals price target raised to $350 from $340 at Argus,119493313,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6cd3ea2a70a752db8cefbeaf0e42612b966faf6ef5205743f26bf19f7f466cd2
company,2023-03-28 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119513623,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.55% to $313.25 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=738e3e63ee9e996740a60ea30b130177507833cb257b2fd5e829ec0826e8640b
company,2023-03-28 08:41:00,"VRTX, BIIB, or IQV: Which Biotech Stock Could Deliver the Highest Return?",119473903,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=32182e74fa2f7ed6c27faf74e0ba2386ae5b735e1d858ab0abdea7811be4aac0
company,2023-03-28 08:35:00,"VRTX, BIIB, or IQV: Which Biotech Stock Could Deliver the Highest Returns?",119473904,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fd799ad7fa0677fe329a03f5122e1a0b5c88b12b265afa8b169d16cff713be0d
company,2023-03-28 08:26:00,"VRTX, BIIB, or IQV: Which Biotech Stock Could Deliver Best Returns?",119473905,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b706dc28706adfd1bbb3857d337a6b184048dadd7e66d2d71e192d2bfb90d5ff
company,2023-03-28 08:22:00,,119473906,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f6781fb33b061e3b6e35a6c90baf04d0ea2139cf4a29c4091273434f2242ba07
company,2023-04-04 14:00:00,Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?,119614707,https://s.yimg.com/ny/api/res/1.2/rV.E3RUjm6D9.ELwgYp_YA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTY-/https://media.zenfs.com/en/motleyfool.com/34c63d66c9d5d47a85b79f262e27fc0f,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has been generating billion-dollar revenue for years, thanks to its portfolio of cystic fibrosis (CF) drugs.  In fact, Vertex is the global leader in CF treatment and likely to hang onto that position for quite some time.  The biotech giant and partner CRISPR Therapeutics (NASDAQ: CRSP) aim to bring exa-cel, a gene editing treatment for blood disorders, to market.",https://finnhub.io/api/news?id=430a4f8f10fb8ae3e50bda257dc767dde115e522a3c3a3f55da39d4a5608a9b0
company,2023-04-04 13:32:05,CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel,119614708,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,VRTX,Yahoo,CRISPR (CRSP) and Vertex complete BLA submissions to the FDA for exa-cel for treating sickle cell disease and transfusion-dependent beta-thalassemia.,https://finnhub.io/api/news?id=5b53e37142b7cfe27268ff4fd8a2e87a71ff540b5171e7a86e978f64fda392de
company,2023-04-04 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",119619374,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.60% to $314.42 Tuesday, on what proved to be an all-around grim trading session for the stock market, with...",https://finnhub.io/api/news?id=5e5057c712df37f1b1afdb1aedfa537ac4b77e6dcc68867eb89ab3b3a855f73f
company,2023-04-04 12:21:00,Vertex Pharmaceuticals Stock Sees Composite Rating Edge Up To 96,119614710,https://media.zenfs.com/en/ibd.com/18eb0476bf432c67b32afefbaa8010cf,VRTX,Yahoo,"On Tuesday, Vertex Pharmaceuticals got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.",https://finnhub.io/api/news?id=31b2e4406903633a33065d1d2e23415779ab2bad784b16690ecf536d7f154154
company,2023-04-04 05:35:00,Maxim Group Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),119644581,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6dc1bf0dcdf1875686d606db95c1623b0bb0cfda19764a8d17e52c19b6a82219
company,2023-04-04 04:00:00,Vortex Energy Completes Acquisition of Blue Ocean Salt Corp.,119644582,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e2ff75487628d30f3fcb1c27c4ed74dedbf37e36a6cec4afd7841ddbb7cbb43
company,2023-04-03 17:50:09,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,119604734,https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $316.33, marking a +0.4% move from the previous day.",https://finnhub.io/api/news?id=5988376140ee318be17182c394d38f001c043e714da5722f0513250b1361d411
company,2023-04-03 13:30:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains,119619375,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.40% higher to $316.33 Monday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=fbd1fd5b798bd8e8751224ec86b28506b6f5ac4673f9ec98bca0a38b7ae772b4
company,2023-04-03 08:20:00,Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags,119590517,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=78d71d6fb7416983a527b8205e3b9fd6a0f8f68532f13bb7711c4a906774ce7c
company,2023-04-03 08:00:00,Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia,119587023,https://media.zenfs.com/en/business-wire.com/0b962d9cdeb0ea3638bb7303c20fa070,VRTX,Yahoo,"BOSTON & ZUG, Switzerland, April 03, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced the completion of the rolling Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for the investigational treatment exagamglogene autotemcel (exa-cel) for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The BLAs include requests for Priority Review, which if granted, would shorten the FDA’",https://finnhub.io/api/news?id=24c7d66813e4c6173e654ce28346d2c73990e1b14a84b7733bdc72d3bde7927d
company,2023-04-03 03:41:00,"Vertex, CRISPR finish rolling submission of application for sickle cell candidate",119591197,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9985489906b224a151a756cebe6bcf5d2fcc13d1c1f79216c3b806ab08ce00c6
company,2023-04-03 03:06:00,"Vertex Pharmaceuticals, Crispr Therapeutics complete rolling BLAs to FDA",119591199,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=414760479649636b8b3c7c067f3a44801f2765bc53e655331d3445529601543f
company,2023-04-02 10:00:38,Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 29% Discount?,119574553,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Key Insights The projected fair value for Vertex Pharmaceuticals is US$443 based on 2 Stage Free Cash Flow to Equity...,https://finnhub.io/api/news?id=0d1adfc9ecdf22e9175df0c0dead31126e16b427bd3fc30fc689ab4995e276bd
company,2023-04-02 05:52:00,A Nasdaq Bull Market Could Begin in April: 3 Top Stocks to Buy Now,119570694,https://s.yimg.com/ny/api/res/1.2/Bp7.W0Ki01dz6AzPT38tXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/30af9483f932a27e4308fa85bca4fa7d,VRTX,Yahoo,"Dec. 28 was the date the Nasdaq Composite Index reached a bottom after declining throughout much of the previous 12 months.  To kick off a new bull market, the index will need to rise by at least 20% above that low.  At the end of March, the Nasdaq needed to climb less than 1% to reach that threshold.",https://finnhub.io/api/news?id=f1ba5949b685cb818e5653635ae7c070e00e097e68416f4acc9d2ce3c189bd11
company,2023-04-02 05:30:00,5 Top Stocks for April,119570903,https://s.yimg.com/ny/api/res/1.2/9DBosFNMW_Iyfpnb_MSOwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTU-/https://media.zenfs.com/en/motleyfool.com/ad61e0115dcfaa015191175a424d4850,VRTX,Yahoo,"Daniel Foelber (Rivian Automotive): Rivian hasn't even spent 18 months on the public markets, and already the stock has made a name for itself for all the wrong reasons.  Its meteoric ascent in November 2021 pole-vaulted its market cap to over $150 billion.  Today, Rivian has a market cap of $11.7 billion.",https://finnhub.io/api/news?id=7bd243fc6dae0803b9a9899315b9584544876f782c984b1610f2015f289d0212
company,2023-04-01 05:30:00,Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics,119551246,https://s.yimg.com/ny/api/res/1.2/SiTIIaIigjOnvwHBKq9WCw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/da67f3a868c94fed3662078b1ef2179e,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) is heading for an important moment: the potential approval of its first product, exa-cel to treat blood disorders.  First, let's talk a little bit about CRISPR's technology.  In T1D, the body destroys islet cells that normally would control blood sugar levels.",https://finnhub.io/api/news?id=a597129b33d00b40ee14bc676c19d9228c3ba6fbd46d33e875fddb6a28e68080
company,2023-04-08 08:00:55,5 S&P 500 Stocks Near Buy Pionts As Recession Fears Rise,119684056,https://media.zenfs.com/en/ibd.com/11817e397a9661529e1edb690f714488,VRTX,Yahoo,"S&P 500 medical stocks Cardinal Health, Vertex Pharmaceuticals, Merck, Intuitive Surgical and Insulet are in focus this week. Medical stocks are coming into favor again — with companies involved in biotech, pharmaceuticals, medical products and more bouncing back.",https://finnhub.io/api/news?id=847a8aaa922911257e7a859ded37546065ff91370e4f78d0832365a96fa79d9b
company,2023-04-08 06:11:00,3 No-Brainer Stocks to Buy in a New Bull Market,119682239,https://s.yimg.com/ny/api/res/1.2/tXVItwiEjNPpIZeuUOAHgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/72129c03de6138a76339cb94978b1075,VRTX,Yahoo,"Three Motley Fool contributors have identified their picks for no-brainer stocks to buy in a new bull market.  Here's why they chose Novo Nordisk (NYSE: NVO), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX).  David Jagielski (Novo Nordisk): In a bull market, investors pay less attention to earnings multiples and are often more willing to pay a big premium for growth stocks.",https://finnhub.io/api/news?id=879a40769330951a3b573385cd2e446c0c2872c087f8bd9d09f0f3d3c6e5dfbe
company,2023-04-08 05:30:00,CRISPR Stock: Bull vs. Bear,119682002,https://s.yimg.com/ny/api/res/1.2/5ZobdNK5trskjhW3trb6nw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/bdda1acaf9594ec2fce16e69d18fca72,VRTX,Yahoo,Is now the moment to get in on this gene editing specialist?  Motley Fool contributors Adria Cimino and Keith Speights discuss the bull and bear cases.  Adria Cimino: CRISPR has reached the most exciting moment in its story as a company so far.,https://finnhub.io/api/news?id=850b56685068136e4ab7136bc9d2987e74b0bf4e0c31085dcb8585f531e9606a
company,2023-04-08 05:06:00,Nasdaq Bear Market: 5 Astonishing Growth Stocks You'll Regret Not Buying on the Dip,119682167,https://s.yimg.com/ny/api/res/1.2/dBM1PXglv1PPHyUAS5XTsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/45feee41c2a773b10b5f9ff3820bd448,VRTX,Yahoo,A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on discounted growth stocks.,https://finnhub.io/api/news?id=2e9f0dce9b037c749c4d92834a99b722f3c831912d1207bf3063664a56995538
company,2023-04-07 13:14:55,5 S&P 500 Stocks Showing Strength As Recession Fears Rise,119674081,https://media.zenfs.com/en/ibd.com/11817e397a9661529e1edb690f714488,VRTX,Yahoo,"S&P 500 medical stocks Cardinal Health, Vertex Pharmaceuticals, Merck, Intuitive Surgical and Insulet are in focus this week. Medical stocks are coming into favor again — with companies involved in biotech, pharmaceuticals, medical products and more bouncing back.",https://finnhub.io/api/news?id=400361990f91653063331d12b1e4b65cec7ab7b75b2b0188b72ae6df95086e7e
company,2023-04-07 10:15:00,2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market,119674082,https://s.yimg.com/ny/api/res/1.2/cAX16ucM3eDL2wBBNL_F7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4736581b449d8c8360193a3b2dd1990b,VRTX,Yahoo,"As Warren Buffett once said, ""If a business does well, the stock eventually follows.""  If you have the capital and risk tolerance for putting money into growth stocks, there is certainly no shortage of companies that present compelling opportunities for the long term.  Here are two such names to consider buying right now, one that the market has discounted over the last year and one which has actually beaten the S&P 500 in that period.",https://finnhub.io/api/news?id=aed777d69fb5ddaa9ccfdd067199d2c7413975237a4edcc64123206ae765bba0
company,2023-04-07 07:15:45,Vertex Pharmaceuticals: A Promising Portfolio After A Year Of Growth,119669102,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/465531391/image_465531391.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex completed submission of their gene therapy for treatment of two hematological treatments. See why we recommend a buy on VRTX stock.,https://finnhub.io/api/news?id=4e72a5b21d3a97eecb8af174a703d09af484cd400cf24340b31111f8ec7acff8
company,2023-04-07 05:41:00,A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right Now,119665928,https://s.yimg.com/ny/api/res/1.2/EvonIW7AwUcR7pkez_.muQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d9a31ac281d36be849186545eb5a6da5,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has gone from strength to strength in a market that has been plagued by volatility.  With the only drugs on the market that treat the underlying cause of cystic fibrosis -- one of them which covers more than 90% of all cystic fibrosis patients in the U.S. alone -- it's safe to say that the demand for Vertex Pharmaceuticals' products is consistent and ongoing.  Vertex Pharmaceuticals has much more than its profitable cystic fibrosis portfolio up its sleeve, however, with a robust pipeline that aims to disrupt many other areas of the rare disease drug market.",https://finnhub.io/api/news?id=6cff01cb40437ed9e991eac7b25207d222ad84e193e645fdb9a5da2bc42492c4
company,2023-04-07 04:46:00,Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital,119686914,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=578fb3281c322e8c803f285a3423603d9796c391d760b3ce03a67a0e7507d490
company,2023-04-06 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",119659059,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.09% to $321.66 Thursday, on what proved to be an all-around positive trading session for the stock market, with...",https://finnhub.io/api/news?id=77c22d734eec7ed55502f00de8558c1894051c5f03e0764be62423c2dfbe467f
company,2023-04-06 09:37:00,2 Smartest Growth Stocks to Buy Without Hesitation Right Now,119663271,https://s.yimg.com/ny/api/res/1.2/AylE0zWyPOfS.CiEv6cGoA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/bd040e9d72525ceccc6912f4b91e518d,VRTX,Yahoo,"Growth stocks have faced continued headwinds from a tough economic landscape and volatile investor sentiment over the past year.  Vertex Pharmaceuticals (NASDAQ: VRTX) has built a thriving and profitable growth story on the power of four products, all of which treat the rare genetic disease cystic fibrosis.  Cystic fibrosis afflicts more than 160,000 people worldwide, and in the past, a diagnosis was something close to a death sentence.",https://finnhub.io/api/news?id=d3ea4ad43d1f891bdfd0eb0c58ebb875a11f1e35a562738958d672eb02dc34a8
company,2023-04-06 08:15:00,"Where to Invest $2,500 Right Now",119663272,https://s.yimg.com/ny/api/res/1.2/JbzZBz5khJOltxGJHH_Oow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MjI-/https://media.zenfs.com/en/motleyfool.com/f38d4a1b2cb3c4638f283c7280f23490,VRTX,Yahoo,Even another bear market doesn't need to deter investors with the appropriate buy-and-hold horizon.,https://finnhub.io/api/news?id=3c99176b8b44e82bb789b5dea7da1541f955f226a21a75cd18ca954ba224e3db
company,2023-04-06 05:37:09,"The Zacks Analyst Blog Highlights bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals",119663273,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals are included in this Analyst Blog.",https://finnhub.io/api/news?id=e1af5bcca4cee97e94fbb8dcf0d9eda4dd031855cea46c0f5a2008393a3b5a6c
company,2023-04-06 05:20:00,2 Top Stocks to Buy Before the Next Nasdaq Bull Market,119663274,https://s.yimg.com/ny/api/res/1.2/9WC36fN5wG_nwIHolGfefQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/32813af31e7415be65698eda1beacd61,VRTX,Yahoo,"Value investing pioneer Benjamin Graham's words ring true in every market environment, but especially in the highly volatile one that investors have been contending with over the past year.  Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price is up nearly 19% over the trailing 12 months, which is no small feat given the S&P 500's broader 11% decline during that same period.  The strength of Vertex Pharmaceuticals' underlying business has also been a catalyst.",https://finnhub.io/api/news?id=e432922e0697cf9cb3a4a7accb399513c8083b4281fb12eb93826d08edcdd7c6
company,2023-04-05 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,119659060,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 2.39% to $321.94 Wednesday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=6b89ef7866bc066a3ad71e3267b8862337847351c2423551f9b39e405982f2b9
company,2023-04-05 10:11:00,2 Under-the-Radar Biotech Stocks to Buy in 2023,119636799,,VRTX,Yahoo,"The biotech industry tends to be highly volatile, because of the hit-and-miss nature of the products they are developing.  Moderna is a recent example, having grown from a $4 billion company to a $59 billion company thanks in large part to the pandemic and the successful rollout of its coronavirus vaccine.  As investors look for the next biotech hitmaker, they might want to take a closer look at two under-the-radar biotech firms that have some outstanding products up their sleeves.",https://finnhub.io/api/news?id=4736c603320b9b1ccb5940eaa60d3a3f3a8a79ff07a4ed35f8107d773970d40c
company,2023-04-05 07:05:00,Video: S&P 500 Analyst Moves: VRTX,119644578,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=30514bfa21beee17031e3e588a478227cd7633718232160906a920c6211ad41b
company,2023-04-05 06:46:00,Vertex Pharmaceuticals Takes Over #108 Spot From Tapestry,119644579,,VRTX,ETF Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=076bb1e3cc8c787f6eb7b5b72752f22a108758f1baa515d3e78b051af772604e
company,2023-04-12 18:11:01,Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group,119737894,,VRTX,Reuters,"Vertex Pharmaceuticals Inc and CRISPR Therapeutics AG's one-dose gene editing therapy for sickle cell disease would be cost effective if priced at up to $1.9 million, an influential U.S. drug pricing group said on Wednesday.",https://finnhub.io/api/news?id=c3ed18b3bfce991a4666f58c582f0983bbfd4df09d102654ad9305f853a59e91
company,2023-04-12 18:10:58,UPDATE 1-Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group,119739894,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,VRTX,Yahoo,"Vertex Pharmaceuticals Inc and CRISPR Therapeutics AG's one-dose gene editing therapy for sickle cell disease would be cost effective if priced at up to $1.9 million, an influential U.S. drug pricing group said on Wednesday.  The two companies are hoping to get approval for the world's first therapy based on Nobel prize-winning CRISPR technology, for two types of blood disorders - sickle cell disease (SCD) and transfusion-dependent beta thalassemia.",https://finnhub.io/api/news?id=11fdca556b0cf86a9e9dc421320dfa3092de9a2c27dbc7ecf726a8146ee4ded0
company,2023-04-12 17:50:09,Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know,119739895,https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $326.37, marking a +0.47% move from the previous day.",https://finnhub.io/api/news?id=992c7e18f9e0a4bd8a8e02b51e95e162424f4e0de734b1dc616809fd7fe4ede3
company,2023-04-12 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",119755460,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.47% higher to $326.37 Wednesday, on what proved to be an all-around dismal trading session for the stock...",https://finnhub.io/api/news?id=8a358705169f81fd111797022aaab5fe82de57e7ce1cba4abdab08657bf1831c
company,2023-04-12 09:49:50,Dow Jones Rallies 150 Points On Cool CPI Inflation Data; Fed Minutes Later,119735958,https://media.zenfs.com/en/ibd.com/ab4fc1215edd43c3de789c54de1750ea,VRTX,Yahoo,"The Dow Jones Industrial Average rallied 150 points Wednesday morning on cool inflation data, with the release of the Consumer Price Index.",https://finnhub.io/api/news?id=c9bb75c00199f14252f8bcc2f71e6e302a080bd740390e46b3b3c3f75f8c53dd
company,2023-04-12 05:30:00,Could This Move Make Vertex's Next Blockbuster Even Bigger?,119739898,https://s.yimg.com/ny/api/res/1.2/utNnS214ZBsCog4W..1l1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/b1379d32a5f4897a4ddea3984e5a6fb3,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) recently reported great news.  It completed the submission of exa-cel, its treatment candidate for blood disorders, to the U.S. Food and Drug Administration (FDA).  Vertex has already prepared the infrastructure to launch the treatment -- and it could become the company's next blockbuster.",https://finnhub.io/api/news?id=6d9a2cb9eafb5e9e8d629f5d14b949b470de46a65b159fc2fae89b90e6bc88ce
company,2023-04-12 04:50:00,Wall Street Analysts Are Neutral on Top Healthcare Picks,119742532,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=42c4546e4a870cc45b8a97202517a1cfebf771bfa00c59681b114796a51bbd13
company,2023-04-11 22:26:28,Why Healthcare Stocks Are A Prescription For Investors In Q2 2023,119725087,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413600685/image_1413600685.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,The recent drop in biopharma stocks presents a buying opportunity for investors. Find out why XLV seems like the best fit.,https://finnhub.io/api/news?id=69173de72e70bacb9558918aee06ad651655d4ae31b435a26de7f0e4e7d3ba03
company,2023-04-11 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, outperforms market",119755461,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.49% higher to $324.83 Tuesday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=21395a28a1075a3c5111001da3050f62074be54f5cba1dc072ce7b0a8f914d26
company,2023-04-11 10:00:25,"Dow Jones Rises As Bitcoin Jumps Above $30,000; 7 Top Stocks To Buy And Watch",119738077,https://media.zenfs.com/en/ibd.com/d00b010488e342d370d40f221f6a8f3c,VRTX,Yahoo,"The Dow Jones rose Tuesday, as the price of Bitcoin surged, topping $30,000 for the first time since June 2022.",https://finnhub.io/api/news?id=056330524ef429a9f469995c43afcdf7121107ea315c9f46c745893d4b12add3
company,2023-04-10 16:48:43,"Dow Jones Futures: Key Inflation Data, Big Bank Earnings Due; Apple, Pioneer, Tesla In Focus",119709793,https://media.zenfs.com/en/ibd.com/d3652d68ddafdabbe97f65fb8ee2c9d4,VRTX,Yahoo,Dow Jones futures: Key inflation data and big bank earnings are key stock market catalysts this week. Apple and Tesla are in focus.,https://finnhub.io/api/news?id=89c0d03acb97d26f1002448ac37bdba93aa8bca37d4d41e61d23d290f8cc420f
company,2023-04-10 14:42:51,Dow Jones Leader Visa Headlines These 4 Stocks In Or Near Buy Zones In Today's Stock Market,119709794,https://media.zenfs.com/en/ibd.com/8239348c9e2d7f0bd6326ebb5ed9b571,VRTX,Yahoo,Dow Jones payments giant Visa and four other top stocks are in or near buy zones in today's stock market.,https://finnhub.io/api/news?id=0b84e29f46bc04cde075647087c005c902f8050a25b541df3edcb40624764461
company,2023-04-10 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119713313,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.49% higher to $323.24 Monday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=53fa4bf4207a87b6377ba58d29d555fe8fb16a1f5feb11aacea356e2478999e2
company,2023-04-10 10:16:00,Vertex Announces Health Canada Market Authorization for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 1 to <2 Years,119713417,https://media.zenfs.com/en/cnwgroup.com/2a71fb924c1faa6a65202d78901e4e99,VRTX,Yahoo,"Vertex Pharmaceuticals (Canada) Incorporated (Nasdaq: VRTX) today announced that Health Canada, as a partner of the Access Consortium, has granted Marketing Authorization for the expanded use of PrORKAMBI® (lumacaftor/ivacaftor) for the treatment of cystic fibrosis (CF) in children ages 1 to <2 years who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.",https://finnhub.io/api/news?id=0bac5895c324e9fe4e66e72e04429fc855c20b84f0d00c5b03c64b6e778b8f37
company,2023-04-10 08:05:00,Vertex to Announce First Quarter 2023 Financial Results on May 1,119713418,https://media.zenfs.com/en/business-wire.com/ddf8fc6b547b5908022eb55991b49284,VRTX,Yahoo,"BOSTON, April 10, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2023 financial results on Monday, May 1, 2023 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (877) 270-2148 (U.S.) or +1(412) 902-6510 (International) and reference the ""Vertex Pharmaceuticals First Quarter 2023 Earnings Call.""",https://finnhub.io/api/news?id=0c8c3149cb9511b94be80b28e8c985124c64307e13030e494a14b266ce6c2956
company,2023-04-10 06:46:00,Vertex Gets Authorization in Canada for Expanded Use of Orkambi in Children with Cystic Fibrosis,119713314,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Robb M. Stewart Vertex Pharmaceuticals Inc. said Monday it received marketing authorization from Canada's medical regulator for the expanded use of its...,https://finnhub.io/api/news?id=61eb9409e2cb4b9d08847315ec3b2d1f26d5c492793517369a417062e0fca81a
company,2023-04-10 05:54:00,My 5 Top Stocks to Buy in April,119700470,https://s.yimg.com/ny/api/res/1.2/uBK1MMrCAw_aaJmFWLH4cA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTg-/https://media.zenfs.com/en/motleyfool.com/e794fdb85212d6842eaa478b457b4d69,VRTX,Yahoo,"Investing in stocks ranks as one of the best ways to make money over the long term. That's obvious when you look at the past. And while history doesn't repeat itself, the factors that caused stocks to perform well over the last century will likely prevail over the next 100 years as well.",https://finnhub.io/api/news?id=67bae5794502405214bc4fa9bc703f524d2dbe82de63e0bcec8b9789844d5a54
company,2023-04-10 05:19:00,Vertex announces Health Canada marketing authorization for ORKAMBI in children,119704890,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f7bddaad032a7380c9a3ad1c3ce988e78b84ac97a21c1c5869114a52cbdbb0d5
company,2023-04-09 23:12:00,"Sana Biotechnology CMO Sunil Agarwal to leave, Gary Meininger to succeed",119706486,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=98cb3cf052badffa26d186c73833c7457c54d6152f59e69c3484ba98f7bb3daf
company,2023-04-09 07:45:00,Where Will CRISPR Therapeutics Be in 5 Years?,119697854,https://s.yimg.com/ny/api/res/1.2/CiYIaMfUfgNOdIsClz_BVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/5dc41f371568cc7b6dfbbaf6411f8ca2,VRTX,Yahoo,"One company that hopes to be at the center of that transition is CRISPR Therapeutics (NASDAQ: CRSP).  The company has a promising treatment that could make a meaningful impact on many lives, while at the same time solidifying itself as a top healthcare stock to watch out for.  Below, I'll look at where CRISPR Therapeutics may be five years from now, and whether investors should consider buying shares of the company today.",https://finnhub.io/api/news?id=d7607e6ae3331f5ba2ae67dbef9588665fc20f6115dcde801a6cff7163d07052
company,2023-04-09 06:30:00,"2 Winning Stocks That Could Turn $10,000 into $50,000 by 2030",119697855,https://s.yimg.com/ny/api/res/1.2/3SJN38nqbN4GvN6G325bYA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/31605ed4db3e839014a1e294506df089,VRTX,Yahoo,"The stock market has a habit of rewarding investors that stay with it through the ups and downs.  Now, the performance of your portfolio in a wide range of market environments will be very specific to the stocks you buy, the length of time that you hold them, the diversification of your holdings, and the types of industries and companies you gravitate toward, to name a few key factors.  Vertex Pharmaceuticals (NASDAQ: VRTX) has built a profitable and market-leading franchise of cystic fibrosis medicines that, to this day, are the only drugs approved to treat the underlying cause of this insidious genetic disease.",https://finnhub.io/api/news?id=27709ade831bd738fbc41a86aa7e2baa384c7a0216e095d71a651193f6cbf36b
company,2023-04-16 05:30:00,Better Growth Stock: Axsome vs. CRISPR Therapeutics,119790675,https://s.yimg.com/ny/api/res/1.2/xrsxTT3trrswhBxEWXA9RQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8101039c37c8c1e0a65ed3460c78cea9,VRTX,Yahoo,"CRISPR recently requested regulatory approval for a product candidate with blockbuster potential.  Axsome bought the sleep disorder drug Sunosi from Jazz Pharmaceuticals and started selling it last spring.  Of course, failure can happen at any point in development -- but risk does decline as a candidate makes it through the earliest safety and efficacy tests.",https://finnhub.io/api/news?id=c5d19edca9b02ce3d205dfb25a122520fc86d1c98b944d2a412f28d978cd3f8c
company,2023-04-14 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,119805773,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.05% higher to $333.52 Friday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=74ea1e49d198570727e159dc73eb8b8ce3491e80d6a1464152f21a16f4f14f49
company,2023-04-14 10:23:00,Is CRISPR Therapeutics Stock a Buy Now?,119772509,https://s.yimg.com/ny/api/res/1.2/tiG3MuVx2_zHbdpv9WpMdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/321a4d4885ec161536191c93eae613dd,VRTX,Yahoo,"Gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP) has significantly lagged the market over the past year, but there are reasons to be optimistic regarding the company's future.  The biotech seems to be nearing approval of exa-cel, a potential treatment for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT) that it developed with Vertex Pharmaceuticals (NASDAQ: VRTX).  CRISPR Therapeutics is currently a clinical-stage biotech, so it will be a big deal if it can cross the finish line with exa-cel.",https://finnhub.io/api/news?id=1ea34a678e394e179096c672c09f13f20137c023c7d02657f1499035ef865ded
company,2023-04-14 08:00:44,Vertex Pharmaceuticals' (NASDAQ:VRTX) 16% CAGR outpaced the company's earnings growth over the same five-year period,119790841,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...",https://finnhub.io/api/news?id=8adb9f0b57762d91ab3995ba763fe62d3483b79db0216fcfb4b55d9f4411aa6d
company,2023-04-14 06:45:01,CRISPR And Vertex: ICER Sheds Light On The Future Of Sickle Cell Treatment,119758375,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=2aa6b83c8e8f6137354538ae2e61712ccc825ee1cd633d6eee1a4c6e8c8e1043
company,2023-04-14 02:48:00,Vertex Pharmaceuticals Reaches Analyst Target Price,119763737,,VRTX,ETF Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dea969c7228e76d3a938fee18ee42f0fbf3e85ceaffe8e185b37d3677bd59a7e
company,2023-04-13 14:17:09,"$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis",119753688,https://media.zenfs.com/en/Benzinga/a34b8156a25ecba749d9c99f787242a9,VRTX,Yahoo,"Prices for incoming sickle cell disease gene therapies from Vertex Pharmaceuticals Inc (NASDAQ: VRTX)/CRISPR Therapeutics AG (NASDAQ: CRSP), dubbed exagamglogene autotemcel (exa-cel), and Bluebird bio Inc’s (NASDAQ: BLUE) lovotibeglogene autotemcel (lovo-cel) at $2 million could be cost-effective under some scenarios. Although “these gene therapies have an incremental cost-effectiveness that is above commonly cited thresholds from the health care system perspective.” The analysis comes from a U.",https://finnhub.io/api/news?id=9933426ff799c04eb15ff0026e8b205902c2138a5e3d76ebd1eb1bfaa5d5fbe1
company,2023-04-13 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",119755459,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.14% to $333.35 Thursday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=d06a912e39bb1d78f81c1d6d0412c4dbcf4d3e4a42dc30e427eb9f21618485e0
company,2023-04-13 11:58:37,Why Shares of CRISPR Therapeutics Jumped Thursday,119772514,https://s.yimg.com/ny/api/res/1.2/oSlYfILwpTi7VVR6clqTdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/97c51c774bebca7b24797fab6ef6ce0c,VRTX,Yahoo,An independent drug-pricing group said that a $1.9 million cost for the company's exa-cel therapy would be cost-effective.,https://finnhub.io/api/news?id=62f869349756256f70e287527bb32384fdf3287ee3dc3e24249a2b3fc8422e13
company,2023-04-13 10:15:00,2 Nasdaq Growth Stocks That Are Screaming Buys in April,119749773,https://s.yimg.com/ny/api/res/1.2/CaUoIldd3CzB_Uo2eyBFJQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/1c27254db9a58f19c1a38bae455efb4c,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) -- are particularly appealing.  Vertex is likely on the verge of realizing its strategic plan to diversify its portfolio of medicines.  If you're not familiar with Vertex, its claim to fame over the last decade has been its cystic fibrosis (CF) therapies.",https://finnhub.io/api/news?id=0c0f6cd1bc289ba81914829ccd5aea4cf136374d09cd6ed28295bbd6561ce3ea
company,2023-04-13 10:00:33,"Dow Jones Reverses Lower After Jobless Claims, Inflation Data; Delta Slides On Earnings",119749775,https://media.zenfs.com/en/ibd.com/af3d8bf275f34dd771b1551f1766e265,VRTX,Yahoo,The Dow Jones turned lower Thursday after first-time jobless claims and more key inflation data. Delta Air Lines sold off on weak earnings.,https://finnhub.io/api/news?id=b50ce5af10e5ad88adc75bd82288507e6c21b09ab6f843d6d6b588e2fa28bd01
company,2023-04-13 05:45:00,CRISPR jumps 15% as Cantor issues bullish view citing exa-cel approval,119742531,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=47ed0483eeae5cec464ec9cb56c6076083801c700f5b68733c156b24c21ee211
company,2023-04-13 05:30:00,These Up-and-Coming Stocks Are Screaming Buys Right Now,119771791,https://s.yimg.com/ny/api/res/1.2/14_1oUryGlW7mmYD1jnVAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/0c6d3fb0f6996cdfc04af733c3c07c1f,VRTX,Yahoo,"Many of these companies are trading at interesting levels and promise growth down the road.  Here, you'll find companies that have recently launched first products -- and those on the way to reaching the commercial stage.  One of the things I like most about Axsome Therapeutics (NASDAQ: AXSM) is that all of the company's five pipeline candidates are phase 2 or more advanced.",https://finnhub.io/api/news?id=020813ac1980f953230f6983f147bd280ba414e84d48b3b21cd955646e531f91
company,2023-04-12 21:27:00,"Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?",119746070,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6e801cf2392cb107a3906829568193f0dcee3dbcb16f591fe6c18b05699cd63a
company,2023-04-20 18:24:13,Top 10 CRISPR Stocks To Buy,119853224,https://media.zenfs.com/en/insidermonkey.com/1b50b8832ff65ee08cc1810509c40e3e,VRTX,Yahoo,"In this article, we discuss the top 10 CRISPR stocks to buy. If you want to see more stocks in this selection, check out Top 5 CRISPR Stocks To Buy. Molecular biology, genetics, and genomics are in a significant period in history where technical capabilities and methods enable the editing of specific DNA segments and […]",https://finnhub.io/api/news?id=2e7cbd0181bdb409fa2792a9241755ecd2dda01c5f53761a60056bb5847a58f7
company,2023-04-20 14:00:00,Better Big Biotech Buy: Biogen vs. Vertex,119879804,https://s.yimg.com/ny/api/res/1.2/J9s2aWYYinZgKiv0E7ISMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e4533a263a83ae392229a8d67f53b401,VRTX,Yahoo,"Two great examples are Biogen (NASDAQ: BIIB) and Vertex Pharmaceuticals (NASDAQ: VRTX).  Biogen is known for its blockbuster multiple sclerosis drugs, including top seller Tecfidera.  Biogen's immunology drug, Rituxan, has also seen sales slip due to biosimilars in the market.",https://finnhub.io/api/news?id=2f947f75705c2b6b1b7e985d1a5256c69d2c3e2b08a78f87911122ab3ead4a67
company,2023-04-20 10:15:00,"Have $1,000? 2 Explosive Growth Stocks to Buy and Hold No Matter What the Market Does Next",119863860,https://s.yimg.com/ny/api/res/1.2/zprKrI5X7A.5QD9qUtm1rQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c3f807808b2864876691ec44c85b1820,VRTX,Yahoo,"For investors with the cash to put to work during all the market's mood swings, it's always a great time to buy more wonderful companies.  Vertex Pharmaceuticals (NASDAQ: VRTX) has created a business with a track record of profitability and market leadership that is a stand-alone example in the highly competitive healthcare industry.  Vertex is known for its leadership in the cystic fibrosis (CF) treatment space as it is the only company with drugs on the market that treat the underlying cause of this genetic disease.",https://finnhub.io/api/news?id=e502eb93e8da15b2d4a5273bf6b577a8da97bdaa66a86bc6af8c863be55ce23e
company,2023-04-20 09:36:25,"Final Trades: Gilead, Vertex, Wynn & more",119846816,https://image.cnbcfm.com/api/v1/image/107228772-5ED4-FMHR-042023-FinalTrades.jpg?v=1682012185&w=1920&h=1080,VRTX,CNBC,"The ""Halftime Report"" traders give their top picks to watch for the second half.",https://finnhub.io/api/news?id=e24a04a8dcfdfc402c46ff887d0a1f93a82a2af5b75b706a1b7182d6d1a7e821
company,2023-04-20 08:12:30,BMEZ: Attractive Discount On This Riskier Healthcare Fund,119838040,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=67cb7483a16fda8737ba9c9bed17bdc0dc52de9831b1a5c9ed5bb1550f23ebe5
company,2023-04-20 00:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,119844032,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7be6ec8e2f6cefaaa44c6a30a16a4a82dc74137aa93f605b5da2dcb5e9819a9b
company,2023-04-19 15:32:00,Supreme Court Extends Decision on Abortion Pills to Friday,119836324,https://s.yimg.com/ny/api/res/1.2/RRpBpUwCI3d.OswGxy.M.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/97636d8c617e0d06836570a86122ea9e,VRTX,Yahoo,"The court’s decision has broad implications for reproductive rights, for the power of the judicial system, and for the pharmaceutical industry.",https://finnhub.io/api/news?id=7c65b3abf9a8973f5c9d99d7d67250c8c1d998a9fb8d637b57b0c66351216b11
company,2023-04-19 09:42:11,"Dow Jones Falls: Netflix Slides On Q1 Results, Tesla Skids On Pre-Earnings Price Cuts",119850642,https://media.zenfs.com/en/ibd.com/c6d64079321d20f2fbc7507bf78b6e9d,VRTX,Yahoo,"The Dow Jones fell Wednesday morning, as Netflix dropped on weak subscriber growth. Tesla skidded on more price cuts ahead of earnings.",https://finnhub.io/api/news?id=2516687529057ad662c8d9e697fedf0a96f0962bdee6f35e44c1de2ef786dbdc
company,2023-04-19 01:20:19,Climbing A Wall Of Worry,119822686,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=17645a5684f17a435791ee9cc8f40cd1d885f03ea2b83c22ee607eaac90fb237
company,2023-04-19 00:31:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",119844033,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f4b94315addf109b6312b4f88043426d459e025e5e913cf2408a7441f8dcec44
company,2023-04-18 17:50:09,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,119819577,https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $325.15, moving -0.79% from the previous trading session.",https://finnhub.io/api/news?id=eb596d38d4a456fe4a60a19f692ccf8ce178492f63ed1c1e2042199bf0f857ac
company,2023-04-18 12:10:04,Why Vertex (VRTX) Could Beat Earnings Estimates Again,119819578,https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0,VRTX,Yahoo,Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,https://finnhub.io/api/news?id=d95f4941ee322f4fa1d8289c6f9bc8e467f789b0fb6e099ac4cfa02fcd98fba2
company,2023-04-18 10:01:12,Dow Jones Falls As Goldman Sachs Slides On Earnings; Nvidia Jumps On Buy Rating,119819579,https://media.zenfs.com/en/ibd.com/b93082b62d669a716dcee1724ff49dd4,VRTX,Yahoo,"The Dow Jones fell modestly Tuesday, as Goldman Sachs dived on weak sales results. Nvidia stock jumped on an analyst buy rating.",https://finnhub.io/api/news?id=cc195b0a4a37464d6ce52a8a86d8009ddb6325d05355a9155b6b05020764b60a
company,2023-04-18 09:45:00,"Got $5,000? Buy and Hold These Fast-Growing Stocks for Years",119819581,https://s.yimg.com/ny/api/res/1.2/KgvJN1ZECByGMeot8NYdLA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/cc67ebee11bae7ea57508345ef9e7559,VRTX,Yahoo,"Stocks of rapidly growing businesses normally trade at a premium and can be great long-term buys.  If you have $5,000 that you can afford to invest right now, two stocks you should consider putting at least some of that money into are Vertex Pharmaceuticals (NASDAQ: VRTX) and Shopify (NYSE: SHOP).  An investment in Vertex could go a long way given the company's solid growth prospects.",https://finnhub.io/api/news?id=91f7954d75d7ca7d2f1310f3d20477f46b0acdc9f40d7ebcfd88a602de5f8357
company,2023-04-18 06:40:45,3 High-Growth Biotech Stocks Poised for Success in 2023,119864046,https://media.zenfs.com/en/investorplace_417/7b62464d32248ed62ee80cadf868b9a3,VRTX,Yahoo,"Many investors look for growth opportunities wherever they can find them. If that describes you, then there are some high-growth biotech stocks that could present an opportunity. Biotech (short for biotechnology) companies research how to use living organisms to make drugs. However, like pharmaceutical companies, biotech companies present substantial risks for investors. Many small biotech companies are not yet profitable and may even be pre-revenue. InvestorPlace - Stock Market News, Stock Advi",https://finnhub.io/api/news?id=d32969562532f95a726d328d6beb5efa2720d26bdd7e0d4158cd614c1a0a86c9
company,2023-04-18 05:52:00,The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now,119814637,https://s.yimg.com/ny/api/res/1.2/RsdTkAgCSU.PFr3LeQC3HQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e9f0b63b500b842216465644cf922648,VRTX,Yahoo,"Staff economists told the FOMC that it's likely that the U.S. will enter into a ""mild recession starting later this year"" because of the banking crisis.  With the FOMC thinking that a recession is more likely, what should investors do?  At first glance, you might not think Dollar General (NYSE: DG) would be such a great stock to buy right now.",https://finnhub.io/api/news?id=e84c58a382dfd83df3d03a69eaedc6806b9be4321f4864775ed1f6dda25b0f91
company,2023-04-18 05:30:00,The Top Healthcare Stocks to Buy With $100,119814638,https://s.yimg.com/ny/api/res/1.2/kgm5lrtdR5fKSMC6KDal_Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9fd276abc97ee103024aa095e5fd4cbc,VRTX,Yahoo,You don't have to start out with thousands of dollars to grow your wealth in the stock market.  Let's talk about two biotech companies that are just beginning their growth story -- and a big pharmaceutical company that's about to embark on a whole new wave of growth.  CRISPR Therapeutics (NASDAQ: CRSP) is a specialist in the exciting area of gene editing.,https://finnhub.io/api/news?id=3f9bc95968d9cfe6c27ddb89699d09e1dec8df7c39f2ea652e00e1bcc5b988cb
company,2023-04-18 04:21:00,"Analysts` Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",119824795,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=626e4f2490a1fd56c1b7a50a0c1312ad4e0e084a8e1072498d92dc0e30834928
company,2023-04-18 00:31:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,119824797,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d0bd3e11305c698fe4eaf32acd3eb2c7856a1be65a71f9238b4274db1c8bf966
company,2023-04-17 18:33:09,"Dow Jones Futures: Netflix, Tesla Earnings On Deck; What To Do Now In Today's Stock Market",119808542,https://media.zenfs.com/en/ibd.com/73f1386ca2f498e8ccfce189e55ef5e1,VRTX,Yahoo,"Dow Jones futures were lower late. Netflix earnings are due and Tesla earnings are on deck, as first-quarter earnings season heats up.",https://finnhub.io/api/news?id=3f9348dba86114eb4bab4c820e69e387eb1fbfc34052e34ce3c075dab591618a
company,2023-04-17 16:05:00,Why CRISPR Therapeutics Stock Is Marching Higher Today,119810323,https://s.yimg.com/ny/api/res/1.2/tz78sC6k6A8tHV2k5FnKKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/ac24f36bf9d2b4808b39e9c29e1e8a94,VRTX,Yahoo,"What happened Shares of CRISPR Therapeutics (NASDAQ: CRSP) are enjoying another strong session Monday. Specifically, the gene-editing company's stock was up by a healthy 7.26% on exceptionally heavy volume as of 2:02 p.",https://finnhub.io/api/news?id=fb3e6e283f9f721a2e7f429d45d383ee42dd18515bd23f537a47bda94ab4d644
company,2023-04-17 16:00:07,"Buy Zones And Breakouts: MBLY, AVGO, CROX And Oracle Among 24 Stocks To Watch",119809960,https://media.zenfs.com/en/ibd.com/29816c3b155ef19bd51cdfb6d63443e9,VRTX,Yahoo,"The best stocks to watch often hail from the top-ranked industries. Here are 24 such stocks, including CROX, AVGO and MBLY.",https://finnhub.io/api/news?id=3a12fb6c855bd58c8df70b914939762c495339d385ac763c8ded79862638b90b
company,2023-04-17 14:50:38,Why Shares of Editas Medicine Rose Monday,119810325,https://s.yimg.com/ny/api/res/1.2/_X.rh4TiDQzCxP80fyy1rQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/2438859d65539b96dd6d8fd5cab72375,VRTX,Yahoo,"Shares of clinical-stage biotech Editas Medicine (NASDAQ: EDIT) rose as much as 14% on Monday, lifted by a trend over the past couple of days favoring gene-editing stocks.  Editas stock also benefited from the news last week that the company was appointing a new chairman of the board and a new independent director.  Several gene-editing companies saw their shares rise when it was reported that the Institute for Clinical and Economic Review (ICER), an independent group, said that exa-cel -- a one-dose treatment for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) being developed by CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals (NASDAQ: VRTX) -- would be cost-effective, at under $1.9 million per dose, compared to the long-term costs most SCD patients face.",https://finnhub.io/api/news?id=8d3b666e4cf7f4277c40e4596a84b3e1579afd85f84c6752812a8fb094a26542
company,2023-04-17 10:14:34,Dow Jones Rises Amid Economic Data; State Street Crashes 18% On Earnings Miss,119808544,https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19,VRTX,Yahoo,"The Dow Jones rose Monday, with Q1 earnings season set to heat up this week. State Street crashed 18% on an earnings miss.",https://finnhub.io/api/news?id=c0b33b1f25f0cdd7c39cf1cba0af7efc643a67dbcaed0f1c33f305eb280d23eb
company,2023-04-17 05:56:00,"Which Stocks Pass Warren Buffett's $10,000 Test?",119796523,https://s.yimg.com/ny/api/res/1.2/wN1D6t7.bNPof.cyGcSTHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/af96f849fd5d8586b95da7145a496181,VRTX,Yahoo,"If you didn't watch Warren Buffett's interview on CNBC last week, it would be worth your while to look at some of the highlights online.  One of the most interesting things he said, in my view, was on the topic of Apple (NASDAQ: AAPL).  ...if you're an Apple user and somebody offers you $10,000 but the only proviso is you'll never be able -- to they'll take away your iPhone and you'll never be able to buy another, you're not gonna take it.",https://finnhub.io/api/news?id=92ced1ed692c2e6058b35a01bbcc5bb3bc3db6d8e71b6d26d8f37ff60cb5d309
company,2023-04-17 05:50:00,Prediction: These Will Be 3 of the Biggest Monster Stocks of the Decade,119795941,https://s.yimg.com/ny/api/res/1.2/EUXQFIaLknvWz4GIPljKAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/294c884ac6a6a339709f4670811e1ce6,VRTX,Yahoo,MercadoLibre (NASDAQ: MELI) combines all three in one fell swoop.  MercadoLibre's logistics business Mercado Envios piggybacks off of the success of its e-commerce segment.  It's not surprising that MercadoLibre continues to enjoy exceptional momentum on this front.,https://finnhub.io/api/news?id=264ae0f574966efe2c5caa2fc5350a742bd17f992f91221d979ce7708e8e3304
company,2023-04-17 00:31:00,"Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market",119824798,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=244d5e86647db5cfea7f6f3655836534644f138a9a4f8d1ce4b5e715423fa073
company,2023-04-24 17:50:09,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,119956375,https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $332.84, moving +0.53% from the previous trading session.",https://finnhub.io/api/news?id=7faad9f2258d193940b2a256a3b1602399ed9e82339015af972dd2ae62812890
company,2023-04-24 14:00:00,3 Healthcare Stocks That Could Help Make You a Fortune,119910796,https://s.yimg.com/ny/api/res/1.2/MGtV5up3FxqAJp4sK1LCcA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/25298be14c02c98533129856342ddc58,VRTX,Yahoo,"When you think of healthcare stocks, you may think of steady growth and security.  Let's check out three healthcare companies that fit the bill.  In fact, if all goes well, Vertex may launch a new CF treatment in the not-too-distant future.",https://finnhub.io/api/news?id=f624c8abe534dd95e232d9feb4d85e1a243b909bd47d40745a295c6a8b482845
company,2023-04-24 13:31:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains,120091344,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.53% higher to $332.84 Monday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=4240455003a0d15f374f9bfd98abe7a30204921a7f91b6d142a5049a318b2327
company,2023-04-24 10:00:02,Earnings Preview: Vertex Pharmaceuticals (VRTX) Q1 Earnings Expected to Decline,119904429,https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462,VRTX,Yahoo,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=799be5eafdea51965365553cf387e01135affc46f44be24fd7aaca0059a3eafc
company,2023-04-24 07:10:11,"The Zacks Analyst Blog Highlights Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI",119904694,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI are included in this Analyst Blog.",https://finnhub.io/api/news?id=e702873f9fef00c6294d3e66d538ddc49ac26beba4da51cc789040d838019b3c
company,2023-04-24 04:00:00,Vortex Energy Announces the Addition of Shawn Ryan as Technical Advisor,119923349,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=dde61a6b0dde4a6520c121296071b6ce3a14f27fe261850d3919b7ec3ff12d9f
company,2023-04-24 03:00:00,Bluebird bio seeks FDA priority review for sickle cell disease therapy lovo-cel,119922307,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2bcb150498665905bc598ba09773af79eef69191c84225d422d3090bc2812a83
company,2023-04-24 01:31:06,Second Quarter Outlook For Biotech Stocks,119900551,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=3480cc3264f6b2d34dd4cc517961cd6de011088287042e735a3127dd26c3056f
company,2023-04-23 23:45:00,"FDA PDUFA Date for Vertex Pharmaceuticals Trikafta is April 28, 2023",119923353,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c172a0aadbaa4dd264ef33b9b51b7ede312362395d8b37f2d7479f6062bbdb00
company,2023-04-22 06:18:00,3 Stocks With Huge Catalysts on the Way,119883422,https://s.yimg.com/ny/api/res/1.2/.cIgkZ1Lxh866RPSPPLgvw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/ae92ec422e51a477a151d49efdd2f51b,VRTX,Yahoo,"Clinical updates and regulatory decisions can happen throughout the year.  Three Motley Fool contributors identified these stocks with huge catalysts on the way: Axsome Therapeutics (NASDAQ: AXSM), CRISPR Therapeutics (NASDAQ: CRSP), and Eli Lilly (NYSE: LLY).  Keith Speights (Axsome Therapeutics): Axsome Therapeutics' first potential catalyst is only a few weeks away.",https://finnhub.io/api/news?id=19654f863ea0bb4ad490fcb90ef1c04cd69bf0e9bb64718fbf01fac650113e06
company,2023-04-21 23:45:00,ClearBridge Multi Cap Growth Strategy Q1 2023 Portfolio Manager Commentary,119880702,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=50ae439da40485c22157d3b97aeb4b6533c3a7c25263c66a96d0a6a018b2c3c9
company,2023-04-21 20:30:00,ClearBridge Aggressive Growth Strategy Q1 2023 Portfolio Manager Commentary,119878616,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=826242f1c0eda308de412a0f400cc4a785fef9f7d281022d7c333ce20f3f4059
company,2023-04-21 20:15:00,ClearBridge Global Growth Strategy Q1 2023 Portfolio Manager Commentary,119878554,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=a7a62ce47d93782687e67ceebc0195c450579d2646c442aafbdf90eb4ef3e6fa
company,2023-04-21 16:20:08,"Top Stock Reports for Linde, Vertex Pharmaceuticals & Edwards Lifesciences",119878821,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Vertex Pharmaceuticals Incorporated (VRTX) and Edwards Lifesciences Corporation (EW).",https://finnhub.io/api/news?id=e2d76eae8bd8b05733830f861741ec0f6b2e5fa2bfe9c8b3652d1a8b6302fbfe
company,2023-04-21 09:49:01,Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?,119877809,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"On Vertex's (VRTX) Q1 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and development updates of its non-CF pipeline.",https://finnhub.io/api/news?id=f48abd1e85113a898798a8ab48c1a5f068c3f0918071229e1a2d8932efe39762
company,2023-04-21 00:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,119885673,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f452c2f17df7a6c79443571be0945c4ce3f45e8bfce7bf4d5b7fa82114e64e55
company,2023-04-28 14:25:06,What To Expect After The Failed AbbVie Drug Sales,120026527,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1167582826/image_1167582826.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"AbbVie's revenue amounted to $12,225 million in the first three months of 2023, 9.7% less than the previous year. Find out my recent analysis of ABBV stock.",https://finnhub.io/api/news?id=c0f00b359589fe76834d317601467cd0a0f98838df1aeacfc271f6821139f223
company,2023-04-28 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",120091338,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.40% higher to $340.73 Friday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=d4cc46c3383f603415a7f5bfbda9b1b55dcfc8ecdafdcf101a673644d5bd317e
company,2023-04-28 12:11:00,NEW YORK MARKET CLOSE: US stocks end upbeat week on the front foot,120021458,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a6b420ad3570edaaf16f6cec6ca0a5f890af7fd6ea307931802e7a515bf83e8b
company,2023-04-28 07:47:00,bluebird bio a new overweight at JP Morgan on sickle cell therapy,120015893,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d49d208b2179ebee41112426e4df9b865147f04c876186b200b6d40e4e1a2913
company,2023-04-28 03:28:07,Strength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?,120006576,https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781,VRTX,Yahoo,Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,https://finnhub.io/api/news?id=77b497d48386bd376718452170f361a68ecabad25c7dc8b0f70c2067365f60e8
company,2023-04-27 23:55:00,"FDA PDUFA Date for Vertex Pharmaceuticals Trikafta is April 28, 2023",120029217,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=888e8cb1fc03a64f23c992a409a000230349f4ba94e2768e193d67659c76a85e
company,2023-04-27 13:55:00,Biggest Gains in Employee Engagement in the Management Top 250,119965864,https://s.yimg.com/ny/api/res/1.2/HBa5IaPMo4wPizK7Sgrb2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/e0ca61dd19e726f5d7e13278354f75c6,VRTX,Yahoo,"The Management Top 250 ranking, developed by the Drucker Institute, measures corporate effectiveness by examining performance in five categories: customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength.  Dell’s score for employee engagement and development jumped 24.3 points, to 64.3.",https://finnhub.io/api/news?id=74b0f66917c17ec4d90ca697f6895e9319aaa0a8f19b489c1a0560af48ad3497
company,2023-04-27 13:32:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,120091339,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 4.97% to $339.37 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...",https://finnhub.io/api/news?id=dcaf377340a940a2b5ba6d16ba333fa4f4001ee1fb4b9ad352be7e39b7de366b
company,2023-04-27 10:23:00,2 Growth Stocks That Could Double in 5 Years,119956361,https://s.yimg.com/ny/api/res/1.2/pT0K135U2yALDeU1_xZ_4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/10af9058c83d1f76c113a6e26f3b8b08,VRTX,Yahoo,"As a group, growth stocks had a year to forget in 2022.  Let's consider why both healthcare stocks could double in the next five years -- and for those keeping score at home, that amounts to a compound annual growth rate of almost 15%.  Vertex Pharmaceuticals is a biotech company best known for its lineup of medicines that treat the underlying causes of cystic fibrosis (CF), a rare genetic disease.",https://finnhub.io/api/news?id=561f71413fca9e76076dfe89539ee1316b51c5abea023e2a9330bf2d49968a72
company,2023-04-27 08:15:00,Is It Too Late to Buy CRISPR Stock?,119956363,https://s.yimg.com/ny/api/res/1.2/rbuBtcRthwKNuge2joZexA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/18b7a0383416b95ad4ced416400a77a6,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) has been a volatile stock over the past couple of years.  Lately, the gene-editing company's shares have been trading for under $51 a share, but I believe they could go much higher, considering the company's long-term potential.  CRISPR is one of just a handful of clinical-stage biotech companies (like Editas Medicine, Intellia Therapeutics, Beam Therapeutics and Verve Therapeutics) that use CRISPR editing to find new therapies.",https://finnhub.io/api/news?id=5912b16943358b85338415d1de9e0864ebe7c03bea98a3056442ec906074dcf5
company,2023-04-27 06:12:00,Vertex gains as AbbVie ends cystic fibrosis development program,119957346,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9c23511386918d1df1afbc9f83c620a50d979bdb7b44e9c04598663a19c62532
company,2023-04-27 04:00:00,Vortex Energy Announces the Addition of Strategic Advisors & Options Issuance,119957347,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5f4f9926008a8e8060fc2ed39c35cb291af1e077c4d5e260995f80e5a29dac6d
company,2023-04-27 03:30:07,"Cytek Biosciences, Inc. (CTKB) Soars 13.4%: Is Further Upside Left in the Stock?",119956364,https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619,VRTX,Yahoo,"Cytek Biosciences, Inc. (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",https://finnhub.io/api/news?id=6daaf53b9e1606ae6913ce90d88a30826da153969230a4a4c3a069409d75e1c5
company,2023-04-26 13:37:00,Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 2 Through 5 With Certain Mutations,119956365,https://media.zenfs.com/en/business-wire.com/57543a8f6fd77ebe506c91fd28811092,VRTX,Yahoo,"BOSTON, April 26, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 2 through 5 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive to TRIKAFTA® based on in vitro data. TRIKAFTA® w",https://finnhub.io/api/news?id=3f24210077dddae7202b3171ea0178b2f48786597701fae1d91e21e027531d90
company,2023-04-26 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",120091340,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 2.60% to $323.30 Wednesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=798587e52260c51e57abbdb3f6252c0e70bf3268a920e6651e90b311486d3573
company,2023-04-26 12:48:00,Health Care Down on Earnings Fears -- Health Care Roundup,120091341,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,"Health-care companies fell sharply amid fears that earnings growth would slow as concerns about Covid 19 subside. Kaiser Permanente, a pioneering integrated...",https://finnhub.io/api/news?id=7d74a91d07113d13a8f326eaa255ecad5cda8bb706ff03d84cfa8009f373ae26
company,2023-04-26 12:02:00,IN BRIEF: Vertex receives US FDA approval for expanded use of Trikafta,119957349,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=11ca067839f6ca5c99c01f5e49783d5adf71c81a079d4bd5458d8e013f9c47e4
company,2023-04-26 10:07:00,Why CRISPR Therapeutics Just Became an Even Better Buy,119949240,https://s.yimg.com/ny/api/res/1.2/kfWETSBr28TOdvTCwVKFkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/58e604e85d73cb984e34a01e3a8a604d,VRTX,Yahoo,CRISPR Therapeutics (NASDAQ: CRSP) is a growth stock with a lot of long-term potential.  Its gene-editing business could be about to take off if exa-cel obtains approval from the Food and Drug Administration (FDA).  What makes gene-editing therapies potential game changers in the healthcare industry is that they have the potential to revolutionize treatment options for diseases.,https://finnhub.io/api/news?id=639adde509ae13c5ed08c31072749ad7d06c3a0c3c02f7a785965791df8e442a
company,2023-04-26 10:03:00,Vertex: FDA OKs Trikafta for Some Children Ages 2 Through 5 With Cystic Fibrosis With Certain Mutations,120091342,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Colin Kellaher Vertex Pharmaceuticals Inc. on Wednesday said the U.S. Food and Drug Administration approved the expanded use of its Trikafta...,https://finnhub.io/api/news?id=2951ef442f8e5ee0d53b20d756829501b9354f390dd59b44890059043f71c779
company,2023-04-26 08:39:00,Vertex announces U.S. FDA approval for expanded use of Trikafta,119957353,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e46a6b13c660dcf7960e952da7c23acce794f17db1562aaa8f65db55d714270c
company,2023-04-25 21:13:00,Vertex wins FDA label expansion for cystic fibrosis therapy Trikafta,119957359,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e98c99670e576239bf91141e039bb417f587d124081948ec1c751729eed9e860
company,2023-04-25 17:45:09,Vertex Pharmaceuticals (VRTX) Stock Moves -0.27%: What You Should Know,119956367,https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $331.93, marking a -0.27% move from the previous day.",https://finnhub.io/api/news?id=e0ebe71f890cc93166d364233bb05ea90aefecbcebbf100423a82cec473f3bc8
company,2023-04-25 15:15:03,IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll,119956369,https://media.zenfs.com/en/ibd.com/fd88dd49a5bbb14fdbe73fa70a0a571c,VRTX,Yahoo,Vertex enters into a partnership to develop novel small molecules. Shares have gained 15% this year.,https://finnhub.io/api/news?id=a728d11db51f76710217ab6b01f5ae4c594668e3194c6a9c0349a91a281dd993
company,2023-04-25 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,120091343,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.27% to $331.93 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=8e545a576f9808a85780ff9d3bcb74914090078eae13a2db1295dc8bf50dace3
company,2023-04-25 13:00:00,3 Biotech Stocks To Watch Today,119917018,https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/04/biotech-stocks-to-watch.jpg,VRTX,StockMarket,Biotech stocks for your late-April 2023 watchlist.,https://finnhub.io/api/news?id=f454f77dee373668f5207d0fb9c803ff8972ad13ea05656eede8fd08306e2def
company,2023-04-25 10:01:02,"Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know",119931087,https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a,VRTX,Yahoo,"Rhythm Pharmaceuticals, Inc. (RYTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",https://finnhub.io/api/news?id=2d4b9be2c04d02b1ebc35daf0451dfd1105c28ff1690d103812d0600a254db33
company,2023-04-25 09:51:15,3 Cash-Rich Biotech Stocks to Bet on for the Long Haul,120015154,https://media.zenfs.com/en/investorplace_417/814bf4787de3c720fc4dce9747086b2d,VRTX,Yahoo,"The Federal Reserve’s recent interest rate hikes mean banks charge much higher interest rates for loans. The interest on loans can be considered the price of borrowing more money. And since acquiring cash now costs more money, it’s becoming much more complicated for companies to invest. For biotech stocks, the pain is clearly borne by investors, who choose to dive into these capital-intensive businesses. For a cash-strapped company, the rising cost of money can be a death sentence. But cash-rich",https://finnhub.io/api/news?id=7012f2c658af39cf7a7bd7f7c9431db810b6146069182d89ed7013509af8f07c
company,2023-04-25 08:01:00,Vertex to Present at the Bank of America Securities 2023 Health Care Conference on May 9,119956373,https://media.zenfs.com/en/business-wire.com/0c9f1a3422e81546f398e5c3df1c6e05,VRTX,Yahoo,"BOSTON, April 25, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 9:20 a.m. PT/12:20 p.m. ET.",https://finnhub.io/api/news?id=9adbeece76d5418e23491fe9f74856224a3fdb8c665517b0e81ec540f6bc81d2
company,2023-04-25 02:03:00,"Stablix, Vertex collaborate for targeted protein stabilization therapeutics",119923347,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6a1d54ecf90cfcdcf5a921551c4ffdb3e72b31e8068de7e0fd4c50a3c3b14b31
company,2023-05-02 16:03:24,Vertex Extends Its Breakout On Better-Than-Expected Profit; Retains Outlook,120113843,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,"Vertex Pharmaceuticals retained its full-year outlook and beat quarterly views, pushing VRTX stock higher early Tuesday.",https://finnhub.io/api/news?id=700b6d951f3d7b2cef7836d75788effd38036f83bc1e2642ea1351d8dc99bd94
company,2023-05-02 14:00:00,Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?,120113845,https://s.yimg.com/ny/api/res/1.2/xy3JY0Ku7p3BFvv2qn92qQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9ebb0f898e95fb1027c30457e83e2716,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment.  The company is known for its combination therapies targeting a defective protein that causes the disease's devastating symptoms.  AbbVie (NYSE: ABBV) had shepherded its own combination-therapy candidate -- also targeting the defective protein -- into phase 2 studies.,https://finnhub.io/api/news?id=c7e99ccf464329c57e9c2fdfe5b221271af65372dc325a6cbae4a3326d1aa8ca
company,2023-05-02 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,120115210,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.30% higher to $346.03 Tuesday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=39fe50d1ceaa58e98ee42ab06082b3c6b65ef4387438addfcd8bfae35065742a
company,2023-05-02 12:43:10,Q1 2023 Vertex Pharmaceuticals Inc Earnings Call,120113847,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,VRTX,Yahoo,Q1 2023 Vertex Pharmaceuticals Inc Earnings Call,https://finnhub.io/api/news?id=2338eea146012b763aa91f671244684ec8342f0702270bf9b3614149ef90862c
company,2023-05-02 12:06:04,"Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/Y",120104121,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,Vertex Pharmaceuticals' (VRTX) first-quarter 2023 earnings and sales beat estimates. Management reiterates financial guidance for 2023.,https://finnhub.io/api/news?id=40150da4dbcc1987c31b28e6dfefe4b8d203083a79d7d56dcff36c96a1f5cf5e
company,2023-05-02 05:30:00,"Patients Lose Access to Free Medicines Amid Spat Between Drugmakers, Health Plans",120098273,https://s.yimg.com/ny/api/res/1.2/3A9KX391wB.keDTe2GtVog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/d2e4c14ba5d915ade81ba5df830692bd,VRTX,Yahoo,The programs have been costing drugmakers billions of dollars a year and have been increasing as health plans seeking to control their own spending have tried to take advantage of the assistance.,https://finnhub.io/api/news?id=3c575d6d10a2d2c27f00d1213f2c86d8aae86d77a1fc23b9384035a34b2d9072
company,2023-05-02 10:02:52,"Final Trades: Transocean, P&G, Vertex",120114354,https://image.cnbcfm.com/api/v1/image/107234173-16830484823ED3-FMHR-FINAL-050223.jpg?v=1683050572&w=1920&h=1080,VRTX,CNBC,"The ""Halftime Report"" traders give their top picks to watch for the second half.",https://finnhub.io/api/news?id=386116c94aa6063abb3552edf0e30387e05c04ddc962b476986956c11ba9bc46
company,2023-05-02 10:00:00,2 Supercharged Stocks to Buy for 2023 and Hold for at Least 10 Years,120102052,https://s.yimg.com/ny/api/res/1.2/1NdmtTRBl5JMyA6nXkyrcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/92b8e67db4d26fc335b9c066bab00704,VRTX,Yahoo,"While no investor can predict with precision what the market will do in the coming weeks or months, the market has shown its ability to rebound from even the worst periods of volatility time and time again.  If you have a minimum buy-and-hold horizon of three to five years for any stocks you own, and the capital to put into the market, even the ongoing volatility that investors are currently witnessing doesn't mean you need to sit idly on the sidelines.  Here are two supercharged growth stocks to consider hitting the buy button on this week and holding for at least a decade.",https://finnhub.io/api/news?id=bf59ff9b8acae307fe0670a5316783746698dfe3b74f8c33c5bd97733c97eec6
company,2023-05-02 09:27:39,Barclays Maintains Vertex Pharmaceuticals (VRTX) Overweight Recommendation,120099309,,VRTX,Fintel,,https://finnhub.io/api/news?id=f7deaffdacceb4706e3106b05c1e73abeb7f8e11089874f5f37d939f89a668dd
company,2023-05-02 09:27:37,HC Wainwright & Co. Maintains Vertex Pharmaceuticals (VRTX) Buy Recommendation,120099311,,VRTX,Fintel,,https://finnhub.io/api/news?id=24b86077124912aa4ced7c1dd29433d48057983a020e1091788f990e1f6f271a
company,2023-05-02 09:27:37,Oppenheimer Maintains Vertex Pharmaceuticals (VRTX) Outperform Recommendation,120099310,,VRTX,Fintel,,https://finnhub.io/api/news?id=40ade298aa2543b2ad4fa928c1f03ba59c119512ce5bcd9b2dfb52699e13675f
company,2023-05-02 09:27:35,Baird Maintains Vertex Pharmaceuticals (VRTX) Neutral Recommendation,120099313,,VRTX,Fintel,,https://finnhub.io/api/news?id=afdc715afd2b3f4395572f94ab3a68e04720f07103175199e59659dd8ece6868
company,2023-05-02 09:27:35,Stifel Maintains Vertex Pharmaceuticals (VRTX) Hold Recommendation,120099312,,VRTX,Fintel,,https://finnhub.io/api/news?id=2fb6c04fa69684da94f227fb7796f3ebc7c444faf1b8a903bcb6e590d05d912b
company,2023-05-02 09:27:33,Morgan Stanley Maintains Vertex Pharmaceuticals (VRTX) Equal-Weight Recommendation,120099315,,VRTX,Fintel,,https://finnhub.io/api/news?id=a46b09f0a112ea39a0546984243f215229d04031e10f2fa641cf14e5eece8484
company,2023-05-02 09:27:33,Guggenheim Maintains Vertex Pharmaceuticals (VRTX) Buy Recommendation,120099314,,VRTX,Fintel,,https://finnhub.io/api/news?id=8ff47ee394a00539f0d122cd52d815fa9a3a6316321b3eef7df4d0d4f43d399a
company,2023-05-02 09:09:00,"2 Incredible Growth Stocks That Could Turn $20,000 Into $100,000 by 2030",120099275,https://s.yimg.com/ny/api/res/1.2/.WE.Kj1CxR8mr4KBHIEuNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDU-/https://media.zenfs.com/en/motleyfool.com/5870e79c1d4f290442faae10a80ec571,VRTX,Yahoo,"The stock market has been an incredibly volatile place to invest over the last year, and it's highly possible that the choppy market waters could persist in the near future.  Vertex Pharmaceuticals (NASDAQ: VRTX) is on a mission to disrupt the multi-billion-dollar rare disease drug market, having built a rock-solid foundation of revenue growth and profits from its existing portfolio of cystic fibrosis (CF) drugs.  While the company counts just four drugs in its current portfolio of approved products, all of which treat CF, these are the only products that have been commercialized to date that treat the genetic ailment's root cause.",https://finnhub.io/api/news?id=a70ec0f408c3cb8423d56cff9bad5c10e64a34da12b20aa0b58513e6097585fe
company,2023-05-02 07:35:00,Morgan Stanley Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),120103413,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=83cc3bf38328160fbb0379b7ee0778a2d92e2b577d0737038e1fca60951b8dfb
company,2023-05-02 07:32:00,"Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Vertex Pharmaceuticals (VRTX) and Axonics Modulation Technologies (AXNX)",120103415,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d8461d745d980bf4e643ad8597ce1b16764e8266bf9de0a6e94d9b84ac7c7215
company,2023-05-02 05:50:00,Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie,120097871,https://s.yimg.com/ny/api/res/1.2/hugjyldIinV8PehOJ5pfDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/627523f410bd691a15c572e062c2b0eb,VRTX,Yahoo,"While the overall market plummeted last year, shares of Vertex Pharmaceuticals (NASDAQ: VRTX) skyrocketed 31%.  Here's why Vertex stock is an even better buy now thanks to AbbVie (NYSE: ABBV).  AbbVie had been evaluating a triple-drug combo targeting cystic fibrosis (CF) in phase 2 testing.",https://finnhub.io/api/news?id=20c751f092b835b41e84c0e53999c01f1d19f519a5763e83cb9efb026510d080
company,2023-05-02 04:49:00,Vertex Pharmaceuticals price target raised to $315 from $299 at RBC Capital,120103417,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c16e5267b677d31015d53e6ca1d85191550d83fcc245445b94e3873cada00b4d
company,2023-05-02 04:28:00,Vertex Pharmaceuticals price target raised to $456 from $341 at Truist,120103418,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4fd4fe50a18fc156121c158fa6f076d494465158958b8e930b17b58eeb26a399
company,2023-05-02 04:00:00,Vortex Engages Independent Trading Group as Market Maker,120103420,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=65bb02d18dc51c93c7cd70d961cce877bdafa4e78e3105df5c5e52b482bc5612
company,2023-05-02 03:47:26,Vertex Pharmaceuticals is Down After Earnings but the Real Catalyst is Still Emerging,120097049,,VRTX,Fintel,,https://finnhub.io/api/news?id=9f9acc00d0f72656b8a4c4c570d154b39d86e315437d1636d912eef365e61b51
company,2023-05-02 03:25:00,Oppenheimer Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),120103422,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0ce17aee8462bae85dda433346ef1ad6d37d07432ef282f0dbf88f56187a357c
company,2023-05-02 03:11:00,Wall Street Analysts Are Bullish on Top Healthcare Picks,120103423,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=34c2aa058b980bc5ac850f29bd0c3732fff9c76a554fb794ce00bb6a3bdc83a9
company,2023-05-02 02:20:00,Vertex Pharmaceuticals price target raised to $350 from $330 at TD Cowen,120103425,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5f9f67e9372cc410ffd1eaf7a9226a743995bcad20b8b0c3806eeb56bb45135c
company,2023-05-02 02:11:00,"Analysts` Opinions Are Mixed on These Healthcare Stocks: Hologic (HOLX), Vertex Pharmaceuticals (VRTX) and Travere Therapeutics (TVTX)",120103427,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=72b33b6c846238fd586d81cd29fb62b4dc29cbb287e7d076e555ebf54f6ba3ef
company,2023-05-02 02:06:00,Vertex Pharmaceuticals price target raised to $340 from $300 at Stifel,120103428,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9946b3ed6d75981c94683b2353a705b8ee937228a4d6a4ec8b2f405e5a419a8d
company,2023-05-02 02:05:00,BMO Capital Gives a Buy Rating to Vertex Pharmaceuticals (VRTX),120103430,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a037de73d46971138ca9554d345a68efd2245b6dde3e78bcf9aaa3c6d4c35f7a
company,2023-05-02 01:41:00,Vertex Pharmaceuticals price target raised to $385 from $339 at Guggenheim,120103432,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=eaaa98067d8ce42c91d47db5bb7f7d78862f5aba0a62707b7bbf867c459c252c
company,2023-05-02 01:34:00,Vertex Pharmaceuticals price target raised to $325 from $280 at Baird,120103433,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=164ba9256b4ba9e6ea9e4ed67bc52c994c8f36b442567ded32d94536cc168457
company,2023-05-02 01:32:00,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Urogen Pharma (URGN),120103435,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3e2515f0ea6439f390ac48b84d4c5792943b9f9f848a81b5603abd55a966ce66
company,2023-05-02 01:30:00,Vertex Pharmaceuticals price target raised to $410 from $350 at Oppenheimer,120102227,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e20658d7fdc6a0bc5cfc505e767fab777975480e83c95dff9ba67256c671d3a6
company,2023-05-02 01:17:00,Vertex Pharmaceuticals price target raised to $380 from $326 at H.C. Wainwright,120103439,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2c4845a82c27b7ac9f14f36ae1ee4b947594cf3ba5a45bf6962eea4110362bfa
company,2023-05-02 00:35:00,Vertex Pharmaceuticals price target raised to $384 from $342 at Barclays,120103440,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=066e79faf8082c469421a45963628efd5c1058512156f15ac6ed48aa46368a2d
company,2023-05-01 21:30:19,Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript,120095110,,VRTX,Yahoo,"My name is Susie Lisa, and as the senior vice president of investor relations, it is my pleasure to welcome you to our first-quarter 2023 financial results conference call.  On tonight's call making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief financial officer.",https://finnhub.io/api/news?id=6efb59e5dddb34926b7ecc8e02305cd151f29859e708d9e0b3c3342d49df110d
company,2023-05-01 20:33:00,GLOBAL BRIEFING: HSBC Q1 pretax profit surges to nearly USD13 billion,120103162,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b200b50f2635a9670fb7fb5a798a06e4dadc9173590a942cc16ad4ade561d6b7
company,2023-05-01 17:37:06,Vertex Pharmaceuticals Incorporated (VRTX) Q1 2023 Earnings Call Transcript,120093676,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ETCompany ParticipantsSusie Lisa - CFA, Senior Vice President, Investor...",https://finnhub.io/api/news?id=1306b926a29713b0fb21faaa0e6daf39194d668df05c426020aa7235e0f2c03c
company,2023-05-01 17:25:09,Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Surpass Estimates,120095111,https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a,VRTX,Yahoo,"Vertex (VRTX) delivered earnings and revenue surprises of 3.39% and 3.02%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=bc09bc7a6ae1afe5480734b3df8d9831e5f92c2b61dd24f6d0300c3b2644eaa2
company,2023-05-01 16:45:24,"Vertex Pharmaceuticals Keeps Its Outlook Despite Beating Views, And Dives",120095112,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,"Vertex retained its full-year outlook Monday despite beating quarterly expectations, and VRTX stock toppled in late trades.",https://finnhub.io/api/news?id=790eeb3e1f7109e5a8cf34a1f935c89ca5537159f450b8b1c3c3f0a3c4268bbb
company,2023-05-01 16:01:00,Vertex Reports First Quarter 2023 Financial Results,120095113,https://media.zenfs.com/en/business-wire.com/d01b71b5546b891e10d0cce44ae05202,VRTX,Yahoo,"BOSTON, May 01, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2023 and reiterated full year 2023 financial guidance.",https://finnhub.io/api/news?id=c286d7de676dfa93a7930144cb06f11fc5147d951ec1be0e476f811187706b8c
company,2023-05-01 13:30:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",120091336,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.25% to $345.00 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...",https://finnhub.io/api/news?id=3312daaeb47ed7c154a12e50dbde9025c8443b8cfe4854e1028dfb1b2f333b81
company,2023-05-01 13:26:18,"Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more",120089310,https://image.cnbcfm.com/api/v1/image/105687856-1547843626883gettyimages-1022511206.jpeg?v=1682976378&w=1920&h=1080,VRTX,CNBC,These are the stocks posting the largest moves in extended trading. ,https://finnhub.io/api/news?id=a5e1e401b52162307cf42e01a3b4863b16cf7cef509644bc068153230f2678bb
company,2023-05-01 12:44:00,IN BRIEF: Vertex quarterly income falls; affirms full-year outlook,120103442,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1469bcc20517423c2d537a9dd0e11c3c9cac093ebde4f1e12f385f0c84d7f832
company,2023-05-01 12:38:51,Vertex Pharmaceuticals Incorporated 2023 Q1 - Results - Earnings Call Presentation,120087217,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2023 Q1 earnings call.,https://finnhub.io/api/news?id=a0e89b681dbfcdbfbce501cde7367f4837426c051a29158dcce516f1ffdf7d4c
company,2023-05-01 12:19:00,Vertex Pharmaceuticals 1Q Net Down On Higher Costs,120091337,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Paul Ziobro Vertex Pharmaceuticals on Monday said first-quarter profit fell as higher expenses tied to drug development and international launches offset...,https://finnhub.io/api/news?id=8bc5b930c04df8d1ddb5e48dfac68d7346f5040e425c87a4583dff694b88ce8d
company,2023-05-01 12:11:00,Vertex: Q1 Earnings Snapshot,120103444,,VRTX,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6c7264906bb166a0595b2ae186f1b56f2e2978fb1a914a52b4b576299d14d884
company,2023-05-01 11:00:03,"ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging",120084580,https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0,VRTX,Yahoo,"ImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug Elahere. The company raises financial guidance for 2023. Post the news, shares moved up 25%.",https://finnhub.io/api/news?id=fd733e2349faa169eba8785356930f1b4596c8e66017676b032be723bd1cd41a
company,2023-05-01 07:15:00,Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector,120080678,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0825110339ed2946101c117c8a6df3532441ee736c1d419bf58fd04b429fffc9
company,2023-05-01 05:50:00,"The Best Stocks to Invest $5,000 in Right Now",120077893,https://s.yimg.com/ny/api/res/1.2/r19leAaYC620Ghg9XhlSHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NzM-/https://media.zenfs.com/en/motleyfool.com/aba4c9cf9ded278755ead6bfe26d4eba,VRTX,Yahoo,"At least, that's what the Federal Reserve and many economists think.  If an economic downturn is indeed on the way, investing in recession-proof stocks and industries is a smart strategy.  The company's name gives away its business.",https://finnhub.io/api/news?id=d77b9e388faf47765b29a4aba9c6341578bcab4fb3ce8a336371702e912119d7
company,2023-05-01 01:53:00,Fly Intel: After-Hours Movers,120090497,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f95c96c76132f3ef21b537f0ae4551f2e5ecccefa5d0f0be0e5316dbe5ff1aac
company,2023-05-01 00:27:00,Vertex Q1 beats thanks to strong Trikafta year-over-year sales increase,120103454,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=144be725aa5f68ba38fffd5f27f514e6f3f212ac9ecc837dd80e455a45dc0749
company,2023-04-30 23:05:00,"Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M",120103457,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1dfe5d425916f7fcec0a9fa1a2d478cba2b17e5e9e3e9e9a066b80f45c7e94e8
company,2023-04-30 23:04:00,"Vertex Pharmaceuticals backs FY23 revenue view of $9.55B-$9.7B, consensus $9.71B",120103461,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8b0480c176472e16c0bda9a0a67ebbc8461fb64fc42559cf087b96d644058ff4
company,2023-04-30 23:04:00,"Vertex Pharmaceuticals reports Q1 EPS $2.69, consensus $3.00",120103459,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f8078da7f021d9aea06753af730b2d50e7362a28adadd0794063e0364fd18449
company,2023-04-30 22:43:00,Vertex options imply 3.8% move in share price post-earnings,120103462,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0788124b41bf898a2a50add802d597fe04c728526ea323c6817e6bc4d5d4093f
company,2023-04-30 20:25:00,GLOBAL BRIEFING: Japan's manufacturing sector contracts at slower pace,120080421,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a5792c01127b3957d296bb47d58cdafadfadb91b27056e47c943fcd18c402942
company,2023-04-30 08:43:00,"2 Stocks That Could Turn $200,000 Into $1 Million by the Time You Retire",120070114,,VRTX,Yahoo,"The stock market has proven its ability to build wealth time and time again.  If you have the capital to invest in the stock market, and a long-term buy-and-hold horizon, there is no shortage of incredible companies begging to be bought right now.  Upstart (NASDAQ: UPST) built a business around an idea designed to revolutionize the lending space.",https://finnhub.io/api/news?id=c94da6ab9721576dac19266101e5bd506dcf7161c64a6c3aaec263cfa8001731
company,2023-04-30 00:35:00,Notable earnings after Monday`s close,120074085,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5c85c6ad55451f6a95722d9db2f1e75ab6b065a76be4c08dd68cede8e5848b99
company,2023-04-29 06:14:00,3 Unstoppable Stocks to Buy Right Now,120050285,,VRTX,Yahoo,"Three Motley Fool contributors have thoughts on which unstoppable stocks are great picks to buy right now.  Here's why they chose AbbVie (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX).  David Jagielski (AbbVie): This year will undoubtedly be a tough one for AbbVie.",https://finnhub.io/api/news?id=d377e0b75d65ac791df04048dd5f294f508ab5ff2dc13b3e6a158e7cde28cc46
company,2023-05-06 13:00:00,This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock,120200603,https://s.yimg.com/ny/api/res/1.2/tfIlAztbkl4.VJ3f.n6AtQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/bc9ec6b1cf1371f7831d04f84b422c25,VRTX,Yahoo,"Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.",https://finnhub.io/api/news?id=983976e36fda160f89ae5efb05ea16f913da96bdb023d3c87e951a058dc6e19f
company,2023-05-05 13:31:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",120253610,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.43% higher to $348.09 Friday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=1060ce7ea919aae231f4dcbcd3fc283771885911ae246e4b0eeaca66a1dbc7f0
company,2023-05-05 12:47:07,Stocks To Watch: Nvidia Partner Drives Liquid-Cooled AI Platform,120180951,,VRTX,Yahoo,"Just one of 21 top-rated stocks to watch on this screen, SMCI stock continues to climb alongside AI partner Nvidia.",https://finnhub.io/api/news?id=25e9eff9ed4885854147605e5551602f727ada11da3568a65c345f8576cc4699
company,2023-05-05 06:26:00,SVB Securities Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),120209241,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=042e82b31aad634a4e83d27e7ce308142c2251928bbf2baa71c0f385ad8892cb
company,2023-05-04 14:52:06,"Top Stock Reports for McDonald's, Deere & Marsh & McLennan",120156653,https://media.zenfs.com/en/zacks.com/ff25a2c39e5be44b9fc8e1855c98cb3d,VRTX,Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Deere & Company (DE) and Marsh & McLennan Companies, Inc. (MMC).",https://finnhub.io/api/news?id=7845737c4dd60a26a0646f3fa55a9166dee8826c9f5d9888a12198063fde2f4a
company,2023-05-04 13:31:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",120253612,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.07% higher to $346.59 Thursday, on what proved to be an all-around rough trading session for the stock market,...",https://finnhub.io/api/news?id=1e02ba0e8b6bbbee61f636b4fc26b0f45e1c4b730455b82d48c7c1f341505cf6
company,2023-05-04 12:20:00,Baron Health Care Fund Q1 2023 Shareholder Letter,120154282,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413600685/image_1413600685.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.",https://finnhub.io/api/news?id=b5222c6026790f30b504854323119e66a4358f9f23cd2d18929af3fafe218129
company,2023-05-04 11:08:00,Vertex Pharmaceuticals Continues Its Impressive Rally: How to Play It,120157212,https://s.yimg.com/ny/api/res/1.2/e539PWSDwttGawMEsVNXaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/thestreet.com/ff9430e4e3dfe339c88d4224d9da79d7,VRTX,Yahoo,"On Monday Vertex Pharmaceuticals  reported an earnings and revenue beat and share prices advanced.  In the daily bar chart of VRTX, below, I can see that the shares have staged an impressive rally from early March.",https://finnhub.io/api/news?id=41674e0f07f5fc097a42ccb1d108344ae8c0279352759300db128ebb510a9b04
company,2023-05-04 10:16:21,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2023 Earnings Call Transcript,120157213,https://media.zenfs.com/en/insidermonkey.com/7da3252a7f37d762e8224576eba25083,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2023 Earnings Call Transcript May 1, 2023 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $3.05, expectations were $3. Operator: Good day, and welcome to the Vertex Pharmaceuticals First Quarter 2023 Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity […]",https://finnhub.io/api/news?id=3194b2a1443770bf0cfa4096f1c85d50e2ce7219784d2e76071c8b654d5f001f
company,2023-05-04 06:07:20,Maxim Group Maintains Vertex Pharmaceuticals (VRTX) Buy Recommendation,120145201,,VRTX,Fintel,,https://finnhub.io/api/news?id=1491afa74dbdf4b3341267a30e93bfe96e71cc435d555c631af3d2d477d3dee0
company,2023-05-04 05:32:00,2 Potentially Explosive Stocks to Buy in May,120155617,https://s.yimg.com/ny/api/res/1.2/z1P_USSvIN.6J1xttHtP0A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/e2d71dc09708f6909126badd2c0659df,VRTX,Yahoo,"Stag Industrial (NYSE: STAG) and Vertex Pharmaceuticals (NASDAQ: VRTX) are off to a good start this year, and some industry tailwinds look to really boost shares in the coming years.  Vertex, already a leader in cystic fibrosis treatment, is on the tip of a gene-editing revolution.  Stag is a real estate investment trust (REIT) that specializes in renting out single-tenant industrial properties with triple-net leases.",https://finnhub.io/api/news?id=d754d48b0aa9071900578348cc42b4314b28d9ce5571c107ed97e39a0dd14001
company,2023-05-04 05:03:00,"Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations",120147821,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6e24ef31dc3701fa743818555a33bead743c420ce9356502e1fe0b265f7cbd64
company,2023-05-03 23:49:00,Vertex Pharmaceuticals assumed with an Overweight at Piper Sandler,120161634,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=69b9cc3da23e54774bed897b817ecdd38f99ec1ec6d95e6c2d1d0d93d0184e42
company,2023-05-03 23:31:00,Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX) and IVERIC bio (ISEE),120159014,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0703c70a12dae666a3862cb671ce6cf58671017981cbf861b1812bafdb8e674e
company,2023-05-03 23:08:32,My Methods To Finding The Best Stock Portfolio,120142585,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172665895/image_172665895.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,This is my journey on the road to finding the best portfolio and my early attempts to find the best stocks in which to invest. Click here to see my recommendations.,https://finnhub.io/api/news?id=9722f5df2c61b4393a9975f042e0af417bec247253a4cc2c10301fb91517b2f6
company,2023-05-03 22:39:00,Vertex assumed Overweight at Piper Sandler despite recent rally,120161638,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=81539588a4fee507c482358a5ab446dd3dabe2b6e698a62df9683b55c9dd521c
company,2023-05-03 21:15:00,Interesting VRTX Put And Call Options For June 23rd,120161640,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d0b003a21deecbef15481b49f0fa0aa98ad2dd5fee0017c22935c2fbd8497ad9
company,2023-05-03 17:07:00,Vertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor) to Treat Eligible Infants With CF Ages 1 Month and Older,120133629,https://media.zenfs.com/en/business-wire.com/6480c3ab4e260a8bc02db5719db91026,VRTX,Yahoo,"BOSTON, May 03, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved KALYDECO® (ivacaftor) for use in children with cystic fibrosis (CF) ages 1 month to less than four months old who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to KALYDECO® based on clinical and/or in vitro assay data. KALYDECO® is already approved in the U.S. and EU for the treatment",https://finnhub.io/api/news?id=18c3a2a7f5696455a4f06f6a7b207942dd503872694fd9d51c2fc6447ea6449d
company,2023-05-03 13:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,120253613,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.10% higher to $346.36 Wednesday, on what proved to be an all-around grim trading session for the stock market,...",https://finnhub.io/api/news?id=54776d133020b403a53f90f1649db2d1da2dd2d06e9b95b0c6f7a33f1ab9e712
company,2023-05-03 10:15:00,Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock,120126006,https://s.yimg.com/ny/api/res/1.2/JwkuTEvIew5IvV9gnDB_ng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/16dcba0a139bfe3546ffd1acb250449f,VRTX,Yahoo,"Had you bought Vertex Pharmaceuticals (NASDAQ: VRTX) shares 10 years ago, you'd be sitting pretty right now.  The drugmaker soundly outperformed the market over that period thanks to its success in developing medicines that target cystic fibrosis.  The first of Vertex's products to treat that rare genetic disease was approved in 2012.",https://finnhub.io/api/news?id=65918b603cf31185536ffb90368de74fe0633b2ab95a8503b0c7f832d1efa16f
company,2023-05-03 10:00:23,Estimating The Fair Value Of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX),120133633,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Key Insights The projected fair value for Vertex Pharmaceuticals is US$422 based on 2 Stage Free Cash Flow to Equity...,https://finnhub.io/api/news?id=79ef1a3a869b71e5c043c7fdcc6072f225a3891edc738f2216968a4524975387
company,2023-05-03 09:37:05,Bernstein Maintains Vertex Pharmaceuticals (VRTX) Outperform Recommendation,120120387,,VRTX,Fintel,,https://finnhub.io/api/news?id=b0dae7a9a2ebb9f1b8b0d788f2dfa36680d433bd1ff7bee0e9f7c1b06a4f1b69
company,2023-05-03 05:50:00,7 Reasons to Buy Vertex Pharmaceuticals Stock Now,120133635,https://s.yimg.com/ny/api/res/1.2/o.daQ0d3Q1Xk3QojkIH1Eg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/93d52538a99b2e99e8bf8f51365b76e8,VRTX,Yahoo,Vertex's shares subsequently added even more to the nice gains already achieved so far this year.  Vertex is the only company in the world with approved therapies that treat the underlying cause of cystic fibrosis (CF).  Its nearest competition is only in phase 2 testing.,https://finnhub.io/api/news?id=5ecd9bdb7da47c337e22ced94902abf90f46fac3316ce8576c6ec36000473f6c
company,2023-05-03 03:22:00,Vertex Pharmaceuticals price target raised to $400 from $325 at Maxim,120124328,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=21a7d51b88666eb3e0f3e4652ab9c551d9c9574efc25065983de06ee0069c2c1
company,2023-05-03 01:33:00,Vertex Pharmaceuticals price target raised to $363 from $344 at Bernstein,120124329,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=798185291c7b1e2ce145d6951ef8309492291a161622e1fd5a16a3cc33b8b9e6
company,2023-05-03 00:08:00,Vertex announces FDA approval for KALYDECO to treat eligible infants with CF,120161643,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ca4982f0db6bb27cab05116af8c383fdfd5487ba59b81733f1370c13878fa8c7
company,2023-05-10 13:31:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,120282802,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.51% to $350.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...",https://finnhub.io/api/news?id=ac5dc26e3abf0c3ab9010a7f31bf3948e924e379b66ae28cfe74dc6b68e61af0
company,2023-05-10 09:53:00,2 Cathie Wood Stocks That Can Get You Through Any Recession,120277439,,VRTX,Yahoo,"Economists at the U.S. Federal Reserve recently uttered the dreaded ""R"" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a while now, so it shouldn't come as too much of a surprise.",https://finnhub.io/api/news?id=dffd26d8dce798e27eef292e242a08626ca215033860d65f267c652e9f1db74b
company,2023-05-09 14:25:44,Why CRISPR Therapeutics Stock Is on Fire Today,120245791,https://s.yimg.com/ny/api/res/1.2/JIFNBIclPnR7CPbIF1ib1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://media.zenfs.com/en/motleyfool.com/7d49c07aa2c042b065bbce0b6aadb762,VRTX,Yahoo,"Thanks to the gene-editing pioneer having a pipeline chock-full of deep value and a possible regulatory approval on tap, investors are bidding up shares today.",https://finnhub.io/api/news?id=18faf38093026f19cf1dfab8eb30125cbc8901d6ca36d8c7383aee3274913449
company,2023-05-09 08:31:12,CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat,120245793,https://media.zenfs.com/en/zacks.com/08f8b914894d5935d128eed004aa482b,VRTX,Yahoo,CRISPR Therapeutics (CRSP) provides updates for its gene therapy candidates.,https://finnhub.io/api/news?id=daa74b716e8216b4e45911297beec13d4f4ceae6aa026238a98c846616b44efb
company,2023-05-09 04:00:00,"Vortex Engages RESPEC to Advance its Robinsons River Salt Project in Newfoundland & Labrador, CANADA",120249838,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0c5f22c216de3398f76a9010e6fdf32f4eb2293c88381ee119ac2e830cc5d71
company,2023-05-08 21:04:00,CRISPR adds 13% to reach seven-month high after Q1 update,120249839,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=425a51a7294f88ebb7933afcd50ad650bd99f0703bc03150ac9b345af8b1201e
company,2023-05-08 13:32:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors,120253608,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.15% to $344.09 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=50b292c36172e01c1560d258f627e08c5af8da1c875bf9e3a1c86890fbdb77c8
company,2023-05-08 10:27:28,Krystal Biotech: 2 Potential Regulatory Approvals To Carry It Forward,120223682,https://media.gettyimages.com/id/1485071205/photo/medical-technicians-working-on-bacterial-culture-and-drug-resistance-of-pathogens-in-the.jpg?b=1&s=170667a&w=0&k=20&c=GwP91LghVPw6umgvKctr0ZYbMSV3rVuOI3CvbEr3d6o=,VRTX,SeekingAlpha,"Krystal Biotech, Inc. has a PDUFA date of May 19, 2023, set for the FDA to review B-VEC for potential U.S. marketing approval. Click for my full KRYS review.",https://finnhub.io/api/news?id=dc0375b296e1db60df523dff5bd4afb147a164c8b15fbb97ee55bc9b9dabb327
company,2023-05-07 07:00:20,Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?,120200601,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ:VRTX) has had a great run on the share market with its stock up by a significant 14...,https://finnhub.io/api/news?id=1059f0394f14f285010d50c5863d82f63fe3d24fd76e2dfad577fde7eda9d147
company,2023-05-07 01:30:18,InvestingPro exclusive: 5 biotech beasts to get your hands on,120200602,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,VRTX,Yahoo,"Here is your VIP list of Pro Picks for the week, offered exclusively to InvestingPro subscribers: a hand-picked selection of S&P 500 stocks that InvestingPro awarded a high financial health score of at least 2.75 out of 5.00.",https://finnhub.io/api/news?id=9ed853bc0c6bb8e70c716a25162c328e95befdfcc7a98b39db25e1ce9146f51d
company,2023-05-13 15:05:24,Vertex Pharmaceuticals Incorporated (VRTX) Presents at BofA Securities 2023 Health Care Conference (Transcript),120339212,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) BofA Securities 2023 Health Care Conference May 9, 2023 12:20 PM ETCompany ParticipantsCharlie Wagner - EVP and CFODavid Altshuler -...",https://finnhub.io/api/news?id=c9b9289e2fbc2b69ab7fdc556e3795d5fb388f0f70d9525f4033934813082ff9
company,2023-05-13 08:45:00,Is CRISPR Therapeutics Stock a Buy Now?,120339738,https://s.yimg.com/ny/api/res/1.2/wZfasHzeGh.MbKezPTK5kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4f9ace9aaf0c2b1fcd4f7daea357ab90,VRTX,Yahoo,"A year ago, CRISPR Therapeutics' (NASDAQ: CRSP) stock was trading for $46 per share.  As of Tuesday afternoon, the biotech stock was at $64.  While other investors have begun to catch on to the upside of the company, it's still a clinical-stage biopharmaceutical company -- that is, one with no marketed therapies yet.",https://finnhub.io/api/news?id=9e67374a5f60c4b7513855d72bb086fc8bc75c1cf4801b7a8f1d047d37826032
company,2023-05-13 08:00:00,3 Growth Stocks to Buy and Hold,120340273,https://s.yimg.com/ny/api/res/1.2/cytFISPmnOiC32LUDPbSSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e9f9df0b7c66cb7380b915a2a9a3b1c4,VRTX,Yahoo,"The stock market's short-term volatility can sometimes cloud investors' judgment and cause panic selling.  In that spirit, we asked three Motley Fool contributors to discuss buy-and-hold-worthy growth stocks.  Read on to find out why they picked Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).",https://finnhub.io/api/news?id=8af2383b113a347e998dd456668776f719495eb7f6797cfcb71d1ef0e9d625fd
company,2023-05-12 14:04:15,Entrada Therapeutics Stock Deserves Higher Resonance After Q1 2023 Report,120322456,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1290320288/image_1290320288.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Entrada is a biotechnology developer of endosomal escape vehicle therapeutics for the treatment of multiple neuromuscular diseases. Read why TRDA stock is a buy.,https://finnhub.io/api/news?id=cbf7ef5dba7a7b971fa0aca0532e864ba991ed47ded41b5a6a455c19484fa036
company,2023-05-12 13:31:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",120333310,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.85% to $347.41 Friday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=cb90d88e64399295db1c2214247adf5ab296913276fb293c99bda3ed1f73f2af
company,2023-05-11 15:13:59,Why These 3 Nasdaq Stocks Were Glowing Green This Week,120304875,https://s.yimg.com/ny/api/res/1.2/BizYXpO99iGhDW6rIr3_Kw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04OTk-/https://media.zenfs.com/en/motleyfool.com/73fdb1e5a2c3e4b3e8bdd76896adae4f,VRTX,Yahoo,"Despite another less-than-stellar Consumer Price Index report and more volatility among regional bank stocks, growth equities, on balance, were on the upswing this week.  The tech-heavy Nasdaq Composite, for instance, edged higher by nearly 3% during the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence.  Among the best performers within the growth stock landscape this week were biopharmaceuticals.",https://finnhub.io/api/news?id=2a9071b1f7d2f99dc9e7464dc8d8612060e66211266551fb67221e3677f70e35
company,2023-05-11 14:00:00,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,120309197,https://s.yimg.com/ny/api/res/1.2/nRGpGaoHyazWYcOZs5F2ow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/fbc9ad808cd384dcaa9444ceaf4f9eb1,VRTX,Yahoo,It's always a great idea to buy stocks and hold them for the long term. That means at least five years. This offers you the opportunity to benefit from any dividend payments and/or growth in earnings.,https://finnhub.io/api/news?id=ac10940817677c75c5131b002e05a46d3ffe5f1891be584db92171b3a6514199
company,2023-05-11 13:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,120333311,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.10% higher to $350.40 Thursday, on what proved to be an all-around grim trading session for the stock market,...",https://finnhub.io/api/news?id=f454d3908c206e43052d2dd2324a5b0e2ecc3ca8af9ee36309a68802d8786e6f
company,2023-05-11 10:00:40,Here's Why We Think Vertex Pharmaceuticals (NASDAQ:VRTX) Might Deserve Your Attention Today,120309198,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...",https://finnhub.io/api/news?id=3b489cfda15d5fef29d7f0e4fb469eed92147de88b4173ce4bd2bc95be2ba0e6
company,2023-05-11 09:05:00,This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?,120309199,https://s.yimg.com/ny/api/res/1.2/aSIiIG4WVuzSsvKcO74hhA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/bbb1f032ee52f98d55ec2cb297e0e20f,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment.  The company's drugs have been life-changing for children and adults living with the disease.  It's also helped the company build up more than $11 billion in cash to support development of new CF drugs and candidates in other areas.,https://finnhub.io/api/news?id=2acb77755f9d2303c44ce0f6b31d92f6cd2d73ac1de4b8b6482016f848c5f1e1
company,2023-05-11 06:24:00,See Which Of The Latest 13F Filers Holds Vertex Pharmaceuticals,120303086,,VRTX,Preferred Stock Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c96ddf1f83d582ee531b9bb9fcdcb215c7270f0b4414fd7fd53751c95438b725
company,2023-05-18 13:30:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,120513760,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.51% to $339.46 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...",https://finnhub.io/api/news?id=bc083ae443fcd857cebdff10d396f5c004e21f21df037ddb985318f684470ed3
company,2023-05-18 11:45:39,Crispr Therapeutics: Potential Beyond Current BLA Filing Of Exa-Cel,120425467,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1490245442/image_1490245442.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Patients are currently being enrolled by CRISPR Therapeutics AG in a potentially pivotal single-arm phase 2 study. Click here for more on CRSP stock prospects.,https://finnhub.io/api/news?id=4057f8281b64d57958a9d0dce72d88dc2ae279a01bf531a561134afe1146ab45
company,2023-05-18 03:21:32,Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Outperformed in Q1,120414836,https://media.zenfs.com/en/insidermonkey.com/a7afd85ac72398ddfb23a21efa2d2f7d,VRTX,Yahoo,"Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate in the broader market rally and declined 3.69% compared to the 3.27% decline for the benchmark Russell […]",https://finnhub.io/api/news?id=927dbb6d37b1c1410c5f7dc510c621abe6a743c3c66266178aad9c0faa9bf43e
company,2023-05-17 22:42:00,Top 5 1st Quarter Trades of INTERNATIONAL BIOTECHNOLOGY TRUST PLC,120426722,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=980c043f72d1d7e0b7f4589ab0ff9cacb51900c6a0bc08143a2cc745a52fd6ab
company,2023-05-17 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",120402325,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.14% to $341.20 Wednesday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=8d49b973b188311dd2edae88ef979427bb179a223ecab1b4215ab7465a1e6ed4
company,2023-05-17 08:05:07,The Ones That Didn't Get Away — 10 Stocks Serve Up Buy Zones,120391684,https://media.zenfs.com/en/ibd.com/91f7d9556f82f7b190af6958f0e08445,VRTX,Yahoo,"While SMCI, Monster and others have already taken off, Wendy's and Core & Main lead among stocks to watch that are setting up.",https://finnhub.io/api/news?id=5ea94005c2f2a3136c80fde4a56b93bbaadd9bf13ba3ca38c6ee3d6090641429
company,2023-05-17 08:41:00,2 Stocks You'll Be Glad You Bought at These Prices,120404815,https://s.yimg.com/ny/api/res/1.2/b3mWT0tUHyE5CcGYA7OkdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/motleyfool.com/b83c18110ffd2c586dc60b4e5f68642f,VRTX,Yahoo,"Last year, the stock market went into a downward spiral, and growth stocks as a group were dragged down more than most.  This year, the stock market appears to be recovering.  Before their likely rebounds make them too expensive, here are two growth stocks to consider investing in now.",https://finnhub.io/api/news?id=8d9f08015da5954a9dc39879beba7ce957917dc6680c7569c7f8282cfd526938
company,2023-05-17 05:59:43,Vertex Pharmaceuticals Rally Likely Not Over,120392675,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/625758234/image_625758234.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals' blockbuster TRIKAFTA is early in its product cycle. Q1 growth was very strong. Find out why VRTX stock is a Buy.,https://finnhub.io/api/news?id=6250674683f77610702670a70220d31d0e5950a998d615d926cc597e5028b978
company,2023-05-16 18:43:49,Vertex Pharmaceuticals Offers Value Despite Recent Gains,120389687,https://media.zenfs.com/en/us.finance.gurufocus/de028088c2fb810b95745f672ea59104,VRTX,Yahoo,The biotech company benefits from a dominant position in the market for cystic fibrosis treatments,https://finnhub.io/api/news?id=b6dc81805044dec61eaaa401ad47f554b0052c4818fdd74733a6e2b3916d52ae
company,2023-05-16 13:31:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",120402326,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.00% to $345.15 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=e775d6cbca765dfe387223beb85a6d98d336f2fa914368188335afb50ff45069
company,2023-05-16 07:00:38,Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders have earned a 17% CAGR over the last five years,120389689,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...",https://finnhub.io/api/news?id=a41e5a9b14704504fe101f1bda28b83de3125a153bbc1a10e76ea53655af40f7
company,2023-05-15 13:31:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,120402327,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.36% higher to $348.65 Monday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=ca7ad1bc9750c557ccba3af8d226f764dadc888f65c4aea80db562cc8fea458d
company,2023-05-22 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market",120513758,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.51% to $339.97 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=a7f2da7c492967fdca3c0c0e4d9293ca485fa8be25ba245a72542cf4df60f287
company,2023-05-22 07:15:00,2 Hot Stocks to Buy and Hold Until You Retire,120480342,,VRTX,Yahoo,"Long-term investors recognize the benefits of a buy-and-hold strategy.  The key to earning good returns is to buy good growth stocks and hold them while ignoring short-term headwinds.  While 2022 was hard on most stocks, this year seems to be going pretty well for these two growth stocks.",https://finnhub.io/api/news?id=903d54ff700f1c2953fa5fea7a42a3f60daa09b9731ee3e4d20624800b7a0b60
company,2023-05-20 05:13:00,2 Stocks Near 52-Week Highs That Still Look Like Bargains,120461727,https://s.yimg.com/ny/api/res/1.2/nQubshC0G2vbKj4U0Khb5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c0f66a4233ab98ce6c54ea36b74d1bca,VRTX,Yahoo,"Shares of Facebook's and Instagram's parent company, Meta Platforms (NASDAQ: META), tanked last year in response to top-line revenue that contracted for the first time since the company went public in 2012.  In the fourth quarter of 2022, the company's operating margin shrank to 20%, which did not compare well to the 40% operating margin the company reported in 2021.  To right the ship, Meta CEO Mark Zuckerberg announced sweeping layoffs earlier this year and declared 2023 would be a much-needed year of efficiency.",https://finnhub.io/api/news?id=7d44252e5cf11ee1c8874855565aaeda360add567906103550c78ecaf87afd1e
company,2023-05-19 13:30:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,120513759,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.66% higher to $341.70 Friday, on what proved to be an all-around dismal trading session for the stock market,...",https://finnhub.io/api/news?id=d26879abaff4358ad2f002d44fc48acf409f3022760b8ec9c1cad2dff9b05911
company,2023-05-19 10:23:00,2 Healthcare Stocks You Can Buy and Hold for the Next Decade,120446653,,VRTX,Yahoo,"Investors who focus on long-term opportunities in the stock market look for well-established companies that are already profitable and have a track record of revenue growth.  Two wildly different healthcare companies that both fit that description are Vertex Pharmaceuticals (NASDAQ: VRTX) and Medtronic (NYSE: MDT).  Vertex, a biopharmaceutical company founded in 1989, has improved annual revenue by 636% over the past decade.",https://finnhub.io/api/news?id=5d28567b0c1b413fc3f489502c6c74be369b837136c6e6bb59f8df32407c1f73
company,2023-05-19 10:00:52,3 Biotech Stocks That Are Revolutionizing Healthcare in 2023,120502225,https://media.zenfs.com/en/investorplace_417/7a6d7cf8fd09137bc1a8f5746ab0adba,VRTX,Yahoo,"The biotechnology (or biotech) sector is a crystal-clear illustration of risk and reward. Many biotech companies work on drugs and therapeutics for some of the most pernicious conditions affecting our society and healthcare system. But finding the best biotech stocks to buy is not always simple. Many biotech companies work on drugs for years. And these biotech stocks will swing wildly on the news. Positive results from a clinical trial can send stocks soaring. Conversely, disappointing results c",https://finnhub.io/api/news?id=c79c83c9c91260ccfd5e7e8509e0f273cea270b16d5d59fc9b404bbbd619b0aa
company,2023-05-19 01:00:00,Vortex Energy Congratulates World Energy GH2 for Receiving International Investment,120446390,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6609ce547b3700b4276ef15af9b1970296df952147e47c09d7fd2bb9b8c9d2ea
company,2023-05-26 09:37:00,2 Biotech Stocks That Could Help Set You Up for Life,120567455,,VRTX,Yahoo,"A few successful drugs are all that are required for a biotech company to shine.  Vertex Pharmaceuticals (NASDAQ: VRTX) is well-known for its star product, Trikafta, a cystic fibrosis (CF) medicine.  In the most recent first quarter, Trikafta contributed nearly $2.1 billion of the $2.3 billion in total product revenue.",https://finnhub.io/api/news?id=7f8e73a6e1890132f3392b977266927d125643470125625ce1b74764e164c24b
company,2023-05-26 08:40:00,10 Health Care Stocks Whale Activity In Today's Session,120570829,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d3029cec4039e56d2e83ccb14764ccd9a0882bd26c7ecc6f2310c54e4d64df6a
company,2023-05-26 00:32:00,"Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market",120577926,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=00b8a0f306b2e691ecb36662b82004c5eda3655776ab4eb124653351d5f45b83
company,2023-05-25 09:40:00,"2 Top Trends to Invest $5,000 in Right Now",120547075,https://s.yimg.com/ny/api/res/1.2/0GOQ6Gvhde_BLceVJIj3Mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTk-/https://media.zenfs.com/en/motleyfool.com/cedce43e5460c4da283275f3f9fd4572,VRTX,Yahoo,"Gene-editing healthcare therapies and renewable energy are two of the strongest trends today and for the next few years.  Both sectors are worthy of sizable investments, particularly if you're looking to make long-term investments.  CRISPR (clustered regularly interspaced short palindromic repeats) gene editing was discovered in 2012, and has the potential to revolutionize some aspects of health care.",https://finnhub.io/api/news?id=f9ba5a84826a5fdb02f830fcdc5f2cbf18d737fed6e22f699eabe8ebffe04198
company,2023-05-25 06:24:00,July 7th Options Now Available For Vertex Pharmaceuticals (VRTX),120547230,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1a3fb8c7b4d8bce14647cedba3f7a076d73af482e58a12685e2e75a43efa7987
company,2023-05-25 05:30:00,Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health,120547076,https://s.yimg.com/ny/api/res/1.2/OfkE6idrdhDbrJtgaGl5nQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/6d0e2c9e772b28052fc6d53112dd92c1,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to innovation in healthcare.  CRISPR has developed a gene-editing approach that aims to fix faulty genes responsible for disease.  Teladoc leads in telemedicine, allowing patients to visit doctors from the comfort of an armchair at home.",https://finnhub.io/api/news?id=4cd37390a1615a0d4a842cda9264d2d16aad875773635a0ff2ff0cb9846cf287
company,2023-05-25 03:56:00,Vertex Pharmaceuticals initiated with a Hold at WestPark Capital,120577927,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fe3a78c8b78ce4ff24bf172ff8cd847ae9b7c2a185afe26cf719754a028ea000
company,2023-05-25 00:32:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",120577929,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=42239f9467fad817e6a857bdc9b1b78bc8f4293e48fc958fbeec7b0b83edd91f
company,2023-05-24 12:23:42,"Vertex: CF Focus, Potential To Alter Acute Pain Treatment Market Landscape",120530512,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1492224286/image_1492224286.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals Incorporated data readout from a phase 3 program could be released by the 1st half of 2024. Find out why VRTX stock is a Strong Buy.,https://finnhub.io/api/news?id=e543f22cea1a8f6460c85b32d84a40bede3efc6ea4e4311a3681b307884e91a7
company,2023-05-24 00:32:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",120535770,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b15ed881ccea821bf86a77006d403a4fb01a978df9895cfb70088d1e5d321673
company,2023-05-23 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",120513757,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 1.90% to $333.51 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=7dd01577e0f7493283b0bc2851a8aba41779733bc45ca5b5c9902cca0a2adcfe
company,2023-05-23 04:30:00,"Tweedy, Browne Fund Q1 2023 Commentary",120495380,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1483793346/image_1483793346.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Portfolio activity slowed somewhat during the quarter as equity prices advanced. Click here to read the full fund letter.,https://finnhub.io/api/news?id=fbc4231c69407164e6eb2e3297734ec375055134123edc38d1b644d7433dd2d1
company,2023-05-30 16:59:07,"Tech Roars Back As MSFT, ASML, AMAT, ORCL Lead Industry Charge",120621551,https://media.zenfs.com/en/ibd.com/11c7b97d67afeafa1c442c8f76a3f8f1,VRTX,Yahoo,"Find top tech stocks to watch like MSFT, ORCL, ADBE, ASML, AVGO and more with this screen highlighting top-ranked industry groups.",https://finnhub.io/api/news?id=8611d1d9164fa3e199557097796032e3e663649e80504d99906fd68f5f14b959
company,2023-05-30 13:31:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",120719635,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.42% to $325.30 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=0ce5b4748097ca0fdbdf77dc3d75b00830cd0d8c453e29307886f419b0ae66ce
company,2023-05-30 13:02:02,Cantor Fitzgerald Reiterates Vertex Pharmaceuticals (VRTX) Overweight Recommendation,120613498,,VRTX,Fintel,,https://finnhub.io/api/news?id=083075e4845477e7b3f41f72e68f3ff1753d95793e53ba095833e796e7ad806a
company,2023-05-30 13:02:02,William Blair Initiates Coverage of Vertex Pharmaceuticals (VRTX) with Outperform Recommendation,120613497,,VRTX,Fintel,,https://finnhub.io/api/news?id=0692fee6f1bfe27f0a035b14638094073786c0fadce125067b6fdae678c174de
company,2023-05-30 08:05:00,Expert Ratings for Vertex Pharmaceuticals,120620044,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b4776c8f1ede69f92686326191795aaa267ce7fae89bd1d87e8cf5259c599215
company,2023-05-30 08:01:00,Vertex to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 13,120608705,,VRTX,Yahoo,"BOSTON, May 30, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in the Goldman Sachs 44th Annual Global Healthcare Conference. Dr. Reshma Kewalramani, Chief Executive Officer and President, and Stuart A. Arbuckle, Executive Vice President and Chief Operating Officer, will participate in a fireside chat on Tuesday, June 13, 2023 at 2:40 p.m. PT.",https://finnhub.io/api/news?id=77a80258c20f71de40944cdb8a129a330d0ad5244ef162feb9620d09bece5682
company,2023-05-30 06:59:00,Cantor Fitzgerald biotech analyst to hold analyst/industry conference call,120620045,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b2425915b0df407641c01340e3e245ec1fb2db4aa877c271cbe800be9b9347fa
company,2023-05-30 05:25:00,Vertex initiated at outperform at William Blair on cystic fibrosis growth,120613149,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e335d03a917b8f829e9f9f246b390f33981f7057ca60034fcfcb686165a64b8c
company,2023-05-30 05:04:00,"Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations",120611831,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c3abf095fa3188d66676252ad05bbb01bcd6c3132436869f3a858c037b43b27e
company,2023-05-30 03:40:00,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ) and COMPASS Pathways (CMPS)",120614808,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=db4ecf156f4af93499e031286c7bf049c4822e06c91b7e5d44b0031ab163e40e
company,2023-05-30 02:11:00,"William Blair starts Vertex with Outperform, $382 fair value estimate",120620054,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=da5cba770e80ffb10ef6efd4ccf104d229a7e19060151f68c4fb5b0acd0ba76d
company,2023-05-30 00:52:00,Vertex Pharmaceuticals initiated with an Outperform at William Blair,120620056,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=086e2a77d3917c274a8b91f38a0987ed1fdd8639a46a333b5f2cd9b29deaeea9
company,2023-05-29 21:03:00,CRISPR Therapeutics an outperform at William Blair on diversified pipeline,120620058,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cfa3a16b8167f6060aa346088eab90fba587ed313f7d5d37bc5821bf3c410bfa
company,2023-05-28 05:53:00,Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More,120594642,,VRTX,Yahoo,Wall Street thinks this stock will rise 12% over the next 12 months.  Let's first address why some on Wall Street don't have greater expectations for Vertex.  One of the biggest factors is the biotech stock's previous success.,https://finnhub.io/api/news?id=0ffa6253b6f478148fc19f20faf36a18f8186c1ee934a7ca1a767c344ecfefb8
company,2023-05-28 05:50:00,Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever,120591883,https://s.yimg.com/ny/api/res/1.2/cphjDMK9n40hgDDjDNDOIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/2f90f0673116536a118510574edc9b75,VRTX,Yahoo,"The good news is that if you've got the money and the time, it's not all that hard to find great investment options.  If the company hits the high end of that range and its share price grows to reflect that internal growth, an initial investment of $10,000 would increase in value to over $163,000 in two decades.  The company's infrastructure assets include natural gas pipelines, electricity transmission lines, smart meters, rail operations, toll roads, telecom towers, data centers, and semiconductor manufacturing foundries.",https://finnhub.io/api/news?id=d5c00cfea5d9b7b375f6f7a6d750ec2bf1c899a97deaaf2fced5536599b10a8d
company,2023-05-27 06:14:00,3 No-Brainer Stocks to Buy for Under $100 Right Now,120583367,https://s.yimg.com/ny/api/res/1.2/e3RC67C8Aj4Z7JuFN.3N8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MzQ-/https://media.zenfs.com/en/motleyfool.com/6ebb77577ec9b056842855f762e8172e,VRTX,Yahoo,"Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Novocure (NASDAQ: NVCR), and Pfizer (NYSE: PFE).  David Jagielski (CRISPR Therapeutics):  Shares of CRISPR Therapeutics are trading below $70, but it may not be long before they take off.  The company has a promising gene-editing therapy in exa-cel for rare blood disorders beta-thalassemia and sickle cell disease that it has been working on with Vertex Pharmaceuticals.",https://finnhub.io/api/news?id=2adf08e0b1e3dad427ed1a39dd3f7dd15395436379cc13027f8cfa7b82606ab5
company,2023-05-27 05:50:00,"The Best Stocks to Invest $20,000 in Right Now",120583368,https://s.yimg.com/ny/api/res/1.2/2lOamPJgGf8.FjBMOiRBCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a73e579cc120f83b74328205100cae4c,VRTX,Yahoo,"Warren Buffett thinks that near-term economic and market forecasts are ""worse than useless.""  My hunch is that the U.S. economy is headed for a mild recession.  Like most investors who aren't billionaires with the surname Buffett, I don't like to see the stocks I buy go down.",https://finnhub.io/api/news?id=c45e5ef61550f931aab35237e27633ce3bc4c1dbeba976bbc777440e8c05335a
company,2023-06-03 09:30:00,"Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?",120689250,,VRTX,Yahoo,"A struggling economy and a bear market haven't been able to stop Vertex Pharmaceuticals (NASDAQ: VRTX).  Vertex's forward multiple comes in at more than four times the upper bounds of this range.  Also, the company's forward price-to earnings (P/E) multiple is higher than that of the biotech industry, which is currently about 15.",https://finnhub.io/api/news?id=776859ace6059c32285332d8ae04774cf4b5652075d88cc076a12748f5ba04fd
company,2023-06-03 07:45:00,"Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade",120688842,,VRTX,Yahoo,"Let's consider three stocks that could: Vertex Pharmaceuticals (NASDAQ: VRTX), DexCom (NASDAQ: DXCM), and Amazon (NASDAQ: AMZN).  Vertex Pharmaceuticals is doing great things.  One of the drugmakers that was closest to entering this market with competing products recently threw in the towel.",https://finnhub.io/api/news?id=c09e04e6cbece5f0c49298967a0c72fde4a7f2ae4b4cda0a982fe70c10d28110
company,2023-06-02 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,120719632,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 3.14% to $333.78 Friday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=9ba6f9efb70a8deb457a340c5870fbbd8dc768e49275882b7bc8f706b1ca333a
company,2023-06-01 13:31:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms market",120719633,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.02% higher to $323.62 Thursday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=5edfd74385bdb13085a8eaf9b69a4575265868f4fbb1163c5538ddc9f8b66dc5
company,2023-06-01 08:46:00,"Barclays ups bluebird rating to overweight, citing sickle cell opportunity",120650872,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=069ba322daffc817fda6731634a117f7a01858775f80c61159e2f66809d49400
company,2023-06-01 04:00:00,Vortex Energy Completes Seismic Interpretation,120647160,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=44659963d729c3c4b469cd5e1e8448cded32974f920267e73a84247d50f23cfa
company,2023-05-31 13:30:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, still outperforms market",120719634,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. dropped 0.53% to $323.57 Wednesday, on what proved to be an all-around rough trading session for the stock market, with...",https://finnhub.io/api/news?id=a746773eb9812ba2eeb59f92532c82625215f38ebe2d2e2bc15efbf6a98a5b3f
company,2023-05-31 10:05:00,"Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer",120641396,https://s.yimg.com/ny/api/res/1.2/4KShvAKBupPpBG4cdsSZsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/64ebc546b2ba395c582cfbdca77c69a4,VRTX,Yahoo,These businesses have considerable growth runways ahead.,https://finnhub.io/api/news?id=f804dfaaecfdef88cbb76a772a24e8421bdd565ebac9a49fbe85d1b88daaba6a
company,2023-05-31 07:45:00,CRISPR Therapeutics: A Galaxy's Worth of Deep Value,120627581,https://s.yimg.com/ny/api/res/1.2/_jLcM9JsxhJuYRNVFJW.7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NTA-/https://media.zenfs.com/en/motleyfool.com/6b34556ac6e43107f2544e1782be9286,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) has been making headlines lately as a result of its groundbreaking gene-editing collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX).  The backstory is that the two companies recently filed for a spate of regulatory approvals for the CRISPR/Cas9 gene-edited product, exa-cel, as a functional cure for two rare blood disorders, sickle cell disease and transfusion-dependent beta thalassemia.  What arguably hasn't been appreciated, however, is CRISPR's other clinical assets in immuno-oncology, regenerative medicine, and in vivo therapeutics.",https://finnhub.io/api/news?id=f90c4123889c6bc28b903089953091fa40b002ac1281234e56df00e5df4d253f
company,2023-05-31 04:03:00,"Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More",120627631,,VRTX,247WallSt,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2a3ee7e08e7c6dd32a1d5e9baccffdcf72160ee88e57a6b4ede628fa3bc3d886
company,2023-06-07 08:55:00,Vertex (VRTX) Stock Poised Well for Growth in 2023: Here's Why,120750687,https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple clinical milestones are likely to be achieved in 2023 and 2024, both in its CF and non-CF portfolio.",https://finnhub.io/api/news?id=d570396d9262f88d2722611441aa48a6ab9fc09c21bcfe46d688c07aef9fe7d7
company,2023-06-07 05:52:00,A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later,120746516,https://s.yimg.com/ny/api/res/1.2/AdN7ewePNGtEqduCUaOEpQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/2075bef5dfea15ff090d75941248ffec,VRTX,Yahoo,These stocks are already performing well but could kick into higher gear in a new S&P 500 bull market.,https://finnhub.io/api/news?id=cc1eaa7a0e8dc872a2f8a86ce4ae01333a01bc110921a5eb748a625b5e1ca7d4
company,2023-06-07 02:03:00,Stocks with top pricing power across all sectors,120750776,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7fb9b7bc4669963694f330d293c49c47d331d50a09a6c430074f66e11421bc15
company,2023-06-06 23:43:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,120780217,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1fe2e860a36ef4885cc62deefe7d22e0141bbc5327b9d66e5131179fb9d4b05f
company,2023-06-05 23:44:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,120738207,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=47f84e9e9d22825dc80593c795376d486eee35cd2f03d464af7241ecc46275f8
company,2023-06-05 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",120719631,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.19% higher to $334.42 Monday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=fc02d57bf5eb5ae6d131f2201c8b4502d3ba667b7c69fe3dd1899932ac0b5c3d
company,2023-06-05 12:07:05,"Wu administration launches initiative to hire 1,000 Bostonian life sciences workers by 2025",120721076,https://s.yimg.com/ny/api/res/1.2/eqFohebQSFLyxhwckfcGaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bizjournals.com/12bd7da323d20f898a64a62fb12b7e81,VRTX,Yahoo,"Speaking from the BIO International Convention at the Boston Convention and Exhibition Center (BCEC) Monday morning, Mayor Michelle Wu announced the Boston Life Sciences Workforce Initiative, which is aimed at getting 1,000 Bostonians into life sciences jobs by 2025.",https://finnhub.io/api/news?id=571f0d5d179e2ad082e6a9fa832f0008373b3bac9d1ab1685c9c445999957bb6
company,2023-06-05 07:00:42,Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 23% Discount?,120707765,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Key Insights Vertex Pharmaceuticals' estimated fair value is US$431 based on 2 Stage Free Cash Flow to Equity Current...,https://finnhub.io/api/news?id=7e9ca26aa79cc0785c8e56f5ee4340cd8892ea8eafc5400ad10deb556863ef29
company,2023-06-10 06:14:00,3 No-Brainer Stocks to Buy in June,120812823,https://s.yimg.com/ny/api/res/1.2/.XRBf10XHZozRfrX46c7aw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/4774f29e0ef8cbe69640c0a7f68514b2,VRTX,Yahoo,"The stock market has risen so far in June and could go even higher.  Three Motley Fool contributors think some stocks are no-brainers to buy this month.  Prosper Junior Bakiny (Axsome Therapeutics): Sporting a market cap of just $3.3 billion, Axsome Therapeutics is a relatively small and unknown drugmaker.",https://finnhub.io/api/news?id=6e746ea78675ede700b98149a09764dd2691abd48aef77fb0468bf8f57bc688f
company,2023-06-09 17:50:19,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,120812824,https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $334.11, moving +0.46% from the previous trading session.",https://finnhub.io/api/news?id=8a2932f21206cbb400478d303526a7d8f130a83d6e87822a74443400b44779b7
company,2023-06-09 13:37:00,"FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel",120803308,https://media.zenfs.com/en/zacks.com/4718122d03716403704541c667907c4e,VRTX,Yahoo,"The FDA grants priority review to Vertex (VRTX)/CRISPR's (CRSP) filings for exa-cel in SCD, with a final decision expected in December.",https://finnhub.io/api/news?id=bc94bd55d9430da33cea4c03072780b144f2975524463c1e78cd4a5579aece84
company,2023-06-09 13:23:43,"Vertex/CRISPR Partnered Cell Therapy Shows Encouraging Response In Sickle Cell Disease, Thalassemia Patients",120804967,https://media.zenfs.com/en/Benzinga/2fdf6cc83fa156d27942ec585c4236ba,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) announced that pivotal trials for exagamglogene autotemcel (exa-cel) for transfusion-dependent beta-thalassemia (TDT) or severe sickle cell disease (SCD) met primary and key secondary endpoints at pre-specified interim analyses. Of the 48 patients with TDT who had received exa-cel at the time of the analysis, 24/27 (88.9%) achieved the primary endpoint of transfusion independence for at least 12 consecut",https://finnhub.io/api/news?id=fb62f5392bc28ff548dff7dc7e4b24f89979a5047cbcf0d2078e720e34654fd6
company,2023-06-09 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",120898561,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.46% higher to $334.11 Friday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=64c7683f387836b9f65921da01ae910c7e455aac53873edde5f7de0be5a88b7e
company,2023-06-09 11:56:04,Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months,120794475,,VRTX,Yahoo,"The FDA could approve Crispr Therapeutics' gene-edited sickle cell treatment as early as December. In response, CRSP stock surged Friday.",https://finnhub.io/api/news?id=6cabebb852b476f9c31267c80d26ecd0b72d14efc6f5a9983fbc6700e50492da
company,2023-06-09 11:00:00,Vertex Presents Data Demonstrating Significant Benefits of Long-Term Treatment With CFTR Modulators at the European Cystic Fibrosis Conference,120794476,,VRTX,Yahoo,"BOSTON, June 09, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 12 scientific abstracts on the company’s portfolio of cystic fibrosis (CF) medicines were presented at this year’s European Cystic Fibrosis Society's (ECFS) 46th European Cystic Fibrosis Conference held June 7-10, 2023, in Vienna, Austria. Together, the data presented show the long-term benefits of treatment with CFTR modulators as well as the importance of treating the underlying cause of CF as early",https://finnhub.io/api/news?id=a114bc989967da614657e19bf4e74a635925ea59fdb33d2f8d25cc218eba460b
company,2023-06-09 10:15:00,2 Top Biotech Stocks to Buy in June,120793310,,VRTX,Yahoo,"Biotech stocks have taken investors on an unpredictable ride so far in 2023.  Two of the better biotech stocks I see this month are Gilead Sciences (NASDAQ: GILD) and Vertex Pharmaceuticals (NASDAQ: VRTX).  While Gilead's shares are down more than 11% so far this year, Vertex's shares are up more than 14%.",https://finnhub.io/api/news?id=d9909a360e307178cb36e5cec25366e9704d85664b5b2303a594d22cd0869861
company,2023-06-09 08:02:31,Is Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?,120794480,,VRTX,Yahoo,Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by a considerable 16% over the past three months. Given that the...,https://finnhub.io/api/news?id=3906cae16ef96b6f0e5c5a6e17983bff1ea60237105cc4ed2004b3f2d4953505
company,2023-06-09 06:07:00,Vertex Pharmaceuticals presents data on CFTR modulators at ECFS Conference,120794160,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=183d521203c345524867bb1ade5588f28aa9f59a2067ae092eaacc474f59baf2
company,2023-06-09 05:38:00,Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?,120794161,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8cf5c6d9331091e2efb97cbad56b104e158c0833dc14b387ec168ceeddabdf92
company,2023-06-09 03:01:00,Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress,120789405,,VRTX,Yahoo,"BOSTON & ZUG, Switzerland, June 09, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that both pivotal trials for exagamglogene autotemcel (exa-cel) in patients with transfusion-dependent beta thalassemia (TDT) or severe sickle cell disease (SCD) met primary and key secondary endpoints at pre-specified interim analyses. The results are being presented at the Annual European Hematology Association (EHA) Congress.",https://finnhub.io/api/news?id=d2747508fbaf9b583329b7be3003378a546c7c5c59a5d331aeffe8ac41b9a80b
company,2023-06-09 01:43:00,"CRISPR, Vertex gain as FDA starts review for gene edited therapy",120794162,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fa976a8fe7bd39b5c83560469b5b1be6381c8c6aa06370f3aeb026c91c96ed10
company,2023-06-09 01:15:00,Crispr Therapeutics price target raised to $74 from $70 at JMP Securities,120794163,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e79df54c141420ee48fad31252a0af713be2cdb1cdf155ea86c80a87ddcb3562
company,2023-06-09 00:14:00,"Vertex, Crispr announce both exagamglogene autotemcel trials met endpoints",120794164,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2f12df7fd11a534013985eb09766abd4958d4b729537c5636cbe21d01a17b4a4
company,2023-06-08 23:12:00,IN BRIEF: Vertex says US accepts treatment applications for exa-cel,120794165,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=405f1822c7a4fbb1bc9e721001fae78f5d9921a0b99c29c38f862cecc5f32b5d
company,2023-06-08 21:10:00,Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application,120798311,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=2e773b142a49ae088459eda82bca2b08a868d19cdd52b8135b890c9530a9a0be
company,2023-06-08 19:23:00,FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia,120787116,https://media.zenfs.com/en/business-wire.com/f593a00e6e791fc510ef5896531e877a,VRTX,Yahoo,"BOSTON & ZUG, Switzerland, June 08, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Applications (BLAs) for the investigational treatment exagamglogene autotemcel (exa-cel) for severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The FDA has granted Priority Review for SCD and Standard Review for TDT and assigned Prescri",https://finnhub.io/api/news?id=a13c045ad6768cb9d378794559fa99bed3c38d5acd074082c80a32663ef31097
company,2023-06-08 13:59:44,RBC Capital Maintains Vertex Pharmaceuticals (VRTX) Sector Perform Recommendation,120778608,,VRTX,Fintel,,https://finnhub.io/api/news?id=0b9e6e379b93f012a2fe405c1b5aad9349178b087a3187f8cb9b3b3284df089a
company,2023-06-08 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",120898562,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 2.44% to $332.58 Thursday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=5e81205d7547f4b1348e1dd420a65de7e0b067163298269094663d95e65e047e
company,2023-06-08 09:21:00,5 Top Stocks to Buy in June,120773636,,VRTX,Yahoo,"It's OK to be more cautious at times and more aggressive at others, but buying stocks regularly helps correct for natural market volatility.  With that in mind, PayPal Holdings (NASDAQ: PYPL), Target (NYSE: TGT), Vertex Pharmaceuticals (NASDAQ: VRTX), Walt Disney (NYSE: DIS), and Chevron (NYSE: CVX) are worth buying in June.  Trevor Jennewine (PayPal Holdings): It's no secret that digital payments are becoming more prevalent, but investors may not realize that digital wallets are driving that trend.",https://finnhub.io/api/news?id=6048fb946dbd0ba07294c7fb6268be697051b52ec2e76923050a81c36171d327
company,2023-06-08 06:00:00,Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?,120774822,,VRTX,Yahoo,Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX).  Let's turn to a smaller biotech that Vertex knows very well: CRISPR Therapeutics (NASDAQ: CRSP).  The two companies are partners in a blood disorders program and recently submitted their treatment candidate for regulatory approval.,https://finnhub.io/api/news?id=0dbb3e034a616775256d1f025258c1a5ce215ff45fe04fd71082b17742e9863d
company,2023-06-08 04:00:00,Vortex Energy Identifies At Least Two Salt Structures Suitable for Hydrogen Storage,120780213,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=117b9f4fb3d102c9cf1412973256b1379da2cab7c2aac83da8bb337e5fe927e6
company,2023-06-08 03:39:00,Vertex Pharmaceuticals price target raised to $323 from $315 at RBC Capital,120780215,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=971317250ee2cf4a4e77c6bb88a034014d3161df30f4c7803aedf659a0a76c62
company,2023-06-08 02:37:00,FDA accepts BLAs for Vertex Pharmaceuticals' investigational treatment exa-cel,120794169,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=786550826716d568af6f3561fd9842098139dbb64733d31779ad73ee9d87ef53
company,2023-06-15 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",120898554,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 2.38% to $349.08 Thursday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=82bb956a3297eb8bc6eac0c6c25575f5a34a1f5f2354e12bd43474c18ef61a26
company,2023-06-15 05:54:00,3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,120883727,https://s.yimg.com/ny/api/res/1.2/fEuNBcwwKYLsaTGTp96caQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/4f558167bedd0fe92382df2afb510542,VRTX,Yahoo,Technological advances are changing life as we know it.  The world is different now than it was 20 years ago in multiple ways thanks to Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL).  Google has become a verb.,https://finnhub.io/api/news?id=0855d25f70ab9e4fab957d6bf45dcc2a350186220c68a26fd766c7447e904774
company,2023-06-15 05:12:00,2 Magnificent Growth Stocks to Buy Before the Next Bull Market,120884155,https://s.yimg.com/ny/api/res/1.2/lbNHrTMb4RxdSJ4rEEBCSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/27aaa3a71a1630430982d34782d9532c,VRTX,Yahoo,"Instead, by investing in a wide range of quality companies in all types of market environments, you can construct a winning portfolio that helps you move closer to your financial goals.  The stock market has been rising at a rapid clip lately.  While it may be too soon to say if the next prolonged bull market is here, when the next one does appear, investors who stayed with quality stocks can be poised for impressive returns.",https://finnhub.io/api/news?id=e07cb0c136759163541e1c5d31aa34a24fff5f3d417b5ab09fab954fd6dc8fc1
company,2023-06-14 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",120898556,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.33% to $340.96 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...",https://finnhub.io/api/news?id=8443c7ec3658f1551e83c4795fbb385444873917cca24d8a5944694422ad19af
company,2023-06-14 11:40:54,10 DNA Stocks Billionaires Are Loading Up On,120863761,https://media.zenfs.com/en/insidermonkey.com/a6c49b3dbb648ec3058d0ce2caa0e41b,VRTX,Yahoo,"In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within an organism. The global genomics market was worth $28.39 billion […]",https://finnhub.io/api/news?id=6e5c1c1b8809714c6cc4c24580adc5eb45e6f35b5785374e48f4c9ca6d46a828
company,2023-06-14 09:45:00,Where Will CRISPR Therapeutics Be in 10 Years?,120878263,https://s.yimg.com/ny/api/res/1.2/1bvZNTve1LJvvWDm.TzmkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/7670046389a7ed11924fe966b766ac37,VRTX,Yahoo,"Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.  The company is on the cusp of having its first therapy approved by the Food and Drug Administration (FDA).",https://finnhub.io/api/news?id=fe6fed9c650f58f0297068307be324a321db0a61751931d70e93e0c92adea876
company,2023-06-14 04:00:00,Vortex Energy Appoints the Honourable George J. Furey as an Advisor and Grants Options,120864294,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=77c8ed791959a034f49336b2247aab3c26b50bd394644973fe51942a2b29399f
company,2023-06-13 18:30:09,Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript),120856712,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 5:40 PM ETCompany ParticipantsReshma Kewalramani -...",https://finnhub.io/api/news?id=f63977abcdbfec71a7b61a83e27ce103a56308a1c5961f243dc5c8516f37fdf4
company,2023-06-13 13:44:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",120898557,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.44% higher to $342.10 Tuesday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=823c1f60c605f246461a160a4e0b237ee99355081ab295be0caca6f79f9eadce
company,2023-06-13 10:00:36,Should You Be Adding Vertex Pharmaceuticals (NASDAQ:VRTX) To Your Watchlist Today?,120845541,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...",https://finnhub.io/api/news?id=a8bdf9374c2f27b622a2eb7078034dde2175834254de945052fa33f6ef78a9ff
company,2023-06-13 06:04:55,15 Most Profitable Drugs In The World,120841577,https://media.zenfs.com/en/insidermonkey.com/417a6a124aa2973d574f195a371d011f,VRTX,Yahoo,"In this article, we will be taking a look at the 15 most profitable drugs in the world. If you wish to see the top ones, feel free to skip our detailed analysis of the pharma industry and head straight to the 5 Most Profitable Drugs In The World. The pharmaceutical industry has long been […]",https://finnhub.io/api/news?id=25bc6b18a938aed4ce4809e8199324b010068daa3560b6d8ba32dd3e2282c743
company,2023-06-13 05:30:00,This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?,120841663,https://s.yimg.com/ny/api/res/1.2/euPynAbIwuUQKbkaTl8trg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTY-/https://media.zenfs.com/en/motleyfool.com/da386aaba1c579553011dd01f76c08b3,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) and partner Vertex Pharmaceuticals just took another step closer to launching a potential game-changing product.  At the same time, the U.S. Food and Drug Administration (FDA) did something that may enter the record books.  The FDA's acceptance of the CRISPR Therapeutics and Vertex files marks a first.",https://finnhub.io/api/news?id=e4b5b1a56944b14d2301359cd095d3dfdfd018b856df701b223d58a88be93db1
company,2023-06-12 14:58:47,HC Wainwright & Co. Reiterates Vertex Pharmaceuticals (VRTX) Buy Recommendation,120832030,,VRTX,Fintel,,https://finnhub.io/api/news?id=aa5f8eb099dea8ad3ec5fec5f9dcbaa0b1694c1ffc054c7c32ca2f624c08f3ae
company,2023-06-12 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,120898559,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.94% to $340.60 Monday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=41b55985ac056add9ea0a5ce803c8145a89520b94802117099c57769152d3842
company,2023-06-12 07:30:00,2 Biotech Stocks That Could Help Make You a Fortune,120827086,,VRTX,Yahoo,Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time.,https://finnhub.io/api/news?id=9b0bffd95148ab4cc2ae57defcf0f0685348bb15c55a44d0645af89b670268e3
company,2023-06-12 06:55:00,5 Stocks to Buy With Explosive 500% Potential,120828096,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c6becc1b4ad733fb8ac26f86c7fb00db42d1834a36d4285394caa59baa248154
company,2023-06-11 21:53:00,"Macro Muddle Coming Up As Market Exceeds Expectations, Small Caps Gain Ground",120832256,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9072050a678518b62c772b6d5fe7ec65e0b03151527e93db45af9ded0c264b26
company,2023-06-11 21:22:00,Editas upgraded to overweight at Raymond James on sickle cell candidate,120845538,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=55531cb2fce5747b53e2b2ac914ad3640a80422d3652c7a535c8525b5acaf780
company,2023-06-19 01:16:46,PBE: Healthcare Dashboard For June,120943664,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/655188172/image_655188172.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Click here for the June edition of the Healthcare Dashboard.,https://finnhub.io/api/news?id=b567e115a5c67f869d3513574b36147a748861f565307e34181e9fd2427d266f
company,2023-06-18 16:56:10,How to Retire Rich: Biotech Stocks Edition,121032614,https://media.zenfs.com/en/investorplace_417/155568656c3c7c82033d9d467e5e2a90,VRTX,Yahoo,"Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector – which falls under the broad healthcare industry – is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement",https://finnhub.io/api/news?id=30a100653ec7406368a3a5492184101887e35c42255ecfcadc8086b9b655a955
company,2023-06-17 10:07:00,2 Market-Beating Stocks With Major Catalysts on the Way,120928550,https://s.yimg.com/ny/api/res/1.2/Y4ReOklbfghVj9uOgyd4hQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e812962fa399e82abe410b5540a29029,VRTX,Yahoo,"For those seeking stocks that have trounced the market over the past year, the biotech sector might be an excellent place to start.  Two drugmakers that have done particularly well for themselves are Vertex Pharmaceuticals (NASDAQ: VRTX) and Biogen (NASDAQ: BIIB).  Vertex Pharmaceuticals has a rich portfolio of cystic fibrosis (CF) drugs that generates growing revenue.",https://finnhub.io/api/news?id=f3471d20701a45ff3b0c74fca80fa596be3a40edf9c6c2c6e6e4ab0226790404
company,2023-06-16 21:00:00,How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities,120929605,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=15265ab21d58d07aa200dc13c9257b8b82e6400561706dd01f51e6e7a2aa15b9
company,2023-06-16 17:50:20,Vertex Pharmaceuticals (VRTX) Stock Moves -0.34%: What You Should Know,120921250,https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $347.89, moving -0.34% from the previous trading session.",https://finnhub.io/api/news?id=2bbdd3ace94b14cd0e187d846c2df248c30c946e3ab31cfbf193ed38e8559344
company,2023-06-16 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Friday, still outperforms market",120938209,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.34% to $347.89 Friday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=c7264b706ca99a75827211ac8ee64c150d486881d9a0f91e127ba81fc9c6801a
company,2023-06-16 03:30:00,Gene Editing Is Working. Wall Street Is Taking Notice.,120907522,https://s.yimg.com/ny/api/res/1.2/dMQ34fBx4Vdl7Vpag00BUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/3779ce242043b3054a95c889f2f5391c,VRTX,Yahoo,"Shares of Crispr Therapeutics are up 45% this year, compared with the Nasdaq Composite's 31% rise.",https://finnhub.io/api/news?id=ae5881f2ca7d84d5912dceb38346556cc55e79f650c612bf625cec7dc0aed494
company,2023-06-23 18:55:00,Vertex Presents Positive VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the American Diabetes Association 83rd Scientific Sessions,121031948,https://media.zenfs.com/en/business-wire.com/c2923d5e61571bdc55cd2db001e74c1a,VRTX,Yahoo,"BOSTON, June 23, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today presented data on all patients dosed in Parts A and B of its Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated islet cell therapy, in people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemic events (SHEs). All six patients treated with VX-880 had undetectable fasting C-peptide (endogenous insulin secretion) at baseline, a history of re",https://finnhub.io/api/news?id=c4d224506fd2583dce3d9ae67b2ea83838093dfec064cc1116c9748d8dde1e53
company,2023-06-23 12:57:00,Vortex Energy Announces Extension of Marketing Campaign,121060796,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=3c7dd3e2f7bcd54474610cd098381f84e3d124ad02e01fad62d0700b0e58e79f
company,2023-06-23 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,121122300,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.33% to $347.00 Friday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=d789c1774936d94d8fe68fae447c70e7ceb77ad912019008726348b3962c8b5c
company,2023-06-23 07:26:00,Cantor Fitzgerald Remains a Buy on Vertex Pharmaceuticals (VRTX),121022266,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=173d405110a3c32ad96286db618275652ea8c6180d8cdf83d7aab8bbffdb6fc5
company,2023-06-23 02:02:00,Vertex Pharmaceuticals reports 'positive' Phase 1/2 VX-880 results,121060797,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9415fd9199d9e70b8986eea913213c8f5492bbef32a89558b1bb44582ac29917
company,2023-06-23 01:00:00,Vortex Energy Unveils 3D Geology Model of the Robinsons River Salt Dome Property,121022267,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0bf3348a2ad30f8021113dc5641e3e22cfdbdf5a178a1067656b3e866d2ef2a
company,2023-06-22 17:50:21,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,121011884,,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $348.16, moving +1.42% from the previous trading session.",https://finnhub.io/api/news?id=90d95a4adbd3ffdf2c78d1a2dea3fa3b0c9479c675943bce3feb797dc0f5f62a
company,2023-06-22 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",121122303,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.42% to $348.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=a5c2a3c85ef9435221a6bd5765948e1fa55694b724136af5d7e51971efa98398
company,2023-06-22 07:31:00,"Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and Pfizer (PFE)",121002047,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=62fe21471e99f277c4ef0f865c34a2bb6ff72c23df67814ac226be8edc768fec
company,2023-06-22 00:34:00,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), PTC Therapeutics (PTCT) and Vertex Pharmaceuticals (VRTX)",121002854,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=003192cbb1925963335c8bf9f78cb0b0768938145c39726b5b8f0ce5487415eb
company,2023-06-21 23:06:00,Analyst Ratings for Vertex Pharmaceuticals,121022269,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6b42f43bc2a02c336f3cbb2968140b11fdfb593ca2962820a76c44680fe94e5a
company,2023-06-21 21:09:00,Alleged Industrial Espionage Makes an Interesting Story,120988431,,VRTX,Yahoo,"If companies can do anything to keep secrets from leaking out.  Motley Fool host Ricky Mulvey and analyst Kirsten Guerra take a look at Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.  To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.",https://finnhub.io/api/news?id=72ddb8c8669d9b9621f91c7852c5cbd1955f5920dde379cb5cc11510c7103c81
company,2023-06-21 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",120994043,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.17% higher to $343.28 Wednesday, on what proved to be an all-around grim trading session for the stock market,...",https://finnhub.io/api/news?id=4f39e91cc8b8a2cb4bc1187f8793cf70a6bf0aefda5ec8daa4814d09b73cae68
company,2023-06-21 05:30:00,Is CRISPR Therapeutics Stock a Buy Now?,120972038,https://s.yimg.com/ny/api/res/1.2/5wMKqVjs4Oxrwr_jTNk8fQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e75babedaf2b1842bb51babf80a23428,VRTX,Yahoo,An important moment may be only a few months away for CRISPR Therapeutics (NASDAQ: CRSP).  The U.S. Food and Drug Administration (FDA) will decide on whether to approve exa-cel for sickle cell disease in December.  It offered the company and partner Vertex Pharmaceuticals priority review for that indication.,https://finnhub.io/api/news?id=a1556f51027a086dfd9bf77757fdd9aaf84ff8fc056dc7855deee12eddd6116d
company,2023-06-21 02:29:00,bluebird bio gains on FDA priority review for new gene therapy,120980368,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=095e1ef5898655387282ca88a1e5b1a42d1c4cb11e707aacfd58f9553741cb59
company,2023-06-20 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",120966409,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.49% to $342.69 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=ee1e56627f18235af928984c39d219bfe1b4b829de3eb1c3ce66f68597ffc99b
company,2023-06-20 09:53:44,Crispr Therapeutics' Exa-Cel In The Lead For Sickle Cell Disease,120959204,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1132644765/image_1132644765.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,FDA bestowed Priority Review for CRISPR's gene therapy that keeps its candidate ahead of rival for potential first-to-market. See why I'm bullish on CRSP stock.,https://finnhub.io/api/news?id=9b0edd1a0de389192cc75897ca3188d93e49b04296cf2efe8f6e917c040daff9
company,2023-06-20 08:25:13,3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever,121047985,https://media.zenfs.com/en/investorplace_417/155568656c3c7c82033d9d467e5e2a90,VRTX,Yahoo,"Even the most conservative investor hopes to find that one stock that can make them millions. That’s why they look at the biotech sector. One “home run” drug or therapeutic to enter the market can send a stock soaring along with an investor’s portfolio. The problem is that many of these long-term biotech stock investments never pan out. On the other hand, many potentially high return biotech stocks are excellent buy and hold candidates. Some of these companies, particularly the small-cap stocks",https://finnhub.io/api/news?id=67bd996eb05dfefedf2fe44ff73ced98f1a3ec2c91e493c491bc05b31d961c42
company,2023-06-20 05:39:00,"2 Unstoppable Growth Stocks That Could Turn $20,000 into $100,000 by 2030",120953766,https://s.yimg.com/ny/api/res/1.2/1ShsMRBe7_3HYoRjnIgWcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8192ab164b7af4147fcfd14026294f1e,VRTX,Yahoo,These one-of-a-kind businesses have an edge over the competition that could steadily push their stock prices in the right direction through the end of the decade and beyond.,https://finnhub.io/api/news?id=c4696c4cff6a57e7f43b0d27c6fed33f97f6d0c41de347d418a224f451628fb7
company,2023-06-20 00:53:07,"PepGen: FDA Setbacks Offset By Canadian Wins, Clinical Data",120953414,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/462756183/image_462756183.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"PepGen (PEPG) faced a setback with FDA's clinical hold notice on its PGN-EDODM1 compound. With mixed prospects in medium-term, hence I reiterate hold. See more here.",https://finnhub.io/api/news?id=b9396cd9cc3a9e4b0badd9ecd65fcc3884fd397a888ea863e121bed0080a54d1
company,2023-06-27 13:36:07,"Tesla, Microsoft Among 34 Stocks To Watch As Market Takes A Breath",121072886,,VRTX,Yahoo,"Including Tesla, Microsoft and Broadcom, this screen highlights the top-rated stocks to watch in the top-ranked industry groups.",https://finnhub.io/api/news?id=597f299876a44636108856623bda57943d498c73483126d1373d52070d2828ac
company,2023-06-27 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",121122293,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.09% to $347.12 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...",https://finnhub.io/api/news?id=e80ffa2d15a9859d85e01fc953cfc2b839150fc6709f02a21e5b3070251ef027
company,2023-06-27 05:35:00,Maxim Group Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),121067920,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06d7dab68a915a2628e5cbd6e54c6a81b6d303e42d2de1b24728b52587f0d52b
company,2023-06-26 16:47:37,HC Wainwright & Co. Reiterates Vertex Pharmaceuticals (VRTX) Buy Recommendation,121058123,,VRTX,Fintel,,https://finnhub.io/api/news?id=73e67b39743df34d87d45b4dc9d0a81f4469fddf5edcc0689326f4e06d2c445e
company,2023-06-26 16:47:33,Evercore ISI Group Maintains Vertex Pharmaceuticals (VRTX) Outperform Recommendation,121058124,,VRTX,Fintel,,https://finnhub.io/api/news?id=b59cdd097132c16f079735102007803a4f75220d30144b2172bef9552c1d7f6b
company,2023-06-26 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,121122298,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.13% higher to $347.45 Monday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=f54b2b41fb039ef9b1982e4164723a70de1f41abffba7a89a378bb0a284b343e
company,2023-06-26 11:21:00,Weight-loss drugs in development aim to replace injections with pills,121056667,https://images.mktw.net/im-793547/social,VRTX,MarketWatch,"Promising results for weight-loss treatments that could compete with Ozempic and Wegovy, along with new screening recommendations for fatty-liver disease,...",https://finnhub.io/api/news?id=5b69d5c7b162374cf061d69d8634715566dc0422226eb0b1d3bf4fd567cb5c4c
company,2023-06-26 07:30:00,Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies,121046259,https://media.zenfs.com/en/business-wire.com/38c5d923b1f050d07cebbf95fa90776e,VRTX,Yahoo,"BOSTON & BASEL, Switzerland, June 26, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials.",https://finnhub.io/api/news?id=a1eafd1fec4af42781572eb2c6ad1957000d7e307fade57036625d83a1d1175f
company,2023-06-26 07:24:29,Vertex Pharmaceuticals Shares Attract Big Money,121062656,https://media.zenfs.com/en/fx_empire_176/a58e845fc046c44d8e0fb2af8b3219af,VRTX,Yahoo,"Vertex Pharmaceuticals, Inc. (VRTX) shares are up an impressive 20% in 2023.",https://finnhub.io/api/news?id=e728d50f1b5e8496f39975f99e7228abecbb74dfac853c160cd717019322ce73
company,2023-06-26 05:44:00,First Week of August 18th Options Trading For Vertex Pharmaceuticals (VRTX),121060783,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=077c8163b9c1aef98d2b44e95430536fc2da3a477a8e662e9eb7043e1c6a2eab
company,2023-06-26 04:24:00,Vertex in deal with Lonza for facility to produce cell-based diabetes therapies,121060784,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f24a77f9560cc7c04a04f138cb4baeaf036221c5452a822e40db9f05ac9c8b55
company,2023-06-26 04:16:00,"Vertex Pharmaceuticals' VX-880 showed treatment benefit, says BMO Capital",121060785,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=66441f67a121cdf954ca75c74e447706e979151d256eb704e960f509f96c0c3a
company,2023-06-26 04:11:00,Vertex Pharmaceuticals price target raised to $379 from $375 at Evercore ISI,121060786,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1d33038b8d2cd5245e3a11ff821f30f9a2a7c8845cc62c77d3998999eb14f28c
company,2023-06-26 03:56:00,Vertex Pharmaceuticals (VRTX) Initiated with a Buy at BMO Capital,121060787,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a8bf9254ee58746646bf2a5a70755f2f2d15df4c70b850b4ea44258fe15af721
company,2023-06-26 02:36:00,Vertex Pharmaceuticals and Lonza to build facility for T1D cell therapies,121060789,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1bad8d51dd559fae50a3b499a7f5a70cf0408c1d2286d9371d6867d56ad6e54c
company,2023-06-26 01:31:00,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Dexcom (DXCM) and Genmab (GMAB)",121050103,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=43c0f6edcde45db885787623ca83bc69b32b8935a0113becea98a7ef1e2f7790
company,2023-06-26 01:11:00,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Esperion (ESPR),121060724,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d37c92d1e572bc16e46a80cbbcbfe4932ebc4d809a444ad272b10c633f15a0d4
company,2023-06-26 00:43:00,"Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead",121058560,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6439151289bdbfdeb183e234c678a9b45f7d412c560fadf2339c2d9edc224a85
company,2023-06-30 23:03:00,"Lilly, Vertex top pharma performers in H1; Moderna, Pfizer the worst",121169588,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b133d23f232c21ebcf38d04ef1d77594bf89bfe9388aa230fd9e23b8b78803bf
company,2023-06-30 12:41:00,"Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market",121177985,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.07% to $351.91 Friday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=69486ccb2e2236c5915225f46442c4d9bec4248b5c054df0a85ab5e9b7f1a5ce
company,2023-06-30 11:09:57,Morgan Stanley Reiterates Vertex Pharmaceuticals (VRTX) Equal-Weight Recommendation,121141749,,VRTX,Fintel,,https://finnhub.io/api/news?id=8ff819577bb9208bd5b0fc3d9da71b1b1b33da9b37b03defa3d5bb27eb7507dc
company,2023-06-30 08:01:00,Vertex to Announce Second Quarter 2023 Financial Results on August 1,121150150,https://media.zenfs.com/en/business-wire.com/c84bf3dededcd8127d9f3e98edc0940b,VRTX,Yahoo,"BOSTON, June 30, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2023 financial results on Tuesday, August 1, 2023 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1(412) 317-0651 (International) and reference the ""Vertex Pharmaceuticals Second Quarter 2023 Earnings Call.""",https://finnhub.io/api/news?id=98d150488ca16a77cb20d6b57bd0024a2f05a85b059c45579f76b28e7c096adf
company,2023-06-30 07:16:00,Morgan Stanley Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),121167866,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=35d5760e3669ea4c82aced1893f52e51262f4db323c99152ba01f4f0c6a52602
company,2023-06-30 05:50:00,Buying These 3 Stocks Could Be the Smartest Investing Move You'll Ever Make,121136457,https://s.yimg.com/ny/api/res/1.2/WRBLvoCWiK9VcZ6UlXQPdw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NDI-/https://media.zenfs.com/en/motleyfool.com/f07fdf4a19f4652f97a27db27832337c,VRTX,Yahoo,"Some decisions have consequences that last a lifetime. Ideally, those consequences will be good ones. Granted, such decisions are relatively few and far between. That's usually the case with investing.",https://finnhub.io/api/news?id=7ba0dda9f3999e001677b08ad514af84e640c6403a1a7b5d0ce6dc9b7e1ed785
company,2023-06-29 17:50:21,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,121127404,https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $348.18, moving -0.74% from the previous trading session.",https://finnhub.io/api/news?id=cb97d2f534715236ee1e2bdaa08157a478dcb72feadb9342070fb793afcf5572
company,2023-06-29 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",121122286,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slumped 0.74% to $348.18 Thursday, on what proved to be an all-around great trading session for the stock market, with...",https://finnhub.io/api/news?id=b5de3519a22f1c88e1491dbd7788e882e89cc4f036fa07766d32fe9b36b3e8f5
company,2023-06-29 08:22:00,Vortex Energy Unaware of any Material Change,121121479,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=da91ca1f283bcc75e5afdf38d81fca93e822844d4853fd199bd2371d77209957
company,2023-06-29 08:00:00,2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,121108675,,VRTX,Yahoo,"There's nothing wrong with owning index funds, but growth stocks by definition outpace the revenue or profit of a typical stock, which likely results in greater gains than index funds can produce.  Vertex Pharmaceuticals (NASDAQ: VRTX) and Novo Nordisk (NYSE: NVO) fit the definition of a growth stock.  Vertex, known for its range of cystic fibrosis (CF) therapies, has increased revenue by 193% over the past five years -- and the company's growth trend could just be getting started.",https://finnhub.io/api/news?id=6adb2717385e49fa0e0bda339f691da239f33b684f46460aed051c58b0488430
company,2023-06-29 07:04:00,Video: S&P 500 Analyst Moves: VRTX,121121480,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bc801db33c7950baee1eaf6d238716f244b150db53a962a0fd9c876d1c3b53da
company,2023-06-29 06:57:00,Vertex Pharmaceuticals Takes Over #106 Spot From AES,121121481,,VRTX,ETF Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a5421ba1eea813a139a7985f6b076dcd41abf127394957d9bbc45406e38faaa7
company,2023-06-28 23:29:00,Sigilon Therapeutics downgraded to Neutral from Buy at BTIG,121121059,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b551826ff441a5dc043ea397df7ffd5479bba4661e715a9d4a33fe64e27bcdfa
company,2023-06-28 12:41:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",121122290,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.05% to $350.78 Wednesday, on what proved to be an all-around dismal trading session for the stock market,...",https://finnhub.io/api/news?id=7f1b7056a8135df6f03315cf259cdbc41f91aee8bb09cd7a46315938bfebcaf5
company,2023-06-28 04:46:00,SVB Securities Gives a Buy Rating to Vertex Pharmaceuticals (VRTX),121089184,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=88ce37d03d18d651b61102b42f1dee93e8f46d0ce18a005bf3d735d80bfb9b28
company,2023-06-28 02:35:00,Vertex Pharmaceuticals price target raised to $360 from $350 at TD Cowen,121089186,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5e7f830fafa96e267501cae3f0dcb85bd03a3ca36ce074b8b4dcd2cdba9193a
company,2023-06-28 02:06:00,BMO Capital Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),121089188,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d29eac393bbf42ccd9a1bb91d5e2eca4d7625eef1fa678b751f35ec3177f58f2
company,2023-07-05 13:05:57,The 3 Best Biotech Stocks to Buy In July,121317565,https://media.zenfs.com/en/investorplace_417/180ce84be58b62c67d477717f09599bb,VRTX,Yahoo,"Although it’s been a difficult year for biotechnology stocks, there are still plenty of reasons for investors to be bullish on the sector. Many of the biggest innovations in medicine are occurring at small and midsized biotech companies in the U.S. These are the incubators for medical advancements and where important scientific breakthroughs are happening. New products and treatments are boosting sales and earnings at biotech companies, making them great long-term investments. Although the S&P B",https://finnhub.io/api/news?id=77104d3f0a6a2071dc5cedc055579fa8a7c1bbd6a9d87a1e565ac28cefd3b46e
company,2023-07-05 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,121278065,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.22% higher to $348.32 Wednesday, on what proved to be an all-around poor trading session for the stock market,...",https://finnhub.io/api/news?id=bc6b5c47da5ecd5c5fdf065dcad6a3e040d9463827c374ce234c4d13fe0643c2
company,2023-07-05 12:40:00,Nkarta Names Alyssa Levin as Chief Financial and Business Officer,121278066,https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png,VRTX,MarketWatch,By Stephen Nakrosis Nkarta on Wednesday said Alyssa Levin was named as its new chief financial and business officer. Levin joins the biopharmaceutical...,https://finnhub.io/api/news?id=7a2faeaa65205b4d8904465df0a4e9fe6f8d540e65c45762a5712d9a9342d8f5
company,2023-07-05 11:06:02,Spero Therapeutics: The Multi-Asset Pipeline Could Outpace The Tebipenem HBr Deal With GSK,121213657,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1394164061/image_1394164061.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Spero can receive up to $525 million in development and sales milestone payments and royalties on net product sales from GSK. Read why SPRO stock is a Strong Buy.,https://finnhub.io/api/news?id=f52c8a6159fbf75ae523ffad053f208f1dd696cc760f2433bfe27c67b00b209b
company,2023-07-05 08:58:00,IN BRIEF: Vertex wins EC approval for cystic fibrosis therapy Orkambi,121237748,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c8128bf1ada69522cef28b401d756999c806ac477b74566d3b19170559272dc2
company,2023-07-05 08:56:00,"MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall, Wednesday, 7/5/2023",121215768,,VRTX,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=52dcf7565ce430d6ffe53ab4274a27e923afd9a4ef7ae43286b11502582690be
company,2023-07-05 07:36:00,CRISPR (CRSP) Shares Rise 24% in the Last Quarter: Here's Why,121210303,https://media.zenfs.com/en/zacks.com/6c310b965624dabfdf36fccc73dc124d,VRTX,Yahoo,"Shares of CRISPR (CRSP) surge 24% in the last quarter after the company, along with Vertex, provides positive regulatory updates on exa-cel BLAs in SCD and TDT treatment.",https://finnhub.io/api/news?id=af390ce88d63944127f713bbb2663c50d29cf3a5c5a8dc35864ad2295a197ce9
company,2023-07-05 03:25:00,3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025,121235165,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8c5d52d11dd7087c8d6dd66ce9ea97bec1136bfaa8e121fbdd30f256acc68b87
company,2023-07-05 03:00:00,European Commission Approves ORKAMBI® (lumacaftor/ivacaftor) for the Treatment of Children With Cystic Fibrosis Ages 1 to <2 Years Old,121211348,https://media.zenfs.com/en/business-wire.com/aa53224c067e58455693d7dbe76aa578,VRTX,Yahoo,"LONDON, July 05, 2023--Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label extension of ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) ages 1 to <2 years old who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the most common form of the disease.",https://finnhub.io/api/news?id=5a1c25c0631b1f82bb1ac5cdff04f6b740556e5a004b931285f81faa666423c9
company,2023-07-05 00:09:00,Vertex Pharmaceuticals granted approval for label extension of Orkambi,121210312,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b3ab5977fb55c8fadf8d04cdc98c3f80f42f7260637afe0796ad028b57e21c87
company,2023-07-04 19:10:26,Vertex: Promising Prospects Amid Stretched Valuation,121203069,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1082582778/image_1082582778.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex's product revenue increased due to the robust uptake of its cystic fibrosis treatments. VRTX stock is rated as a buy. Read the article to learn more.,https://finnhub.io/api/news?id=5ddc6dc314a29d342fdf33ac844026b7bbecadadf1a13ffae7169900ada4db7f
company,2023-07-03 15:31:59,Morgan Stanley Reiterates Vertex Pharmaceuticals (VRTX) Equal-Weight Recommendation,121187947,,VRTX,Fintel,,https://finnhub.io/api/news?id=c0e83a882c025cdc3fa744bc4cb5d29e118b3ffcee2e468614ff49aa2de656e9
company,2023-07-03 07:55:43,Vertex: Resilient Growth And Promising Pipeline,121184072,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1366552805/image_1366552805.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals continues to outperform in the biotechnology industry. Click here for my take on VRTX stock and its prospects.,https://finnhub.io/api/news?id=41abf57259e3ee1df5d4c446e38aae58fe28087ba6539e5f3536255c5996d881
company,2023-07-03 06:36:00,Peering Into Vertex Pharmaceuticals's Recent Short Interest,121184057,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee9a6575227343258947863bd586eac0050f994fdbfe63639aac0bd9f46c1f6c
company,2023-07-03 05:30:00,Vertex Pharmaceuticals Stock: Bear vs. Bull,121181890,https://s.yimg.com/ny/api/res/1.2/R65zx10_w23_gs9kee3YVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/26ecd6166f610f5f4583938eaed1c106,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) is heading toward a big moment: a regulatory decision on what may become its next game-changing product.  Investors previously worried about Vertex's ability to expand beyond CF, so a nod here could be big.  Vertex shares have climbed more than 20% so far this year.",https://finnhub.io/api/news?id=80f4030a9a2c04c4233955aa31fdc0ceda94e224462db6ad0d7587652d44f059
company,2023-07-03 02:52:00,Vertex Pharmaceuticals price target raised to $340 from $305 at Morgan Stanley,121184058,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e9ca2a4fae44edb6f815ac11b5e6ef0ffd22d610ce92f46ccfe713275c8df631
company,2023-07-09 06:13:00,"Want to Get Richer? 2 Unstoppable Stocks to Invest $1,000 In This Week",121282698,,VRTX,Yahoo,"Airbnb (NASDAQ: ABNB) has built a business that serves the changing reality of what travel looks like in the modern, digital age.  There's certainly been a broad resurgence in leisure travel over the last 12 to 15 months as borders have reopened and pandemic-era restrictions have faded.  This has been evidenced by a considerable jump in cross-border travel, one that Airbnb continues to benefit from.",https://finnhub.io/api/news?id=75b4112dc39063bab31ac1fcaf552e6c7dd84aac9652b54b8f39e47d1ea4963a
company,2023-07-08 06:14:00,3 No-Brainer Stocks You Can Buy Right Now,121271408,https://s.yimg.com/ny/api/res/1.2/lRRq75KlTAcXsYfZ2uGCWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/49bca5e715104ee86e349432c7e2de3c,VRTX,Yahoo,"Here's why they think AbbVie (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer stocks to buy right now.  Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie isn't currently popular with investors.  The company's shares are down by 14% year to date.",https://finnhub.io/api/news?id=3b1fa2224f9898d8b05eb28ffafefacd93b517753f8dcae33d4decef4bc87d54
company,2023-07-07 12:42:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors,121278061,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 2.19% to $338.18 Friday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=50b115f816642043c0d8040c24b4e9e40b4cab10c6193cb7675e2a34024b27a6
company,2023-07-07 09:00:39,An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 23% Undervalued,121267097,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"Key Insights Using the 2 Stage Free Cash Flow to Equity, Vertex Pharmaceuticals fair value estimate is US$450 Vertex...",https://finnhub.io/api/news?id=b8e1a00d3645222c939c260ade33bcd21316971876bc27396b82a90585fa0068
company,2023-07-07 05:25:00,"Video: Nasdaq 100 Movers: VRTX, DDOG",121260190,,VRTX,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=88b7e34736b49ecea649271737151435c7eabc72ce0e7186216e227cf30d717b
company,2023-07-07 04:32:00,"Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades'",121260191,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=054b1d375e7f2005284d3f8adf7f961a5741c32dd0b39a32dea362cfbfa64d8d
company,2023-07-06 17:50:22,Vertex Pharmaceuticals (VRTX) Stock Moves -0.73%: What You Should Know,121247557,https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $345.76, moving -0.73% from the previous trading session.",https://finnhub.io/api/news?id=f07d1c3122d2017a1b30e648b4292fffa12b454bf72397665a334bfea2e03f48
company,2023-07-06 12:42:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, still outperforms market",121278063,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.73% to $345.76 Thursday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=11cc78eb00e5f4d602cff50c172407f1488256dfcb4f06f0133512c9a9bad1d5
company,2023-07-06 10:45:00,Vertex (VRTX) Gets Nod in EU for Orkambi Expanded Indication,121237114,https://media.zenfs.com/en/zacks.com/4718122d03716403704541c667907c4e,VRTX,Yahoo,Vertex's (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of cystic fibrosis in patients (aged 1 to <2 years) who have two copies of the F508del mutation.,https://finnhub.io/api/news?id=1d7fe564d1723d7c40c8252d7ac9f1f97eeb4167b194b0999445e06eecf41ffb
company,2023-07-06 09:49:06,"Final Trades: Delta, Vertex, Cooper & more",121238832,https://image.cnbcfm.com/api/v1/image/107267649-5ED1-FMHR-070623-FinalTrades.jpg?v=1688665746&w=1920&h=1080,VRTX,CNBC,"The ""Halftime Report"" traders give their top picks to watch for the second half.",https://finnhub.io/api/news?id=56cef8a605bfa6fb64524008937e0257d1e7586219f433d974c6bb949771e330
company,2023-07-06 09:17:00,2 Growth Stocks That Might Be Too Cheap to Ignore,121237116,https://s.yimg.com/ny/api/res/1.2/XnTzEBowtsfsiwDXKqWUfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/6bedfb308c34a6ecc78d6d68641eadf1,VRTX,Yahoo,"Biotech giant Vertex Pharmaceuticals has had an impressive stock market performance over the past year.  In the first quarter, Vertex revenue jumped by 13% year over year to $2.37 billion.  Second, Vertex completed regulatory submissions to health agencies in the U.S. and Europe for what will almost certainly be its next blockbuster, exa-cel.",https://finnhub.io/api/news?id=cc40c12554c0f725762d8716af3a6cba31e6821db79a727a5b4dc35fd1cd4ab3
company,2023-07-06 06:33:00,2 Supercharged Growth Stocks to Invest In Before the Next Bull Market,121229097,https://s.yimg.com/ny/api/res/1.2/I.pRjR68TlISOqVsMpibRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTk-/https://media.zenfs.com/en/motleyfool.com/2f7e486bb38495f4f4475b5d379d2869,VRTX,Yahoo,"Upstart (NASDAQ: UPST) continues to pursue its mission to change the way the lending industry operates.  This multi-trillion-dollar space long relied on outdated means of assessing consumer creditworthiness, often using little more than the FICO score to determine whether to approve or deny people for loans.  This system left many potentially creditworthy people unable to access credit, despite having never defaulted on a credit product in their life.",https://finnhub.io/api/news?id=dbb95ae21b1761f985cb3ac2585528537eb33b369fad73be8fdea8d88ce595e9
company,2023-07-05 20:24:53,3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025,121326757,https://media.zenfs.com/en/investorplace_417/b912a2b47d4b301fa5481b7d77ee6c13,VRTX,Yahoo,"Investing in the biotech sector is mostly about risk and reward. When a company achieves FDA approval on a drug or therapeutic, it frequently has a source of revenue and profit that can last for years. And investors who buy and hold these stocks are typically rewarded with handsome total returns. Even penny stocks can become triple-digit return biotech stocks. However, that payoff can take a long time. Just getting a drug through the clinical trial stage can take several years. And some candidat",https://finnhub.io/api/news?id=85a12560fa65a8e600ea7e13f1558ff7e8c7d21d34db259b97062ac92ca07038
company,2023-07-13 17:50:20,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,121376967,https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $349.02, marking a +0.86% move from the previous day.",https://finnhub.io/api/news?id=a7ab48fc35c8006b02c7a92a8d38ab928dc5e26b6c93661a4c56d7b52fdf2dc8
company,2023-07-13 08:36:17,"U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million",121365112,https://static.reuters.com/resources/r/?m=02&d=20230713&t=2&i=1638723735&r=LYNXMPEJ6C0JE,VRTX,Reuters,"An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals/CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.",https://finnhub.io/api/news?id=d065a1849f384170ab712994dbf94fa4612e0c12c16baa242bf15f05c40dcb99
company,2023-07-13 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,121397530,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.86% higher to $349.02 Thursday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=72f341a0e3ba0b717f0a58e61428876af581fb67f93e254fd36b27b352248410
company,2023-07-13 08:00:01,"U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 mln ",121365113,,VRTX,Reuters,"An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals/CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.",https://finnhub.io/api/news?id=c844925d9df3a1079be186c1f1979f103cde80c8c1334483c1f1c18bd646fbf8
company,2023-07-13 08:00:00,ClearBridge Multi Cap Growth Strategy Q2 2023 Portfolio Manager Commentary,121362201,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1435226184/image_1435226184.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,The ClearBridge Multi Cap Growth Strategy underperformed its benchmark in the second quarter of 2023. Click here to read the full fund letter.,https://finnhub.io/api/news?id=bfc8f0193e74352c1fa225564487a50f10d3f478867c9aba57da1398ee735597
company,2023-07-13 07:45:00,3 Top Biotech Stocks Defying the Bear Market,121360107,,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) has made quite a name for itself in the market with its cystic fibrosis drugs.  In 2022, Trikafta alone brought in $7.6 billion in revenue out of Vertex's total product revenue of $8.9 billion.  The company's net profits increased 53% to $3.8 billion in 2022.",https://finnhub.io/api/news?id=c0d58644d16940e55f81cba3a8c367d82bcc653084360fc17760152b119cdc76
company,2023-07-13 06:40:00,VRTX September 1st Options Begin Trading,121362673,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4094bed07f2e7530f39dfb32e9b851f22c2793b84743d9674482bc1ed2757579
company,2023-07-13 05:50:00,Got $500? 3 Growth Stocks to Buy That Could Double Your Money,121358576,https://s.yimg.com/ny/api/res/1.2/ARt0C68kORRjOjFbBZHIcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/1fae18c93184888f30b0242429109f74,VRTX,Yahoo,"There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good.",https://finnhub.io/api/news?id=dfff96bc044861c813a0f9263c5e644fffeac992751b846200e5c8a8e5f14731
company,2023-07-13 04:25:00,3 Pharma Stocks That AI is Loving in July,121384827,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=185fc356a85fb1b11af77ffe5df9cf7b2c435995b9746e6ca4cf2aaa5d02bbf2
company,2023-07-12 07:51:55,3 Biotech Stocks That AI is Loving in July,121443938,https://media.zenfs.com/en/investorplace_417/7b62464d32248ed62ee80cadf868b9a3,VRTX,Yahoo,Artificial intelligence (AI) has become an invaluable tool for investors seeking opportunities in the stock market. Its ability to analyze large amounts of data and recognize patterns makes it an ally in identifying high-potential stocks. I asked ChatGPT which biotech stocks it recommends for investment in July and it provided the following three companies. Let’s talk about these three AI recommended biotech stocks: Vertex (VRTX) Source: Pavel Kapysh / Shutterstock.com One of the companies ChatG,https://finnhub.io/api/news?id=ec5a7a4873338969b33b02c6351af7ab3b6478e79ef68a83d1505b0568c6cda4
company,2023-07-12 06:00:00,3 Things About Vertex Pharmaceuticals That Smart Investors Know,121332253,https://s.yimg.com/ny/api/res/1.2/YAkcZkU2sm3lDriEImHh2Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/e0086158e9b88a45803686959bf8e260,VRTX,Yahoo,"Vertex Pharmaceuticals' (NASDAQ: VRTX) stock has climbed nearly 20% so far this year, and for good reason.  The biotech company completed a regulatory submission for what may become its next blockbuster product.  Vertex and partner CRISPR Therapeutics hope to launch exa-cel, a gene-editing treatment for blood disorders, as soon as next year.",https://finnhub.io/api/news?id=bbb0560ff1e00b139a9ec8aa92b33f503592f2741aa3443d3c74528b91954b6a
company,2023-07-11 12:42:00,Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors,121350357,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.79% to $341.74 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=dc07e1f26453709a2089a1bb9aecfddf8728b58425b52c6094fbe8287dd9b955
company,2023-07-11 07:01:02,Is Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Latest Stock Performance Being Led By Its Strong Fundamentals?,121317560,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 6.0% over the past three months. Given that the market rewards...,https://finnhub.io/api/news?id=5f70e0c6aa26dde0662267a7a25eb6fad63a077596a29900d0f9b6f222100f56
company,2023-07-11 06:00:00,2 Top Healthcare Stocks Defying the Bear Market,121311185,,VRTX,Yahoo,Let's check out two top healthcare stocks that have defied the bear market -- and that could supercharge your portfolio over the long haul.  CRISPR Therapeutics (NASDAQ: CRSP) is at the start of what could be a big growth story.  The company specializes in CRISPR/Cas9 gene editing.,https://finnhub.io/api/news?id=57eb8a3d36322fe837ba5efd5bf114dc0b72b46b88cd44d656f02b7d72cca56a
company,2023-07-11 05:30:00,Sitting on Cash? These 2 Stocks Are Great Buys,121314947,,VRTX,Yahoo,Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term.,https://finnhub.io/api/news?id=bc31d1e8240437eabf2cf4aaed74bd5abeba2f06fb63c04d805c641988681507
company,2023-07-10 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,121350358,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.86% to $344.46 Monday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=103022ade193a87ca584b136d55a83f1f913035da1f2c9d43a00460ef6c859bb
company,2023-07-10 04:46:00,RBC Capital Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),121321783,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c116fea68878679b3ffef12c9318abeefd439c3bd909dbef6813fc5003ecbc32
company,2023-07-10 00:38:00,Here's How Much $1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today,121321784,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d9737ac257d589791ddbdbbf9af227435306844d6e7dfeb4e437e84334bbb11e
company,2023-07-17 12:43:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",121510581,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.49% to $357.98 Monday, on what proved to be an all-around great trading session for the stock market, with the...",https://finnhub.io/api/news?id=dfcd1e845d75b417b0af6ace45fc0e5ef0f535fc1cc2c9b048f7808c44fd4ea8
company,2023-07-17 07:34:00,Vertex Pharmaceuticals Unusual Options Activity For July 17,121459200,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=957c424d6e913b613f60f92e0f2c267ae3c304e78b212e94de3f21756db1e927
company,2023-07-17 05:30:00,2 Monster Stocks to Buy Without Any Hesitation,121422002,https://s.yimg.com/ny/api/res/1.2/bP8FjloIMY1VJvWSrzw_9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDE-/https://media.zenfs.com/en/motleyfool.com/3a402188988743c64f417e1f92dc8b39,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) brings in billions of dollars annually thanks to its cystic fibrosis (CF) treatments.  Vertex's Trikafta has the ability to treat 90% of CF patients today.  Vertex also is studying another candidate in pivotal trials that could even beat Trikafta.,https://finnhub.io/api/news?id=56902d6b5a765531099199df5fe551a4d532044df2882b325b7af9011f05ad80
company,2023-07-16 01:45:00,ClearBridge Aggressive Growth Strategy Q2 2023 Portfolio Manager Commentary,121412930,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/495508944/image_495508944.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,The ClearBridge Aggressive Growth Strategy underperformed its benchmark in the second quarter. Click here to read the full fund letter.,https://finnhub.io/api/news?id=999bf18c6e74384d50b7037949c0b929f3b4b03142c6043392953478028db546
company,2023-07-15 10:00:13,Should You Be Adding Vertex Pharmaceuticals (NASDAQ:VRTX) To Your Watchlist Today?,121405866,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...",https://finnhub.io/api/news?id=0ed42487efd47ed2a3843c2017883be0e282a0041df4c462031338920be63676
company,2023-07-14 12:54:37,More Challenges Await AbbVie Following A Disappointing Quarter,121394328,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1374841003/image_1374841003.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"AbbVie Inc., one of the leaders in the global immunology market, will release its financial report for the second quarter of 2023. Click here to read more.",https://finnhub.io/api/news?id=5dcefae653c6ddb97d78b5ea409041ed34cc77beab6f76dc5c9437d3a76dc4c0
company,2023-07-14 12:42:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains,121397529,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rose 1.07% to $352.74 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...",https://finnhub.io/api/news?id=72bd974af2a2eb0dff971586833bdd1d419bb54931ab34563a9a5fe32f216f5b
company,2023-07-14 05:30:00,Vertex Pharmaceuticals: Buy at the High?,121382243,,VRTX,Yahoo,Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year.  It's not surprising Vertex has advanced.  The company is about to erase investors' one big concern about its future: its dependence on one treatment area.,https://finnhub.io/api/news?id=0c903978757e47be02d289f2d4e2577434b4dcaa4dc94941d3cf8efdcbf8427b
company,2023-07-13 21:24:24,3 Pharma Stocks That AI is Loving in July,121489121,https://media.zenfs.com/en/investorplace_417/5b06085ec403fd81519de4f4d5892664,VRTX,Yahoo,"When it comes to investing in pharmaceutical stocks, an intriguing area for future growth is gene editing. This is an exciting field that may provide a solution to some of our most vexing diseases, such as cancer and diabetes. And in 2023, many companies are closer than ever to a solution. So, although I know that’s not how it works, it was interesting that when ChatGPT gave me a list of pharmaceutical stocks, it included several which have partnerships with gene editing companies. It’s importan",https://finnhub.io/api/news?id=d3c9274bb18dc0577045a9514b68ddeb1dcc257cc5d49b010c967c8b4565db98
company,2023-07-21 15:00:00,Vortex Energy Announces Further Extension of Marketing Campaign,121552191,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=54d7689af7ddfe7969ad0948c0d8941ea75b8fd257cc33a98db714a25cf0cd54
company,2023-07-21 12:42:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains,121538252,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.18% higher to $362.46 Friday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=51e0fe5f30e6fe3720b89a5eb494e69676b0dc8042085e07296cd296c6c5655c
company,2023-07-21 11:24:00,"Drug Stock Vertex May See Boost From Non-Opioid Painkillers, Says Analyst",121538253,https://images.barrons.com/im-821581/social,VRTX,MarketWatch,Leerink Partners analyst David Risinger raised his price target to $442 from $396. His new target indicates a 20% upside from the recent price of $365.,https://finnhub.io/api/news?id=5c48bef9b016d324cb77e530fc28c88c4099c398f87f80e36ae370181342e24a
company,2023-07-21 08:15:00,2 Soaring Stocks With More Upside Potential,121522989,,VRTX,Yahoo,"Investors looking for stocks with explosive growth potential would do well to take a gander at the biotech industry.  Clinical and regulatory wins can fuel excellent stock market performances for companies in the sector in a relatively short period, say a year.  With that in mind, let's look at two biotechs that have crushed the market this year: CRISPR Therapeutics (NASDAQ: CRSP) and Krystal Biotech (NASDAQ: KRYS).",https://finnhub.io/api/news?id=7a8ec6a971a9f3dc8e6d7d4123ff04ba3191189125b8100d42dfdd9e3a991e80
company,2023-07-21 08:00:00,B of A Securities Maintains Buy Rating for Vertex Pharmaceuticals: Here's What You Need To Know,121552192,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f69678bc7ec7a62768ee30f06e3be8622582f8789954683bae9f1942db0c7a1a
company,2023-07-21 07:00:20,Vertex Pharmaceuticals (NASDAQ:VRTX) stock performs better than its underlying earnings growth over last five years,121532033,https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b,VRTX,Yahoo,"The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...",https://finnhub.io/api/news?id=fd449ee901c77246882c9b65a3bbf17dfb389f9bb057e3e6dc126ae9a96aae78
company,2023-07-21 05:30:00,Is Now a Good Time to Buy CRISPR Therapeutics?,121522990,,VRTX,Yahoo,"CRISPR Therapeutics (NASDAQ: CRSP) may be a few months away from a transformation.  CRISPR and big biotech partner Vertex Pharmaceuticals submitted exa-cel, a gene editing candidate for blood disorders, to regulators in the U.S., Europe, and the U.K. And U.S. regulators expect to issue a decision on the candidate for one particular indication -- sickle cell disease -- in December.  Meanwhile, CRISPR shares have soared more than 40% since the start of the year.",https://finnhub.io/api/news?id=473c35edf00fc04f27e564c624bcd2107d50539431d9196f1fd581b8d8a82587
company,2023-07-21 04:00:00,Vertex Pharmaceuticals price target raised to $400 from $350 at BofA,121552193,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e59ad52f47679be474b93d6185b1fd1c98f57cb1f9ca14e47ff2106b721da02
company,2023-07-20 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",121510578,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.91% higher to $361.82 Thursday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=c8c647e1affd58d050c6338859576625fac3491f5e568da9e6e497214cb23c36
company,2023-07-20 12:37:48,Vir Biotech slumps to over 3-year low as flu prevention therapy fails trial,121502112,,VRTX,Reuters,Vir Biotechnology's shares plunged 45% to a more than three-year low on Thursday after the company's experimental antibody therapy to prevent a type of flu failed to meet its goals in a mid-stage trial.,https://finnhub.io/api/news?id=0744cf3f0e9e71e41b6bee0069c7968a8adbe0d794beb264c28fa6febe4c6d22
company,2023-07-19 17:50:21,Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know,121486506,https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $358.57, moving -0.11% from the previous trading session.",https://finnhub.io/api/news?id=e78c13b70537d50e2a6dbae120193becc9e491ced4a49dd7aab34ee2ab51cefc
company,2023-07-19 12:42:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,121510579,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.11% to $358.57 Wednesday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=417c2834d13f114c4afc0f8741aafc2e115c42f21e7bc948cfb678d49566ed16
company,2023-07-19 11:41:47,Royalty Pharma: Not Quite In The 'Buy Zone' Yet,121479220,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1395657524/image_1395657524.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Royalty Pharma shares have fallen 45% from their all-time high. Does that make RPRX a buy? Click here for our conclusion.,https://finnhub.io/api/news?id=0ed30aad0ed72d27cf14a989dcca8277d425de3c3236b2b3b55d2681726c560d
company,2023-07-19 08:15:00,3 Healthcare Stocks to Buy and Hold for the Next 10 Years,121467591,,VRTX,Yahoo,"The healthcare sector is unlikely to become obsolete anytime soon, but individual companies can very much get left behind if they fail to keep up with the changing dynamics of the industry.  Let's look at three healthcare stocks that are leaders or innovators in their respective niches and could provide excellent returns in the next 10 years: Vertex Pharmaceuticals (NASDAQ: VRTX), Moderna (NASDAQ: MRNA), and Gilead Sciences (NASDAQ: GILD).  Vertex Pharmaceuticals has soundly beaten the market in the past 10 years, and the company is in an excellent position to do so in the next decade.",https://finnhub.io/api/news?id=3e43132bf1b25824695836d51c4ae2e3164951f80dde0a7d54271dac92bb74ac
company,2023-07-19 05:49:03,Cramer’s Mad Dash on Vertex: Their non-opioid pain innovation could be 'the holy grail of medical',121475946,https://image.cnbcfm.com/api/v1/image/107273639-16897743471689774344-30371530909-1080pnbcnews.jpg?v=1689774543&w=1920&h=1080,VRTX,CNBC,CNBC’s Jim Cramer delivers his daily Mad Dash.,https://finnhub.io/api/news?id=11fde89f75f89898f890d0173afd37ce712444edbd66e0e2a96b5b917d390d0c
company,2023-07-19 05:21:00,3 No-Brainer Stocks to Buy With $400 Right Now,121466497,https://s.yimg.com/ny/api/res/1.2/v3FA.20nUCEf9sldMrFcgg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/72aa36cc74ad1005f775a361d3b799e5,VRTX,Yahoo,"Despite never knowing (with any certainty) when corrections will begin, how long they'll last, or how steep the ultimate decline will be in the major U.S. stock indexes, history has shown that every sizable drop was eventually put in the rearview mirror by a bull market rally.  With the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite still well below their all-time highs, bargains can still be had.  The first phenomenal stock that makes for a surefire buy with $400 right now is healthcare conglomerate Johnson & Johnson (NYSE: JNJ), which is perhaps better known as J&J.",https://finnhub.io/api/news?id=b072db51d12a7b1176d9a7d1efb3b857a337e94469ce5241cb4e837dd335769c
company,2023-07-19 04:09:00,bluebird bio gains as BofA upgrades citing FDA nod for new gene therapy,121475613,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0e067c89039dcb5ef8f5f40c5c66071761b4e2da129ee2e48ec03359c68eb485
company,2023-07-19 03:31:00,"Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling",121472207,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e4085e1a3197e4e19243a130a0dc55f4bee1831bc606f95115508215ebf13b8d
company,2023-07-18 23:16:00,3 Tech Stocks to Watch for Groundbreaking Innovations in 2030,121480591,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bc692a2a9d5c2936ac351406ca62a42b30d20693e4ebcbb431eaee64fb3d443f
company,2023-07-18 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Tuesday, still underperforms market",121510580,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.28% higher to $358.98 Tuesday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=963a146bcda1b3a2610a87fe16e533f19ecbe26ace1a2c1fab000b51675aa0e2
company,2023-07-18 05:39:00,Halozyme Therapeutics (HALO) Soars 5.4%: Is Further Upside Left in the Stock?,121443936,https://media.zenfs.com/en/zacks.com/bb23fde4664fe8d7e62272b04d0f4d01,VRTX,Yahoo,Halozyme Therapeutics (HALO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,https://finnhub.io/api/news?id=5c6863ff84eff3efd1cbe6502ab313408e38a5b52f23e8f2fba8d4a7c0d83673
company,2023-07-18 04:00:00,Vortex Energy enters into Agreement to Acquire Additional Mineral License in Newfoundland,121459198,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=10622a33b317f1455a838308ae78b0fef7646c2b7ab9326ee7cf05f2ff2d73f8
company,2023-07-25 17:50:20,Vertex Pharmaceuticals (VRTX) Stock Moves 0.28%: What You Should Know,121592964,https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $358.06, marking a +0.28% move from the previous day.",https://finnhub.io/api/news?id=0314c5dbd683ec6316de4b7c77196c338eaf778002953833dc1f2c79d8aa7801
company,2023-07-25 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,121698152,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.28% higher to $358.06 Tuesday, on what proved to be an all-around favorable trading session for the stock...",https://finnhub.io/api/news?id=1c2b5d48c29fbf3784bd6b92f0387b2c8bc201de6db47bdd93bc5fde2cd6b738
company,2023-07-25 10:01:24,Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth,121592966,https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9,VRTX,Yahoo,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=583eec88bbf2c8b4fd371b82717c75628921deead8ea713a952d86b04f54e4c3
company,2023-07-25 05:33:00,A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings,121593212,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9a67956750895a87c7982a54e8a7241eacb12e993cb4311aa4f89ba78cb5c3b6
company,2023-07-24 17:55:38,The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023,121707622,https://media.zenfs.com/en/investorplace_417/155568656c3c7c82033d9d467e5e2a90,VRTX,Yahoo,"Growth investors are frequently looking for biotech stocks to buy. So what exactly is a biotech stock? It’s a company that’s somehow involved in the creation of innovative drugs. This can be through research, development, or production. This sector saw a huge pandemic-related boost when the mRNA technology that many of them specialize in was thrust into the spotlight. The biotech industry is underpinned by some pretty undeniable growth trends. First and foremost is the aging global population. A",https://finnhub.io/api/news?id=5f16a99b70bb70f3f31acf714e4baed1cce516c2c570c34fd152241083fbaec8
company,2023-07-24 10:34:54,Vertex Shares Have Been Heavily Accumulated All Year,121572384,https://media.zenfs.com/en/fx_empire_176/98b4f7ccce248729fc9684c1ade06ae7,VRTX,Yahoo,"Vertex Pharmaceuticals, Inc. (VRTX) shares are up 25% in 2023. This uptrend is being powered by healthy appetite for the stock.",https://finnhub.io/api/news?id=92914e4abe3556eb9bbfec5d45dc014b5c6faa1b5ae54ef579c1172f1915e5fa
company,2023-07-24 00:00:00,Vortex Energy Announces Large Scale Hydrogen Storage Estimates at the Robinsons River Salt Project,121593219,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=4c1fe66faa5837449c1f50ee6e10d22c537d222153b646865217d19e87ef968c
company,2023-07-23 23:44:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors,121593220,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f5f764cb21a15fbe2d2f0c72f15a764111d7d698988ee67740e1e47f0254d3f7
company,2023-07-23 23:30:00,"Eaton Vance Worldwide Health Sciences Fund Buys Vertex Pharmaceuticals, Exits Dechra Pharmaceuticals",121577063,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=655f312d941a2ad7d4e7e1e336fc13f804f6e2712735be7d18852727ba5056ea
company,2023-07-23 22:00:00,"The Power Play by The Market Herald Releases New Interviews with Gamelancer Media, Soma Gold, Pelangio Exploration and Vortex Energy Discussing Their Latest News",121574036,,VRTX,Accesswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fee467c694fbd755d97c0bf707c9e6610f0bc61812c7e521809d7ec8a2bd7807
company,2023-07-22 05:50:00,"The Best Stocks to Invest $5,000 in Right Now",121546757,,VRTX,Yahoo,"Others could be worried about the stock market's nosebleed valuation and avoid stocks altogether.  Vertex Pharmaceuticals (NASDAQ: VRTX) hasn't skyrocketed 50% or more as some stocks have so far in 2023.  More importantly, I think Vertex has plenty of room to run.",https://finnhub.io/api/news?id=d7c8e17a41b6011b9a8e102fe5958bc60276997627ee4e55112d9a6437e35826
company,2023-07-22 03:38:52,B of A Securities Maintains Vertex Pharmaceuticals (VRTX) Buy Recommendation,121545135,,VRTX,Fintel,,https://finnhub.io/api/news?id=73e8a1830d8c34c15215cf7f01688deb0c3207764c388db9dce8f81e276756ec
company,2023-07-28 17:14:36,3 Biotech Stocks to Buy Before the Breakout,121804477,https://media.zenfs.com/en/investorplace_417/fbd46d09c1dbea1cc1b5fa33ff586264,VRTX,Yahoo,"During this Q3 of 2023, there have been many changes to U.S. healthcare at different levels. At the state level, there were changes to gender-affirming care. At the national level, the FDA has approved over-the-counter birth control pills and considered aspartame to be a carcinogen. The user count of telemedicine services continues to increase, and technological advancements in drug-making have led to the clinically testing a drug created by Artificial Intelligence in Hong Kong. These developmen",https://finnhub.io/api/news?id=8c4637a4a998f3eb90432d1a3d16c4a465120b659b252b5443971ab078e44c90
company,2023-07-28 13:01:08,Vertex & CRISPR Therapeutics - Partners On Exa-Cel - But Unequally Valued,121676338,,VRTX,SeekingAlpha,,https://finnhub.io/api/news?id=47c382f5bc3eb054393de85b3bc3eddd5dd93789c3e2b7bcab760043f804f7be
company,2023-07-28 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,121698149,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. rallied 1.26% to $354.05 Friday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=3246bcc62205874b3b0a1779734620dae7a312de030f17516c99583d859f81b6
company,2023-07-28 00:13:00,Vertex And CRISPR Therapeutics - Partners On Exa-cel - But Unequally Valued,121679619,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d25fac19c439d052b7cf73a8aec3b3f414b2ccc8af6439ffa0028cbae3e1158b
company,2023-07-27 21:46:00,Bernstein Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),121694997,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=16c89d3d5b0940548af5e2b12e3ee686d5e9dcdbf034df364eaaa9b471038ce9
company,2023-07-27 12:43:00,Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors,121698150,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. sank 0.65% to $349.64 Thursday, on what proved to be an all-around dismal trading session for the stock market, with...",https://finnhub.io/api/news?id=bbbcc4dcdd2f3dd306b47bd3fb284e7f802aedd394fdec554b3db3aadf98d17c
company,2023-07-27 12:38:00,Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?,121631379,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"On Vertex's (VRTX) Q2 earnings call, investors focus will likely be on the sales performance of its cystic fibrosis medicines and development updates of its non-CF pipeline.",https://finnhub.io/api/news?id=120cb9c0fe0293cc41d4ba6fa1ce4fc63fa1b7a849ae9ec309648ab27b4d9ace
company,2023-07-27 10:15:00,Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?,121627129,,VRTX,Yahoo,"Turning to equity markets is still one of the best ways for most people to accumulate wealth over long periods, so retirement savers should strongly consider this option.  Let's look at one biotech stock, Vertex Pharmaceuticals (NASDAQ: VRTX), and determine whether it falls in the first or the second category.",https://finnhub.io/api/news?id=fe17ed9b3a5a10259dfe9455cdb2bebf66ea5685c92f59d80a6a7457b1a375e2
company,2023-07-27 07:00:14,3 Biotech Stocks You Better Be Buying on Each and Every Dip,121765194,https://media.zenfs.com/en/investorplace_417/9518f083f65a4cb28beb7b1b2a7b1fae,VRTX,Yahoo,"Biotechnology is one of the most exciting and innovative sectors in the market, offering investors the potential for high returns coupled with groundbreaking discoveries. However, due to regulatory hurdles, clinical failures and intense competition, biotech investing also comes with high risks. Therefore, it is important to pick quality biotech stocks that have a competitive edge, solid financial position and clear growth strategy. Below are three biotech stocks that fit these criteria. These po",https://finnhub.io/api/news?id=d02d6512516ef2c6a6c10d40820e89114c6384b442358d06b016a949d4006645
company,2023-07-26 15:53:59,Crispr Therapeutics: Biotech To Watch With Regulatory Approvals Of Exa-Cel On Deck,121606735,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1567916715/image_1567916715.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"FDA review date of CRISPR Therapeutics exa-cel for patients with severe sickle-cell disease has been set for December 8, 2023. Find out more on CRSP stock here.",https://finnhub.io/api/news?id=82a0cbbe8932f5a87dbee957a9fba5d134ed441b22214a0b732dc711e633c066
company,2023-07-26 13:23:00,"If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names",121740490,https://media.zenfs.com/en/investorplace_417/180ce84be58b62c67d477717f09599bb,VRTX,Yahoo,"The biotechnology industry is simply amazing, always advancing and bringing new drugs to fight complicated and serious diseases. If you are thinking about investing in this sector, it is crucial to know the best biotech stocks that can give you great returns. In this article, I’m going to introduce you to three companies that are making waves in this field and are pioneering stocks in biotech. They are making a difference and deserve to be on your radar! Best Biotech Stocks: Regeneron (REGN) Sou",https://finnhub.io/api/news?id=3320563637d26743716986be9315eabb7ae409ffb9c2e77a1623c293892a653d
company,2023-07-26 12:43:00,"Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market",121698151,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.72% to $351.91 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...",https://finnhub.io/api/news?id=7ee0bb8661f4f91dd92578934b097bd520d9f486e4860e47cf95e1f6f2e9c9e1
company,2023-07-26 11:15:00,2 No-Brainer Cathie Wood Stocks to Buy Right Now,121607352,https://s.yimg.com/ny/api/res/1.2/8jXLuBp3lo13APICW49BGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03ODI-/https://media.zenfs.com/en/motleyfool.com/34af273c0ea7144bb0e9537ee096e670,VRTX,Yahoo,Cathie Wood is enjoying a remarkable comeback in 2023.  Pharmaceutical behemoths Vertex Pharmaceuticals (NASDAQ: VRTX) and Pfizer (NYSE: PFE) are perfect examples.  Read on to learn more about these two low-risk Cathie Wood stocks.,https://finnhub.io/api/news?id=70b49864cd412904fa31b800652116e4515ab79ab4364728bc5cbd68737e1db7
company,2023-07-26 10:02:16,Earnings Preview: Repligen (RGEN) Q2 Earnings Expected to Decline,121607353,https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9,VRTX,Yahoo,Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=5fbfdf787d75e0d1b18553b007920ae4f9cb18ce5d25bbd75691cecedfa47908
company,2023-08-02 19:33:05,Vertex Pharmaceuticals (VRTX): A Fairly Valued Stock with Strong Growth Prospects,121811237,https://media.zenfs.com/en/us.finance.gurufocus/18f710f044682ffbecac1706736afb23,VRTX,Yahoo,"Vertex Pharmaceuticals Inc (NASDAQ:VRTX) saw a daily gain of 3.07%, with an Earnings Per Share (EPS) (EPS) of $12.56.  Read on to discover more about Vertex Pharmaceuticals' financial performance and its value as per the GF Value Line.  Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a leading biotechnology company that focuses on the discovery and development of small-molecule drugs for treating serious diseases.",https://finnhub.io/api/news?id=65d4fb60ed78578db05858e4604d156ef1353798bdd9ed96c511b97775e737ff
company,2023-08-02 18:08:48,S&P 500 Gains and Losses Today: Weak Guidance from AMD Weighs on Chip Stocks,121781925,https://s.yimg.com/ny/api/res/1.2/dcse5YMFUPffdedK4CGZgw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xMDM3/https://media.zenfs.com/en/investopedia.com/d31d1971b436b4299d277bf8635ad923,VRTX,Yahoo,"The S&P 500 index finished 1.4% lower on August 2, 2023, after chipmaker AMD issued weaker-than-expected third-quarter guidance, which weighed on the sector.",https://finnhub.io/api/news?id=4de033655a99ce6fd60216d089ed2a412660b3773dd58a76cf6c0324c2640188
company,2023-08-02 16:15:00,1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August,121782833,https://s.yimg.com/ny/api/res/1.2/8D3WuCjWWRyuu9eWCL2GwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/6d943d30ed0b3cf87d086e271ead53ad,VRTX,Yahoo,"Cathie Wood has made a remarkable comeback in 2023 after a disappointing year for her Ark Innovation ETF in 2022.  The fund has dramatically outperformed the broader markets this year, as investors flock to buy undervalued tech and biotech stocks.  The gene-editing pioneer Crispr Therapeutics (NASDAQ: CRSP), for example, stands out as a potential gold mine for risk-tolerant investors.",https://finnhub.io/api/news?id=389c61b87e6ad3311ac737aa884024a43f0b01cff5950ab3af7e815f2ebfa732
company,2023-08-02 16:03:05,Vertex Stock Surges As Investors Eye Its Chockfull Calendar Of Expected Drug News,121811240,,VRTX,Yahoo,"Vertex Pharmaceuticals faces numerous catalysts this year and next, an analyst said Wednesday. And VRTX stock popped.",https://finnhub.io/api/news?id=2c25911270340f84859526c56d7d533e256c5eeb2abcb6e82f5abf3520b36fd6
company,2023-08-02 12:50:05,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2023 Earnings Call Transcript,121811241,https://media.zenfs.com/en/insidermonkey.com/1b68bb36c75ef75472617b8c48f21d38,VRTX,Yahoo,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2023 Earnings Call Transcript August 1, 2023 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $3.89, expectations were $3.88. Operator: Good afternoon and welcome to the Vertex Pharmaceuticals Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn […]",https://finnhub.io/api/news?id=d0b597f68485863d6a67abab28f636175fe45e07226f51df9e6ed64a94d068f0
company,2023-08-02 12:06:00,"Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View",121774095,https://media.zenfs.com/en/zacks.com/5c26ab1f8b890434759145296588998c,VRTX,Yahoo,"Vertex Pharmaceuticals' (VRTX) second-quarter 2023 earnings and sales beat estimates. Based on strong Trikafta uptake, management raises its financial guidance for 2023.",https://finnhub.io/api/news?id=3485bddd62dfbf49882d60a0bf43207f5cabf857f13316fc155c7fc5cdb92b8e
company,2023-08-02 10:07:05,Vertex Stock Wavers Despite Chock-Full Calendar Of Expected Drug News,121768687,,VRTX,Yahoo,"Vertex Pharmaceuticals faces numerous catalysts this year and next, an analyst said Wednesday. But VRTX stock wavered.",https://finnhub.io/api/news?id=73c095f268063437ce45a2ca3eae168d8aa850af46fa6f6ff6bce45bd682c224
company,2023-08-02 10:04:56,Oppenheimer Reiterates Vertex Pharmaceuticals (VRTX) Outperform Recommendation,121767351,,VRTX,Fintel,,https://finnhub.io/api/news?id=a811fbcb94139bc98f6ce84fab05ddcaaf8b2f8534126a6bc18204a9f84df7f0
company,2023-08-02 10:04:52,BMO Capital Maintains Vertex Pharmaceuticals (VRTX) Outperform Recommendation,121767353,,VRTX,Fintel,,https://finnhub.io/api/news?id=7f6904f7c212b550c5b72e38b51d0d6f4f04dacfe3a14dc513ecd11370f961be
company,2023-08-02 10:04:52,Wells Fargo Maintains Vertex Pharmaceuticals (VRTX) Overweight Recommendation,121767352,,VRTX,Fintel,,https://finnhub.io/api/news?id=bd3125fba21e5755b42dcfa850cff58c4f551ad95d452e9ac3f602f26d741eb0
company,2023-08-02 09:16:07,Q2 2023 Vertex Pharmaceuticals Inc Earnings Call,121768689,,VRTX,Yahoo,Q2 2023 Vertex Pharmaceuticals Inc Earnings Call,https://finnhub.io/api/news?id=c075395acc0b14506b061fd907d96ca72c202a4244a6a0ef5a63a38f7049f54e
company,2023-08-02 07:47:06,HC Wainwright & Co. Reiterates Vertex Pharmaceuticals (VRTX) Buy Recommendation,121764469,,VRTX,Fintel,,https://finnhub.io/api/news?id=d2888bdddd009b048d269adb0e1056051be0f2f7363e9b31c1a52a8ad352ad03
company,2023-08-02 07:47:02,Bernstein Maintains Vertex Pharmaceuticals (VRTX) Outperform Recommendation,121764470,,VRTX,Fintel,,https://finnhub.io/api/news?id=10894352bd37726a40021c469c10dfd509a488c5ae0ab90fc353624cc3f8ad1e
company,2023-08-02 07:46:58,Barclays Maintains Vertex Pharmaceuticals (VRTX) Overweight Recommendation,121764471,,VRTX,Fintel,,https://finnhub.io/api/news?id=df7813089a01fc57e5d2952eb8bb1caf38a95490dcdf8750841d002061f7329f
company,2023-08-02 05:31:00,"Analysts’ Top Healthcare Picks: Tenet Healthcare (THC), Vertex Pharmaceuticals (VRTX)",121803844,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d311c10785995574ab146a7f8b0a0d2413ebd30dc642d1ba206ec722e31c3633
company,2023-08-02 04:19:00,Vertex Pharmaceuticals price target raised to $425 from $410 at Wells Fargo,121805027,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=68921d3199761ae603e4967c64d14f5745841f7cf5f909ec48b744248063772d
company,2023-08-02 02:35:00,Vertex Pharmaceuticals price target raised to $370 from $360 at TD Cowen,121805029,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b19c05b19ff27c7dd6533cd3ca2d6d604d38d14c0c9369a2ba3c0d2a8d8a4a22
company,2023-08-02 02:31:00,Wall Street Analysts Are Bullish on Top Healthcare Picks,121778465,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7da2b0fcc008afac4f091701543786137f72463882bc0aaadd1a341a7ed91855
company,2023-08-02 01:24:00,Vertex Pharmaceuticals price target raised to $390 from $380 at Bernstein,121805035,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b8102a983e6d098e218d78e09c9393b8e3b8fee35bebc664e0f26aa4d28fb1c4
company,2023-08-02 01:21:00,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Entrada Therapeutics Inc (TRDA) and Minerva Neurosciences (NERV)",121771921,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9942c67e644546e2a9540d38798bbcb2d01fca83cd5910cb770b50360ac7eb39
company,2023-08-02 00:48:00,Vertex Pharmaceuticals price target raised to $399 from $384 at Barclays,121805038,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fd786dd4ae226e0c8dbaf5a300d86d29fc1878f834b15f47bd7abc82c9d24b23
company,2023-08-02 00:33:00,"Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Vertex Pharmaceuticals (VRTX) and IQVIA Holdings (IQV)",121780775,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6cc753821781e2b27a1f567b8fdf4054b86aea01430ab0ca84e51a2fcc0f3558
company,2023-08-01 23:44:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,121805040,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=f8e88dab2e8e04a9d2defe21d9be0ea64be6c7841f76cbb9ddaf45374ea621e7
company,2023-08-01 21:46:00,Bernstein Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),121805041,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9500d3150836d39646384b835d6cc6b20f8a080003c8748657ec59fba3c79aa2
company,2023-08-01 21:15:00,"Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline",121778467,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=36b39c731e35867f38cf035332597c398843bcb12bf306193f106796b5627a72
company,2023-08-01 21:00:25,Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript,121758245,,VRTX,Yahoo,"My name is Susie Lisa, and as the senior vice president of investor relations, it is my pleasure to welcome you to our second-quarter 2023 financial results conference call.  On tonight's call making prepared remarks we have Dr. Reshma Kewalramani, Vertex's CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief financial officer.",https://finnhub.io/api/news?id=3222035c02813775f4d64863aa685c309bc4b35dc2e7a621205ea50d516de914
company,2023-08-01 18:53:02,Vertex Pharmaceuticals Incorporated (VRTX) Q2 2023 Earnings Call Transcript,121757629,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,"Vertex Pharmaceuticals Incorporated (NASDAQ:NASDAQ:VRTX) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ETCompany ParticipantsSusie Lisa - CFA, Senior Vice President of Investor...",https://finnhub.io/api/news?id=f38046a8ffb5ef7f9f43e15a6dda3343a4a6a1e482258c9a036b07a740363354
company,2023-08-01 18:28:53,"Dow Jones Futures Fall On U.S. Debt Downgrade; AMD, ELF Lead 5 Earnings Movers Late",121751938,https://media.zenfs.com/en/ibd.com/2797379671af2ddf44cba019e2b33855,VRTX,Yahoo,Futures fell as Fitch downgraded U.S. debt ratings. AMD and ELF Beauty were big earnings movers late,https://finnhub.io/api/news?id=56f1b94598d390a58da81944aa357744983e1274d7a7eb9936952a256b4abdc6
company,2023-08-01 17:15:06,Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates,121755714,https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83,VRTX,Yahoo,"Vertex (VRTX) delivered earnings and revenue surprises of 1.04% and 3.47%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=d57e4a55b3dd00cc0cfbfed95a5e038762631e6c81da29b81b8ae6ba1f6fec0d
company,2023-08-01 17:15:05,Cash Machine Vertex Rides A Single Drug To Its Second-Quarter Beat And Raise,121752438,https://media.zenfs.com/en/ibd.com/36341c7359b2a531328260e35b43cafc,VRTX,Yahoo,"Vertex Pharmaceuticals rode cystic fibrosis pill Trikafta to a beat-and-raise on Tuesday, but VRTX stock inched lower.",https://finnhub.io/api/news?id=cf83a55cbad80f58df63c1d4afcd3b0f476797a1400f4110ab61b3af6fbeb8bf
company,2023-08-01 16:47:22,Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength,121756646,,VRTX,Reuters,"Vertex Pharmaceuticals raised its full-year sales forecast on Tuesday, banking on strong demand for its cystic fibrosis (CF) treatment.",https://finnhub.io/api/news?id=fcdb4d0fc273c0a7c08224c30af922848e2c6902e5bda95eea3417d73571443d
company,2023-08-01 16:01:00,Vertex Reports Second Quarter 2023 Financial Results,121752442,https://media.zenfs.com/en/business-wire.com/9d64407ba6718373c9a58828ee5aade0,VRTX,Yahoo,"BOSTON, August 01, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the second quarter ended June 30, 2023 and updated its full year 2023 financial guidance.",https://finnhub.io/api/news?id=54407e399e7b101fa73a79f3dbf1016ff5cc10ceb24296354699646d9bde5864
company,2023-08-01 13:02:00,"Vertex second quarter earnings rise, driven by treatments performance",121750282,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=44373f27baf238cc0129ddc7621db03a3dd7c3f32b40d12b4b267ad16996d436
company,2023-08-01 12:42:38,Vertex Pharmaceuticals Incorporated : Q2 2023 Presentation,121747301,,VRTX,Finnhub,"Post PoC VX-880 - Post PoC
          
          
            VX-548  - Phase 2 VX-864  - Phase 2
          
        
      
      
        
          
            
              
                PoC:...",https://finnhub.io/api/news?id=fbd2864c1e64457359f0c6eddcf5a95b0a4a679fa7e79b39203e53282c2037b5
company,2023-08-01 12:34:02,Vertex Pharmaceuticals 2Q Profit Up On Higher Cystic Fibrosis Drug Revenue,121746981,,VRTX,Finnhub,"By Paul Ziobro 

  Vertex Pharmaceuticals posted higher second-quarter earnings, boosted by higehr sales of its cystic fibrosis drugs. 

  The Boston-based drugmaker on Tuesday reported a profit of...",https://finnhub.io/api/news?id=5aebb10cc551d5c7da5e028db754d3b6e6ec61c9b3dcb35c905d6bf277b35203
company,2023-08-01 12:11:26,Vertex : Q2 Earnings Snapshot,121745745,,VRTX,Finnhub,"BOSTON  — BOSTON  — Vertex Pharmaceuticals Inc.  on Tuesday reported second-quarter profit of $915.7 million.
  The Boston-based company said it had net income of $3.52 per share. Earnings,...",https://finnhub.io/api/news?id=28ce5a2bcd336b58320de3e531036f85cfd672ad0fd3c02d8d058bca0be0f9d3
company,2023-08-01 12:06:00,Vertex: Q2 Earnings Snapshot,121750283,,VRTX,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a347f0473f88a1b89d7ca0d31dca3a28017e1082616c94c68d18e3f43cf3fa8e
company,2023-08-01 07:54:00,"Stocks Dip, Bond Yields Rise And Dollar Gains As Investors Turn Cautious: What's Driving Markets Tuesday",121739146,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=7baf45c9b4bc1960ac657a2db17e67ce4611d8d0dc4e537a25ea2ef9e97a76ac
company,2023-08-01 07:37:00,Peering Into Vertex Pharmaceuticals's Recent Short Interest,121750286,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=485b9372e9d5b38cf5b0c23f6ce9f56bf986dac9b6ea4faf68c9b859d6a8191f
company,2023-08-01 01:52:00,"Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested",121735694,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e1d91a7658d236c5ca9bc5d983f8666d6d0b8502a6ef23bcaa2997abf7063b0
company,2023-08-01 00:00:00,Vortex Energy Closes Purchase of Additional Mineral License in Newfoundland,121750288,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=9d10bbb83530d28e8c488c73459e3abaf5625b089b04e89ef8a65e3703798816
company,2023-07-31 23:46:00,Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),121750289,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fb174ef31e2aec797e75205085aebf583a2134529edac21ad0c1a5e15fc05ca8
company,2023-07-31 23:44:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",121750290,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=87af2bb23a7e9ee218ec102596a79803dc1426877ed766f53dfab3ee8827c1d1
company,2023-07-31 23:06:00,"Vertex Pharmaceuticals Non-GAAP EPS of $3.89 beats by $0.01, revenue of $2.49B beats by $70M",121750292,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ce91c1eea2b9b92c6b63ae70e8178ccacad612a91488a1a754686a5349a8d5d9
company,2023-07-31 23:06:00,Vertex Pharmaceuticals raises FY23 CF product revenue to $9.7B-$9.8B,121750291,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d19d13064eeaa09e2519e2c5aea6050e5bcf47692811111e6a217ae4e50c2eb6
company,2023-07-31 23:05:00,"Vertex Pharmaceuticals reports Q2 EPS $3.52, consensus $3.88",121750293,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=09ee79b1ad4649ca6cbe8e8e58840aa61aaa54eb02fc44410e0b0f5029677076
company,2023-07-31 09:58:00,"Drug, Biotech Stocks' Q2 Earnings Due on Aug 1: PFE, MRK & More",121716363,https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c,VRTX,Yahoo,"Let's look at five big biotech, pharma companies, PFE, MRK, VRTX, EXEL and INCY, slated to release quarterly results on Aug 1.",https://finnhub.io/api/news?id=08194fd8c4ac490e48c6c18b46b5ee867e500e2b7e58e95d1a13a894c899f834
company,2023-07-31 06:24:00,"Rising Stars, Falling Trends: July's Industry ETF Winners And Losers",121714630,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a2513ac2c4e93ac45d5789202c68488577f66e023b45bf60ebb00af1e564493d
company,2023-07-31 05:30:00,These 2 Stocks Are Heading for a Big Moment. Time to Buy?,121716166,https://s.yimg.com/ny/api/res/1.2/TsZG8jnkaq1mP3I7pUwamA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8de45eaf2636e765318d3b72787bbf30,VRTX,Yahoo,"Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) both are approaching a crucial moment in their stories.  The biotech companies are awaiting regulatory decisions for exa-cel, their potential blockbuster treatment for blood disorders.  For Vertex, this represents a first step beyond its cystic fibrosis (CF) specialty.",https://finnhub.io/api/news?id=7f2987ea2c9a83a91d312a139eecf4568efc7cfee86de093bf4e5e08a6da8d09
company,2023-07-30 23:44:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,121723927,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b0a6b85e861294f0c4f63da7f7b5e1be4c4dbcf0cec81e253205ab1b97001baf
company,2023-08-06 09:15:00,2 Top Biotech Stocks to Buy in August,121859503,,VRTX,Yahoo,"Consider biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Eli Lilly (NYSE: LLY).  Vertex Pharmaceuticals is best known for its dominance of the market for therapies that treat the underlying causes of cystic fibrosis (CF).  In the second quarter, the company's top line of $2.49 billion jumped by 14% year over year.",https://finnhub.io/api/news?id=931e5f1bff231e7a1b5b2d5eebfa617e91cfa90afcaebce37562faf3b9447db0
company,2023-08-05 09:15:00,3 Top Healthcare Stocks to Buy for August,121847926,,VRTX,Yahoo,"Shares of Humana, Vertex Pharmaceuticals, and Idexx Laboratories have all increased by at least 20% so far this year.",https://finnhub.io/api/news?id=f9f1ca63a442d0cf9f522b0e427f14c5bbb710df3fec51946b9125f98480c3e8
company,2023-08-05 06:55:00,3 Fantastic Growth Stocks to Buy in August,121847329,https://s.yimg.com/ny/api/res/1.2/bl33t7buqyLYhNDZ_lURHA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/515807248283f33de96485e7625b360e,VRTX,Yahoo,What's a great thing to do during the hot month of August? One option is to find somewhere cool. Another is to invest in stocks that could deliver their own kind of sizzle. We asked three Motley Fool contributors to identify some fantastic growth stocks to buy in August.,https://finnhub.io/api/news?id=89de4543e644c958781bd441fc1bf22987c3d2417b03bc31e2a22da869274dc1
company,2023-08-04 09:30:15,Vertex (VRTX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates,121821719,https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9,VRTX,Yahoo,"Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",https://finnhub.io/api/news?id=0c69f5c3c09bf56329d939c3a6995c26f33bad282c0abb34b2c70574a7f6da18
company,2023-08-04 07:28:29,12 Best Biotech ETFs To Buy,121816783,https://media.zenfs.com/en/insidermonkey.com/20f5140b0d6593c9f87e143fb6bf21b3,VRTX,Yahoo,"In this article, we discuss 12 best biotech ETFs to buy. If you want to skip our detailed discussion on the biotech industry, head directly to 5 Best Biotech ETFs To Buy. According to Precedence Research, the worldwide biotechnology market was valued at approximately $1,224.31 billion in 2022. It is projected to reach a value […]",https://finnhub.io/api/news?id=af1e1b6f8477b7d8f0479f16bd95d787edeee13485c3c13722b1776c33cc1845
company,2023-08-04 05:54:24,Vertex Announces Publication of VX-548 Positive Phase 2 Proof-of-Concept Results in New England Journal of Medicine,121819625,,VRTX,Finnhub,"a rare, life-threatening genetic disease - and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust clinical pipeline of investigational small molecule, mRNA, cell...",https://finnhub.io/api/news?id=c5d7fe71c72871dc068112d7fa1d1bbf00964abb7770d9f78e2338b1eaa58934
company,2023-08-04 05:21:00,2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid,121814426,https://s.yimg.com/ny/api/res/1.2/bjRzvQpguol.TXRYAOhkVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MTA-/https://media.zenfs.com/en/motleyfool.com/020b3ce301bb38cc63f04d7698b0c4b6,VRTX,Yahoo,"Two Nasdaq 100 components are plain-as-day bargains, while another Nasdaq 100 stock could struggle to live up to lofty expectations.",https://finnhub.io/api/news?id=bc2109dc750f989ceefe379827ccc41a618c1eec02cfd87e0de8a60152bf8af7
company,2023-08-03 23:44:00,Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors,121850508,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6ff7bc1b52bd01dad7f06ed5b704fe54cad3b911ab4ce8f7b8f69b0db58f2dee
company,2023-08-03 22:26:00,Vertex Pharmaceuticals (VRTX) Gets a Hold from Robert W. Baird,121825515,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=e02f0330f2423c271e0589b8f02c6beff03f413fdb109779ecceb9118c6355a1
company,2023-08-03 09:23:00,"Company News for Aug 3, 2023",121806122,https://media.zenfs.com/en/zacks.com/aac9cf811d947ca04e386fc3eb384f65,VRTX,Yahoo,"Companies in The News Are: VRTX, DVN, AFL, HUM",https://finnhub.io/api/news?id=ca4b518b62b67e9d1d305f7c16bd95206d11106b7a164ba9df7a31395688cd3d
company,2023-08-03 08:00:00,"Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine",121811234,https://media.zenfs.com/en/business-wire.com/8afb7e3130510b946535ebeaf88da1e4,VRTX,Yahoo,"BOSTON, August 03, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced publication in the New England Journal of Medicine (NEJM) of preclinical data and the results from its Phase 2 proof-of-concept trials evaluating treatment with the selective, oral NaV1.8 inhibitor VX-548 for acute pain following abdominoplasty and bunionectomy surgeries.",https://finnhub.io/api/news?id=198da8b99030f85918112a93069f2cd3a0b964b616aa7bde089916634731676d
company,2023-08-03 07:59:00,Regeneron Pharmaceuticals Inc: A Biotech Powerhouse with High Outperformance Potential,121800711,,VRTX,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=00e34fa766edd10e23d68516b4ba854e3386a8a1ebd38c596b2bd79422064528
company,2023-08-03 05:51:00,This Is Arguably the Single Best Stock to Buy Right Now,121811235,,VRTX,Yahoo,Here are five arguments for why Vertex Pharmaceuticals (NASDAQ: VRTX) deserves the honor.  Vertex is fresh on my mind because it just reported great second-quarter results.  Vertex's net profit margin of close to 37% makes it one of the most profitable drugmakers on the planet.,https://finnhub.io/api/news?id=167118927505e289e3ef9c8870e8f57a314cde8dc17a18881e9b7e69edab901f
company,2023-08-03 04:10:00,"Vertex: VX-548 preclinical studies, Phase 2, proof-of-concept results published",121805014,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a49954f51932ce94ca035dd3233362caec852ce5ebf326307e313def46cc9695
company,2023-08-03 03:21:00,"Analysts Are Bullish on Top Healthcare Stocks: Oculis Holding (OCS), Vertex Pharmaceuticals (VRTX)",121797349,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b228b663421ebf8dd23b1626c5064857b357d471ec24510f6dcd5595a9639c48
company,2023-08-03 02:49:27,RBC Capital Maintains Vertex Pharmaceuticals (VRTX) Sector Perform Recommendation,121788588,,VRTX,Fintel,,https://finnhub.io/api/news?id=966ff42cea53c6a5a2790640e63935136d5d8fc77241c79ac589d1f6dfbb3b44
company,2023-08-03 02:49:23,Morgan Stanley Maintains Vertex Pharmaceuticals (VRTX) Equal-Weight Recommendation,121788589,,VRTX,Fintel,,https://finnhub.io/api/news?id=33070e6d6ae766ea17db8dec7e6128138bdcdb13c244134dae1fcd610a07eb19
company,2023-08-03 02:45:00,Maxim Group Remains a Buy on Vertex Pharmaceuticals (VRTX),121805020,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e1dc4e5d7e92770c05936580c02fcb35b9d9fd8bf246b7a9b4833ee9edc6378
company,2023-08-03 01:31:00,Here's Why Investors Should Buy These 2 Medical Stocks After Earnings,121788579,https://media.zenfs.com/en/zacks.com/179f4c375002ae13fe2efe3d4634dcec,VRTX,Yahoo,Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.,https://finnhub.io/api/news?id=2171c95a0e7c3ad1a3580d752555d24c60b83a0d91312c8a6778b8b3c3ad5c7d
company,2023-08-02 23:44:00,"Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market",121805022,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=be4cdf1b465c813b53c2487d29a92d952b857e02869729da288568ad5a15eda0
company,2023-08-10 10:50:27,Vertex: Continued Advances In Cystic Fibrosis Market With Expansion Plans,121960413,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1598361009/image_1598361009.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Vertex Pharmaceuticals is performing well in cystic fibrosis market with its drug Trikafta, leading to 2023 guidance increase. Find out why VRTX stock is a Strong Buy.",https://finnhub.io/api/news?id=6c20c1deadafbc73ca6ae690e132fa27eb22a992ece642dcf99fc9cdcb57ed6e
company,2023-08-10 06:40:00,Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?,121955780,,VRTX,Yahoo,"Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) has made for a solid investment over the past decade, more than quadrupling in value during that period.  The company is a leader in cystic fibrosis treatments with an eye for more growth and diversification in the long run.  Does Vertex have the potential to be a millionaire-making investment going forward?",https://finnhub.io/api/news?id=0a8c6199331b0336dab492225fb3ea3ffe1b42e5ca030c6793394910146503de
company,2023-08-10 06:00:00,Vertex Pharmaceuticals: Strategically Positioning For Future Success,121952247,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/643782354/image_643782354.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Vertex Pharmaceuticals showed strong Q2 '23 earnings, with a 14% revenue increase driven by international sales of Trikafta/Kaftrio and US growth. Read more here.",https://finnhub.io/api/news?id=4eb770d3c64fb5c5afd22dc42e1224edfe3e0a90c70299da36e6323be5deffe4
company,2023-08-10 05:50:00,3 Explosive Stocks to Buy Right Now,121949416,https://s.yimg.com/ny/api/res/1.2/nGdOq7CdMU2.6DCpj.oW5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/258240fcc29ebdc83b63910239fa8991,VRTX,Yahoo,"Some stocks are like the jack-in-the-box toy that kids play with. They wait and wait until the time is right, then they suddenly jump. Other stocks are more like the Energizer Bunny. They keep going and going.",https://finnhub.io/api/news?id=8bb2f7d6082149909a72a56884938b348e2dec5a3ea470732ba2182422fabd7f
company,2023-08-10 05:21:00,3 Top Biotech Stocks Defying the Bear Market,121948605,https://media.zenfs.com/en/motleyfool.com/dce7e2cf49f0fe9c427faecbf7208d98,VRTX,Yahoo,"If you look at the S&P 500, which is up more than 18% this year, or the Nasdaq Composite, which is up more than 34% in 2023, it appears the markets are booming.  The iShares Biotechnology ETF is down more than 3% so far in 2023, and the SPDR S&P Biotech EFT is down more than 5%.  The two ETFs reflect negative market sentiment toward biotech stocks, in general, this year.",https://finnhub.io/api/news?id=bc02d8fd34b650dec45e4add65eb9f9c0db81c610121b7ac4624001d0fcffb87
company,2023-08-09 23:44:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",121972209,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=008a5b70b6d042387e97b533ccc54ac83545089e812558b80cd35bb20b58a6a0
company,2023-08-09 14:30:00,2 Supercharged Growth Stocks That Could Make You Richer,121931085,,VRTX,Yahoo,"If you're looking for stocks that can deliver better-than-average returns in the long run, you might want to consider these two biotechs: Exact Sciences (NASDAQ: EXAS) and Vertex Pharmaceuticals (NASDAQ: VRTX).  Exact Sciences is the company behind Cologuard, a noninvasive test that can detect colorectal cancer and a fair amount of pre-cancerous polyps from a stool sample.  Colorectal cancer is the second-leading cause of cancer deaths in the U.S., but it can be prevented or cured if detected early.",https://finnhub.io/api/news?id=9763baa3ca449cef720b11738e3c507878b8a3339da3e8203a677ce795a763ec
company,2023-08-09 09:30:00,2 Great Stocks Under $100 to Buy and Hold for 10 Years,121924608,https://s.yimg.com/ny/api/res/1.2/Xa878VM_mnWDHwZaaKy86Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/87cc1ffa927486498f8ede5754a12554,VRTX,Yahoo,"Neither has performed well over the past year, but investors would do well to focus on the longer term.",https://finnhub.io/api/news?id=159910d88dd902ba282606038996154e11ed2850b5df1f7eb00fb494de0a8c86
company,2023-08-09 05:35:00,Is Vertex Pharmaceuticals Stock a Buy Now?,121931089,,VRTX,Yahoo,"As one of the hottest and most-watched companies in the biopharmaceutical sector, Vertex Pharmaceuticals (NASDAQ: VRTX) has a unique mix of stability and growth potential that's attractive to a broad crowd of investors.  Given its collection of medicines on the market and a highly promising pipeline that's packed with some very sophisticated candidates, buying its shares today could be a great decision in five years.  In short, Vertex is exposed to an abundance of growth opportunities in the near term.",https://finnhub.io/api/news?id=304daa8231da1b572fa14f8463311a9efe241c474ba9dd548e389b3643899e05
company,2023-08-08 23:44:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market",121942422,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a176e1379bbfa7140d1b2f16f709f64160f5db0e092c03374b7cfbe10ec89623
company,2023-08-08 12:14:52,Why CRISPR Therapeutics Stock Is Jumping Today,121905094,https://s.yimg.com/ny/api/res/1.2/TBGeCSPiEdBcRhHyStEgzQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/eeb274a51c378ffe28655205ef36d349,VRTX,Yahoo,Shares of CRISPR Therapeutics (NASDAQ: CRSP) were jumping 9.1% as of 11:31 a.m. ET on Tuesday after rising as much as 13% earlier in the day.  CRISPR Therapeutics reported second-quarter revenue of $70 million.  Credit Suisse's Richard Law reiterated a neutral rating for the gene-editing stock but increased his price target from $62 to $63.,https://finnhub.io/api/news?id=f79f9d2aa30ebccc2cbfe02ae9c5bd814aace5bde182108807bc7f52f5b37840
company,2023-08-08 11:09:00,CRISPR Therapeutics (CRSP) Q2 Loss Narrower Than Expected,121905097,https://media.zenfs.com/en/zacks.com/4718122d03716403704541c667907c4e,VRTX,Yahoo,CRISPR Therapeutics' (CRSP) second-quarter results beat the mark for both earnings and sales.,https://finnhub.io/api/news?id=3ad28aee18d92927e9804fc1f5f249bd2878af0aa6eb41ce468049736fea991f
company,2023-08-07 23:44:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,121942423,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=6ba59cc200341436eff2119cf66dd6d2b2304f0923e8bc804ad38a3833ae2905
company,2023-08-07 22:52:00,Why did CRISPR Therapeutics stock soar today? Q2 results,121903849,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ed00c4fc5327a3cf8b353d16b54ac2be74be7b05b5216df9643ddbc3e23e3b0f
company,2023-08-07 14:41:24,Canaccord Genuity Maintains Vertex Pharmaceuticals (VRTX) Hold Recommendation,121877114,,VRTX,Fintel,,https://finnhub.io/api/news?id=b0e2384cbc5c3ff1c67f76f23ff13aa9571f28ab531a62cfc7dde66ab8b5d98e
company,2023-08-07 11:01:00,CRISPR (CRSP) to Post Q2 Earnings: What's in the Offing?,121873191,https://media.zenfs.com/en/zacks.com/4718122d03716403704541c667907c4e,VRTX,Yahoo,"CRISPR (CRSP) currently does not have any marketed product in its portfolio. The company is expected to provide regulatory updates on exa-cel applications, along with other pipeline updates.",https://finnhub.io/api/news?id=92aad0cfade837cc50f0a68e3ded254dbcb70791fab2e59dfc14e545baecb696
company,2023-08-07 01:30:00,Vertex Pharmaceuticals price target raised to $315 from $312 at Canaccord,121872895,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a47aca64af6b7c140c75da2ac944b8c2a52c2eb82aded2a6569aba8cdf80b1f1
company,2023-08-06 23:44:00,"Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market",121903850,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e5b497fc7903f4dda19637aa231e8abffd3f56d5ae4a01098c94b091aae8264
company,2023-08-14 06:24:57,Vertex Pharmaceuticals Incorporated 2023 Q2 - Results - Earnings Call Presentation,122022458,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,VRTX,SeekingAlpha,The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2023 Q2 earnings call.,https://finnhub.io/api/news?id=33d0cc459eb65c9eeb58873f30741b9c0b251bc0b6882121b143224cb9b6f35f
company,2023-08-14 06:15:00,Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold,122021980,https://s.yimg.com/ny/api/res/1.2/HIbQgwRuk51ytsZDAr7Q9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9b8b9cadfdc3016fd331c82386206d61,VRTX,Yahoo,"The market experienced a wild ride in 2022, making investors hesitant to invest in the stock market.  In this recovering market, growth stocks that are still undervalued are a good option for risk-averse investors.  CRISPR Therapeutics (NASDAQ: CRSP) is a gene-editing biotech company.",https://finnhub.io/api/news?id=a08975460e754003cd3fd3c7b4ee5450ead1ab701ce01d2ed6aae107dac4f3a1
company,2023-08-14 03:00:00,Second Half Outlook For Biotech Stocks,122020901,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1135352098/image_1135352098.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,"Biotech stocks faced challenges in the first half of the year, with the Nasdaq Biotechnology Index losing 3%. Click here to read my thoughts.",https://finnhub.io/api/news?id=a07177ca11c3822b3066921c2b90b02d4d96fa59771bca0c5129d11cb3fcb5ea
company,2023-08-13 23:44:00,Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors,122096154,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=241b7600162f010bdd89d0335e3ff966ac71696c2e708dbe490b2e5d6b59512f
company,2023-08-13 22:03:00,Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years,122096155,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1da890238a2b117bfcc2c96c047f9c92fed4543634c79159eb14a95e5b2898e7
company,2023-08-13 05:52:00,Want to Get Richer? Buy and Hold These 5 Unstoppable Stocks,122011467,https://s.yimg.com/ny/api/res/1.2/y0IPQPoEPkFNTW7k7Vhi1g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/45c5e1bffa9b13e2325a7bda9288deff,VRTX,Yahoo,"A recent Bankrate survey found that Americans think they'd need to make $483,000 per year on average to feel rich. Few currently earn that amount, though. No one can honestly guarantee you that you'll become rich based on that definition.",https://finnhub.io/api/news?id=72f6ba3ba865ab358849ea3ae94095703ef173f6de18643eb5b20c3142b113d7
company,2023-08-13 00:55:35,Vertex Pharmaceuticals Still Looks Attractive,122011148,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418835107/image_1418835107.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals' Q2 financials showed strong revenue growth and it has some undervalued pipeline opportunities. Find out why VRTX stock is a Buy.,https://finnhub.io/api/news?id=b60496868eb51bf64e75f7e2cc0d703e5d3dbf0a5375a54aff96f3efe0adc6b9
company,2023-08-11 13:57:07,"Meta, Google, Tesla Lead AI Stocks And More For Weekend Watchlist",121988579,,VRTX,Yahoo,"Including Meta, Tesla and Google stock, this screen showcases top-rated AI stocks to watch in the Top 20 industry groups.",https://finnhub.io/api/news?id=af6886109de431f5aa2e8fcfb787806812652cedcd2279956815aa466090ddb7
company,2023-08-10 23:44:00,Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day,121994010,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=76f132da3668fd4c520fb1c5d7b2ccbd20110aa6c6bd4e56d2b73e103920cbba
company,2023-08-18 12:43:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",122208250,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.28% higher to $344.82 Friday, on what proved to be an all-around mixed trading session for the stock market,...",https://finnhub.io/api/news?id=185d6ac7acddbd1bcefecfbfac45a3f54445d69af5a7aceb64defa0dbc727ee9
company,2023-08-18 05:50:00,3 Monster Stocks to Buy Without Any Hesitation,122108757,https://s.yimg.com/ny/api/res/1.2/htyiH8Ok1Xb2pInHY3JndQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/325eb4f535733aa0247f0bb453578d13,VRTX,Yahoo,"Amazon (NASDAQ: AMZN) ranks as one of the biggest monster stocks on the planet with a market cap of close to $1.4 trillion.  The company is also on a roll, with its shares soaring more than 60% year to date.  Amazon has plenty of room to run.",https://finnhub.io/api/news?id=63eb4260fa8773a28c63284b3029c74f84d9d2d78ff3101c6e47e18f412ff03b
company,2023-08-17 21:48:00,Peering Into Vertex Pharmaceuticals's Recent Short Interest,122125383,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=fdffdddb7e0f733249449d45b127fd3eac31df874ef0f541807f62efc0fbf6bc
company,2023-08-17 12:43:00,"Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market",122208252,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.13% higher to $343.87 Thursday, on what proved to be an all-around dismal trading session for the stock...",https://finnhub.io/api/news?id=341aeb0cf99851a84f3fa17dcaf020c3a1b3a67b34c2cbb42a4dfa8951fbadbf
company,2023-08-17 09:20:00,2 Excellent Stocks to Buy and Hold Forever,122101345,https://s.yimg.com/ny/api/res/1.2/jwPnk.EoXjOrLEZMA_KfsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/9e2bcd47a1ac785c1d470fdb73d66d5d,VRTX,Yahoo,"Let's look at two healthcare companies whose shares are worth buying and holding on to for good: Vertex Pharmaceuticals (NASDAQ: VRTX) and Novartis (NYSE: NVS).  Vertex Pharmaceuticals has been an outstanding performer over the past decade.  In October 2020, Vertex Pharmaceuticals' shares dropped like a rock after it decided to discontinue a phase 2 clinical trial for VX-864, a non-CF program targeting alpha-1 antitrypsin deficiency that many thought was promising.",https://finnhub.io/api/news?id=2f4cc8add8130aa0f7c7fb166cceb8632ca3f100b1f53200b4519039355dbefc
company,2023-08-17 02:00:00,Vortex Energy Announces Its 2023 Fall Program on Its Robinsons River Salt Project,122096148,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c48f9cec1f88c5df409233e74a029a77e30b6586a69512962ad46e6b868d0c49
company,2023-08-17 00:18:00,The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023,122085069,,VRTX,InvestorPlace,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=cf8e9718b0eb1d13887b974a39915baab52fb9e1709eb54479c794dfcb563afb
company,2023-08-16 22:21:00,CRISPR Therapeutics upgraded to buy at Citi on near-term approvals,122090676,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=de0a3fd6ce5d02258cf02e0c5068eb150aee51ab4583943339f9d64b87b037bd
company,2023-08-16 16:01:00,"Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+",122078804,https://media.zenfs.com/en/ibd.com/a0087e245354977c880d4d8274a97075,VRTX,Yahoo,"Vertex Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.",https://finnhub.io/api/news?id=1bd372579dafef809277caa6735d5461cb190fcc035b6dabf550c11175b282b1
company,2023-08-15 23:44:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,122096152,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=1e07157f985bec360c6d154ca83ae5be7357121f6475215d18b7e21c45b1d9e5
company,2023-08-15 20:30:00,6 Pharma and Life Sciences Stocks That Are Actually Up This Year,122208254,https://images.barrons.com/im-836258/social,VRTX,MarketWatch,"For investors, tracking the stocks that are up in what has otherwise been a grim year for drugmakers can help identify trends in the market.",https://finnhub.io/api/news?id=e48a65cdd49c25dcfa5b4b73b08a791897a093f39f880f89feba61daa461da6a
company,2023-08-14 23:44:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,122096153,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=c0de1697142ddf78c6f33b4879bc80e8b085853bc8e035967e2d3d14a6511c65
company,2023-08-22 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,122208247,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.10% to $350.40 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...",https://finnhub.io/api/news?id=b14cd26cef5008790edda9c1833fe80dab5afefba6ffd8fe4b95ea039753cb0a
company,2023-08-22 10:00:00,3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,122164166,https://s.yimg.com/ny/api/res/1.2/2Y4WavxGRW3RRb4m9Jfgxw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/5b2761d8178b15cd6848ce3d278f59a2,VRTX,Yahoo,"Investors looking to earn outsized returns over long periods (which describes most investors) would do well to consider shares of innovative companies such as CRISPR Therapeutics (NASDAQ: CRSP), Sarepta Therapeutics (NASDAQ: SRPT), and DexCom (NASDAQ: DXCM).  Gene-editing specialist CRISPR Therapeutics currently has no products on the market.",https://finnhub.io/api/news?id=d4f5ae6edce8b433b893e4462b7c86e606d39fa5d2794abf9cdbb63420594d30
company,2023-08-22 04:20:00,Gene Therapy Breakthroughs On The Horizon,122162500,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291142709/image_1291142709.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,The Institute for Clinical and Economic Review has recently released a report about exagamglogene autotemcel from Vertex/CRISPR and lovotibeglogene autotemcel by bluebird. Read more here...,https://finnhub.io/api/news?id=0e3dc20a1a279b5fa7e15fd74b6104c805691eaa30a4a319ce4936d6964d81ed
company,2023-08-21 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day,122208249,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. advanced 1.72% to $350.74 Monday, on what proved to be an all-around mixed trading session for the stock market, with...",https://finnhub.io/api/news?id=1c839df39a888d399f8c44e7478e776f03b3b9b1872b6d260450ca08f971f1b2
company,2023-08-21 09:00:03,These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,122153074,https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,VRTX,Yahoo,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,https://finnhub.io/api/news?id=9712fe0aea3bb2e774ecb0e1f543b505a17d39f5a3040672d562308105da9506
company,2023-08-21 07:32:00,Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner,122167987,,VRTX,TalkMarkets,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=69cc7b9ae897565daa11296f7604a1c94e5f9d1ead14b73d33cb55044f706e31
company,2023-08-21 06:59:00,"Vertex/CRISPR, bluebird sickle cell therapies could be cost-effective - ICER",122167025,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d299c6c9c17d7ef3ca10eec5d4decfeadec244ec7add1be32b7461e0dabe18ca
company,2023-08-20 23:02:00,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",122168625,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=95a1501146562e48225074d47e1a4cdd910b67e6f13898cf0553e1465901b9b9
company,2023-08-19 05:06:00,4 Superlative Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip,122131253,https://s.yimg.com/ny/api/res/1.2/sDuLAEf9mEZYTreIn12s5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/c82c0b8eebe2e9bab0b5965446860d8c,VRTX,Yahoo,"With the Nasdaq Composite still 15% below its record-closing high, amazing deals are hiding in plain sight.",https://finnhub.io/api/news?id=ecb7857861c05d667da24d59e155898a27ca44907251eb7da48d448f015ea1ab
company,2023-08-25 12:43:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",122262122,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.95% higher to $350.06 Friday, on what proved to be an all-around great trading session for the stock market,...",https://finnhub.io/api/news?id=f3d0301932ac8c694b51452c4c03e3a2754f42e2262ab561017924f15de64502
company,2023-08-25 05:33:00,Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years,122238431,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=40196fabbf05cbabf5a5500da0a6d0000244a369cc73f9d3466ef059003c1ef0
company,2023-08-24 16:17:49,Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy,122328032,https://media.zenfs.com/en/investorplace_417/885dc5d5079dba1815226bb1cd01b3cf,VRTX,Yahoo,"The stock market recovered nicely from last year’s debacle. The Nasdaq Composite Index in particular went from a 34% loss in 2022 to a 29% gain so far this year. Yet even with all the major indexes trading higher than they were at the start of the year, The Dow Jones Industrial Average, S&P 500, and the Nasdaq are all well below their all-time highs of 2021. That suggests investors can still readily find no-brainer stocks to buy if they’re willing to look. And it doesn’t take a lot of money to m",https://finnhub.io/api/news?id=441d2eed72dbb5263f6815647096d15fcb51240b58d92a28c8fd6ad91915033b
company,2023-08-24 12:42:00,Vertex Pharmaceuticals Inc. stock outperforms market despite losses on the day,122262123,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 1.09% to $346.77 Thursday, on what proved to be an all-around rough trading session for the stock market, with the...",https://finnhub.io/api/news?id=f41588eea17740246d60a651a400c0537c438fb0eb11d18c8fb226abd6bad5f0
company,2023-08-24 07:30:00,2 No-Brainer Biotech Stocks to Buy Right Now,122199617,https://s.yimg.com/ny/api/res/1.2/nu1brphQXiyZ25JGOZYhIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/2af3a2590f0f0d756ff780def39f2a4f,VRTX,Yahoo,"Cystic fibrosis specialist Vertex Pharmaceuticals (NASDAQ: VRTX) has risen 19% in 2023, while cancer specialist Exelixis (NASDAQ: EXEL) has gained 31% -- and both medical areas are likely to see strong demand for a long time to come.  Vertex is well-known for its cystic fibrosis (CF) drugs and has maintained consistent revenue and profits in recent years.",https://finnhub.io/api/news?id=95679955498782490230b72d4b29a3e61ba90d6a7aa5b675681e916ab9b64534
company,2023-08-24 05:58:00,3 Clever Tricks to Find Winning Biotech Stocks,122198596,https://s.yimg.com/ny/api/res/1.2/3S_EkmPNTf9vR0JJTNiNZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/a0f4439163d1b6c070e2c900c5d864cf,VRTX,Yahoo,"Investing in biotech is not for the faint of heart, but knowing how to pick probable winners and avoid lemons can make the balance of risks and rewards look a lot more palatable.  In fact, having a playbook of clever tricks is a big part of succeeding.  Teamwork makes the dream work, and that's why most biotech players are eager to forge collaborations with other biopharma businesses, especially larger ones in big pharma.",https://finnhub.io/api/news?id=7fc3d1e51528643b2a2ec8102302ffaa2d9ae9bc03dadd9f83c830c2a7dfd213
company,2023-08-23 22:44:00,Bluebird bio favored at Baird as sickle cell disease space gets busy,122215742,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=bb54d67de3fbadbafab44956eabbe4477599c35bb5eeccbd3cb5929293b52a1d
company,2023-08-23 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",122208245,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.06% higher to $350.60 Wednesday, on what proved to be an all-around great trading session for the stock...",https://finnhub.io/api/news?id=7258dd49ed8b7cd0c63e4450bc3eeaaa417672da484ebb914a21bb2c2766ee7d
company,2023-08-23 06:37:00,December 15th Options Now Available For Vertex Pharmaceuticals (VRTX),122223479,,VRTX,Stock Options Channel,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d3866df3d2d80ec55db48a8b6eafe44ccfd94db1adb0d0c0dd3103d86ff3d0c1
company,2023-08-30 16:01:00,Vertex to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference on September 13,122328026,https://media.zenfs.com/en/business-wire.com/59f926f3990464ada6ed7821546a577a,VRTX,Yahoo,"BOSTON, August 30, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in the Morgan Stanley 21st Annual Global Healthcare Conference. Dr. Reshma Kewalramani, Chief Executive Officer and President, and Charles Wagner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat on Wednesday, September 13, 2023 at 11:30 a.m. ET.",https://finnhub.io/api/news?id=168290fad615279c7465bbaf42d4d033fffbfcb492a3ecb866aed546b72196d0
company,2023-08-30 12:43:00,Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors,122331147,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. shed 0.14% to $350.76 Wednesday, on what proved to be an all-around favorable trading session for the stock market,...",https://finnhub.io/api/news?id=42dfce6e3e3754bcd45d16d7bb6f055af2ef6b115b68d28e43aa6efc8efefd53
company,2023-08-30 12:23:14,Vertex makes room in its C-suite for new technical operations role,122328029,https://s.yimg.com/ny/api/res/1.2/DRskCSBZEX4QZbPCpfs8CA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xODAw/https://media.zenfs.com/en/bizjournals.com/7d18ae5e91ee6c69c628160c4afbb152,VRTX,Yahoo,Vertex Pharmaceuticals Inc. has promoted E. Morrey Atkinson to a new role in its C-suite: chief technical operations officer.,https://finnhub.io/api/news?id=1ce735d4f9961e026e341ea89c208da68f0a1ba10092fc04bb6b9d0c14292a8a
company,2023-08-30 09:27:00,Vertex (VRTX) Outperforms Industry Year to Date: Here's Why,122328030,https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e,VRTX,Yahoo,"Vertex Pharmaceuticals (VRTX) is expected to benefit from several catalysts this year. The company is likely to achieve multiple clinical milestones in 2023 and 2024, both in its CF and non-CF portfolio.",https://finnhub.io/api/news?id=1150330e083a4b68a72267a7b18b7e5b7bd84953e973436cce0fd4da0bace9e5
company,2023-08-30 03:16:00,Vertex Pharmaceuticals (VRTX) Receives a Hold from Jefferies,122318420,,VRTX,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=50db434bf35b535d61b53e55da4a278f8e0062bd452f0cbd841e14dbdf1987de
company,2023-08-29 12:43:00,"Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market",122331148,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slipped 0.10% to $351.26 Tuesday, on what proved to be an all-around positive trading session for the stock market,...",https://finnhub.io/api/news?id=7553595c4f0c2e3a52753293449b5379fbabcb36a6bca3ce04de7d20932f5979
company,2023-08-29 11:19:00,IN BRIEF: Vertex puts Atkinson in charge of technical operations,122318421,,VRTX,Alliance News,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=288c684e0b7c9773ca2d3d80d9eb2630b6a827b1d403fdefcbffb4261981279b
company,2023-08-29 09:00:00,"Vertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations",122328031,https://media.zenfs.com/en/business-wire.com/6a53c27d4b26e3386fa92a52c5ebe7b2,VRTX,Yahoo,"BOSTON, August 29, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that E. Morrey Atkinson, Ph.D., has been appointed Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations, effective immediately. Dr. Atkinson has served as Senior Vice President of Global Commercial Manufacturing and Supply Chain since July 2020. This new role and function unifies responsibility for small molecule, cell and gene thera",https://finnhub.io/api/news?id=66ac483ab2af78c08f1f2702a3df723c6cec86f02290fc0498efedf399d36013
company,2023-08-29 04:28:00,Vertex appoints Atkinson EVP Chief Technical Operations Officer,122318423,,VRTX,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=49acab70caa4b4afce45895884db62fa23a59fd3a3b0f7bc6cfa376026a2326e
company,2023-08-29 04:06:00,Vertex appoints Atkinson  EVP Chief Technical Operations Officer,122318424,,VRTX,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=204f21fdea24455dedc7154e7fe4c70bb69969b7b5f85961e5d4c96e40262fc3
company,2023-08-28 18:29:27,Crispr Therapeutics: ICER Puzzles The Prospects,122293006,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1451099185/image_1451099185.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,CRISPR Therapeutics' collaboration with Vertex on gene-editing therapy for sickle cell disease and thalassemia faces uncertainty. Read here for more details.,https://finnhub.io/api/news?id=0d0fed37fee5045c63005b66a2d272dc20f2a7b56d0760bce6ecc5129f20af72
company,2023-08-28 12:42:00,"Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",122293867,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.44% higher to $351.60 Monday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=73f94a33f15798b4be14acaf218353f76fca1564aaa581f1248bab8c0278ad4c
company,2023-08-28 08:30:00,3 Top Growth Stocks I'd Buy Right Now Without Hesitation,122274430,,VRTX,Yahoo,"Growth stocks are back in style after getting battered in last year's downturn.  Vertex Pharmaceuticals has a significant catalyst ahead.  The company is awaiting approval for exa-cel, a treatment for sickle cell disease (SCD) and beta-thalassemia (TDT) developed with CRISPR Therapeutics.",https://finnhub.io/api/news?id=ece2435af5500fad35ef7a9e8d857426342e62f0340417a8bc8e781ac94f6a3f
company,2023-08-28 03:23:00,"Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling",122277360,,VRTX,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=13d4df4a3552010d865f279d794f30ced53ed7996264107c0074e53e1be8cd85
company,2023-09-01 17:45:15,Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know,122386758,https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a,VRTX,Yahoo,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $351.13, marking a +0.8% move from the previous day.",https://finnhub.io/api/news?id=1f9977a998bf80ffd12b2973ad26c039567e5ec8ae3beb8e9284e8679738cf73
company,2023-09-01 15:00:00,Vortex Energy Announces Further Extension of Marketing Campaign,122391802,,VRTX,GlobeNewswire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=5a7ccd70003901fc33f018abc9a164e798564a2e1b1246643e7623e7a84bbe10
company,2023-09-01 12:43:00,"Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market",122411831,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. inched 0.79% higher to $351.10 Friday, on what proved to be an all-around positive trading session for the stock...",https://finnhub.io/api/news?id=a51699c7d1c9841fe0c6afd3995b7e74f8af5ef8146b57f9dfdaf1d2dbac5fbe
company,2023-09-01 11:31:38,Sarepta Therapeutics (SRPT) Up 12.7% Since Last Earnings Report: Can It Continue?,122367946,https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9,VRTX,Yahoo,Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://finnhub.io/api/news?id=579c6e29289b1a4ed402b7fba1e1b4868a227ad61b165806ad22b2d10c4c187c
company,2023-09-01 08:19:00,Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. ,122389564,https://images.barrons.com/im-02511824/social,VRTX,MarketWatch,"Companies like Danaher and Repligen that make the lab equipment and consumables needed to manufacture drugs can produce long-term, stable earnings in a...",https://finnhub.io/api/news?id=a496bd333b4b2ac45304de34d2d3a770fdbbdc846dac6844bda09e39b6b4da5d
company,2023-09-01 06:33:00,"As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs",122373668,,VRTX,MarketWatch,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=327a1fe720bdda25ee08dc8f66c784a9f022d2556b5bde8061e441b5cff96468
company,2023-08-31 12:43:00,Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day,122411835,https://images.mktw.net/im-220105/social,VRTX,MarketWatch,"Shares of Vertex Pharmaceuticals Inc. slid 0.69% to $348.34 Thursday, on what proved to be an all-around grim trading session for the stock market, with the...",https://finnhub.io/api/news?id=03a64e351132662b141fdae30e959bcc26e0ef65a470c378ca11858574b9183a
company,2023-08-31 05:43:19,Vertex Pharmaceuticals: Critical Period For The Pipeline Is Approaching,122342000,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1458140515/image_1458140515.jpg?io=getty-c-w1536,VRTX,SeekingAlpha,Vertex Pharmaceuticals engages in developing and commercializing therapies for treating cystic fibrosis. Find out why I'm currently neutral on VRTX stock.,https://finnhub.io/api/news?id=19be9e14990f09b112aa449e542e1158a5489713ab073af61c10ccac7c80ff94
company,2023-08-31 05:42:17,The 3 Most Promising Biotech Stocks to Own Now,122432344,https://media.zenfs.com/en/investorplace_417/a223aac5680c9c1f2246ecb3a55e9d5e,VRTX,Yahoo,"Despite polls showing most Americans are unhappy with the state of the economy, President Biden has defended his policies with claims he is improving the finances and living standards of minority voters. This commitment to economic inclusivity bodes well for overall economic health and long-term growth. As policies prioritize equitable access to resources such as healthcare, the increased consumer base can stimulate demand across industries. In particular, biotech stands to benefit as advancemen",https://finnhub.io/api/news?id=9b941a149cfd9741598900241f87c9677f6933127f1003084432cd005af5b071
